UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-K

ANNUAL REPORT

PURSUANT TO SECTIONS 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

(MARK ONE)

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31 2022

, 2023

OR

TRANSITION REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 001-06462

TERADYNE, INC.

(Exact Name of Registrant as Specified in Its Charter)

MASSACHUSETTS

04-2272148

MASSACHUSETTS

04-2272148
(State or Other Jurisdiction of

Incorporation or Organization)

(I.R.S. Employer

Identification Number)

600 RIVERPARK DRIVE

NORTH READING, MASSACHUSETTS

01864

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s telephone number, including area code: (978) (978) 370-2700

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value
$0.125 per share

TER

Nasdaq Stock Market LLC

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b).

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act (check one):

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes No

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

The aggregate market value of the voting stock held by non-affiliates of the registrant as of July 1, 2022,2, 2023, was approximately $10.0$11.0 billion based upon the closing price of the registrant’s Common Stock on the Nasdaq Stock Market on that date.

The number of shares outstanding of the registrant’s only class of Common Stock as of February 17, 2023,16, 2024, was 156,047,868

153,080,607shares.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant’s proxy statement in connection with its 20232024 annual meeting of shareholders are incorporated by reference into Part III of this Form 10-K.


Table of Contents


TERADYNE, INC.

INDEX

Page No.

PART I.

Item 1.

Business

Business

2

Item 1A.

Risk Factors

13

10

Item 1B.

Unresolved Staff Comments

27

21

Item 2.1C.

Cybersecurity

Properties27

21

Item 3.2.

Properties

Legal Proceedings27

23

Item 3.

Legal Proceedings

23

Item 4.

Mine Safety Disclosure

27

23

PART II.

Item 5.

Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities

28

24

Item 6.

(Reserved)

(Reserved)28

24

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operation

28

25

Item 7A.

Quantitative and Qualitative Disclosures about Market Risk

43

36

Item 8.

Financial Statements and Supplementary Data

45

38

Item 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

102

87

Item 9A.

Controls and Procedures

102

87

Item 9B.

Other Information

102

87

Item 9C.

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

102

87

PART III.

Item 10.

Directors, Executive Officers and Corporate Governance

103

88

Item 11.

Executive Compensation

103

88

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

103

88

Item 13.

Certain Relationships and Related Transactions, and Director Independence

103

88

Item 14.

Principal Accountant Fees and Services

103

88

PART IV.

Item 15.

Exhibits and Financial Statement Schedule

104

89

Item 16.

Form 10-K Summary

105

90

Signatures

Signatures111

95



TERADYNE, INC.

FORM 10-K

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Annual Report on Form 10-K contains “forward-looking statements” within the meaningregarding Teradyne's future business prospects, financial performance or position and results of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Securities Exchange Act.operations. When used herein, the words “will,such as “anticipate,“would,“expect,” “plan,” “could,” “may,” “will,” “believe,” “anticipate,” “plan,” “expect,” “estimate,” “project,“goal,“intend,” “may,” “see,” “target” andor other words andcomparable terms of similar meaning are intended to identify forward-looking statements although not all forward-looking statements contain these identifying words. Forward-looking statements involve risks and uncertainties, including, but not limited to, those discussed in the section entitled “Risk Factors” of this annual reportAnnual Report on Form 10-K and elsewhere, and in our other reports we filefilings with the Securities and Exchange Commission (“SEC”). Readers are cautioned not to place undue reliance on these forward-looking statements which reflect management’s analysis only as of the date hereof and are subject to risks and uncertainties that could cause actual results to differ materially from those stated or implied. Teradyne assumes no obligation to update these forward-looking statements for any reason, except as may be required by law.

1



PART I

Item 1: Business

Item 1:

Business

Teradyne, Inc. (“Teradyne”) was founded in 1960 and is a leading global supplier of automated test equipment and robotics solutions.

We design, develop, manufacture and sell automaticautomated test systems and robotics products. Our automaticautomated test systems are used to test semiconductors, wireless products, data storage and complex electronics systems in many industries including consumer electronics, wireless, automotive, industrial, computing, communications, and aerospace and defense industries. Our robotics products include collaborative robotic arms and autonomous mobile robots (“AMRs”) used by global manufacturing, logistics and industrial customers to improve quality, increase manufacturing and material handling efficiency and decrease manufacturing and logistics costs. Our automaticautomated test equipment and robotics products and services include:

semiconductor test (“Semiconductor Test”) systems;

storage and system level test (“Storage Test”) systems, defense/aerospace (“Defense/Aerospace”) test instrumentation and systems, and circuit-board test and inspection (“Production Board Test”) systems (collectively these products represent “System Test”);

wireless test (“Wireless Test”) systems; and

robotics (“Robotics”) products.

The market for our test products is concentrated with a limited number of significant customers accounting for a substantial portion of the purchases of test equipment. A few customers drive significant demand for our products both through direct sales and sales to the customer’s supply partners. We expect that sales of our test products will continue to be concentrated with a limited number of significant customers for the foreseeable future.

In 2022,2023, the demand in the mobility and compute segments of our Semiconductor Test business was lower duecontinued to end market slowdownbe impacted by a correction cycle driven by excess semiconductor inventory, primarily in these segments as well as a slower technology transition in onethe mobility segment of our largest end-markets. While the market. The depth of thethis slowdown and the timing of the recovery are uncertain, however, strong automotive and image sensor demand partially offset these declines. The growth of DDR5 and High Bandwidth Memory ("HBM") devices for data center applications continued to drive demand for our products in the memory market in 2023. Over the midterm, we expect the ramp of 3 nanometer process technology starting in 2023 followed byand gate-all-around process technology, increasing multichip packaging, additional device complexity and unit growth will drive additional demand for test over our four year forecast period.Semiconductor Test.

Our Robotics segment consists of Universal Robots A/S (“UR”), a leading supplier of collaborative robotic arms, and Mobile Industrial Robots A/S (“MiR”), a leading maker of autonomous mobile robots (“AMRs”)AMRs for industrial automation. In September 2022, we merged MiR and AutoGuide, LLC (“AutoGuide”), a maker of high payload AMRs, to become a single supplier of AMRs. The market for our Robotics segment products is dependent on the adoption of new automation technologies by large manufacturers as well as small and medium enterprises (“SMEs”) throughout the world. We expect Robotics sales channel expansion combined withDemand in the fourth quarter of 2023 increased, tied to introduction of new products and seasonally high demand in Robotics after market softness and the impact of our channel transformation resulted in a weaker than forecasted first half of 2023.

On November 7, 2023, Teradyne and Technoprobe S.p.A (“Technoprobe”), a leader in the design and production of probe cards, announced the establishment of a strategic partnership that will seek to driveaccelerate growth for both companies and enable higher performance semiconductor test interfaces for customers worldwide. As part of the partnership, Teradyne will make an investment of 481.0 million Euros in 2023.exchange for a 10% equity investment in Technoprobe and Technoprobe will acquire 100% of Teradyne’s Device Interface Solutions ("DIS") business in exchange for $85.0 million. The transaction is expected to close during the first half of 2024.

BothIn 2023, inflation had minimal effect on our results. While both our test and robotics businesses may continue to be influenced by supply constraints, which could impact our revenue and costs, in 2023. In 2022, inflation had minimal effectwe do not anticipate that supply chain constraints will have a material impact on our results. In 2022, we were unable to supply approximately $20 million of revenuefinancial results in our test businesses for which we had customer demand.2024.

Our financial statements are denominated in U.S. dollars. While the majority of our revenues are in U.S. dollars, approximately 70 percent of our Robotics revenue issales are denominated in foreign currencies. InThere was no material impact to our 2023 results due to changes in foreign exchange rates, however, in 2022, the strengthening of the U.S. dollar was a factor in lower than forecasted revenues in our Robotics segment. Continued strengtheningStrengthening of the U.S. dollar would adversely affect Robotics revenue growth in 2023.2024.

2



Our corporate strategy continues to focus on profitably gaining market share in our test businesses through the introduction of differentiated products that target expanding segments and accelerating growth through continued investment in our Robotics businesses. We plan to continue investing in our growth while balancing capital allocations between returning capital to our shareholders through stock repurchases and dividends and using capital for acquisitions.

Investor Information

We are a Massachusetts corporation incorporated on September 23, 1960. We are subject to the informational requirements of the Securities Exchange Act of 1934 (“Exchange Act”). We file periodic reports, proxy statements and other information with the SEC. The SEC maintains an internet site (http://www.sec.gov) that contains reports, proxy and information statements and other information regarding issuers that file documents electronically.

You can access financial and other information, including the charters of our Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee, our Corporate Governance Guidelines and Code of Conduct, by clicking the Investors link on our web site at www.teradyne.com. We make available, free of charge, copies of our filings with the SEC, including our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act through our web site as soon as reasonably practicable after filing such material electronically or otherwise furnishing it to the SEC.

Products

Semiconductor Test

We design, manufacture, sell and support Semiconductor Test products and services on a worldwide basis. The test systems we provide are used both for wafer level and device package testing of semiconductor devices. These devices are used in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game applications, among others. Semiconductor devices span a broad range of functionality, from very simple low-cost devices such as appliance microcontrollers, operational amplifiers or voltage regulators to complex digital signal processors, Artificial Intelligence/Machine Learning (“AI/ML”) training, high performance computing and microprocessors as well as memory devices. Semiconductor Test products and services are sold to integrated device manufacturers (“IDMs”) that integrate the fabrication of silicon wafers into their business, “Fabless” companies that outsource the manufacturing of silicon wafers, “Foundries” that cater to the processing and manufacturing of silicon wafers, and semiconductor assembly and test providers (“OSATs”) that provide test and assembly services for the final packaged devices to both Fabless companies and IDMs. Fabless companies perform the design of integrated circuits without manufacturing capabilities and use Foundries for wafer manufacturing and OSATs for test and assembly. These customers obtain the overall benefit of comprehensively testing devices and reducing the total costs associated with testing by using our Semiconductor Test systems to:

improve and control product quality;

measure and improve product performance;

reduce time to market; and

increase production yields.

Our FLEX Test Platform architecture advances our core technologies to produce test equipment that is designed for high efficiency multi-site testing. Multi-site testing involves the simultaneous testing of many devices in parallel. Leading semiconductor manufacturers are using multi-site testing to significantly improve their “Cost of Test” economics. The FLEX Test Platform architecture addresses customer requirements through the following key capabilities:

A high efficiency multi-site architecture that reduces tester overhead such as instrument setup, synchronization and data movement, and signal processing;

3


The IG-XL™ software operating system which provides fast program development, including instant conversion from single to multi-site test; and

Broad technology coverage by instruments designed to cover the range of test parameters, coupled with a universal slot test head design that allows easy test system reconfiguration to address changing test needs.

FLEX Test Platform purchases are made by IDMs, OSATs, Foundries and Fabless customers. The FLEX Test Platform has become a widely used test solution at OSATs by providing versatile testers that can handle the widest range of devices, allowing OSATs to leverage their capital investments. The broad consumer, automotive and broadband markets have historically driven most of the device volume growth in the semiconductor industry. These markets include mobile phones and tablets, PCs, servers, networking

3


and automotive electronics. These end use markets continue to be drivers for the FLEX Test Platform family of products because they require a wide range of technologies and instrument coverage. In 2019, we introduced our next generation UltraFLEXPlus tester, the newest member of the UltraFLEX family, UltraFLEXPlus uses the new PACETM architecture to deliver superior economics and fast time to market for complex digital devices.

Our J750™ test system shares the IG-XL software environment with the family of FLEX Test Platform systems. The J750 is designed to handle high volume semiconductor devices, such as microcontrollers, that are central to the functionality of almost every consumer electronics product, from small appliances to automobiles. J750 test systems combine compact packaging, high throughput and ease of production test. We extended the J750 platform technology to create the IP750 Image Sensor™ test system. The IP750 is focused on testing image sensor devices used in smartphones, automobiles and other imaging products. We have continued to invest in the J750 platform with new instrument releases that bring new capabilities to existing market segments and expand the J750 platform to new devices that include high end microcontrollers and the latest generation of image sensors.

Our Magnum platform addresses the requirements of mass production test of memory devices for flash and DRAM memory. Flash and DRAM memory are widely used core building blocks in modern electronic products finding wide application in consumer, industrial, and computing equipment. Magnum 7, the newest member of the family introduced at the end of 2021, is a next generation memory test solution designed for parallel memory test in the flash, DRAM and multi-chip package markets. In 2019, we introduced a high-speed DRAM test version of our Magnum platform called Magnum EPIC giving us full product coverage of the memory test market.

Our ETS platform is used by semiconductor manufacturers and assembly and test subcontractors, primarily in the analog/mixed signal markets that cover more cost sensitive applications. Our proprietary SmartPin technology enables high efficiency multi-site testing, on an individual test system, permitting greater test throughput. Semiconductors tested by ETS platform systems are incorporated into a wide range of products in historically high-growth markets, including mobile devices, automotive electronics, computer peripherals, and notebook and desktop computers. The Eagle platform includes the ETS-88, a high performance multi-site production test system designed to test a wide variety of high volume power and precision devices, including Silicon Carbide (SiC) and Gallium Nitride (GaN) power devices used in vehicle electrification, and the ETS-800, a high performance multi-site production test system, is used to test high complexity power devices in automotive, industrial and consumer applications.

System Test

Our System Test segment is comprised of three business units: Storage Test, Defense/Aerospace, and Production Board Test.

4


Storage Test

The Storage Test business unit addresses the high throughput, automated manufacturing test requirements of hard disk drive (“HDD”) and semiconductor manufacturers. Our HDD products address the client and enterprise storage markets. The client market is driven by the needs of desktop, laptop, and external HDD storage products. The enterprise market is driven by the needs of data centers and cloud storage. Our system level test product for the semiconductor production market is used to test devices following wafer and package test. The business unit’s products lead in addressing customer requirements related to factory density, throughput and thermal performance.

Defense/Aerospace

We are a leading provider of high performance test systems, subsystems, instruments and service for the defense and aerospace markets. Our test products are used to ensure the readiness of military and commercial aerospace electronics systems. New programs, such as tactical aircraft and missile systems, as well as upgrade programs, continue to fuel the demand for high performance test systems in this market. Our test products are well-suited to the demands of defense/aerospace electronics manufacturers and repair depots worldwide. Our leadership in this market is underscored by our success with major Department of Defense programs across all U.S. military service branches and many allied defense services worldwide.

Production Board Test

Our test systems are used by electronics manufacturers and OEMs worldwide to perform In-Circuit-Test (“ICT”) and device programming of printed circuit board assemblies. Fast, accurate and cost-effective test capabilities are hallmark features of our Test Station product families. We offer the Test Station in off-line and automated in-line configurations. The automated in-line configurations address the growing requirements for automating production lines for high volume applications, such as automotive electronics, computing, and communications.

4


Wireless Test

Our Wireless Test segment is a business operatesunit run under the LitePoint brand name and providesproviding wireless test solutions utilized in the developmentfor silicon validation, wireless module manufacturing, and manufacturing of wireless devices and modules.end device manufacturing. The world’s leading makers of smartphones, tablets, notebooks, laptops, peripherals,access points, and Internet-of-Things (“IoT”) devices rely on LitePoint technologyequipment to ensure their products get into consumerconsumer’s hands with high quality and high efficiency.

LitePoint hardware and software wireless test solutions are used in test insertions thatsystems span design verification to high volume manufacturing and are deployed across the entire production eco-systemchain from the wireless chipset suppliers to the consumer brands. Wireless devices are often tested at multiple points along the manufacturing process that include insertions at component, system-in-package (“SiP”), module, PCB, SMT and finished product stages.

Design verification isinvolves comprehensive automated testing of small quantities of devices in an important stepR&D lab to ensure the device meets its design targets over a wide range of conditions and scenarios. High Volume manufacturing involves the calibration and testing of each wireless device to ensure the product will deliver the intended customer experience. This ensures all the products perform identically in the development processterms of their wireless characteristics.

LitePoint equipment serves an ever-expanding number of wireless standards in three segments: connectivity, cellular, and secure ranging. Connectivity encompasses numerous short range unlicensed communication standards. Cellular includes standards operating in licensed spectrum from a few GHz to 10s of GHz (mmWave). Finally, secure ranging uses Ultra Wideband (UWB) technology to provide centimeter level positioning with secure data transactions for evaluatingapplications such as “digital keys” and item location (tag type trackers).

LitePoint serves these wireless segments with multiple product families. The LitePoint IQxel-MX and IQxel-MW7G series provide leading edge measurement performance prior to starting production. As end market unit volumes have increased, the quantity of unitsfor both design validation and the amount of data that must be analyzed for a successful product launch continues to grow. LitePoint products provide easy to use, domain specific tools for rapid analysis of product performance. This helps to speed time to market.

In high volume manufacturing wireless test enables the calibration of each individual product’s wireless performanceconnectivity products. The LitePoint IQxstream-5G and IQgig-5G families combine support for 4G and 5G technologies across a wide range of frequencies to improve range, data throughput and battery life. Testing also verifies product specifications for product quality control. As markets become increasingly competitive, product performance and quality provide brand differentiation.

5


Wireless standards can be thought of in three categories: connectivity, cellular and location. Connectivity covers many standards such as Wi-Fi and Bluetooth. LitePoint’s IQxel products cover emerging Wi-Fi standards such as WiFi 6E and WiFi 7 which makes use of the newly allocated 6-7GHz spectrum. Connectivity also includes a variety of other standards such as Bluetooth Classic, Bluetooth 5.0 and Bluetooth low energy, Zigbee, Z-Wave, NFC, LoRa and others.

The IQxel product family’s high performance wireless and multi-device testing economics are aligned withserve all the needs of networking equipment, Internet gateways, IoTboth end user (smartphones) and network infrastructure (small cells and O-RAN) equipment. Finally, the IQgig-UWB+ provides comprehensive certification and manufacturing test support for UWB (802.15.14) products and embedded modules used in smartphones, tablets, and PCs. In 2021, LitePoint introduced the IQxel-MX testing solution for the testing of Wi-Fi devices. Another connectivity product, the IQnfc, addresses the use of NFC technology for payments with mobile devices.

Cellular standards include 2G, 3G, 4G and the new 5G mobile phone technologies. LitePoint’s IQxstream is a multi-device production test optimized solution for high speed testing of GSM, EDGE, CDMA2000, TD-SCDMA, WCDMA, HSPA+, LTE and 5G technologies. It is used for calibration and verification of smartphones, tablets, small cell radio units and embedded cellular modules. The IQcell, is a multi-device cellular signaling test solution which enables user experience testing of LTE and 5G cellular devices over-the-air. The IQgig family provides test solutions at the intermediate and millimeter wave frequencies for 5G, proximity radar and 802.11ad.

Location technologies have traditionally been satellite-based wireless signals such as GPS and GLONASS, which are tested on LitePoint’s connectivity and cellular equipment. A new technology called Ultra-WideBand is being adopted in IoT, automotive and mobile phones. Ultra-WideBand provides finer location capability and is tested on LitePoint’s IQgig-UWB equipment.

To complement the test systems, LitePoint offers turnkey test software for over 350 of the most popular wireless chipsets. These optimized solutions provide rapid development of high volume manufacturing solutions with a minimum of engineering effort by customers.secure ranging.

Robotics

Our Robotics segment is comprised of two business units: Universal Robots and Mobile Industrial Robots.

Universal Robots

Universal Robots is a leading supplierprovider of collaborative robots which(cobots) used across various industries, including automotive, food & beverage, metal & machining, electronics, pharmaceutical, and in education. Founded in 2005 and headquartered in Odense, Denmark, Universal Robots aims to create a world where people work with robots, not like robots. Its mission is simple: “Automation for anyone. Anywhere.”

Since introducing the world's first commercially viable cobot in 2008, Universal Robots has sold over 75,000 cobots worldwide and has developed a product portfolio reflecting a range of reaches and payloads, including the UR3e, UR5e, UR10e, UR16e, UR20 and UR30 robots. All models are low-cost, easy-to-deploy and simple-to-program robots that work side by side with production workersrobust, built to improve quality, increase manufacturing efficiency and decrease manufacturing costs. Collaborative robots are designed to mimic the motion of a human arm and can be fitted with task specific grippers or end effectors to supportwithstand a wide range of applications. Universal Robots offers a variety of collaborative robot models, including the UR3, UR5, UR10, UR16industrial environments, and UR20, each with different weight carrying capacity and arm reach. All models arecan be easily integrated into existing production environments. Universal Robots’ products are differentiated by their:

setups, providing a number of game-changing benefits:

easy

Straightforward programming using a graphical interface which allows– UR's intuitive software, PolyScope, enables users to program the collaborative robot ina cobot easily and have an application up and running within a few hours;

hours.

High return on investment – cobots require a lower initial investment than traditional robotics and have an average payback time of 12-18 months.
Versatile deployment – cobots' high degree of flexibility and ease of use in allowingallows customers to change the task and pace of the collaborative robot is performing as theircobot according to production demands dictate;demands.
Collaborative-capable safety functions – following a risk assessment, most cobots can seamlessly operate alongside employees, assisting with dull, dirty, and dangerous tasks.
Cutting-edge precision engineering – UR's global team of talented engineers creatively tackles customer challenges, ensuring our cobots are rigorously tested and built for demanding industrial tasks.

An extensive ecosystem has grown around the company's cobot technology creating innovation, choice for customers and a wide range of components, kits and solutions to suit every application. UR also provides an all-encompassing customer experience including UR Academy - an award-winning training program, available both online and in person in more than 120 training centers worldwide, and three tiers of service offerings carefully designed to accelerate customer success.

5


safe operations as collaborative robots can assist workers in side-by-side production environments requiring no special safety enclosures or shielding to protect workers; and

short payback period, on average 12-18 months.

6


In 2018, Universal Robots introduced its e-Series collaborative robots which include technology advances that enable faster developmenthas recently established global Centers of applications, greater precisionExcellence for Welding, Palletizing, and improved safety. Universal Robots offers four e-Series collaborative robot models UR3e, UR5e, UR10e,Machine Tending applications. These centers, led by subject matter experts, serve as knowledge hubs, offering expert recommendations and UR16e. In 2021, Universal Robots introducedguidance on the upgraded version of its UR10e with 25% more payload to address market demand. In 2022, Universal Robots introduced the first of its next generation industrial collaborative robots, the UR20. This model, which begins shipmentlatest trends in the first half of 2023, has a 1750 millimeter reachfield to UR partners and 20 kg payload capacity. UR20 handles more tasks, fits more applications and assists in more environments.key customers worldwide.

Mobile Industrial Robots

In September 2022, we merged MiR and AutoGuide to becomeis a single supplierleading provider of AMRs to accelerate the creation of the industry’s widest ranging autonomous mobile robot platformrobots (AMRs) for the manufacturing and logistics segments. The MiR isAMRs enhance productivity, offering a leading supplier ofhigh return on investment by streamlining workforce efficiency, reducing lead times, and improving workplace safety. These AMRs which are low-cost, easy-to-deploy and simple-to-program mobile robots that increase manufacturing and warehouse efficiency and decrease costs. Collaborative autonomous mobile robots are designed to move material from point to point via autonomous navigation rather thanoperate autonomously, eliminating the need for traditional mobile robot guidance infrastructure such as painted or magnetic strips and are designed to navigate safely around obstacles and people.infrastructure. MiR currently offers four collaborative autonomous mobile robot models, MiR100, three models—MiR250, MiR600, and MiR1350, MiR1350—each with differentvarying payload carrying capacity.capacities, all managed by our unified fleet management software, MiR 600Fleet. Launched in fall 2021, MiR600 and MiR1350 were launched in the fall 2021. are industrial-grade robots with IP52 rating, compliant with ISO 3691-4 safety standards, and TÜV certified.

All models can be easily integrated into existing production environments. MiR’s products are differentiated by their:

easy programming using a graphical interface which allows users to program the AMR in a few hours;

easeEase of use, speedUse and Speed of Deployment: Our robots are designed for quick deployment and flexibility, in allowing customers to change the task as their demands dictate;

adapt tasks based on changing demands.

Safe Operations: Equipped with 360 safety coverage, our robots navigate around static and dynamic obstacles, ensuring safety in busy environments.
Reliable Autonomous Navigation: The MiR robots demonstrate consistent, reliable autonomous navigation overacross large manufacturing and warehouse areas; and

areas.

short

Short Payback Period: With an average payback period on averageof 12–24 months.

months, MiR's products provide a swift return on investment.

MiR also supports high payload AMRs, an emerging and fast-growing segment of the global forklift market used for material transport of payloads up to 4,500 kg in manufacturing, warehouse and logistics applications. These products complement MiR’s lower payload products.

Sales and Distribution

In 2023, revenues from Texas Instruments Inc., a customer of our Semiconductor Test segment, accounted for 10% of our consolidated revenues. In 2021, and 2020, revenues from Taiwan Semiconductor Manufacturing Company Ltd., a customer of our Semiconductor Test segment, accounted for 12% and 15%, respectively, of our consolidated revenues. In each of the years, 2023, 2022 2021 and 2020,2021, our five largest direct customers in aggregate accounted for 26%32%, 33%26% and 36%33% of our consolidated revenues, respectively.

OSAT customers, such as Taiwan Semiconductor Manufacturing Company Ltd., often purchase our test systems based upon recommendations from OEMs, IDMs and Fabless companies. In all cases when an OSAT customer purchases a test system from us, we consider the OSAT as the customer since credit risk, title and risk of loss, among other things, are between Teradyne and the OSAT. We estimate consolidated revenues driven by Qualcomm, a customer of our Semiconductor Test, System Test, and Wireless Test segments, combining direct and indirect sales, accounted for approximately 11% of our consolidated revenues in 2022 and less than 10% in 2021 and 2020.2022. We estimate consolidated revenues driven by one OEM customer, of our Semiconductor Test and Wireless Test segments, combining direct sales to that customer with sales to the customer’s OSATs (which include Taiwan Semiconductor Manufacturing Company Ltd.), accounted for less than 10%approximately 19% of our consolidated revenues in 2022, and 19% and 25% of our consolidated revenues in 2021 and 2020, respectively.2021. The loss of, or significant decrease in demand from this OEM customer or any of our five largest direct customers, could have a material adverse effect on our business, results of operations and financial condition.

We have sales and service offices located throughout North America, Central America, Asia and Europe. We sell in these areas predominantly through a direct sales force, except for Robotics products, which are sold

7


principally through distributors. Our manufacturing activities for our test businesses are primarily conducted through subcontractors and outsourced contract manufacturers with significant operations in China and Malaysia. The manufacturing activities for our Robotics businesses are done primarily in our production facilities in Denmark and the U.S.

Sales to customers outside the United States were 85%84%, 89%85%, and 90%89%, respectively, of our consolidated revenues in 2023, 2022 2021 and 2020.2021. Sales are attributed to geographic areas based on the location of the customer site.

See also “Item 1A: Risk Factors” and Note T: “Operating Segment, Geographic and Significant Customer Information” in Notes to Consolidated Financial Statements.

6


Competition

Competition

We face significant competition throughout the world in each of our reportable segments. Competitors in the Semiconductor Test segment include, among others, Advantest Corporation and Cohu, Inc.

Competitors in the System Test segment include, among others, Keysight Technologies, Inc., Advantest Corporation, Test Research, Inc. and SPEA S.p.A. and Astronics Corporation.

Competitors in our Wireless Test segment include, among others, Rohde & Schwarz GmbH & Co. KG, Anritsu Company, Keysight Technologies, Inc., National Instruments Corporation, Welzek and iTest.

Competitors in our Robotics segment include manufacturers of traditional industrial robots such as KUKA Robotics Corporation, ABB, FANUC, Staubli and Yaskawa Electric Corporation, companies with emerging collaborative robot offerings such as Techman, Doosan, Jaka, and AUBO Robotics, and manufacturers of autonomous mobile robots in the material handling space such as Omron, Fetch, OTTO Motors, Vecna, SeegridRockwell Automation, Junion, HikRobot, Agilox, and Balyo.KION.

Some of our competitors may have greater financial and other resources to pursue engineering, manufacturing, marketing, and distribution of their products. We also face competition from emerging Asian companies and from internal suppliers at several of our customers. Some of our competitors have introduced or announced new products with certain performance characteristics which may be considered equal or superior to those we currently offer. We expect our competitors to continue to improve the performance of their current products and to introduce new products or new technologies that provide improved cost of ownership and performance characteristics. See also “Item 1A: Risk Factors.”

Backlog

At December 31, 20222023 and 2021,2022, our backlog of unfilled orders in our four reportable segments was as follows:

  2022   2021 

 

2023

 

 

2022

 

  (in millions) 

 

(in millions)

 

Semiconductor Test

  $879.6   $824.1 

 

$

822.8

 

 

$

879.6

 

System Test

   253.0    375.4 

 

 

223.8

 

 

 

253.0

 

Robotics

 

 

42.3

 

 

 

42.6

 

Wireless Test

   60.0    56.8 

 

 

35.7

 

 

 

60.0

 

Robotics

   42.6    28.1 
  

 

   

 

 

 

$

1,124.6

 

 

$

1,235.2

 

  $1,235.2   $1,284.4 
  

 

   

 

 

Customers may delay delivery of products or cancel orders suddenly and without advanced notice, subject to possible cancellation penalties. Due to possible customer changes in delivery schedules and cancellation of orders, our backlog at any particular date is not necessarily indicative of the actual sales for any succeeding

8


period. Delays in delivery schedules or cancellations of backlog during any particular period could have a material adverse effect on our business, financial condition or results of operations.

Raw Materials

Our products contain electronic and mechanical components that are provided by a wide range of suppliers. Some of these components are standard products, while others are manufactured to our specifications. We have experienced delays in obtaining timely delivery of certain components. These delays have impacted and may continue to impact the manufacturing of certain products and the timing of delivery of those products to our customers. While the majority of our components are available from multiple suppliers, certain items are obtained from sole sources. We may experience a temporary adverse impact if any of our sole source suppliers delay or cease to deliver products.

Intellectual Property and Licenses

The development of our products, both hardware and software, is based in significant part on proprietary information, our brands and technology. We protect our rights in proprietary information, brands and technology through various methods, such as:

patents;
copyrights;
trademarks;

patents;7


Table of Contents

copyrights;

trademarks;

trade secrets;

standards of business conduct and related business practices; and

technology license agreements, software license agreements, non-disclosure agreements, employment agreements, and other agreements.

However, these protections might not be effective in all circumstances. Competitors might independently develop similar technology or exploit our proprietary information and our brands in countries where we lack enforceable intellectual property rights or where enforcement of such rights through the legal system provides an insufficient deterrent. Also, intellectual property protections can lapse or be invalidated through appropriate legal processes. We do not believe that any single piece of intellectual property or proprietary rights is essential to our business.

Human Capital

We believe that our future success depends upon our continued ability to attract, develop, and retain a high-performance workforce, comprised of people with shared values. As of December 31, 2022,2023, we employed approximately 6,500 employees, of whom approximately 2,000 were employed in the United States and approximately 4,500 were employed outside of the United States. Our largest non-US employee populations are in the Philippines (17%(18%), Denmark (12%), China (11%(10%), Taiwan (6%(7%) and Costa Rica (6%). We also leverage contractors to provide flexibility for our business and manufacturing needs. As of December 31, 2022,2023, we worked with approximately 300 contractors globally. Since the inception of our business, we have experienced no work stoppages or other labor disturbances.

Corporate Culture

Our core values are conducting business with honesty and integrity, collaborating with our colleagues as a company without doors, and partnering with our customers every step of the way, because customers count on us.

9


We strive to foster a positive work environment that helps employees thrive. It is a priority for us to ensure that our people feel inspired, supported, safe and able to achieve their personal best. We are committed to equality through nondiscrimination, harassment prevention and pay equity policies. We value a diverse, inclusive and respectful work environment where all employees enjoy challenging assignments, development opportunities and a safe, positive culture.

We are committed to conducting business in a responsible manner, with strategic operational policies, procedures and values that support transparency, sustainability and legal compliance. We ensure ethical operations and business commitments through robust governance of the company’s code of conduct and global environmental, health and safety programs.

Competitive Pay and Benefits

The primary objective of our compensation program is to provide a compensation and benefits package that will continue to attract, retain, motivate and reward high performing employees who operate in a highly competitive and technologically challenging environment. We seek to achieve this objective by linking a significantmeaningful portion of compensation to company and business unit performance. We enable employees worldwide to share in the success of the company through various programs including a stock purchase program, equity compensation, profit sharing and bonus plans. We seek competitiveness and fairness in total compensation with reference to peer comparisons and internal equity.

In addition to providing our employees with competitive compensation packages, we offer benefits designed to meet the needs of employees and their families worldwide, including paid time off, parental leave, bereavement leave, health insurance coverage, flexible work arrangements, contributions to retirement savings, and access to employee assistance and work-life programs.

Employee Development and Training

We believe that employee development and training is a key factor in attracting, motivating, improving and retaining a strong, competitive global workforce. We provide continual development to our employees focused on developing their job skills and competencies. Examples include new manager competencies like giving feedback and coaching, and training in software development tools and project management. Our employees worldwide also receive annual performance reviews and are involved in setting goals for their own development and performance. Employees and managers look back on the previous year, review career development plans and create goals for the next year. In 2022, we implemented a new learning management system integrated with our human resource system. This enabled our business to more easily create and offer business training courses.

8


We are committed to recruiting and developing talent at the collegiate level to help advance Science, Technology, Engineering and Mathematics (“STEM”) education for the future generation. For example, our paid internships and entry-level positions offer real-world experience, and our co-op program offers higher education students a unique learning opportunity as students alternate one semester in a work assignment and one semester in the classroom. Additionally, we offer reimbursement for educational courses related to an employee’s work or as part of a degree program, including tuition, lab fees and books. We also offer a scholarship program for employees with college-age children, step-children and grandchildren. In 2022, almost2023, approximately half of the scholarship recipients were outside of the United States.

Employee Engagement

We conduct regular employee surveys to check in with our global workforce and obtain input on a number of topics. The feedback we receive from these surveys helps us assess employee sentiment, identify areas of improvement and guides our decision-making as it relates to people management. In addition, our CEO and other executives meet with employees wordwideworldwide on a frequent basis through exchange meetings and quarterly

10


webcasts. The exchange meetings allow the executives to directly interact with a small group of employees, while the global webcasts enable all employees to engage with senior leaders and ask questions in an open Q&A session.

We also offer employees worldwide an opportunity to network and connect with colleagues who share similar interests. This includes global groups such as New Employees to Teradyne, Woman’s Affinity Group, Veterans, Blue and Green (for team members that are committed to the environment), Runner’s affinity group and LGBTQ+ advocates.

Diversity and Inclusion

We believe in fostering a diverse workforce and equitable and inclusive culture in order to build a stronger and more resilient company for our customers, our investors, our employees and our communities worldwide. To support this effort, we have a Diversity and Inclusion Charter which was developed by our Diversity, Equity and Inclusion (“DEI”) executive sub-committee and designed to ensure that we build diversity across our workforce. In addition, inSince 2021, we hired our firsthave had a DEI program manager to steer our DEI efforts and launchedmaintain an internal DEI website for employees. We have established programs for recruiting and hiring candidates from various backgrounds and experiences. We have implemented policies regarding gender pay equity and have conductedregularly conduct audits of pay equity in the United States which have not identified any pay equity issues in the employee populations tested.States. We conduct mandatory DEI-related training for our employees worldwide and offer a wide variety of optional DEI-related training courses as well. We are an equal opportunity and affirmative action employer committed to making employment decisions without regard to race, religion, ethnicity or national origin, gender, sexual orientation, gender identity or expression, age, disability, protected veteran status or any other characteristics protected by law.

We have a tradition of amplifying the charitable actions of our employees and responding to the needs of the communities where we work. To support positive change in society, we have donated to organizations fighting for social justice and racial equality. We also sponsor the Massachusetts Conference for Women and the California Conference for Women offering opportunities for business networking, professional development and personal growth. To make it easier for employees to support charitable activities and magnify the impact of support, we established a formal matching gift program, “Teradyne Cares.Gives.” The program matches up to $1,000 per year of an employee’s donations to charities of their choosing, selected from a wide range of qualified non-profit organizations.

Additionally, advancing education for future generations is a primary initiative at Teradyne. We seek to increase the diversity of STEM graduates worldwide through our support of STEM programs at the middle, high school and collegiate level ranging from middle and high school robotics competitions to college scholarships, to underwriting university programs to increase the diversity of STEM graduates worldwide.level. We also donate test equipment and robots to colleges, universities, and vocational programs.

Health and Safety

The health and safety of our employees worldwide is our highest priority. We are committed to complying with all applicable regulatory health and safety requirements wherever we operate. We conduct internal audits, regular reviews and monitoring of regulations to ensure compliance with laws and regulations at the local, state, province and country levels. We ensure workers are provided with the knowledge to perform their jobs safely by deploying mandatory environmental, health and safety training. We also require contractors to complete safety training prior to working at any Teradyne site. We monitor, track and report common safety metrics such as accidents, near misses and illness. Our injury and illness rate is below the industry average. We also provide our employees with a flexible and adjustable workspace, which includes reviewing ergonomics issues in the workplace, educating employees to self-identify risks and ensuring they have the work environment they need to do their jobs safely and effectively.

11


Throughout the novel coronavirus (COVID-19) pandemic, we have focused on ensuring the health and safety of our employees and providing the resources to effectively work remotely and to work in a safe environment when on site. We have encouraged our workforce to become fully vaccinated. We have also supported our global workforce by sending regular all-employee communications, providing development opportunities for managers and employees to support effectively working virtually, establishing emergency response teams to empower local decision-making, conducting surveys to check in with employees, sharing regular video updates from our leadership team, and establishing a well-defined return to work process.

Regulatory Environment

We are subject to various federal, state, and local government laws and regulations relating to international trade, business conduct, the protection of employee health and safety and the environment.

9


We accrue for all known environmental liabilities when it becomes probable that we will incur cleanup costs and those costs can reasonably be estimated. Estimated environmental costs are not expected to materially affect the financial position or results of our operations in future periods. However, estimates of future costs are subject to change due to protracted cleanup periods and changing environmental remediation laws and regulations.

We are subject to U.S. laws and regulations that limit and restrict the export of some of our products and services and may restrict our transactions with certain customers, business partners and other persons. In certain circumstances, export control and economic sanctions regulations prohibit the export of certain products, services, and technologies, and in other circumstances we are required to obtain an export license before exporting the controlled item. For example, we must comply with current U.S. Department of Commerce export control regulations restricting transactions with certain customers in China. We must also comply with export restrictions and laws imposed by other countries affecting trade and investments. We maintain an export compliance program but there are risks that the compliance controls could be circumvented, exposing us to legal liabilities. Compliance with these laws has limited our sales and likely will continue to limit sales to certain customers in the future. Changes in, and responses to, U.S. trade policy could reduce the competitiveness of our products and cause our sales to drop, which could have a material adverse effect on our business, financial condition or results of operations.

Item 1A: Risk Factors

12


INFORMATION ABOUT OUR EXECUTIVE OFFICERS

Pursuant to General Instruction G (3) of Form 10-K, the following table is included in Part I of this Annual Report on Form 10-K in lieu of being included in the Proxy Statement for the Annual Meeting of Shareholders. The table sets forth the names of all of our executive officers and certain other information relating to their positions held with Teradyne and other business experience. Our executive officers do not have a specific term of office but rather serve at the discretion of the Board of Directors.

Executive Officer

Age

Position

Business Experience for The Past 5 Years

Gregory S. Smith

59Chief Executive Officer, President and President of RoboticsChief Executive Officer since February 2023; President of Teradyne since July 2022; President of Robotics since October 2020; President of Semiconductor Test from February 2016 to September 2020; Vice President, SOC Business Group and Marketing Manager for Semiconductor Test Group from January 2014 to February 2016; Business Unit Manager, Complex SOC Business Unit from 2009 to January 2014.

Sanjay Mehta

54Vice President, Chief Financial Officer and TreasurerVice President, Chief Financial Officer and Treasurer of Teradyne since April 2019; Senior Vice President and General Manager of Compute and XR Products at Qualcomm Technologies, Inc. (“Qualcomm”) from June 2018 to March 2019; President of Qualcomm’s semiconductor segment (“QCT”) China from March 2016 to June 2018; Senior Vice President Business Operations of QCT at Qualcomm from November 2015 to March 2016; Chief Financial Officer and Senior Vice President, Sales Operations, of QCT at Qualcomm from October 2010 to November 2015.

Charles J. Gray

61Vice President, General Counsel and SecretaryVice President, General Counsel and Secretary of Teradyne since April 2009.

Bradford B. Robbins

64President of Wireless TestPresident of Wireless Test since August 2014; Chief Operating Officer of LitePoint Corporation from 2012 to 2014; Vice President of Teradyne since 2001.

Richard J. Burns

60President of Semiconductor TestPresident of Semiconductor Test since October 2020; Vice President, Semiconductor Test Engineering from February 2016 to September 2020.

Item 1A:

Risk Factors

The risks described below are not the only risks that we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

13


Risks Associated with Teradyne’s Markets

Our business is impacted by global and industry-specific economic cycles, which are difficult to predict, and actions we have taken or may take to offset these cycles may not be sufficient.

Capital equipment providers in the electronics, semiconductor industries and robotics, such as Teradyne, have, in the past, been negatively impacted by both sudden slowdowns in the global economies and recurring cyclicality within those industries. These cycles have resulted in periods of over-supply; a trend we believe will continue to occur. Our business and results of operations depend, in significant part, upon capital expenditures of manufacturers of semiconductors electronics and other industrial products, which in turn depend upon the current and anticipated market demand for those products. Disruption or deterioration in economic conditions may reduce customer purchases of our products, thereby reducing our revenues and earnings. In addition, such adverse changes in economic conditions, and resulting slowdowns in the market for our products, may, among other things, result in increased price competition for our products, increased risk of excess and obsolete inventories, increased risk in the collectability of our accounts receivable from our customers, potential reserves for doubtful accountscredit losses and write-offs of accounts receivable, increased risk of restructuring charges, and higher operating costs as a percentage of revenues, which, in each case and together, adversely affect our operating results. We are unable to predict the likely duration, frequency and severity of disruptions in financial markets, credit availability, and adverse economic conditions throughout the world, and we cannot ensure that the level of revenues or new orders for a fiscal quarter will be sustained in subsequent quarters. We have taken actions to address the effects of general economic variability and recurring industry cyclicality, including implementing cost control and reduction measures. We cannot predict whether these measures will be sufficient to offset global or market-specific disruptions that might affect our businesses and we may need to take additional or different measures in the future.

We are subject to intense competition.

We face significant competition throughout the world in each of our reportable segments. Some of our competitors have substantial financial and other resources to pursue engineering, manufacturing, marketing and distribution of their products. In addition, we are subject to trade regulations imposed by the United States government, which may not impact some of our competitors. We also face competition from emerging Asian companies and internal development at several of our customers. Some of our competitors have introduced or announced new products with certain performance characteristics that may be considered equal or superior to those we currently offer. We expect our competitors to continue to improve the performance of their current products and to introduce new products or new technologies that provide improved cost of ownership and performance characteristics. New product introductions by competitors could cause a decline in revenues or loss of market acceptance of our products.

The market for our products is concentrated, and our business depends, in part, on obtaining orders from a few significant customers.

10


The market for our products is concentrated with a limited number of significant customers accounting for a substantial portion of the purchases of test equipment. In each of the years, 2023, 2022 2021 and 2020,2021, our five largest direct customers in aggregate accounted for 26%32%, 33%26% and 36%33% of consolidated revenues, respectively.

We estimate consolidated revenues driven by Qualcomm, a customer of our Semiconductor Test, System Test, and Wireless Test segments, combining direct and indirect sales to Qualcomm, accounted for approximately 11% of our consolidated revenues in 2022 and less than 10% in 2021 and 2020. We estimate consolidated revenues driven by one OEM customer, of our Semiconductor Test and Wireless Test segments, combining direct sales to that customer with sales to the customer’s OSATs (which include Taiwan Semiconductor Manufacturing Company Ltd.), accounted for less than 10%19% of our consolidated revenues in 2022,2021.

Customer consolidation could affect our operating results.

There has been a trend toward customer consolidation in the semiconductor industry through business combinations, including mergers, asset acquisitions and 19%strategic partnerships. If this trend continues, it could make us more dependent on fewer customers who may be able to exert increased pressure on our prices and 25%other contract terms and could increase the portion of our consolidated revenues in 2021total sales concentration for any single customer. Customer consolidation activity could also reduce the demand for our products and 2020, respectively.services if such customers streamline research and development or operations, reduce purchases or delay purchasing decisions. These outcomes could negatively impact our operating results and financial condition.

14


If we fail to develop new technologies to adapt to our customers’ needs andor if our customers fail to accept our new products, our revenues will be adversely affected.

We believe that our technological position depends primarily on the technical competence and creative ability of our engineers. In a rapidly evolving market, such as ours, the development or acquisition of new technologies, commercialization of those technologies into products and market acceptance and customer demand for those products are critical to our success. Successful product development or acquisition, introduction and acceptance depend upon a number of factors, including:

new product selection;

ability to meet customer requirements including with respect to safety and cyber security;

development of competitive products by competitors;

timely and efficient completion of product design;

timely and efficient implementation of manufacturing and manufacturing processes;

timely remediation of product performance issues, if any, identified during testing;

assembly processes and product performance at customer locations;

differentiation of our products from our competitors’competitors' products;

management of customer expectations concerning product capabilities and product life cycles;

transition of customers to new product platforms;

compliance with product safety regulations;

ability to protect products from cyber attacks when used by our customers;

ability to attract and retain technical talent; and

innovation that does not infringe on the intellectual property rights of third parties.

Risks Associated with Operating a Global Business

We are subject to risks of operating internationally.

A significant portion of our totalconsolidated revenues is derived from customers outside the United States. Our international sales and operations are subject to significant risks and difficulties, including:

unexpected changes in legal and regulatory requirements affecting international markets;

cost increases due to inflation

inflation;

changes in tariffs and exchange rates;

social, political and economic instability, acts of terrorism and international conflicts;

11


disruption caused by health pandemics, such as the coronavirus;

pandemics;

difficulties in protecting intellectual property;

difficulties in accounts receivable collection;

cultural differences in the conduct of business;

difficulties in staffing and managing international operations;

compliance with anti-corruption laws;

compliance with data privacy regulations;

15


compliance with customs and trade regulations; and

compliance with international tax laws and regulations.

In addition, an increasing portion of our products and the products we purchase from our suppliers are sourced or manufactured in foreign locations, including China, Malaysia and Denmark, and a large portion of the devices our products test are fabricated and tested by foundries and subcontractors in Taiwan, China, Korea and other parts of Asia. As a result, we are subject to a number of economic and other risks, particularly during times of political, health or financial instability in these regions. Disruption of manufacturing or supply sources in these international locations could materially adversely impact our ability to fill customer orders and potentially result in lost business.

We are subject to risks associated with doing business in China.

In addition to the risks associated with the tariffs and trade regulations detailed below, we are subject to the following risks associated with doing business in China:

adverse changes in Chinese political, economic or social conditions or Chinese laws, regulations or policies, including the imposition of unexpected or confiscatory taxation, restrictions on currency conversion, imports and sources of supply, devaluations of currency, the nationalization or other expropriation of private enterprises, or the reversal of economic reform policies that encourage private economic activity, foreign investments and greater economic decentralization;
differing economic practices compared to most developed countries, including with respect to the amount of government involvement, control of foreign exchange and allocation of resources;
uncertainties presented by the Chinese legal system, which is not fully integrated and continues to rapidly evolve, impeding our ability to interpret certain Chinese laws and regulations, predict and evaluate the outcome of administrative and court proceedings and the level of legal protection to enforce contracts we have entered into in China; and Chinese controls on the convertibility of Renminbi into foreign currencies and, in certain cases, the remittance of currency out of China, restricting our ability to remit sufficient foreign currency to pay dividends or make other payments to us, or otherwise satisfy foreign currency-denominated obligations.

The foregoing risks and the ongoing geopolitical tensions and economic uncertainty between the United States and China and the unknown impact of current and future Chinese rules and regulations, may cause increased costs, as well as restrictions on our ability to sell, or a decreased demand from customers to purchase, our products, which could harm our business, financial condition and operating results.

The Israel-Hamas conflict may have a material impact on our Business

The Israel-Hamas conflict could have a negative impact on our future revenue and supply chain, either of which could adversely affect our business and financial results. Our customers in Israel may experience delays in product releases due to impacts to their labor force and impacts on their suppliers because of the conflict, which could materially impact demand for our products. Similarly, our suppliers in Israel may experience delays in providing us with parts due to the conflict. In addition, the global economic uncertainty following the start of the conflict could impact demand for our products.

Risks Related to Teradyne’s Finances

We may not fully realize the benefits of our acquisitions or strategic alliances.

In June 2015, we acquired Universal Robots, in 2018, we acquired Energid and MiR and, in 2019, we acquired Lemsys and AutoGuide. In November 2023, we announced entering into strategic partnership agreement with Technoprobe which included

12


Teradyne acquiring 10% of the equity in Technoprobe. We may not be able to realize the benefits of acquiring or successfully growing these businesses. We may continue to acquire additional businesses, form strategic alliances, or create joint ventures with third parties that we believe will complement or augment our existing businesses. We may not be able to realize the expected synergies and cost savings from the integration with our existing operations of other businesses or technologies that we may acquire. In addition, the integration process for our acquisitions may be complex, costly and time consuming and include unanticipated issues, expenses, and liabilities. We may have difficulty in developing, manufacturing, and marketing the products of a newly acquired company in a manner that enhances the performance of our combined businesses or product lines and allows us to realize value from expected synergies. Following an acquisition, we may not achieve the revenue or net income levels that justify the acquisition. Acquisitions may also result in one-time charges (such as acquisition-related expenses, write-offs or restructuring charges) or in the future, impairment of goodwill or acquired intangible assets, or adjustments to contingent consideration liabilities that adversely affect our operating results. Additionally, we may fund acquisitions of new businesses, strategic alliances, or joint ventures by utilizing our cash, incurring debt, issuing shares of our common stock, or by other means. Additionally, we may face restrictions pursuant to the terms of an acquisition or strategic alliance agreement, such as the three year restriction on the transfer or disposition of the Technoprobe shares upon closing of the agreement, subject to certain early termination events.

We may incur higher tax rates than we expect and may have exposure to additional international tax liabilities and costs.

We are subject to paying income taxes in the United States and other countries where we operate. Our effective tax rate is dependent on where our earnings are generated and the tax regulations and the interpretation and judgment of administrative tax or revenue authorities in the United States and other countries. We have pursued a global tax strategy that could be adversely affected by the mix of earnings and tax rates in the countries where we operate, changes to tax laws, tax regulations or an adverse tax ruling by administrative authorities. We are also subject to tax audits in the countries where we operate. Any material change in our tax liability resulting from changes in tax laws, tax regulations, administrative rulings or audits from an administrative tax or revenue authority could negatively affect our financial results.

As a multinational corporation, we are subject to income taxes as well as non-income-based taxes, in both the United States and various foreign jurisdictions. In certain foreign jurisdictions, we qualify for tax incentives and tax holidays based on our ability to meet, on a continuing basis, various tests relating to our employment levels, research and development expenditures and other qualification requirements in a particular foreign jurisdiction. While we intend to operate in such a manner to maintain and maximize our tax incentives and tax holidays, no assurance can be given that we have so qualified or that we will so qualify for any particular year or jurisdiction. If we fail to qualify or fail to remain qualified for certain foreign tax incentives and tax holidays, we may be subject to further taxation or an increase in our effective tax rate which would adversely impact our financial results. In November 2020, we entered into an agreement with the Singapore Economic Development

16


Board which extended our Singapore tax holiday under substantially similar terms to the agreement which expired on December 31, 2020. The new tax holiday is scheduled to expire on December 31, 2025.

The tax savings attributable to the Singapore tax holiday for the years ended December 31, 2023, 2022 and 2021 and 2020 were $1.4 million or $0.01 per diluted share, $16.0 million or $0.09 per diluted share, and $33.3 million or $0.18 per diluted share, and $29.9 million or $0.16 per diluted share, respectively. These tax savings may not be achievable in subsequent years due to changes in Singapore’s tax laws, issuance of new global minimum tax laws, or the expiration of the tax holiday.

In addition, we may incur additional costs, including headcount expenses, in order to maintain or obtain a foreign tax incentive or tax holiday in a particular foreign jurisdiction.

We have significant guarantees, indemnification, and customer confidentiality obligations.

From time to time, we make guarantees to customers regarding the delivery, price and performance of our products and guarantee certain indebtedness, performance obligations or lease commitments of our subsidiary and affiliate companies. We also have agreed to provide indemnification to our officers, directors, employees and agents, to the extent permitted by law, arising from certain events or occurrences, while the officer, director, employee or agent, is or was serving at our request in such capacity. Additionally, we have confidentiality obligations to certain customers and if breached would require the payment of significant penalties. If we become liable under any of these obligations, it could materially and adversely affect our business, financial condition or operating results. For additional information see Note M: “Commitments and Contingencies—GuaranteesContingencies-Guarantees and Indemnification Obligations” in Notes to Consolidated Financial Statements.

We may discontinue or reduce our quarterly cash dividend or share repurchase program.

13


In January 2014, our Board of Directors initiated a quarterly cash dividend. Since 2014, the Board of Directors has increased our quarterly cash dividend from $0.06 per share to $0.11$0.12 per share. Holders of our common stock are only entitled to receive dividends when and if they are declared by our Board of Directors.

In January 2021, our Board of Directors approved a $2.0 billion share repurchase program. In 2022 and 2021, we repurchased $752.1 million, and $600.0 million, respectively of common stock. In January 2023, our Board of Directors cancelled the 2021 repurchase program and approved a new $2.0 billion share repurchase program. In 2023, we repurchased $400.5million of common stock. We intend to repurchase up to $90.0 million in 2024. Under the share repurchase program, we may repurchase outstanding shares of our common stock from time to time in the open market and through privately negotiated transactions. Unless terminated earlier by resolution of our Board of Directors, the repurchase program will expire when we have repurchased all shares authorized for repurchase under the share repurchase program.

Future cash dividends and share repurchases are subject to the discretion of our Board of Directors and will depend, among other things, upon our earnings, capital requirements and financial condition. While we have declared a quarterly cash dividend on our common stock and authorized a share repurchase program, we are not required to do either and may reduce or eliminate our cash dividend or share repurchase program in the future. The reduction or elimination of our cash dividend or our share repurchase program could adversely affect the market price of our common stock.

We have incurred indebtedness and may incur additional indebtedness.

On December 12, 2016, we completed a private offering of $460.0 million aggregate principal amount of 1.25% convertible senior unsecured notes (the “Notes”) due December 15, 2023 and received net proceeds, after issuance costs, of approximately $450.8 million, $33.0 million of which was used to pay the net cost, after being partially offset by proceeds from the sale of the warrants, of the convertible note hedge transactions and $50.1 million of which was used to repurchase 2.0 million shares of our common stock. Holders of the Notes may require us to repurchase the Notes upon the occurrence of certain fundamental changes involving us or the holders may elect to convert into shares of our common stock. As of February 22, 2023, one hundred and twenty four holders had converted $424.9 million worth of notes.

17


On May 1, 2020, we entered into a three-year, senior secured revolving credit facility of up to $400.0 million. On December 10, 2021, the credit agreement was amended to extend the maturity date of the credit facility to December 10, 2026. On October 5, 2022, the credit agreement was amended to increase the amount of the credit facility to $750.0 million from $400.0 million. The amended credit agreement provides that, subject to customary conditions, we may seek to obtain from existing or new lenders the available incremental amount under the credit facility, not to exceed the greater of $200.0 million or 15% of consolidated EBIDTA. We could borrow funds under this credit facility at any time for general corporate purposes and working capital. As of February 22, 2023,2024, we have not borrowed any funds under this credit facility.

The issuance of the NotesOur outstanding and any additional indebtedness, among other things, could:

make it difficult to make payments on this indebtedness and our other obligations;

make it difficult to obtain any necessary future financing for working capital, capital expenditures, debt service requirements or other purposes;

require the dedication of a substantial portion of any cash flows from operations to service for indebtedness, thereby reducing the amount of cash flows available for other purposes, including capital expenditures;expenditures, and

limit our flexibility in planning for or reacting to changes in our business and the industries in which we compete.

complete.

Restrictive covenants in the agreement governing our senior secured revolving credit facility may restrict our ability to pursue business strategies.

The agreement governing our senior secured revolving credit facility limits our ability, among other things, to incur additional secured indebtedness; sell, transfer, license or dispose of assets; consolidate or merge; enter into transactions with our affiliates; and incur liens. In addition, our senior secured revolving credit facility contains financial and other restrictive covenants that limit our ability to engage in activities that may be in our long-term best interest, such as, subject to permitted exceptions, making capital expenditures in excess of certain thresholds, making investments, loans and other advances, and prepaying any additional indebtedness while our indebtedness under our senior secured revolving credit facility is outstanding. Our failure to comply with financial and other restrictive covenants could result in an event of default, which if not cured or waived, could result in the lenders requiring immediate payment of all outstanding borrowings or foreclosing on collateral pledged to them to secure the indebtedness.[3]

Our convertible note hedge and warrant transactions could impact the value of our stock.

On December 12, 2016, we completed a private offering of $460.0 million aggregate principal amount of 1.25% convertible senior unsecured notes (the “Notes”) that matured on December 15, 2023. Concurrent with the offering of the Notes, we entered into convertible note hedge transactions (the “Note Hedge Transactions”) with the initial purchasers or their affiliates (the “Option Counterparties”). The Note Hedge Transactions cover, subject to customary anti-dilution adjustments, the number of shares of our common stock that underlie the Notes, with a strike price equal to the conversion price of the Notes of $31.46. The Note Hedge Transactions cover, subject to customary anti-dilution adjustments, approximately 1.6 million shares of our common stock. On November 4, 2021, we made an irrevocable election under the indenture to require the principal portion of the remaining Notes to be settled in cash.

Separately and concurrent with the pricing of the Notes, we entered into warrant transactions with the Option Counterparties (the “Warrant Transactions”) in which we sold net-share-settled (or, at our election subject to certain conditions, cash-settled) warrants to the Option Counterparties. The Warrant Transactions, which expire between March 18, 2024 and July 10, 2024, cover, subject to customary

14


anti-dilution adjustments, approximately 14.614.7 million shares of our common stock. The strike price of the warrants is $39.48$39.40 per share. The Warrant Transactions could have a dilutive effect to ourresult in increased common stock outstanding to the extent that the market price per share of our common stock, as measured under the terms of the Warrant Transactions, exceeds the applicable strike price of the warrants.

18


The Note Hedge Transactions are expected to reduce the potential dilution to our common stock upon any conversion of the Notes. However, the Warrant Transactions could separately have a dilutive effect to the extent that the market value per share of our common stock exceeds the applicable strike price of the warrants. The net cost of the Note Hedge Transactions, after being partially offset by the proceeds from the sale of the warrants, was approximately $33.0 million.

In connection with establishing their initial hedge of these convertible note hedge and warrant transactions, the Option Counterparties have entered into various derivative transactions with respect to our common stock and/or purchase shares of our common stock or other securities, including the Notes, concurrent with, or shortly after, the pricing of the Notes. In addition, the Option Counterparties may modify their hedge positions by entering into or unwinding various derivative transactions with respect to our common stock or by selling our common stock or other securities, including the Notes, in secondary market transactions (and may do so during any observation period related to the conversion of the Notes). These activities could adversely impact the value of our common stock and the Notes.

We may not be able to pay our debt and other obligations.

If our cash flows are inadequate to meet our obligations, we could face substantial liquidity problems. If we are unable to generate sufficient cash flows or otherwise obtain funds necessary to make required payments on the Notesour senior secured revolving credit facility or certain of our other obligations, we would be in default under the terms thereof, which would permit the holders of those obligations to accelerate their maturity and also could cause defaults under future indebtedness we may incur. Any such default could have a material adverse effect on our business, prospects, financial position and operating results. In addition, we cannot be certain that we would be able to repay amounts due on the Notes if those obligations were to be accelerated following the occurrence of any other event of default as defined in the instruments creating those obligations, or if the holders of the Notes require us to repurchase the Notes upon the occurrence of a fundamental change involving us. Moreover, we cannot be certain that we will have sufficient funds or will be able to arrange for financing to pay the principal amount due on the Notes at maturity.

Foreign currency exchange rates and fluctuations in those rates may affect the Company’s ability to realize projected growth rates in its sales and earnings.

Our financial statements are denominated in U.S. dollars. While the majority of our revenues are in U.S. dollars, approximately 70 percent70% of our Robotics revenue isin 2023 was denominated in foreign currencies. Correspondingly, our results of operations and our ability to realize projected growth rates in sales and earnings in Robotics could be adversely affected if the U.S. dollar strengthens significantly against foreign currencies.

Adverse developments affecting the financial services industry, including events or risks involving liquidity, defaults or non-performance by financial institutions, could have a material adverse effect on our business, financial condition or results of operations.

On March 10, 2023, Silicon Valley Bank (SVB), who is a lender in our revolving credit facility and where we maintain certain accounts and cash deposits, was placed into receivership with the Federal Deposit Insurance Corporation (FDIC), which resulted in all funds held at SVB being temporarily inaccessible by SVB’s customers. As of March 13, 2023, access to our cash and cash equivalents at SVB was fully restored. Although our cash balances at SVB are insignificant and we do not expect further developments at SVB to have a material impact on our cash and cash equivalents, we do hold cash balances in several large financial institutions significantly in excess of FDIC and global insurance limits. If other banks and financial institutions with whom we have banking relationships enter receivership or become insolvent in the future, we may be unable to access, and we may lose, some or all of our existing cash, cash equivalents and investments to the extent those funds are not insured or otherwise protected by the FDIC.

Our stock price has been subject to fluctuations, and will likely continue to be subject to fluctuations, which may be volatile and due to factors beyond our control.

The market price of our common stock is subject to wide fluctuations in response to various factors, some of which are beyond our control. In addition to the factors discussed in this "Risk Factors" section and elsewhere in this report, factors that could cause fluctuations in the market price of our common stock include the following:

ratings changes by any securities analysts who follow our company;
announcements by us or our competitors of significant technical innovations, acquisitions, strategic partnerships, joint ventures, or capital commitments;
changes in operating performance and stock market valuations of other technology companies generally, or those in our industry in particular;
changes in accounting standards, policies, guidelines, interpretations, or principles;
actual or anticipated developments in our business or our competitors’ businesses or the competitive landscape generally;
developments or disputes concerning our intellectual property or our products and platform capabilities, or third-party proprietary rights;
cybersecurity attacks or incidents;
announced or completed acquisitions of businesses or technologies by us or our competitors;
changes in our board of directors or management;
announced or completed equity or debt transactions involving our securities;

15


sales of shares of our common stock by us, our officers, directors, or other stockholders; and
other events or factors, including those resulting from global and macroeconomic conditions, including heightened inflation, rising interest rates, bank failures, and a potential recession, and speculation regarding the same, as well as public health crises, geopolitical tension, incidents of terrorism, or responses to these events.

In addition, the market for technology stocks and the stock markets in general have experienced extreme price and volume fluctuations. Stock prices of many technology companies have fluctuated in a manner unrelated or disproportionate to the operating performance of those companies. In the past, stockholders have instituted securities class action litigation following periods of market volatility. If we were to become involved in securities litigation, it could subject us to substantial costs, divert resources and the attention of management from our business, and adversely affect our business, results of operations, financial condition, and cash flows. A decline in the value of our common stock, including as a result of one or more factors set forth above, may result in substantial losses for our stockholders.

Risks Related to Operations

Our operating results are likely to fluctuate significantly.

Our operating results are affected by a wide variety of factors that could materially adversely affect revenues or profitability. The following factors could impact future operations:

a worldwide economic slowdown or disruption in the global financial or industrial markets;

cost increases from inflation on materials, employee wages, third party labor, and contract manufacturing;

competitive pressures on selling prices;

our ability to introduce, and the market acceptance of, new products;

changes in product revenues mix resulting from changes in customer demand;

19


the level of orders received which can be shipped in a quarter because of the tendency of customers to wait until late in a quarter to commit to purchase due to capital expenditure approvals and constraints occurring at the end of a quarter, or the hope of obtaining more favorable pricing from a competitor seeking the business;

engineering and development investments relating to new product introductions, and the expansion of manufacturing, outsourcing and engineering operations in Asia;

provisions for excess and obsolete inventory relating to the lack of demand for and the discontinuance of products;

impairment charges for certain long-lived and intangible assets, and goodwill;

an increase in the leasing of our products to customers;

disruption caused by health pandemics, such as the coronavirus;

the success of sales channel expansion in Robotics;

our ability to expand our global distribution channel for our collaborative and mobile robots;

parallel or multi-site testing which could lead to a decrease in the ultimate size of the market for our semiconductor and electronic test products; and

the ability of our suppliers and subcontractors to meet product quality or delivery requirements needed to satisfy customer orders for our products, especially if consolidated revenues increase.

As a result of the foregoing and other factors, we have experienced and may continue to experience material fluctuations in future operating results on a quarterly or annual basis which could materially and adversely affect our business, financial condition, operating results or stock price.

If our suppliers do not meet product or delivery requirements, we could have reduced revenues and earnings.

If any of our suppliers were to cancel contracts or commitments or fail to meet the quality or delivery requirements needed to satisfy customer orders for our products, we could lose time-sensitive customer orders, have significantly decreased revenues and earnings and be subject to contractual penalties, which would have a material adverse effect on our business, results of operations and financial condition. In addition, we rely on contract manufacturers for certain of our products, and our ability to meet customer orders

16


for those products depends upon the timeliness and quality of the work performed by these subcontractors, over whom we do not exercise any control.

To a certain extent, we are dependent upon the ability of our suppliers and contract manufacturers to help meet increased product or delivery requirements. It may be difficult for certain suppliers to meet delivery requirements in a period of rapid growth, therefore impacting our ability to meet our customers’ demands.

Our suppliers are subject to trade regulations, including tariffs and export restrictions imposed by the United States Government and by the governments of other countries. These regulations could impact our suppliers’ ability to provide us with components for our products or could increase the price of those components.

We rely on the financial strength of our suppliers. There can be no assurance that theThe loss of suppliers either as a result of financial viability, bankruptcy or otherwise will not have a material adverse effect on our business, results of operations or financial condition.

Our operations may be adversely impacted if our outsourced contract manufacturers or service providers fail to perform.

We depend on Flex Ltd. (“Flex”) to manufacture and test our FLEX and J750 family of products from its facilities in China and, starting in 2022, also Malaysia; Plexus Corp. (“Plexus”) to manufacture and test our

20


Magnum products from its facilities in Malaysia and, starting in 2023, also Thailand and ETS family of products from its facility in Malaysia; SAM Meerkat to manufacture and test our storage test family of products from its facilities in Malaysia and Thailand and on other contract manufacturers to manufacture other products. If for any reason these contract manufacturers cannot provide us with these products in a timely fashion, or at all, we may not be able to sell these products to our customers until we enter a similar arrangement with an alternative contract manufacturer. The Flex facility located in China may be impacted by the ongoing trade dispute between the United States and China, by regulations implemented by the United States or China, or disruption caused by health pandemics, such as the coronavirus.

If we experience a problem with our supply of products from Flex, Plexus, SAM Meerkat, or our other contract manufacturers, it may take us significant time to either manufacture the product or find an alternate contract manufacturer, which could result in substantial expense and disruption to our business.

We have also outsourced certain general and administrative functions to reputable service providers, many of which are in foreign countries, sometimes impacting communication with them because of language and time differences. Their presence in foreign countries also increases the risk they could be exposed to political risk. Additionally, there may be difficulties encountered in coordinating the outsourced operations with existing functions and operations. If we fail in successfully coordinating and managing the outsourced service providers, it may cause an adverse effect on our operations which could have a material adverse effect on our business, results of operations or financial condition.

Our business may suffer if we are unable to attract and retain key employees.

Competition for employees with skills we require is intense in the high technology industry. We expect intense competition for employees to continue in 2023. Our success will depend on our ability to attract and retain key technical employees. The loss of one or more key or other employees, a decrease in our ability to attract additional qualified employees, or the delay in hiring key personnel could each have a material adverse effect on our business, results of operations or financial condition.

Our operations, and the operations of our customers and suppliers, are subject to risks of natural catastrophic events, severe weather, widespread health epidemics, acts of war, terrorist attacks and the threat of domestic and international terrorist attacks, any one of which could result in cancellation of orders, delays in deliveries or other business activities, or loss of customers and could negatively affect our business and results of operations.

Our business is international in nature, with our sales, service and administrative personnel and our customers and suppliers located in numerous countries throughout the world. Our operations, and those of our customers and suppliers, are subject to disruption for a variety of reasons, including work stoppages, acts of war, terrorism, health epidemics, fires, earthquakes, hurricanes, typhoons, volcanic eruptions, energy shortages, telecommunication failures, tsunamis, flooding or other natural disasters. Such disruption could materially increase our costs and expenses as well as cause delays in, among other things, shipments of products to our customers, our ability to perform services requested by our customers, or the installation and acceptance of our products at customer sites. Any of these conditions could have a material adverse effect on our business, financial condition or results of operations.

Global climate change can result in natural disasters occurring more frequently, with greater intensity and with less predictability. For example, in December 2021, our operations in Cebu, Philippines experienced a devastating typhoon. Our employees in Cebu succeeded in restoring most of our operations within days despite the severity of the damage in the region. We have offered support services to many of our employees impacted by the typhoon and have incurred additional costs to maintain our operations following the disaster. The long-term effects of climate change on the global economy and the semiconductor industry in particular are unclear but could be severe.

21


The global supply shortage of electrical components and inflationary cost increases has impacted our ability to meet customer demand and could adversely affect our business and financial results.

The global supply shortage of electrical components, including semiconductor chips, continued to impact our supply chain in 2022.2023. As a result, we have experienced, and expect to continue tomay experience in the future, increases in our lead times and costs for certain components for certain products and delays in the delivery of some orders placed by our customers. In addition, in 2022,2023, inflationary pressures contributed to increased costs for product components and wage inflation, which had minimal impact on our cost of products, gross margin and profit for the year. Our supply chain team, and our suppliers, continue to manage numerous supply, production and logistics obstacles. In an effort to mitigate these risks, in some cases, we have incurred higher costs due to investment in supply chain resiliency and to secure available inventory or have extended or placed non-cancellable purchase commitments with semiconductor suppliers, which introduces inventory risk if our forecasts and assumptions prove inaccurate. We have also sourced components from additional suppliers and multi-sourced and pre-ordered components and finished goods inventory in some cases in an effort to reduce the impact of the adverse supply chain conditions we have experienced. However, if we are unable to secure manufacturing capacities from our current or new suppliers and contract manufacturers, on acceptable terms or at all, or successfully manage our purchase commitments and inventory for components, our ability to deliver our products to our customers in the desired quantities, at competitive prices or in a timely manner may be negatively impacted for 2023.2024. Also, our suppliers and contract manufacturers have increased their prices, which increased our cost of products. We have been and may continue to be, affected by wage inflation. We also have been, and may continue to attempt to, offset the effect of these inflationary pressures by increasing the prices of our products. However, we may not be fully able to pass additional costs on to our customers, which could have a negative impact on our results of operations and financial condition. In 2022,

Our operations may be adversely impacted if our outsourced contract manufacturers or service providers fail to perform.

We depend on Flex Ltd. (“Flex”) to manufacture and test our FLEX and J750 family of products from its facility in Malaysia; Plexus Corp. (“Plexus”) to manufacture and test our Magnum products from its facilities in Malaysia and also Thailand and ETS family of products from its facility in Malaysia; SAM Meerkat to manufacture and test our storage test family of products from its facilities in Malaysia and Thailand and on other contract manufacturers to manufacture other products. If for any reason these contract manufacturers cannot provide us with these products in a timely fashion, or at all, we weremay not be able to sell these products to our customers until we enter a similar arrangement with an alternative contract manufacturer.

If we experience a problem with our supply of products from Flex, Plexus, SAM Meerkat, or our other contract manufacturers, it may take us significant time to either manufacture the product or find an alternate contract manufacturer, which could result in substantial expense and disruption to our business.

We have also outsourced certain general and administrative functions to reputable service providers, many of which are in foreign countries, sometimes impacting communication with them because of language and time differences. Their presence in foreign countries also increases the risk they could be exposed to political and cybersecurity risk. Additionally, there may be difficulties encountered in coordinating the outsourced operations with existing functions and operations. If we fail in successfully coordinating and managing the outsourced service providers, it may cause an adverse effect on our operations which could have a material adverse effect on our business, results of operations or financial condition.

Our business may suffer if we are unable to supply approximately $20 millionattract and retain key employees.

Competition for employees with skills we require is intense in the high technology industry. We expect intense competition for employees to continue in 2024. Our success will depend on our ability to attract and retain key technical employees. The loss of revenueone or

17


more key or other employees, a decrease in our test businessesability to attract additional qualified employees, or the delay in hiring key personnel could each have a material adverse effect on our business, results of operations or financial condition.

Our operations, and the operations of our customers and suppliers, are subject to risks of natural catastrophic events, severe weather, widespread health epidemics, acts of war, terrorist attacks and the threat of domestic and international terrorist attacks, any one of which could result in cancellation of orders, delays in deliveries or other business activities, or loss of customers and could negatively affect our business and results of operations.

Our business is international in nature, with our sales, service and administrative personnel and our customers and suppliers located in numerous countries throughout the world. Our operations, and those of our customers and suppliers, are subject to disruption for which we hada variety of reasons, including work stoppages, acts of war, terrorism, health epidemics, fires, earthquakes, hurricanes, typhoons, volcanic eruptions, energy shortages, telecommunication failures, tsunamis, flooding or other natural disasters. Such disruption could materially increase our costs and expenses as well as cause delays in, among other things, shipments of products to our customers, our ability to perform services requested by our customers, or the installation and acceptance of our products at customer demand.sites. Any of these conditions could have a material adverse effect on our business, financial condition or results of operations.

Global climate change can result in natural disasters occurring more frequently, with greater intensity and with less predictability. For example, in December 2021, our operations in Cebu, Philippines experienced a devastating typhoon. Our employees in Cebu succeeded in restoring most of our operations within days despite the severity of the damage in the region. The long-term effects of climate change on the global economy and the semiconductor industry in particular are unclear but could be severe.

Risks Related to Intellectual Property (“IP”) and Cybersecurity

Third parties may claim we are infringing their intellectual property and we could suffer significant litigation costs, licensing expenses or be prevented from selling our products.

We have been sued for patent infringement and receive notifications from time to time that we may be in violation of patents held by others. An assertion of patent infringement against us, if successful, could have a material adverse effect on our ability to sell our products or it could force us to seek a license to the intellectual property rights of others or alter such products so that they no longer infringe the intellectual property rights of others. A license could be very expensive to obtain or may not be available at all. Similarly, changing our products or processes to avoid infringing the rights of others may be costly or impractical. Additionally, patent litigation could require a significant use of management resources and involve a lengthy and expensive defense, even if we eventually prevail. If we do not prevail, we might be forced to pay significant damages, obtain licenses, modify our products, or stop making our products; each of which could have a material adverse effect on our financial condition, operating results or cash flows.

If we are unable to protect our IP, we may lose a valuable asset or may incur costly litigation to protect our rights.

We protect the technology that is incorporated in our products in several ways, including through patent, copyright, trademark and trade secret protection and by contractual agreement. However, even with these protections, our IP may still be challenged, invalidated or subject to other infringement actions. While we believe that our IP has value in the aggregate, nowe do not believe that any single element of our IP is in itself essential. If a significant portion of our IP is invalidated or ineffective, our business could be materially adversely affected.

A breach of our operational or security systems could negatively affect our business and results of operations.

We rely on various information technology networks and systems to process, transmit and store electronic information, including proprietary and confidential data, and to carry out and support a variety of business

22


activities, including manufacturing, research and development, supply chain management, sales and accounting. We have experienced several attempted cyber-attacks of our network. None of the attempted attacks have caused a disruption to our operations or had a material adverse effect on our business or financial results. As a result of the attempts, we have taken further preventive security measures to protect our systems. Despite these preventative security measures we have implemented, we may continue to be vulnerable to attempts by third parties to gain unauthorized access to our networks or sabotage our systems. These attempts, which might be related to criminal hackers, industrial espionage or state-sponsored intrusions, include trying to covertly introduce malware to our computers, networks and systems and impersonating authorized users. In addition, third party suppliers and service providers that we rely on to manage our networks and systems and process and store our proprietary and confidential data, including the data of our customers and suppliers, may also be subject to similar attacks. Employees and contractors may also attempt to gain unauthorized access to our systems and steal proprietary and confidential data. Such attempts could result in the misappropriation, theft, misuse, disclosure or loss or destruction of

18


the intellectual property, or the proprietary, confidential or personal information, of Teradyne or our employees, customers, suppliers or other third parties, as well as damage to or disruptions in our information technology networks and systems. These threats are constantly evolving and expanding, such as through the increased use of artificial intelligence in our products and expanding remote work opportunities for our employees, thereby increasing the difficulty of defending against them or implementing adequate preventative measures. While we seek to detect and investigate all security incidents and to prevent their recurrence, attempts to gain unauthorized access to our information technology networks and systems may be successful, and in some cases, we might be unaware of an incident or its magnitude and effects. A failure in or a breach of our operational or security systems or infrastructure, or those of our suppliers and other service providers, including as a result of cyber-attacks, could have a material adverse effect on our business or financial results, disrupt our business, result in the disclosure or misuse of proprietary or confidential information, damage our reputation, cause losses and increase our costs. We expect to continue to devote significant resources to the security of our information technology networks and systems.

A breach of the security of our products could negatively affect our business and results of operations.

We may be subject to security breaches of certain of our products caused by viruses, illegal break-ins or hacking, sabotage, or acts of vandalism by third parties or our employees or contractors. A breach of our product security systems could have a material adverse effect on our business or financial results, disrupt our business, result in the disclosure or misuse of proprietary or confidential information, damage our reputation, cause losses, and increase our costs. We expect to continue to devote significant resources to the security of our products.

Risks Related to the COVID-19 Pandemic

The novel coronavirus (COVID-19) pandemic has impacted our business and could materially adversely affect our results of operations, financial condition, liquidity, or cash flows.

During the global COVID-19 pandemic, government authorities implemented numerous measures in an effort to contain the spread of the virus, such as travel bans and restrictions, limitations on gatherings or social distancing requirements, quarantines, shelter-in-place orders, vaccination and testing mandates, and business limitations and shutdowns. These measures impacted our day-to-day operations and disrupted our business, workforce and operations, as well as the operations of our customers, contract manufacturers and suppliers. The COVID-19 pandemic also significantly increased economic and demand uncertainty in our markets. The COVID-19 pandemic, and the numerous measures implemented in response, adversely impacted our results of operations, including increasing costs company-wide, but we cannot accurately estimate the full extent of the impact to our 2022, 2021 and 2020 financial results or to our future financial results.

We will continue to monitor the COVID-19 pandemic. However, we are unable to accurately predict the future of COVID-19, which will depend on future developments that are highly uncertain and cannot be predicted with accuracy, including, but not limited to, any new surges or new strains or variants of the virus in areas where we do business, the availability and use of vaccinations and any further actions we may take as required by government authorities or that we determine are in the best interest of our employees, customers, contract manufacturers and suppliers.

23


Risks Related to Legal and Regulatory Compliance

The implementation of tariffs on our products may have a material impact on our business.

Our business operations and supply chain are global and may be disrupted by the implementation of tariffs.

In 2018, the United States Trade Representative imposed a 25% tariff on many lists of products, including certain Teradyne products that are made in China and imported into the United States. We have implemented operational changes that mitigate the impact of the 25% tariff on the import of our impacted products into the United States. As a result, the existing tariff has not had a material adverse effect on our business, financial condition or results of operations. The implementation of additional tariffs by the United States could have a material adverse effect on our business, financial condition or results of operations.

In addition to the actions taken by the United States, China has implemented retaliatory tariffs on products made in the United States and imported into China, including certain Teradyne products. We have implemented, if appropriate, operational changes that would mitigate the impact of the retaliatory tariffs. However, notwithstanding our efforts, the retaliatory tariffs or other trade restrictions implemented by China could disrupt our business operations, sales and supply chain and, therefore, have a material adverse effect on our business, financial condition or results of operations.

Trade regulations and restrictions impact our ability to manufacture certain products and to sell products to and support certain customers, which may materially adversely affect our sales and results of operations.

We are subject to U.S. laws and regulations that limit and restrict the export of some of our products and services and may restrict our transactions with certain customers, business partners and other persons. In certain circumstances, export control and economic sanctions regulations prohibit the export of certain products, services and technologies, and in other circumstances are required to obtain an export license before exporting the controlled item. We must also comply with export restrictions and laws imposed by other countries affecting trade and investments. We maintain an export compliance program but there are risks that the compliance controls could be circumvented, exposing us to legal liabilities. Compliance with these laws has not significantly limited our sales but could significantly limit them in the future. Changes in, and responses to, U.S. trade policy could reduce the competitiveness of our products and cause our sales to drop, which could have a material adverse effect on our business, financial condition or results of operations.

The U.S. government from time to time has issued export restrictions that prohibit U.S. companies from exporting U.S. manufactured products, foreign manufactured products with more than 25% controlled U.S. content, as well as U.S. origin technology. For example, the U.S. Department of Commerce has restricted the access of U.S. origin technologies to certain Chinese semiconductor companies including YMTC and CXMT by adding those companies to the Entity List under U.S. Export Administration Regulations (“EAR”). The addition of certain of these companies to the entity list has had and will continue to have an adverse impact on our business with these customers. We will take appropriate actions, including filing for licenses with the U.S. Department of Commerce to attempt to minimize the impact of the restrictions on these companies.our business.

19


On May 16, 2019, Huawei and 68 of its affiliates, including HiSilicon, were added to the U.S. Department of Commerce Entity List under the EAR. This action by the U.S. Department of Commerce imposed new export licensing requirements on exports, re-exports, and in-country transfers of all U.S. regulated products, software and technology to the designated Huawei entities. On August 17, 2020, the U.S. Department of Commerce published final regulations expanding the scope of the U.S. EAR to include additional products that would become subject to export restrictions relating to Huawei entities including HiSilicon. These new regulations restrict the sale to Huawei and the designated Huawei entities of certain non-U.S. made items, such as semiconductor devices, manufactured for or sold to Huawei entities including HiSilicon under specific, detailed conditions set forth in the new regulations. These new regulations have impacted our sales to Huawei, HiSilicon and their suppliers. We are taking appropriate actions, including filing license applications and obtaining licenses

24


from the U.S. Department of Commerce. However, we do not expect these actions will mitigate the impact of the regulations on our sales to Huawei, HiSilicon and other suppliers. As a result, the regulations will continue to have an adverse impact on our business and financial results. It is uncertain the extent these new regulations and any additional regulations that may be implemented by the U.S. Department of Commerce or other government agency may have on our business with other customers or potential customers. Also, our controls related to Entity List compliance could be circumvented, exposing us to legal liabilities.

On April 28, 2020, the U.S. Department of Commerce published new export control regulations for certain U.S. products and technology sold to military end users or for military end-use in China, Russia and Venezuela. The definition of military end user is broad. The regulations went into effect on June 29, 2020. In December 2020, the U.S. Department of Commerce issued a list of companies in China and other countries that it considered to be military end users. Compliance with the new export controls has impacted our ability to sell products to certain customers in China. In addition, while we maintain an export compliance program, our compliance controls could be circumvented, exposing us to legal liabilities. We will continue to assess the impact of the newthese export controls on our business and operations and take appropriate actions, including filing for licenses with the U.S. Department of Commerce, to minimize any disruption. However, we cannot be certain that the actions we take will mitigate all the risks associated with the export controls that may impact our business.

On October 7, 2022, the U.S. Department of Commerce published new regulations restricting the export to China of advanced semiconductors, supercomputer technology, equipment for the manufacturing of advanced semiconductors and components and technology for the manufacturing in China of certain semiconductor manufacturing equipment. The new restrictions are lengthy and complex. We continue to assess the impact of these regulations on our business. We have determined that restrictions on the sale of semiconductor testers in China to test certain advanced semiconductors will impactimpacted our sales to certain companies in China and our manufacturing and development operations in China. Several multinational companies manufacturing these advanced semiconductors in China have obtained one-year licenses allowing suppliers such as Teradyne to continue to provide testers to the facilities operated by these companies. We expect that other companies manufacturing advanced semiconductors in China will not receive licenses, thereby restricting our ability to provide testers to the facilities operated by these companies that do not receive a license. We also are filing license requests to sell to and support certain customers in China for certain end uses that, if granted, may reducemitigated the impact of these restrictions on our business. At this time, we do not knowbusiness by obtaining licenses from the U.S. Department of Commerce. On October 17, 2023, the U.S. Department of Commerce released new rules updating the export controls issued on October 7, 2022. The new rules, which took effect on November 17, 2023, significantly limit the impact these end user and end useof the October 7, 2022 restrictions will have on our business in China or on future revenues. In addition to the specific restrictions impacting our business,business. However, the regulations may continue to have an adverse impact on certain actual or potential customers and on the global semiconductor industry. To the extent the regulations impact actual and potential customers or disrupt the global semiconductor industry, our business and revenues will be adversely impacted. We also have determined that the restrictions on the export of certain US origin components and technology for use in the development and production in China of certain semiconductor manufacturing equipment impact our manufacturing and development operations in China. We have received a temporary authorization from the U.S. Department of Commerce allowing us to continue our manufacturing and development operations in China until the U.S. Department of Commerce issues a license to replace this temporary authorization. We cannot assess the likelihood or timing of receiving this license. In addition to requesting a license, we are implementing procedures for minimizing the impact of these new regulations on our operations in China, but there is no assurance that these procedures will succeed.

In response to the regulations issued by the U.S. Department of Commerce, the Chinese government has passed new laws, including blocking legislation, which may impact our business activities in China. The Company is assessing the potential impact of these new Chinese laws and monitoring relevant laws and regulations issued by the Chinese government. The impact of these new Chinese laws on our business activities in China remains uncertain at this time.

We may be subject to product recalls and warranty and product liability claims.

We invest significant resources in the design, manufacturing and testing of our products. However, from time to time, we discover design or manufacturing defects in our products after they have been shipped and, as a

25


result, we have incurred development and remediation costs and settled warranty and product liability claims. In addition, when our products contain defects or have reliability, quality or safety issues, we have conducted a product recall which resulted in significant repair or replacement costs and substantial delays in product shipments and may damage our reputation which could make it more difficult to sell our products. We could continue to have warranty and product liability claims or product recalls in the future. Any of these results could have a material adverse effect on our business, results of operations or financial condition.

We may incur significant costs of complying with present and future environmental regulations and may incur significant liabilities if we fail to comply with such environmental regulations.

We are subject to both domestic and international environmental regulations and statutory strict liability relating to the use, storage, discharge, site cleanup and disposal of hazardous chemicals used in our manufacturing processes. In addition, future regulations in response to global climate change may affect us, our suppliers, and our customers. Such regulations could cause us to incur additional direct costs for compliance, as well as increased indirect costs resulting from our customers, suppliers, or both incurring additional compliance costs that are passed on to us. Future climate change regulations could result in decreased demand for

20


our products. If we fail to comply with present and future regulations, or are required to perform site remediation, we could be subject to future liabilities or cost, including penalties or the suspension of production. Present and future regulations may also:

restrict our ability to expand facilities;

restrict our ability to ship certain products;

require us to modify our operations logistics;

require us to acquire costly equipment; or

require us to incur other significant costs and expenses.

Pursuant to present regulations and agreements, we are conducting groundwater and subsurface assessment and monitoring and are implementing remediation and corrective action plans for facilities located in Massachusetts and New Hampshire which are no longer conducting manufacturing operations. As of December 31, 2022,2023, we have not incurred material costs as a result of the monitoring and remediation steps taken at the Massachusetts and New Hampshire sites.

The directive on the Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipment (the “RoHS Directive”) and the directive on Waste Electrical and Electronic Equipment (the “WEEE Directive”) altered the form and manner in which electronic equipment is imported, sold and handled in the European Union. Other jurisdictions, such as China, have followed the European Union’s lead in enacting legislation with respect to hazardous substances and waste removal. Ensuring compliance with the RoHS Directive, the WEEE Directive and similar legislation in other jurisdictions, and integrating compliance activities with our suppliers and customers could result in additional costs and disruption to operations and logistics and thus, could have a negative impact on our business, operations or financial condition.

We currently are, and in the future may be, subject to litigation or regulatory proceedings that could have an adverse effect on our business.

From time to time, we may be subject to litigation or other administrative, regulatory or governmental proceedings, including tax audits and resulting claims that could require significant management time and resources and cause us to incur expenses and, in the event of an adverse decision, pay damages or incur costs in an amount that could have a material adverse effect on our financial position or results of operations.

We may face risks associated with shareholder activism.

We may become subject to campaigns by shareholders advocating corporate actions such as financial restructuring, increased borrowing, special dividends, stock repurchases or divestitures. Such activities could

26


interfere with our ability to execute our business plans, be costly and time-consuming, disrupt our operations, divert the attention of management, or result in our initiating borrowing or increasing our share repurchase plan or dividend, any of which could have an adverse effect on our business or stock price.

Provisions of our charter and by-laws and Massachusetts law may make a takeover of Teradyne more difficult.

There are provisions in our basic corporate documents and under Massachusetts law that could discourage, delay or prevent a change in control, even if a change in control may be regarded as beneficial to some or all of our stockholders.

Item 1B: Unresolved Staff Comments

Item 1B:

None.

Item 1C: Cybersecurity

We believe cybersecurity is critical to supporting our vision and enabling our strategy. As a producer of leading-edge electronic testing products and maker of advanced robotics, we face a multitude of cybersecurity threats that range from attacks common to most industries, such as ransomware and denial-of-service, to attacks from more advanced, persistent, and highly organized adversaries, including nation state actors, that may target us for our role in critical infrastructure sectors. Our customers, suppliers, and partners face similar cybersecurity threats and, while we have not been materially affected to date, a cybersecurity incident impacting us or any of these entities could materially adversely affect our operations, performance, and results of operations. These cybersecurity threats and related risks make it imperative that we maintain a strong focus on cybersecurity.

21


Governance

The Board of Directors oversees management’s processes for identifying and mitigating risks, including cybersecurity risks, to help align our risk exposure with our strategic objectives. Senior leadership, including our Chief Information Security Officer ("CISO"), regularly brief the Audit Committee of the Board of Directors on our cybersecurity and information security posture.

The corporate information security organization, under the CISO, has implemented a governance structure and processes to assess, identify, manage, and report cybersecurity risks. The CISO chairs management’s Cybersecurity Steering Committee, in which current cyber threats, program performance, and ongoing risk mitigations are regularly reviewed. Cybersecurity related risks are also integrated into our overall enterprise risk management ("ERM") process. These risks are included in the risk universe that the ERM function evaluates to assess top enterprise risks on an annual basis and is reviewed and evaluated by the Board of Directors. The Board of Directors is also apprised of cybersecurity issues or incidents deemed to have a moderate or higher business impact as they arise, even if considered immaterial.

In the event of a significant incident, we intend to follow our detailed incident response playbooks, which outline the steps to be followed from incident detection through mitigation, recovery and notification, including escalation to functional areas (e.g., legal), and escalation to senior leadership via the Cybersecurity Steering Committee. Upon escalation, the Cybersecurity Steering Committee will review all inputs, assess the materiality of the incident, and then brief the Board of Directors on the determination and on how management intends to respond.

Risk management and strategy

Our global information security organization, led by our CISO, is responsible for our overall information security strategy, policy, security engineering, operations, and cyber threat detection and response. Our CISO is an experienced cybersecurity senior executive with more than 25 years of experience building and leading cybersecurity, risk management and information technology teams. The information security organization manages and continually enhances a robust enterprise security structure with the goal of preventing cybersecurity incidents to the extent feasible, while simultaneously increasing system resilience and deploying highly proficient detection and response capabilities in an effort to minimize the business impact should an incident occur.

Central to this organization is our global cyber operations team, which is responsible for the protection, detection, and response capabilities used in the defense of critical data and enterprise computing services. We also have a corporate-wide insider threat detection program to proactively identify external and internal threats and mitigate those threats in a timely manner. Our broader Teradyne employee community also has a key role in our cybersecurity defenses and is immersed in a comprehensive training and awareness curriculum to build and promote a corporate culture supportive of security.

Third parties also play a role in our cybersecurity. We engage third-party services to provide 24x7x365 monitoring, escalation, and response to cyber events. In addition to consulting on best practices, we leverage third parties for independent evaluations of our security controls through penetration testing and independent audits. These evaluations include testing both the design and operational effectiveness of security controls. We also share and receive threat intelligence with our industry peers, cybersecurity associations, and our cyber controls vendors.

We rely on contract manufacturing organizations and distributors to deliver our products to our customers, and a cybersecurity incident at one of these organizations or a key supplier could materially adversely impact us. We assess third party and supply chain cybersecurity controls through risk monitoring services tailored to align with our risk policy. Notwithstanding the extensive approach we take to cybersecurity, we may not be successful in preventing or mitigating a cybersecurity incident that could have a material adverse effect on us, either directly within our managed environment or indirectly via a third-party partner or supply chain vendor. Periodically we have a recognized independent security expert firm to assess our cyber security maturity along with risks and provide feedback on where we should continue to improve to mitigate exposures. We share this review with our Board and develop a security roadmap which incorporates this feedback.

Additionally, for our business that supports the defense and aerospace sector, we must comply with extensive regulations, including requirements imposed by the Defense Federal Acquisition Regulation Supplement ("DFARS") related to adequately safeguarding controlled unclassified information ("CUI") and reporting cybersecurity incidents to the DoD. We have implemented cybersecurity policies and frameworks based on industry and governmental standards to align closely with DoD requirements, instructions, and guidance. Moreover, we are pursuing the necessary controls to support the Cybersecurity Maturity Model Certification ("CMMC") program, DoD’s program to ensure members of the defense industrial base meet cybersecurity requirements for handling CUI and federal contract information. We believe we are well positioned to meet the requirements of the CMMC and are preparing for certification once the requirements are effective.

22


Item 2: Properties

Unresolved Staff Comments

None.

Item 2:

Properties

We conduct manufacturing, engineering, sales and marketing, service, corporate administration and other operations in various leased and owned facilities throughout the world. We own approximately 720,000 square feet of office space and lease overapproximately 1,500,000 square feet of office space. Our corporate headquarters is in North Reading, Massachusetts, in buildings that we own consisting of approximately 422,000 square feet. We believe our existing facilities and planned expansions noted below are adequate to meet our current and reasonably foreseeable requirements. We regularly evaluate our expected facility needs and periodically make adjustments based on these evaluations. In 2019, we purchased land in Denmark, approximately 200,000 square feet, to construct a new building for our Robotics operations. The new building construction is expected to be completed by the first quarterhalf of 2024.

Item 3:

Legal Proceedings

We are subject to legal proceedings, claims and investigations that arise in the ordinary course of business such as, but not limited to, patent, employment, commercial and environmental matters. We believe that we have meritorious defenses against all pending claims and intend to vigorously contest them. While it is not possible to predict or determine the outcomes of any pending claims or to provide possible ranges of losses that may arise, we believe the potential losses associated with all these actions are unlikely to have a material adverse effect on our results of operations, financial condition or cash flows.

Item 4: Mine Safety Disclosure

Item 4:

Mine Safety Disclosure

Not Applicable.

2723



PART II

Item 5: Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities

Item 5:

Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities

Our common stock is traded on the Nasdaq Global Select Market under the trading symbol “TER.” As of February 17, 2023,22, 2024, there were approximately 1,2141,148 holders of record of shares of our common stock.

See “Item 7: Management’s Discussion and Analysis of Financial Condition and Results of Operations,” for information on the frequency and amounts of our quarterly cash dividends, equity compensation plans and performance graph.

The following table includes information with respect to repurchases we made of our common stock during the three months ended December 31, 20222023 (in thousands except per share price):

Period

 (a) Total
Number of
Shares
(or Units)
Purchased
  (b) Average
Price Paid per
Share (or Unit)
  (c) Total
Number of
Shares (or Units)
Purchased as
Part of Publicly
Announced
Plans
or Programs
  (d) Maximum
Number

(or Approximate
Dollar Value) of
Shares (or Units)
that may Yet Be
Purchased
Under the Plans
or Programs
 

October 3, 2022 – October 30, 2022

  30  $69.41   30  $647,918,955 

October 31, 2022 – November 27, 2022

  1   82.03   —     647,918,955 

November 28, 2022 – December 31, 2022

  1   92.64   —     647,918,955 
 

 

 

  

 

 

  

 

 

  
  32(1)  $70.14(1)   30  
 

 

 

  

 

 

  

 

 

  

Period

 

(a) Total
Number of
Shares
(or Units)
Purchased

 

 

 

(b) Average
Price Paid per
Share (or Unit)

 

 

 

(c) Total Number of
Shares (or Units)
Purchased as Part of
Publicly Announced
Plans or Programs

 

 

(d) Maximum Number
(or Approximate Dollar
Value) of Shares (or
Units) that may Yet Be
Purchased Under the
Plans or Programs

 

October 2, 2023 – October 29, 2023

 

 

363

 

 

 

$

97.65

 

 

 

 

362

 

 

$

1,615,390

 

October 30, 2023 – November 26, 2023

 

 

185

 

 

 

 

85.97

 

 

 

 

185

 

 

 

1,599,497

 

November 27, 2023 – December 31, 2023

 

 

1

 

 

 

 

93.70

 

 

 

 

 

 

 

1,599,497

 

 

 

 

549

 

(1)

 

$

93.70

 

(1)

 

 

547

 

 

 

 

(1)

Includes approximately two thousand shares at an average price of $83.49 withheld from employees for the payment of taxes.

(2)

In January 2021, the Board of Directors authorized the repurchase of up to $2.0 billion of common stock. In January 2023, the Board of Directors cancelled the 2021 repurchase program and approved a new $2.0 billion of common stock. Unless terminated by resolution of our Board of Directors, the repurchase program will expire when we have repurchased all shares authorized for repurchase under the share repurchase program.

(1)
Includes approximately two thousand shares at an average price of $94.13 withheld from employees for the payment of taxes.
(2)
As of January 1, 2023, share repurchases net of share issuances are subject to a 1% excise tax under the Inflation Reduction Act. Excise tax incurred is included as part of the cost basis of shares repurchased in the Condensed Consolidated Statements of Convertible Common Shares and Stockholders' Equity.
(3)
In January 2023, the Board of Directors cancelled the 2021 repurchase program and approved a new $2.0 billion of common stock. Unless terminated by resolution of our Board of Directors, the repurchase program will expire when we have repurchased all shares authorized for repurchase under the share repurchase program.

We satisfy U.S. federal and state minimum withholding tax obligations due upon the vesting and the conversion of restricted stock units into shares of our common stock, by automatically withholding from the shares being issued, a number of shares with an aggregate fair market value on the date of such vesting and conversion that would satisfy the minimum withholding amount due.

Item 6: (Reserved)

Item 6:

24


Item 7: Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

(Reserved)

Item 7:

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

We are a leading global supplier of automated test equipment and robotics products. We design, develop, manufacture and sell automaticautomated test systems and robotics products. Our automaticautomated test systems are used to test semiconductors, wireless products, data storage and complex electronics systems in many industries including consumer electronics, wireless, automotive, industrial, computing, communications, and aerospace and defense industries. Our Robotics products include collaborative robotic arms and autonomous mobile robots (“AMRs”) used by global manufacturing, logistics and industrial customers to improve quality, increase manufacturing and

28


material handling efficiency and decrease manufacturing and logistics costs. Our automaticautomated test equipment and robotics products and services include:

semiconductor test (“Semiconductor Test”) systems;

storage and system level test (“Storage Test”) systems, defense/aerospace (“Defense/Aerospace”) test instrumentation and systems and circuit-board test and inspection (“Production Board Test”) systems (collectively these products represent “System Test”);

wireless test (“Wireless Test”) systems; and

robotics (“Robotics”) products.

The market for our test products is concentrated with a limited number of significant customers accounting for a substantial portion of the purchases of test equipment. A few customers drive significant demand for our products both through direct sales and sales to the customer’s supply partners. We expect that sales of our test products will continue to be concentrated with a limited number of significant customers for the foreseeable future.

In 2022,2023, the demand in the mobility and compute segments of our Semiconductor Test business was lower duecontinued to end market slowdownbe impacted by a correction cycle driven by excess semiconductor inventory, primarily in these segments as well as a slower technology transition in onethe mobility segment of our largest end-markets. While the market. The depth of thethis slowdown and the timing of the recovery are uncertain, however, strong automotive and image sensor demand partially offset these declines. The growth of DDR5 and High Bandwidth Memory ("HBM") devices for data center applications continued to drive demand for our products in the memory market in 2023. Over the midterm, we expect the ramp of 3 nanometer process technology starting in 2023 followed byand gate-all-around process technology, increasing multichip packaging, additional device complexity and unit growth will drive additional demand for test over our four year forecast period.Semiconductor Test.

Our Robotics segment consists of Universal Robots A/S (“UR”), a leading supplier of collaborative robotic arms, and Mobile Industrial Robots A/S (“MiR”), a leading maker of AMRs for industrial automation. In September 2022, we merged MiR and AutoGuide, LLC (“AutoGuide”), a maker of high payload AMRs, to become a single supplier of AMRs. The market for our Robotics segment products is dependent on the adoption of new automation technologies by large manufacturers as well as small and medium enterprises (“SMEs”) throughout the world. We expect Robotics sales channel expansion combined withDemand in the fourth quarter of 2023 increased, tied to introduction of new products and seasonally high demand in Robotics after market softness and the impact of our channel transformation resulted in a weaker than forecasted first half of 2023.

On November 7, 2023, Teradyne and Technoprobe S.p.A, (“Technoprobe”), a leader in the design and production of probe cards, announced establishment of a strategic partnership that will seek to driveaccelerate growth for both companies and enable higher performance semiconductor test interfaces for customers worldwide. As part of the growthpartnership, Teradyne will make an investment of 481.0 million Euros in 2023.exchange for a 10% equity investment in Technoprobe and Technoprobe will acquire 100% of Teradyne’s Device Interface Solutions ("DIS") business in exchange for $85.0 million. The transaction is expected to close during the first half of 2024.

BothIn 2023, inflation had minimal effect on our results. While both our test and robotics businesses may continue to be influenced by supply constraints, which could impact our revenue and costs, in 2023. In 2022, inflation had minimal effectWe do not anticipate that supply chain constraints will have a material impact on our results. In 2022, we were unable to supply approximately $20 million of revenuefinancial results in our test businesses for which we had customer demand.2024.

Our financial statements are denominated in U.S. dollars. While the majority of our revenues are in U.S. dollars, approximately 70 percent of our Robotics revenue is denominated in foreign currencies. InThere was no material impact to our 2023 results due to changes in foreign exchange rates, however, in 2022, the strengthening of the U.S. dollar was a factor in lower than forecasted revenues in our Robotics segment. Continued strengthening of the U.S. dollar would negativelyadversely affect Robotics revenue growth in 2023.2024.

Our corporate strategy continues to focus on profitably gaining market share in our test businesses through the introduction of differentiated products that target expanding segments and accelerating growth through continued investment in our Robotics businesses. We plan to continue investing in our growth while balancing capital allocations between returning capital to our shareholders through stock repurchases and dividends and using capital for acquisitions.

Impact25


Table of the COVID-19 Pandemic on our BusinessContents

During the novel coronavirus (COVID-19) pandemic, government authorities implemented numerous measures in an effort to contain the spread of the virus, such as travel bans and restrictions, limitations on

29


gatherings or social distancing requirements, quarantines, shelter-in-place orders, vaccination and testing mandates, and business limitations and shutdowns. Additionally, we took proactive, aggressive action to protect the health and safety of our employees, customers, contract manufacturers and suppliers, and to comply with all government orders around the globe. The spread of COVID-19 caused us to modify our business practices, which included implementing social distancing protocols, limiting employee travel and requiring employees to work remotely. These measures impacted our day-to-day operations and disrupted our business, workforce and operations, as well as the operations of our customers, contract manufacturers and suppliers. Due to the COVID-19 pandemic, there has also been uncertainty and disruption in the global economy and our markets. We are not aware of any specific event or circumstance that would require an update to our estimates or judgments or a revision of the carrying value of our assets or liabilities as of February 22, 2023, the date of issuance of this Annual Report on Form 10-K.

We believe the COVID-19 pandemic, and the numerous measures implemented by authorities in response, adversely impacted our results of operations, including by increasing costs, but we cannot accurately estimate the amount of the impact to our 2022 and 2021 financial results or to our future financial results. In addition, the pandemic has disrupted our contract manufacturers and suppliers, and has resulted in some instances in short-term cost increases to meet customer demand. While a continuation of the pandemic may further impact our workforce and operations, as well as those of our customers, contract manufacturers and suppliers, we expect that our manufacturing facilities will remain operational, at sufficient capacity to support production demand. We are monitoring our operations closely in an effort to avoid any potential productivity loss caused by responses to the COVID-19 pandemic.

We experienced interruptions to our supply chain as a result of the COVID-19 pandemic. Our suppliers have faced and may continue to face difficulties maintaining operations in light of COVID-19 disruptions and government-ordered restrictions. Our supply chain team, and our suppliers, continue to manage numerous supply, production, and logistics obstacles caused by the pandemic. There is no assurance that these efforts will be successful. The COVID-19 pandemic may continue to disrupt our ability to obtain components required to manufacture our products, adversely affecting our operations and in some instances resulting in higher costs and delays, both for obtaining components and shipping finished goods to customers.

We will continue to monitor the COVID-19 pandemic. We may take further actions as may be required or recommended by government authorities or that we determine are in the best interests of our employees, customers, contract manufacturers and suppliers. In these circumstances, there may be developments outside our control requiring us to adjust our operating plan. As a result, given the uncertain nature of this situation, we are not able to accurately predict the full extent of the impact of COVID-19 on our business, financial condition, results of operations, liquidity, or cash flows in the future.

Supply Chain Constraints and Inflationary Pressures

The global supply shortage of electrical components, including semiconductor chips, continued to impactimpacted our supply chain in 2022. As a result,the first half of 2023. In the second half of 2023, we experienced,saw improvements related to supply constraints and, expect to continue toconsequently, did not experience material increases in our lead times and costs for certain components for certain of our products.components. In addition, in 2022,the 2023, inflationary pressures contributed to increased costs for product components and wage inflation, which had a minimal impact on our cost of products, gross margin and profit for the year. Our supply chain team, and our suppliers, continue to manage numerous supply, production, and logistics obstacles. In an effort to mitigate these risks, in some cases, we have incurred higher costs due to investment in supply chain resiliency and to secure available inventory or have extended or placed non-cancellable purchase commitments with semiconductor suppliers, which introduces inventory risk if our forecasts and assumptions prove inaccurate. We have also sourced components from additional suppliers and multi-sourced and pre-ordered components and finished goods inventory in some cases in an effort to reduce the impact of the adverse supply chain conditions we have experienced. However, if we are unable to secure manufacturing capacities fromThough these mitigation efforts have not had a material impact on our current or new suppliers and contract manufacturers, on

30


acceptable terms or at all, or successfully managefinancial results, our purchase commitments and inventory for components,continuing efforts may not be successful. While our ability to deliver our products to our customersbusinesses could be impacted by supply constraints in the desired quantities, at competitive prices orfuture, we do not anticipate supply chain constraints will have a material impact on our financial results in a timely manner may be negatively impacted for 2023.2024.

Impact of Russia’s invasion of Ukrainethe Israel-Hamas conflict on our Business

Russia’s invasion of Ukraine, in February 2022, did not have a significant direct impact on our business as we have minimal business in Russia and Ukraine. However, following the invasion, the U.S. and other countries imposed significant sanctions against the Russian government and many Russian companies and individuals. Although we do not have significant operations in Russia, the sanctions and Russia’s response to the sanctions, have impacted our business in other countries andThe recent Israel-Hamas conflict could have a negative impact on our future revenue and supply chain, either of which could adversely affect our business and financial results. Our customers in Israel may experience delays in product releases due to impacts to their labor force and impacts on their suppliers because of the conflict, which could materially impact demand for our products. Similarly, our suppliers in Israel may experience delays in providing us with parts due to the conflict. In addition, the global economic uncertainty following the invasion, sanctions and Russia’s response tostart of the sanctionsconflict could impact demand for our products.

Impact of October 7, 2022 and October 17, 2023 U.S. Department of Commerce Regulations on our Business

On October 7, 2022, the U.S. Department of Commerce published new regulations restricting the export to China of advanced semiconductors, supercomputer technology, equipment for the manufacturing of advanced semiconductors and components and technology for the manufacturing in China of certain semiconductor manufacturing equipment. The newAs previously disclosed, the restrictions are lengthy and complex. We continue to assess the impact of these regulations on our business. We have determined that restrictions on the sale of semiconductor testers in China to test certain advanced semiconductors will impact ourimpacted Teradyne’s sales to certain companies in China and Teradyne’s manufacturing and development operations in China. Several multinational companies manufacturing these advanced semiconductors in China have obtained one-year licenses allowing suppliers such as Teradyne to continue to provide testers to the facilities operated by these companies. We expect that other companies manufacturing advanced semiconductors in China will not receive licenses, thereby restricting our ability to provide testers to the facilities operated by these companies that do not receive a license. We are also filing license requests to sell to and support certain customers in China for certain end uses that, if granted, may reducemitigated the impact of these restrictions on our business. At this time, we do not knowits business by obtaining licenses from the Department of Commerce. On October 17, 2023, the Department of Commerce released new rules updating the exporting controls issued on October 7, 2022. The new rules which took effect on November 17, 2023 significantly limit the impact these end user and end useof the October 7, 2022 restrictions will have on our business in China or on future revenues. In addition to the specific restrictions impacting our business,Teradyne’s business. However, the regulations may continue to have an adverse impact on certain actual or potential customers of Teradyne and on the global semiconductor industry. To the extent the regulations impact actual and potential customers or disrupt the global semiconductor industry, ourTeradyne’s business and revenues will be adversely impacted. We also have determined that the restrictions on the export of certain U.S. origin components and technology for use in the development and production in China of certain semiconductor manufacturing equipment impact our manufacturing and development operations in China. We have received a temporary authorization from the U.S. Department of Commerce allowing us to continue our manufacturing and development operations in China until the U.S. Department of Commerce issues a license to replace this temporary authorization. We cannot assess the likelihood or timing of receiving this license. In addition to requesting a license, we are implementing procedures for minimizing the impact of these new regulations on our operations in China, but there is no assurance that these procedures will succeed.

See Part II—Item 1A, “Risk Factors,” included herein for updates to our risk factors regarding risks associated with the COVID-19 pandemic, supply chain issues, international conflicts, and international conflicts.legal and regulatory compliance.

Critical Accounting Policies and Estimates

We have identified the policies and estimates discussed below as critical to understanding our business and our results of operations and financial condition. The impact and any associated risks related to these estimates on our business operations is discussed throughout Management’s Discussion and Analysis of Financial Condition and Results of Operations where such policies affect our reported and expected financial results. For a full description of our accounting policies related to the below items refer to Note B. Accounting Policies, included in the Notes to Consolidated Financial Statements in this Annual Report.

31


Critical accounting estimates are complex and may require significant judgment by management. Changes to the underlying assumptions may have a material impact on our financial condition and results of operations. These estimates may change, as new events occur, and additional information is obtained. Actual results could differ significantly from these estimates under different assumptions or conditions.

Revenue Recognition

In accordance with ASC 606, “Revenue from Contracts with Customers” (“ASC 606”), we recognize revenues, when or as control is transferred to a customer. Our determination of revenue requires judgment in the determination of performance obligations and allocation of the transaction price to performance obligations. We often sell bundled orders that include both product and services or multiple different products within the same order. We evaluate each of the deliverables to determine if it meets the definition of a performance obligation, which requires that it is capable of being distinct and distinct within the context of the contract. This

26


determination is based on an assessment of contractual rights of the contract and the ability of the performance obligation to perform on its own or with readily available resources. In bundled transactions we estimate the standalone selling price of each identified performance obligation and use that estimate to allocate the transaction price among said performance obligations. The estimated standalone selling price is determined using all information reasonably available to us, including standalone transactions, market information and other observable inputs.

Inventories

Inventories are stated at the lower of cost using a standard costing system which approximates cost based on a first-in, first-out basis or net realizable value. On a quarterly basis, we evaluate all inventories for net realizable value. This quarterly process identifies obsolete and excess inventory. Obsolete inventory, which represents items for which there is no demand, is fully reserved. Excess inventory, which represents inventory items that are not expected to be consumed within the forecasted demand window, is written down to estimated net realizable value. Forecasted demand information is obtained from the sales and marketing groups and incorporates factors such as backlog and future revenues. The demand forecast is based on assumptions around the product life and customer and market forecasts.expectations.

Retirement and Postretirement Plans

We recognize net actuarial gains and losses and the change in the fair value of the plan assets in our operating results in the year in which they occur or upon any interim remeasurement of the plans. Discount rate and expected return on assets are two assumptions which are important elements of pension plan expense and asset/liability measurement. We evaluate our discount rate and expected rate of return on assets assumptions annually on a plan and country specific basis. We evaluate other assumptions related to demographic factors, such as retirement age, mortality and turnover periodically, and update them to reflect our experience and expectations for the future.

In developing the expected return on U.S. Qualified Pension Plan (“U.S. Plan”) assets assumption, we evaluated input from our investment manager and pension consultants, including their forecast of asset class return expectations. We believe that 2.0%4.75% was an appropriate rate of return on assets to use for 2022.2023. The December 31, 20222023 asset allocation for our U.S. Plan was 94% invested in fixed income securities, 5% invested in equity securities, and 1% invested in other securities. Our investment manager regularly reviews the actual asset allocation and periodically rebalances the portfolio to ensure alignment with our target allocations.

The discount rate that we utilized for determining future pension obligations for the U.S. Plan is based on the FTSE Pension Index adjusted for the U.S. Plan’s expected cash flows and was 4.75% at December 31, 2023, down from 4.95% at December 31, 2022, up from 2.65% at December 31, 2021.2022. We estimate that in 20232024 we will recognize approximately $0.4$0.2 million of pension expense for the U.S. Plan. The U.S. Plan pension expense estimate for 20232024 is based on a 4.95%

32


4.75% discount rate and a 4.75%4.65% return on assets. Future pension expense or income will depend on future investment performance, changes in future discount rates and various other factors related to the employee population participating in our pension plans.

Goodwill, Intangible and Long-Lived Assets

We assess goodwill for impairment at least annually in the fourth quarter, as of December 31, on a reporting unit basis, or more frequently, when events and circumstances occur indicating that the recorded goodwill may be impaired. We review intangible and long-lived assets for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate. Goodwill impairment will be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. Impairment of intangible and long-lived assets would result in the asset being written down to its estimated fair value. The calculated fair value of a reporting unit or intangible or long-lived asset is dependent upon discounted cash flow (“DCF”) models, discount rates, and market multiples. DCF models rely on our forecasted mid-term plans which are subjective based on customer or market conditions and can change materially. We utilize third party specialists when determining discount rates and selected market multiples. A change in any of these key assumptions could result in a reporting unit, intangible asset, or long-lived asset being impaired in a future period.

Convertible Debt

We adopted Accounting Standards Update (“ASU”) ASU 2020-06 – “Debt—Debt with Conversion and Other Options and Derivatives and Hedging—Contracts in Entity’s Own Equity,” on January 1, 2022 using the modified retrospective method of adoption. As a result of adoption, we recorded an increase of $1.4 million to current debt for unsettled shares, an increase of $1.8 million to deferred tax assets, an increase of $6.6 million to long-term debt for unamortized debt discount, and an increase to retained earnings of $94.6 million for the reclassification of the equity component. Mezzanine equity representing unsettled shares value was reduced to zero and additional paid-in capital was reduced by $100.8 million. In accordance with ASU 2020-06, we account for a

27


convertible debt instrument as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. Unsettled shares are recorded in current debt, and there is no recognition of a debt discount, which was previously amortized to interest expense. Settled shares reduce the outstanding debt balance in an amount equal to the cash paid, but do not result in any gain or loss on extinguishment. We use the if-converted method in the diluted EPS calculation for convertible instruments.

Income Taxes

Deferred tax assets and liabilities are determined based on differences between financial reporting and tax basis of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The measurement of deferred tax assets is reduced by a valuation allowance if it is more likely than not that some or all of the deferred tax assets will not be realized. Evaluating the positive and negative evidence regarding the realization of the net deferred tax assets in accordance with ASC 740, “Accounting for Income Taxes” is a key judgment in the valuation of income taxes. This assessment included the evaluation of scheduled reversals of deferred tax liabilities, estimates of projected future taxable income and tax-planning strategies. Although realization is not assured, based on our assessment, we concluded that it is more likely than not that such assets, net of the existing valuation allowance, will be realized.

Results of Operations

Information pertaining to fiscal year 20202021 results of operations, including a year-to-year comparison against fiscal year 2021,2022, was included in our Annual Report on Form 10-K for the year ended December 31, 20212022 under Part II, Item 7, “Management’s Discussion and Analysis of Financial Position and Results of Operations,” which was filed with the SEC on February 23, 2022.22, 2023. This information is incorporated by reference herein.

33


The following table sets forth the percentage of total net revenues included in our consolidated statements of operations:

  Years Ended December 31, 

 

Years Ended December 31,

 

  2022 2021 

 

2023

 

 

2022

 

Percentage of revenues:

   

 

 

 

 

 

 

Revenues:

   

 

 

 

 

 

 

Products

   82.1  86.3

 

 

78.3

%

 

 

82.1

%

Services

   17.9   13.7 

 

 

21.7

 

 

 

17.9

 

  

 

  

 

 

Total revenues

   100.0   100.0 

 

 

100.0

 

 

 

100.0

 

Cost of revenues:

   

 

 

 

 

 

 

Cost of products

   33.0   35.1 

 

 

33.0

 

 

 

33.0

 

Cost of services

   7.8   5.3 

 

 

9.6

 

 

 

7.8

 

  

 

  

 

 

Total cost of revenues (exclusive of acquired intangible assets amortization shown separately below)

   40.8   40.4 

 

 

42.6

 

 

 

40.8

 

  

 

  

 

 

Gross profit

   59.2   59.6 

 

 

57.4

 

 

 

59.2

 

Operating expenses:

   

 

 

 

 

 

 

Selling and administrative

   17.7   14.8 

 

 

21.6

 

 

 

17.7

 

Engineering and development

   14.0   11.5 

 

 

15.6

 

 

 

14.0

 

Acquired intangible assets amortization

   0.6   0.6 

 

 

0.7

 

 

 

0.6

 

Restructuring and other

   0.5   0.3 

 

 

0.8

 

 

 

0.5

 

  

 

  

 

 

Total operating expenses

   32.8   27.2 

 

 

38.7

 

 

 

32.8

 

  

 

  

 

 

Income from operations

   26.4   32.4 

 

 

18.7

 

 

 

26.4

 

Non-operating (income) expenses:

   

 

 

 

 

 

 

Interest income

   (0.2  (0.1

 

 

(1.0

)

 

 

(0.2

)

Interest expense

   0.1   0.5 

 

 

0.1

 

 

 

0.1

 

Other (income) expense, net

   (0.2  0.7 

 

 

 

 

 

(0.2

)

  

 

  

 

 

Income before income taxes

   26.6   31.4 

 

 

19.6

 

 

 

26.6

 

Income tax provision

   4.0   4.0 

 

 

2.9

 

 

 

4.0

 

  

 

  

 

 

Net income

   22.7  27.4

 

 

16.8

%

 

 

22.7

%

  

 

  

 

 

28


Revenues

Revenues for our reportable segments were as follows:

  2022   2021   2021-2022
Dollar
Change
 

 

2023

 

 

2022

 

 

2022-2023
Dollar
Change

 

  (in millions) 

 

(in millions)

 

Semiconductor Test

  $2,080.6   $2,642.3   $(561.7

 

$

1,818.6

 

 

$

2,080.6

 

 

$

(262.0

)

Robotics

 

 

375.2

 

 

 

403.1

 

 

 

(27.9

)

System Test

   469.3    467.7    1.6 

 

 

338.2

 

 

 

469.3

 

 

 

(131.1

)

Robotics

   403.1    375.9    27.2 

Wireless Test

   201.7    216.9    (15.2

 

 

144.3

 

 

 

201.7

 

 

 

(57.4

)

Corporate and Eliminations

   0.3    —      0.3 

 

 

 

 

 

0.3

 

 

 

(0.3

)

  

 

   

 

   

 

 

 

$

2,676.3

 

 

$

3,155.0

 

 

$

(478.7

)

  $3,155.0   $3,702.9   $(547.9
  

 

   

 

   

 

 

34


The decrease in Semiconductor Test revenues of $561.7$262.0 million, or 21.3%12.6%, was driven primarily by lower tester sales for compute and mobility applications. The decrease in mobileRobotics revenues of $27.9 million, or 6.9%, was driven primarily by softening demand due to slowing global industrial activity and high performance compute processor applications, partially offset by an increase in advance driver assistance systems (“ADAS”) tester sales.macro-economic headwinds and the impact of the transformation of Universal Robots' sales channel. The increasedecrease in System Test revenues of $1.6$131.1 million, or 0.3%27.9%, was primarily due to higherlower sales in Defense/Aerospace and in Production Board Test, partially offset by a decline in Storage Test sales of system level testers. The rise in Robotics revenues of $27.2 million, or 7.2%, was driven primarily by higher demand for UR’s collaborative robotic arms and MiR’s autonomous mobile robots, partially offset by changes in foreign exchange rates.hard disk drive testers. The decrease in Wireless Test revenues of $15.2$57.4 million, or 7.0%28.5%, was primarily due to a decrease in cellularsales of connectivity test product sales, partially offset by an increase in ultra-wide band test product sales.products.

Our reportable segments accounted for the following percentages of consolidated revenues:

  2022 2021 

 

2023

 

 

2022

 

Semiconductor Test

   66  71

 

 

68

%

 

 

66

%

Robotics

 

 

14

 

 

 

13

 

System Test

   15   13 

 

 

13

 

 

 

15

 

Robotics

   13   10 

Wireless Test

   6   6 

 

 

5

 

 

 

6

 

  

 

  

 

 

 

 

100

%

 

 

100

%

   100  100
  

 

  

 

 

Revenues by country as a percentage of total revenues were as follows (1):

  2022 2021 

 

2023

 

 

2022

 

United States

 

 

16

%

 

 

15

%

Korea

 

 

15

 

 

 

17

 

Taiwan

   20  30

 

 

14

 

 

 

20

 

Korea

   17   14 

China

   16   17 

 

 

12

 

 

 

16

 

United States

   15   11 

Japan

 

 

11

 

 

 

5

 

Europe

   9   7 

 

 

10

 

 

 

9

 

Japan

   5   4 

Malaysia

   5   4 

Thailand

   4   4 

Philippines

   4   5 

 

 

7

 

 

 

4

 

Singapore

   3   3 

 

 

4

 

 

 

3

 

Thailand

 

 

3

 

 

 

4

 

Malaysia

��

 

3

 

 

 

5

 

Rest of the World

   2   1 

 

 

5

 

 

 

2

 

  

 

  

 

 

 

 

100

%

 

 

100

%

   100  100
  

 

  

 

 

(1)

Revenues attributable to a country are based on the location of the customer site.

(1)
Revenues attributable to a country are based on the location of the customer site.

The breakout of product and service revenues was as follows:

  2022   2021   2021-2022
Dollar
Change
 

 

2023

 

 

2022

 

 

2022-2023
Dollar
Change

 

  (in millions) 

 

(in millions)

 

Product revenues

  $2,591.6   $3,196.6   $(605.0

 

$

2,096.3

 

 

$

2,591.6

 

 

$

(495.3

)

Service revenues

   563.5    506.3    57.2 

 

 

580.0

 

 

 

563.5

 

 

 

16.5

 

  

 

   

 

   

 

 

 

$

2,676.3

 

 

$

3,155.0

 

 

$

(478.8

)

  $3,155.0   $3,702.9   $(547.9
  

 

   

 

   

 

 

29


35


Our product revenues decreased $605.0$495.3 million, or 18.9%19.1%, primarily due to lower tester sales in Semiconductor Test for mobilecompute and high performance compute processormobility applications, a decrease in sales in Storage Test of system level and hard disk drive testers, and a decrease in cellular test product sales in Wireless Test partially offset by the rise in Robotics revenues driven primarily by elevated demand for collaborative robotic arms and autonomous mobile robots.sales of connectivity test products. Our service revenues increased $57.2$16.5 million, or 11.3%2.9%, primarily in Semiconductor Test and Storage Test.

In 2023, revenues from Texas Instruments Inc., a customer of our Semiconductor Test segment, accounted for 10% of our consolidated revenues. In 2021, revenues from Taiwan Semiconductor Manufacturing Company Ltd., a customer of our Semiconductor Test segment, accounted for 12% of our consolidated revenues. In 20222023 and 2021,2022, our five largest direct customers in aggregate accounted for 26%32% and 33%26% of our consolidated revenues, respectively. We estimate consolidated revenues driven by Qualcomm, a customer of our Semiconductor Test, System Test and Wireless Test segments, combining direct and indirect sales, accounted for approximately 11% of our consolidated revenues in 2022 and less than 10% in 2021. We estimate consolidated revenues driven by one OEM customer, of our Semiconductor Test and Wireless Test segments, combining direct sales to that customer with sales to the customer’s OSATs, accounted for less than 10% of our consolidated revenues in 2022 and 19% of our consolidated revenues in 2021.2022.

Gross Profit

  2022 2021 2021-2022
Dollar /
Point
Change
 

 

2023

 

 

2022

 

 

2022-2023
Dollar /
Point
Change

 

  (in millions) 

 

(in millions)

 

Gross profit

  $1,867.2  $2,206.7  $(339.5

 

$

1,536.7

 

 

$

1,867.2

 

 

$

(330.5

)

Percent of total revenues

   59.2  59.6  (0.4

 

 

57.4

%

 

 

59.2

%

 

 

(1.8

)

Gross profit as a percent of total revenues decreased by 0.41.8 points, primarily due to a lower volume, higher service costs partially offset by favorablespending to strengthen our supply chain, and product mix and lower variable compensation.mix.

The breakout of product and service gross profit was as follows:

  2022 2021 2021-2022
Dollar /
Point
Change
 

 

2023

 

 

2022

 

 

2022-2023
Dollar /
Point
Change

 

  (in millions) 

 

(in millions)

 

Product gross profit

  $1,549.0  $1,896.5  $(347.5

 

$

1,213.4

 

 

$

1,549.0

 

 

$

(335.6

)

Percent of product revenues

   59.8  59.3  0.5 

 

 

57.9

%

 

 

59.8

%

 

 

(1.9

)

Service gross profit

  $318.1  $310.2  $7.9 

 

$

323.4

 

 

$

318.1

 

 

$

5.3

 

Percent of service revenues

   56.5  61.3  (4.8

 

 

55.7

%

 

 

56.5

%

 

 

(0.8

)

Service

Product revenues gross profit percentage decreased 4.8%by 1.9 points, primarily due to lower margins in Semiconductor Test driven by an increase in headcount.volume, higher spending to strengthen our supply chain, and product mix.

We assess the carrying value of our inventory on a quarterly basis by estimating future demand and comparing that demand against on-hand and on-order inventory positions. Forecasted revenues information is obtained from the sales and marketing groups and incorporates factors such as backlog and future revenues. This quarterly process identifies obsolete and excess inventory. Obsolete inventory, which represents items for which there is no demand, is fully reserved. Excess inventory, which represents inventory items that are not expected to be consumed within the forecasted demand window, is written down to estimated net realizable value.

During the year ended December 31, 2023, we recorded an inventory provision of $28.4 million included in cost of revenues, primarily due to downward revisions to previously forecasted demand levels for certain products. Of the $28.4 million of total excess and obsolete provisions, $22.5 million was related to Semiconductor Test, $2.3 million was related to Robotics, $1.9 million was related to System Test, and $1.7 million was related to Wireless Test.

During the year ended December 31, 2022, we recorded an inventory provision of $31.5 million included in cost of revenues, primarily due to downward revisions to previously forecasted demand levels for certain products. Of the $31.5 million of total excess and obsolete provisions, $21.5 million was related to Semiconductor Test, $4.6 million was related to Wireless Test, $3.7 million was related to Robotics, and $1.7 million was related to System Test.

3630



During the year ended December 31, 2021, we recorded an inventory provision of $15.5 million included in cost of revenues, primarily due to downward revisions to previously forecasted demand levels for certain products. Of the $15.5 million of total excess and obsolete provisions, $6.7 million was related to Semiconductor Test, $6.4 million was related to Robotics, $1.8 million was related to Wireless Test, and $0.6 million was related to System Test.

During the years ended December 31, 20222023 and 2021,2022, we scrapped $8.8$26.4 million and $10.9$8.8 million of inventory, respectively, and sold $1.8$5.2 million and $2.5$1.8 million of previously written-down or written-off inventory, respectively. As of December 31, 2022,2023, we had inventory related reserves for amounts which had been written-down or written-off totaling $136.8$136.0 million. We have no pre-determined timeline to scrap the remaining inventory.

Selling and Administrative

Selling and administrative expenses were as follows:

  2022 2021 2021-2022
Change
 

 

2023

 

 

2022

 

 

2022-2023
Change

 

  (in millions) 

 

(in millions)

 

Selling and administrative

  $558.1  $547.6  $10.5 

 

$

577.3

 

 

$

558.1

 

 

$

19.2

 

Percent of total revenues

   17.7  14.8 

 

 

21.6

%

 

 

17.7

%

 

 

 

The increase of $10.5$19.2 million in selling and administrative expenses was primarily driven by increasedue to the charge of $5.9 million related to the modification of Teradyne’s chief executive officer’s outstanding equity awards in headcountconnection with his retirement and greaterhigher sales and marketing spending in Robotics partially offset by lower variable compensation.and Semiconductor Test.

Engineering and Development

Engineering and development expenses were as follows:

  2022 2021 2021-2022
Change
 

 

2023

 

 

2022

 

 

2022-2023
Change

 

  (in millions) 

 

(in millions)

 

Engineering and development

  $440.6  $427.6  $13.0 

 

$

418.1

 

 

$

440.6

 

 

$

(22.5

)

Percent of total revenues

   14.0  11.5 

 

 

15.6

%

 

 

14.0

%

 

 

 

The increasedecrease of $13.0$22.5 million in engineering and development expenses was primarily driven by increase in headcountdue to lower variable compensation and greaterlower spending in Robotics and Semiconductor Test, partially offset by lower variable compensation.higher spending in Robotics.

Restructuring and Other

During the year ended December 31, 2023, we recorded $14.7 million of severance charges related to headcount reductions of 215 people primarily in Semiconductor Test and Robotics, which included charges related to a voluntary early retirement program for employees meeting certain conditions, $3.1 million of acquisition and divestiture expenses related to the Technoprobe transaction, a $1.5 million contract termination charge, and a charge of $1.1 million for an increase in environmental liability.

During the year ended December 31, 2022, we recorded a charge of $14.7 million related to the arbitration claim filed against Teradyne and AutoGuide related to an earn-out dispute which was settled on March 25, 2022 for $26.7 million, $2.9 million of severance charges primarily in Robotics, and a charge of $2.7 million for an increase in environmental and legal liabilities, partially offset by a $3.4 million gain on sale of an asset.

During the year ended December 31, 2021, we recorded a charge of $12.0 million related to the arbitration claim filed against Teradyne and AutoGuide related to an earn-out dispute, $1.5 million of severance charges primarily in Robotics, $0.5 million of acquisition related compensation and expenses and $2.5 million for an increase in environmental and legal liabilities, offset by a $7.2 million gain for the decrease in the fair value of the AutoGuide contingent consideration liability.

37


Interest and Other

  2022   2021   2021-2022
Change
 

 

2023

 

 

2022

 

 

2022-2023
Change

 

  (in millions) 

 

(in millions)

 

Interest income

  $(6.4  $(2.6  $(3.8

 

$

(27.3

)

 

$

(6.4

)

 

$

(20.9

)

Interest expense

   3.7    17.8    (14.1

 

 

3.8

 

 

 

3.7

 

 

 

0.1

 

Other (income) expense, net

   (5.8   24.6    (30.4

 

 

(1.0

)

 

 

(5.8

)

 

 

4.8

 

Interest income increased $3.8by $20.9 million due to higher interest rates. Interest expense decreased $14.1 million primarily due to the January 1, 2022 adoption of ASU 2020-06 which eliminated the amortization of the debt discount which was $10.3 millionrates in 2021.2023. Other (income) expense, net decreased by $30.4$4.8 million primarily due to $28.8 million losses on convertible debt conversions recognized in 2021 and an increasethe change in pension actuarial gains,gains/losses, from $2.2 million gain in 2021 toa $25.6 million gain in 2022 to a $2.7 million loss in 2023, partially offset by changesthe change in unrealized gains/losses on equity securities, from a $9.7 million loss in 2022 to a $7.2 million gain in 2021 to a $9.0 million loss in 2022,2023, and a $4$7.5 million increaseunrealized gain on our call option purchased in foreign exchange losses.connection with our agreement to acquire a 10% investment in Technoprobe S.p.A.

31


Income (Loss) Before Income Taxes

  2022   2021   2021-2022
Change
 

 

2023

 

 

2022

 

 

2022-2023
Change

 

  (in millions) 

 

(in millions)

 

Semiconductor Test

  $634.5   $977.0   $(342.5

 

$

453.3

 

 

$

634.5

 

 

$

(181.2

)

System Test

   166.9    163.1    3.8 

 

 

94.1

 

 

 

166.9

 

 

 

(72.8

)

Wireless Test

   66.8    83.5    (16.7

 

 

30.6

 

 

 

66.8

 

 

 

(36.2

)

Robotics

   (16.2   (8.2   (8.0

 

 

(54.3

)

 

 

(16.2

)

 

 

(38.1

)

Corporate and Eliminations (1)

   (11.6   (54.5   42.9 

 

 

1.9

 

 

 

(11.6

)

 

 

13.5

 

  

 

   

 

   

 

 

 

$

525.6

 

 

$

840.4

 

 

$

(314.8

)

  $840.4   $1,161.0   $(320.6
  

 

   

 

   

 

 

(1)

Included in Corporate and Eliminations are interest income, interest expense, net foreign exchange gains (losses), intercompany eliminations, pension and postretirement plan actuarial gains (losses), legal and environmental fees, contingent consideration adjustments, acquisition related charges and compensation and loss on convertible debt conversions in 2021.

(1)
Included in Corporate and Eliminations are interest income, interest expense, net foreign exchange gains (losses), intercompany eliminations, employee severance, pension and postretirement plan actuarial gains (losses), legal and environmental fees, acquisition and divestiture related expenses, contract termination settlement charge, and an expense for the modification of Teradyne's former chief executive officer's outstanding equity awards.

The decrease in income before income taxes in Semiconductor Test was driven primarily by lower revenues in mobiletester sales for compute and high performance compute processor applications, partially offset by lower variable compensation.mobility applications. The increasedecrease in income before income taxes in System Test was primarily due to higherlower sales in Defense/Aerospace and in Production Board Test, partially offset by a decline in Storage Test sales of system level and hard disk drive testers. The decrease in income before income taxes in Wireless Test was driven primarily by lowera decrease in sales in cellular test products partially offset by elevated sales in ultra-wide bandof connectivity test products. The decrease in income before income taxes in Robotics was driven primarily by ansoftening demand due to slowing global industrial activity and macro-economic headwinds and the impact of the transformation of Universal Robots sales channel. The increase in headcount and greater spending, partially offset by higher revenue for collaborative robotic arms and autonomous mobile robots. The change in income before income taxes in Corporate and Eliminations of $42.9 million was primarily due primarily to $28.8 million of legal settlement charges in 2022 related to litigation for the earn-out dispute in connection with the AutoGuide acquisition, changes in unrealized gains/losses on convertible debt conversions recognized in 2021equity securities and an increase of $23.4 million in pension actuarial gains in 2022.higher interest income.

Income Taxes

Income tax expense for 2023 and 2022 and 2021, totaled $124.9$76.8 million and $146.4$124.9 million, respectively. The effective tax rate for 2023 and 2022 was 14.6% and 2021 was 14.9% and 12.6%, respectively.

The increasedecrease in the effective tax rate from 20212022 to 20222023 is primarily attributable to increases in benefit from tax credits and the U.S. foreign derived intangible income deduction. These decreases in expense were partially offset by a shift in the geographic distribution of income, which increased the income subject to taxation in higher tax rate jurisdictions relative to lower tax rate jurisdictions increasesand a reduction in expensebenefit from U.S. global low-taxed income and increases in expenseequity compensation.

38


from non-deductible officer compensation. These increases in expense were partially offset by increases in benefits from the U.S. foreign derived intangible income deduction and tax credits.

We qualify for a tax holiday in Singapore by fulfilling the requirements of an agreement with the Singapore Economic Development Board under which certain headcount and spending requirements must be met. The tax savings attributable to the Singapore tax holiday for the years ended December 31, 2023 and 2022 were $1.4 million or $0.01 per diluted share and 2021 were $16.0 million or $0.09 per diluted share and $33.3 million or $0.18 per diluted share, respectively. In November 2020, we entered into an agreement with the Singapore Economic Development Board which extended our Singapore tax holiday under substantially similar terms to the agreement which expired on December 31, 2020. The new tax holiday is scheduled to expire on December 31, 2025.

Capital Resources and Material Cash Requirements

Our cash, cash equivalents and marketable securities balance decreased by $495$68.0 million in 20222023 to $1,005$937.2 million. Cash decreased due to stock repurchases in the amount of $752$397.2 million, quarterly cash dividend payments in the amount of $70$67.9 million, and payments of convertible debt principal in the amount of $67$50.3 million, partially offset by cash generated by our global operations.

Operating activities during 2023 provided cash of $585.2 million. Changes in operating assets and liabilities used cash of $9.6 million. This was due to a $33.2 million decrease in operating assets and a $42.8 million decrease in operating liabilities.

The decrease in operating assets was due to a $71.0 million decrease in accounts receivable due to lower sales and a $5.3 million decrease in inventories, partially offset by a $43.1 million increase in prepayments and other assets due to prepayments to our contract manufacturers.

32


The decrease in operating liabilities was due to a $57.2 million decrease in deferred revenue and customer advance payments, a $26.9 million decrease in income taxes, a $21.2 million decrease in accrued employee compensation, and $5.5 million of retirement plan contributions, partially offset by a $45.0 million increase in accounts payable, and a $23.0 million increase in other accrued liabilities.

Investing activities during 2023 used cash of $179.6 million, due to $161.9 million used for purchases of marketable securities, $159.6 million used for purchases of property, plant and equipment, and $5.0 million used for issuance of convertible loan, partially offset by $85.0 million and $61.4 million in proceeds from maturities and sales of marketable securities, respectively, and $0.5 million in proceeds from the cancellation of Teradyne owned life insurance policies related to the cash surrender value.

Financing activities during 2023 used cash of $501.9 million, due to $397.2 million used for the repurchase of 3.9 million shares of common stock at an average price of $102.47 per share, $67.9 million used for dividend payments, $50.3 million used for the payments of convertible debt principal, and $20.8 million used for payments related to net settlement of employee stock compensation awards, partially offset by $34.3 million from the issuance of common stock under employee stock purchase and stock option plans.

Operating activities during 2022 provided cash of $577.9 million. Changes in operating assets and liabilities used cash of $272.6 million. This was due to a $170.9 million increase in operating assets and a $101.7 million decrease in operating liabilities.

The increase in operating assets was due to a $140.7 million increase in prepayments and other assets due to prepayments to our contract manufacturers, and an $80.8 million increase in inventories, partially offset by a $50.6 million decrease in accounts receivable due to lower sales.

The decrease in operating liabilities was due to a $40.3 million decrease in accrued employee compensation, a $29.8 million decrease in income taxes, a $10.8 million decrease in accounts payable, a $9.3 million decrease in other accrued liabilities, a $6.2 million decrease in deferred revenue and customer advance payments, and $5.1 million of retirement plan contributions.

Investing activities during 2022 provided cash of $43.8 million, due to $268.1 million and $222.9 million in proceeds from sales and maturities of marketable securities, respectively, $3.4 million due to sale of an asset, partially offset by $287.4 million used for purchases of marketable securities and $163.2 million used for purchases of property, plant and equipment.

Financing activities during 2022 used cash of $893.0 million, due to $752.1 million used for the repurchase of 7.3 million shares of common stock at an average price of $103.69 per share, $69.7 million used for dividend payments, $66.8 million used for the payments of convertible debt principal, and $33.2 million used for payments related to net settlement of employee stock compensation awards, partially offset by $28.7 million from the issuance of common stock under employee stock purchase and stock option plans.

Operating activities during 2021 providedIn January 2023, May 2023, August 2023 and November 2023, our Board of Directors declared a quarterly cash dividend of $1,098.4 million. Changes in operating assets and liabilities used cash of $98.8 million. This was due to a $227.1 million increase in operating assets and a $128.4 million increase in operating liabilities.

The increase in operating assets was due to a $175.8 million increase in prepayments and other assets due to prepayments to our contract manufacturers, a $57.8 million increase in accounts receivable due to greater sales, partially offset by a $6.5 million decrease in inventories.

The increase in operating liabilities was due to a $63.5 million increase in other accrued liabilities, a $35.1 million increase in accrued employee compensation, a $22.9 million increase in accounts payable, and a $9.9 million increase in deferred revenue and customer advance payments, partially offset by a $5.6 million decrease in income taxes, and $5.4 million of retirement plan contributions.

39


Investing activities during 2021 provided cash of $120.4 million, due to $660.1 million and $266.5 million in proceeds from maturities and sales of marketable securities, respectively, partially offset by $661.8 million used for purchases of marketable securities, $132.5 million used for purchases of property, plant and equipment, and $12.0 million used for an investment in MachineMetrics, Inc. (“MachineMetrics”).

Financing activities during 2021 used cash of $1,008.6 million, due to $600.0 million used for the repurchase of 4.8 million shares of common stock at an average price of $125.74$0.11 per share, $343.0 million used for the payments of convertible debt principal, $66.0 million used forshare. Total dividend payments and $32.3 million used for payments related to net settlement of employee stock compensation awards, partially offset by $32.7 million from the issuance of common stock under employee stock purchase and stock option plans.

in 2023 were $67.9 million. In January 2022, May 2022, August 2022 and November 2022, our Board of Directors declared a quarterly cash dividend of $0.11 per share. Total dividend payments in 2022 were $69.7 million.

In January 2021, May 2021, August 2021 and November 2021, our Board of Directors declared a quarterly cash dividend of $0.10 per share. Total dividend payments in 2021 were $66.0 million.

In January 2021, our Board of Directors approved a repurchase program for up to $2.0 billion of common stock. In 2022, we repurchased 7.3 million shares of common stock for $752.1 million at an average price of $103.69 per share. In 2021, we repurchased 4.8 million shares of common stock for $600.0 million at an average price of $125.74 per share. The cumulative repurchases as of December 31, 2022, under this repurchase program were 12.0 million shares of common stock for $1,352.1 million at an average price per share of $112.44.

In January 2023, our Board of Directors cancelled the 2021 repurchase program and approved a new repurchase program for up to $2.0 billion of common stock. WeIn 2023, we repurchased 3.9 million shares of common stock for $397.2 million, which excludes related excise tax, at an average price of $102.47 per share. In 2022, we repurchased 7.3 million shares of common stock for $752.1 million at an average price of $103.69 per share against the 2021 repurchase program. The cumulative repurchases as of December 31, 2022, under the 2021 repurchase program, were 12.0 million shares of common stock for $1,352.1 million at an average price per share of $112.44. In 2024 we intend to repurchase up to $500.0 million of common stock in 2023 subject to market conditions.$90.0 million.

While we declared a quarterly cash dividend and authorized a share repurchase program, we may reduce or eliminate the cash dividend or share repurchase program in the future. Future cash dividends and stock repurchases are subject to the discretion of our Board of Directors, which will consider, among other things, our earnings, capital requirements and financial condition.

On November 7, 2023, Teradyne announced a strategic partnership with Technoprobe S.p.A including Teradyne's agreement to acquire a 10% equity investment in Technoprobe for 481.0 million Euros. Teradyne will face a three year restriction on the transfer or disposition of the Technoprobe shares upon closing of the agreement, subject to certain early termination events.

On May 1, 2020, we entered into a credit agreement providing a three-year, senior secured revolving credit facility of $400 million. On December 10, 2021, the credit agreement was amended to extend the senior secured revolving credit facility to December 10, 2026. On October 5, 2022, the credit agreement was amended to increase the amount of the credit facility to $750.0 million from $400.0 million. As of February 22, 2023, we have not borrowed any funds under the credit facility.

33


We expect operations to continue to be the primary source of cash to operate the business and meet material cash commitments, including any payments of convertible debt principal, our stock repurchase program, our quarterly dividends, our office lease obligations, contractual obligations related to inventory purchases and the construction of new facilities. We believe our cash, cash equivalents and marketable securities balance will be sufficient to pay our quarterly dividend and meet our working capital and expenditure needs for at least the next twelve months. Inflation has not had a significant long-term impact on earnings. At this time, the COVID-19 pandemic has not had an impact on our liquidity, but there is no assurance that continued impacts resulting from the pandemic will not have an adverse effect in the future.

At December 31, 2022,2023, our future contractual obligations were related to debt, leases, retirement plan liabilities, deferred tax benefits, and purchase obligations. See Note J. “Debt”, Note I. “Leases”, Note P. “Retirement Plans”, and Note S. “Income Taxes” of Notes to Consolidated Financial Statements in this Annual Report for information about those obligations, which Notes are incorporated by reference into this section. Our purchase obligations were approximately $654.8$414.4 million, with $570.3$379.1 million expected to be paid within twelve months.

40


Retirement Plans

ASC 715-20, “Compensation—Retirement Benefits—Defined Benefit Plans,” requires an employer with defined benefit plans or other postretirement benefit plans to recognize an asset or a liability on its balance sheet for the overfunded or underfunded status of the plans as defined by ASC 715-20. The pension asset or liability represents the difference between the fair value of the pension plans’ assets and the projected benefit obligation as of December 31. For other postretirement benefit plans, the liability is the difference between the fair value of the plan’s assets and the accumulated postretirement benefit obligation as of December 31.

For the year ended December 31, 2022,2023, our pension income,expense, which includes the U.S. Qualified Pension Plan (“U.S. Plan”), certain qualified plans for non-U.S. subsidiaries, and a U.S. Supplemental Executive Defined Benefit Plan, was approximately $19.7$6.8 million. Pension income/expense is calculated based upon a number of actuarial assumptions. Discount rate and expected return on assets are two assumptions which are important elements of pension plan expense and asset/liability measurement. We evaluate our discount rate and expected rate of return on assets assumptions annually on a plan and country specific basis. We evaluate other assumptions related to demographic factors, such as retirement age, mortality and turnover periodically, and update them to reflect our experience and expectations for the future.

In developing the expected return on U.S. Plan assets assumption, we evaluated input from our investment manager and pension consultants, including their forecast of asset class return expectations. We believe that 2.0%4.75% was an appropriate rate of return on assets to use for 2022.2023. The December 31, 20222023 asset allocation for our U.S. Plan was 94% invested in fixed income securities, 5% invested in equity securities, and 1% invested in other securities. Our investment manager regularly reviews the actual asset allocation and periodically rebalances the portfolio to ensure alignment with our target allocations.

We recognize net actuarial gains and losses and the change in the fair value of plan assets in our operating results in the year in which they occur or upon any interim remeasurement of the plans. We calculate the expected return on plan assets using the fair value of the plan assets. Actuarial gains and losses are generally measured annually as of December 31 and, accordingly, recorded during the fourth quarter of each year or upon any interim remeasurement of the plans.

The discount rate that we utilized for determining future pension obligations for the U.S. Plan is based on the FTSE Pension Index adjusted for the U.S. Plan’s expected cash flows and was 4.75% at December 31, 2023, down from 4.95% at December 31, 2022, up from 2.65% at December 31, 2021.2022. We estimate that in 2023,2024, we will recognize approximately $0.4$0.2 million of pension expense for the U.S. Plan. The U.S. Plan pension expense estimate for 20232024 is based on a 4.95%4.75% discount rate and a 4.75%4.65% return on assets. Future pension expense or income will depend on future investment performance, changes in future discount rates and various other factors related to the employee population participating in our pension plans.

As of December 31, 2022,2023, our pension plans had no unrecognized pension prior service cost.

The assets of the U.S. Plan consist substantially of fixed income securities. U.S. Plan assets have decreasedincreased from $149.6 million at December 31, 2021 to $111.8 million at December 31, 2022 to $112.6 million at December 31, 2023, while the U.S. Plan’s liability decreasedincreased from $134.5 million at December 31, 2021 to $100.0 million at December 31, 2022. In 2022 the decrease in plan assets and plan liability was due to an increase in interest rates. In 2020, the accrued pension obligations for approximately 115 retiree participants were transferred to an insurance company and resulted in a $24.4$101.1 million reduction in the pension benefit obligation and pension assets. We recorded $2.2 million of pension actuarial loss and a settlement loss of $0.5 million related to the retiree group annuity transaction.at December 31, 2023.

Our funding policy is to make contributions to our pension plans in accordance with local laws and to the extent that such contributions are tax deductible. During 2022,2023, we made contributions of $3.2$3.1 million to the U.S. supplemental executive defined benefit pension plan, and $0.9$1.0 million to certain qualified plans for non-U.S.

41


subsidiaries. In 2023,2024, we expect to contribute approximately $3.1 million to the U.S. supplemental executive defined benefit pension plan. Contributions to be made in 20232024 to certain qualified plans for non-U.S. subsidiaries are based on local statutory requirements and are estimated at approximately $1.3$1.4 million.

34


Equity Compensation Plans

In addition to our 1996 Employee Stock Purchase Plan discussed in Note Q: “Stock-Based Compensation” in Notes to Consolidated Financial Statements, we have a 2006 Equity and Cash Compensation Incentive Plan (the “2006 Equity Plan”) under which equity securities are authorized for issuance. The 2006 Equity Plan was initially approved by stockholders on May 25, 2006.

At our annual meeting of stockholders held May 21, 2013, our stockholders approved an amendment to the 2006 Equity Plan to increase the number of shares issuable thereunder by 10.0 million, for an aggregate of 32.0 million shares issuable thereunder, and our stockholders also approved an amendment to our 1996 Employee Stock Purchase Plan to increase the number of shares issuable thereunder by 5.0 million, for an aggregate of 30.4 million shares issuable thereunder. At our annual meeting of stockholders held May 12, 2015, our stockholders approved an amendment to the 2006 Equity Plan to extend its term until May 12, 2025. At our annual meeting of stockholders held May 7, 2021, our stockholders approved an amendment to our 1996 Employee Stock Purchase Plan to increase the number of shares issuable thereunder by 3.0 million, for an aggregate of 33.4 million shares issuable thereunder.

The following table presents information about these plans as of December 31, 20222023 (share numbers in thousands):

Plan category

 Number of securities
to be issued upon
exercise of
outstanding options,
warrants and rights
 Weighted average
exercise price of
outstanding options,
warrants and rights
 Number of securities remaining
available for future issuance
under equity compensation
plans (excluding securities
reflected in column one)
 

 

Number of securities
to be issued upon
exercise of
outstanding options,
warrants and rights

 

 

Weighted-average
exercise price of
outstanding options,
warrants and rights

 

 

Number of securities remaining
available for future issuance
under equity compensation
plans (excluding securities
reflected in column one)

 

 

Equity plans approved by shareholders

  1,505(1)  $55.90   8,954(2) 

 

 

1,548

 

(1)

 

$

94.85

 

 

 

7,863

 

(2)

(1)

Includes 1,317,544 shares of restricted stock units that are not included in the calculation of the weighted average exercise price.

(2)

Consists of 5,060,445 securities available for issuance under the 2006 Equity Plan and 3,893,933 of securities available for issuance under the Employee Stock Purchase Plan.

(1)
Includes 1,377,662 shares of restricted stock units that are not included in the calculation of the weighted average exercise price.
(2)
Consists of 4,352,428 securities available for issuance under the 2006 Equity Plan and 3,510,784 of securities available for issuance under the Employee Stock Purchase Plan.

The purpose of the 2006 Equity Plan is to motivate employees, officers and directors by providing equity ownership and compensation opportunities in Teradyne. The aggregate number of shares available under the 2006 Equity Plan as of December 31, 20222023 was 5,060,4454,352,428 shares of our common stock. The 2006 Equity Plan authorizes the grant of stock-based awards in the form of (1) non-qualified and incentive stock options, (2) stock appreciation rights, (3) restricted stock awards and restricted stock unit awards, (4) phantom stock, and (5) other stock-based awards. Awards may be tied to time-based vesting schedules and/or performance-based vesting measured by reference to performance criteria chosen by the Compensation Committee of the Board of Directors, which administers the 2006 Equity Plan. Awards may be made to any employee, officer, consultant and advisor of Teradyne and our subsidiaries, as well as to our directors. The maximum number of shares of stock-based awards that may be granted to one participant during any one fiscal year is 2,000,000 shares of common stock.

As of December 31, 2022,2023, total unrecognized compensation expense related to non-vested restricted stock units and options was $61.1$73.7 million and is expected to be recognized over a weighted average period of 2.5 years.

4235



Performance Graph

The following graph compares the change in our cumulative total shareholder return in our common stock with (i) the Standard & Poor’s 500 Index and (ii) the Morningstar Global Semiconductor Equipment & Materials GR USD Industry Group. The comparison assumes $100.00 was invested on December 31, 20172018 in our common stock and in each of the foregoing indices and assumes reinvestment of dividends, if any. Historic stock price performance is not necessarily indicative of future price performance.

LOGOimg13843946_0.jpg 

Recently Issued Accounting Pronouncements

ForIn November 2023, the year endedFinancial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures", which will require us to disclose significant segment expenses and other segment items used by the Chief Operating Decision Maker ("CODM") on an annual and interim basis as well as provide in interim periods all disclosures about a reportable segment’s profit or loss and assets that are currently required annually. Additionally, we will be required to disclose the title and position of the CODM. The new standard is effective for fiscal years beginning after December 31, 2022, there were15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. This ASU will have no recently issued accounting pronouncements that had,impact on our results of operations, cash flows or are expectedfinancial condition. Upon adoption, we will apply the amendments in this ASU retrospectively to have, a material impact to our consolidatedall prior period disclosures presented in the financial statements.

In December 2023, FASB issued ASU 2023-09 –“Income Taxes (Topic 740): Improvements to Income Tax Disclosures”, which requires expanded disclosures relating to the tax rate reconciliation, income taxes paid, income (loss) before income tax expense (benefit) and income tax expense (benefit), requiring a greater disaggregation of information for each. The provisions of ASU 2023-09 are effective for fiscal years beginning after December 15, 2024. The amendments in this update should be applied on a prospective basis, but retrospective application is permitted. We are currently evaluating the impact of this new standard.

Item 7A:

Item 7A: Quantitative and Qualitative Disclosures about Market Risks

Quantitative and Qualitative Disclosures about Market Risks

Concentration of Credit Risk

Financial instruments which potentially subject us to concentrations of credit risk consist principally of cash equivalents, marketable securities, forward currency contracts and accounts receivable. Our cash equivalents consist primarily of money market funds invested in U.S. Treasuries and government agencies. Our fixed income available-for-sale marketable securities have a minimum rating of AA by one or more of the major credit rating agencies. We place forward currency contracts with high credit-quality financial institutions in order to minimize credit risk exposure. Concentrations of credit risk with respect to accounts receivable

36


are limited due to the large number of geographically dispersed customers. We perform ongoing credit evaluations of our customers’ financial condition and from time to time may require customers to provide a letter of credit from a bank to secure accounts receivable. As of December 31, 2023, a customer of our Semiconductor Test segment, Texas Instruments Inc., accounted for 18% of our accounts receivable balance. There were no customers who accounted for more than 10% of our accounts receivable balance as of December 31, 2022 and December 31, 2021.2022.

In addition to market risks described in our Annual Report on Form 10-K, we have an equity price risk related to the fair value of our convertible senior unsecured notes issued in December 2016. In December 2016, Teradyne issued $460 million aggregate principal amount of 1.25% convertible senior unsecured notes (the “Notes”) due December 15, 2023. As of December 31, 2022, $50.2 million of principal remained outstanding and

43


the Notes had a fair value of $139.0 million. The table below provides a sensitivity analysis of hypothetical 10% changes of Teradyne’s stock price as of the end of the last quarter of 2022 and the estimated impact on the fair value of the Notes. The selected scenarios are not predictions of future events, but rather are intended to illustrate the effect such event may have on the fair value of the Notes. The fair value of the Notes is subject to equity price risk due to the convertible feature. The fair value of the Notes will generally increase as Teradyne’s common stock price increases and will generally decrease as the common stock price declines in value. The change in stock price affects the fair value of the Notes, but does not impact Teradyne’s financial position, cash flows or results of operations due to the fixed nature of the debt obligation. Additionally, we carry the Notes at face value less unamortized debt issuance costs on our balance sheet, and we present the fair value for required disclosure purposes only. In connection with the offering of the Notes we also sold warrants. The warrants will have a dilutive effect on our earnings per share to the extent that the average market price of our common stock for a given reporting period exceeds the applicable strike price of the warrants.

Hypothetical Change in Teradyne Stock Price

 Fair Value  Estimated change in fair
value
  Hypothetical
percentage increase
(decrease) in fair value
 

10% Increase

 $152,962  $13,955   10.0

No Change

  139,007   —     —   

10% Decrease

  125,068   (13,939  (10.0

See Note J: “Debt” for further information.

Exchange Rate Risk Management

We regularly enter into foreign currency forward contracts to hedge the value of our monetary assets and liabilities in Japanese Yen, British Pound, Korean Won, Taiwan Dollar, Singapore Dollar, Euro, Philippine Peso, Chinese Yuan, and Danish Krone. These foreign currency forward contracts have maturities of approximately one month. These contracts are used to minimize the effect of exchange rate fluctuations associated with the remeasurement of monetary assets and liabilities.

We also enter into foreign currency forward contracts to hedge the impact of exchange rates on our revenues in Japanese Yen and Taiwan Dollar. These contracts have maturities of less than one year. We do not engage in currency speculation.

On November 7, 2023, in connection with our agreement to acquire 10% investment in Technoprobe S.p.A, we purchased a call option to buy 481.0 million Euros. The expiration date of the option is April 26, 2024. Since the transaction price was agreed to in Euros, this option contract reduces the impact to the purchase price of changes in the Euro to U.S. Dollar exchange rate.

We performed a sensitivity analysis assuming a hypothetical 10% fluctuation in foreign exchange rates to the hedging contracts and the underlying exposures described above. As of December 31, 20222023 and 2021,2022, the analysis indicated that these hypothetical market movements would not have a material effect on our consolidated financial position, results of operations or cash flows.

Interest Rate Risk Management

We are exposed to potential losses due to changes in interest rates. Our interest rate exposure is primarily related to short-term and long-term marketable securities.

In order to estimate the potential loss due to interest rate risk, a fluctuation in interest rates of 25 basis points was assumed. Market risk for the short and long-term marketable securities was estimated as the potential change in the fair value resulting from a hypothetical change in interest rates for securities contained in the investment portfolio. The potential change in the fair value from changes in interest rates is immaterial as of December 31, 20222023 and 2021.2022.

37


Item 8: Financial Statements and Supplementary Data

44


Item 8:
Financial Statements and Supplementary Data
Report of Independent Registered Public Accounting Firm

To the

Board of Directors and Shareholders of Teradyne, Inc.

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of Teradyne, Inc. and its subsidiaries (the “Company”) as of December 31, 20222023 and 2021,2022, and the related consolidated statements of operations, comprehensive income, convertible common shares and shareholders’shareholders' equity and cash flows for each of the three years in the period ended December 31, 2022,2023, including the related notes and schedule of valuation and qualifying accounts for each of the three years in the period ended December 31, 20222023 appearing under Item 15(c) (collectively referred to as the “consolidated financial statements”). We also have audited the Company’sCompany's internal control over financial reporting as of December 31, 2022,2023, based on criteria established in

Internal Control - Integrated Framework
(2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 20222023 and 2021,2022, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 20222023 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022,2023, based on criteria established in

Internal Control - Integrated Framework
(2013) issued by the COSO.

Changes in Accounting Principles

As discussed in Note B to the consolidated financial statements, the Company changed the manner in which it accounts for convertible debt in 2022.

Basis for Opinions

The Company’sCompany's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management’s Annual Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company’sCompany's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an

45

understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in

38


accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Critical Audit Matters

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Conversions of Senior Unsecured Notes

Revenue Recognition - Certain Product Revenue

As described in NotesNote B and J to the consolidated financial statements, during 2022, forty two holdersthe Company recognizes revenue for transactions that do not meet the criteria for over time recognition at a point in time when shipped or delivered based on contractual terms. The transaction price is the amount of consideration the Company expects to be entitled to in exchange for such products, which is generally at contractually stated prices. The Company’s convertible senior unsecured notes, originally issued on December 12, 2016, converted $66.8 million of the senior unsecured notes. The Company may satisfy its conversion obligation by paying cashtotal product revenue was $2.1 billion for the principal amountyear ended December 31, 2023, of the senior unsecured notes and paying or delivering cash, shares of the Company’s common stock orwhich a combination of cash and shares of the Company’s common stock, at management’s election for the amount in excess of principal.

majority relates to certain product revenue.

The principal considerationsconsideration for our determination that performing procedures relating to the conversions of senior unsecured notesrevenue recognition for certain product revenue is a critical audit matter are (i) theis a high degree of auditauditor effort in performing procedures and evaluating management’s calculationrelated to revenue recognition for certain of the conversion transactions and the related settlement calculations and (ii) the audit effort involved the use of professionals with specialized skill and knowledge.

Company’s product revenue.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management’s review of conversion transactions related to the Company’s senior unsecured notes, which included controls related to the conversion values and related settlement calculations.recognition process for certain product revenue. These procedures also included, among others on(i) testing the completeness, accuracy, and occurrence of revenue recognized for a test basis (i) evaluating the appropriatenesssample of the conversion

46

and settlement accounting;shipment or delivery; (ii) testing the completenesscut off of revenue recognized for a sample of certain product revenue transactions near period end by obtaining and accuracyinspecting source documents, such as purchase orders, invoices and proof of the conversion values;shipment or delivery; and (iii) recalculating the settlement amounts. Professionals with specialized skillconfirming a sample of outstanding customer invoice balances as of December 31, 2023 and, knowledge were used to assist in the evaluationfor confirmations not returned, obtaining and inspecting source documents, such as purchase orders, invoices, proof of the appropriateness of the conversionshipment or delivery, and settlement accounting.
subsequent cash receipts.

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts

February 22, 2023

2024

We have served as the Company’s auditor since 1968.

47

39


TERADYNE, INC.

CONSOLIDATED BALANCE SHEETS

   
December 31,
 
   
2022
  
2021
 
   
(in thousands, except per
share amount)
 
ASSETS
         
Current assets:
         
Cash and cash equivalents
  $854,773  $1,122,199 
Marketable securities
   39,612   244,231 
Accounts receivable, less allowance for credit losses of $1,955 and $2,012 in 2022 and 2021, respectively
   491,145   550,749 
Inventories, net
   325,019   243,330 
Prepayments
   532,962   406,266 
Other current assets
   14,404   9,452 
   
 
 
  
 
 
 
Total current assets
   2,257,915   2,576,227 
Property, plant and equipment, net
   418,683   387,240 
Operating lease right-of-use assets, net
   73,734   68,807 
Marketable securities
   110,777   133,858 
Deferred tax assets
   142,784   102,428 
Retirement plans assets
   11,761   15,110 
Other assets
   28,925   24,096 
Acquired intangible assets, net
   53,478   75,635 
Goodwill
   403,195   426,024 
   
 
 
  
 
 
 
Total assets
  $3,501,252  $3,809,425 
   
 
 
  
 
 
 
LIABILITIES
         
Current liabilities:
         
Accounts payable
  $139,722  $153,133 
Accrued employees’ compensation and withholdings
   212,266   253,667 
Deferred revenue and customer advances
   148,285   146,185 
Other accrued liabilities
   112,271   124,187 
Operating lease liabilities
   18,594   19,977 
Income taxes payable
   65,010   88,789 
Current debt
   50,115   19,182 
   
 
 
  
 
 
 
Total current liabilities
   746,263   805,120 
Retirement plans liabilities
   116,005   151,141 
Long-term deferred revenue and customer advances
   45,131   54,921 
Deferred tax liabilities
   3,267   6,327 
Long-term other accrued liabilities
   15,981   15,497 
Long-term operating lease liabilities
   64,176   56,178 
Long-term income taxes payable
   59,135   67,041 
Debt
   —     89,244 
   
 
 
  
 
 
 
Total liabilities
   1,049,958   1,245,469 
   
 
 
  
 
 
 
Commitments and contingencies (Note M)
         
Mezzanine equity:
         
Convertible common shares
   —     1,512 
SHAREHOLDERS’ EQUITY
         
Common stock, $0.125 par value, 1,000,000 shares authorized, 155,759 and 162,251
shares issued and outstanding at December 31, 2022 and 2021, respectively
   19,470   20,281 
Additional paid-in capital
   1,755,963   1,811,545 
Accumulated other comprehensive loss
   (49,868  (5,948
Retained earnings
   725,729   736,566 
   
 
 
  
 
 
 
Total shareholders’ equity
   2,451,294   2,562,444 
   
 
 
  
 
 
 
Total liabilities, convertible common shares and shareholders’ equity
  $3,501,252  $3,809,425 
   
 
 
  
 
 
 

 

 

December 31,

 

 

 

2023

 

 

2022

 

 

 

(in thousands, except per share amount)

 

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

757,571

 

 

$

854,773

 

Marketable securities

 

 

62,154

 

 

 

39,612

 

Accounts receivable, less allowance for credit losses of $1,988 and $1,955 in 2023 and 2022,
    respectively

 

 

422,124

 

 

 

491,145

 

Inventories, net

 

 

309,974

 

 

 

325,019

 

Prepayments

 

 

548,970

 

 

 

532,962

 

Other current assets

 

 

37,992

 

 

 

14,404

 

Current assets held for sale

 

 

23,250

 

 

 

 

Total current assets

 

 

2,162,035

 

 

 

2,257,915

 

Property, plant and equipment, net

 

 

445,492

 

 

 

418,683

 

Operating lease right-of-use assets, net

 

 

73,417

 

 

 

73,734

 

Marketable securities

 

 

117,434

 

 

 

110,777

 

Deferred tax assets

 

 

175,775

 

 

 

142,784

 

Retirement plans assets

 

 

11,504

 

 

 

11,761

 

Other assets

 

 

38,580

 

 

 

28,925

 

Acquired intangible assets, net

 

 

35,404

 

 

 

53,478

 

Goodwill

 

 

415,652

 

 

 

403,195

 

Long-term assets held for sale

 

 

11,531

 

 

 

 

Total assets

 

$

3,486,824

 

 

$

3,501,252

 

LIABILITIES

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

180,131

 

 

$

139,722

 

Accrued employees’ compensation and withholdings

 

 

191,750

 

 

 

212,266

 

Deferred revenue and customer advances

 

 

99,804

 

 

 

148,285

 

Other accrued liabilities

 

 

114,712

 

 

 

112,271

 

Operating lease liabilities

 

 

17,522

 

 

 

18,594

 

Income taxes payable

 

 

48,653

 

 

 

65,010

 

Current debt

 

 

 

 

 

50,115

 

Current liabilities held for sale

 

 

7,379

 

 

 

 

Total current liabilities

 

 

659,951

 

 

 

746,263

 

Retirement plans liabilities

 

 

132,090

 

 

 

116,005

 

Long-term deferred revenue and customer advances

 

 

37,282

 

 

 

45,131

 

Deferred tax liabilities

 

 

183

 

 

 

3,267

 

Long-term other accrued liabilities

 

 

19,998

 

 

 

15,981

 

Long-term operating lease liabilities

 

 

65,092

 

 

 

64,176

 

Long-term income taxes payable

 

 

44,331

 

 

 

59,135

 

Long-term liabilities held for sale

 

 

2,000

 

 

 

 

Total liabilities

 

 

960,927

 

 

 

1,049,958

 

Commitments and contingencies (Note M)

 

 

 

 

 

 

SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

Common stock, $0.125 par value, 1,000,000 shares authorized, 152,698 and 155,759 shares issued
    and outstanding at December 31, 2023 and 2022, respectively

 

 

19,087

 

 

 

19,470

 

Additional paid-in capital

 

 

1,827,274

 

 

 

1,755,963

 

Accumulated other comprehensive loss

 

 

(26,978

)

 

 

(49,868

)

Retained earnings

 

 

706,514

 

 

 

725,729

 

Total shareholders’ equity

 

 

2,525,897

 

 

 

2,451,294

 

Total liabilities, convertible common shares and shareholders’ equity

 

$

3,486,824

 

 

$

3,501,252

 

The accompanying notes are an integral part of the consolidated financial statements.

48

40


TERADYNE, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

   
Years Ended December 31,
 
   
2022
  
2021
  
2020
 
   
(in thousands, except per share amount)
 
Revenues:
             
Products
  $2,591,572  $3,196,575  $2,690,906 
Services
   563,473   506,306   430,563 
   
 
 
  
 
 
  
 
 
 
Total revenues
   3,155,045   3,702,881   3,121,469 
Cost of revenues:
             
Cost of products
   1,042,555   1,300,106   1,157,476 
Cost of services
   245,339   196,119   178,252 
   
 
 
  
 
 
  
 
 
 
Total cost of revenues (exclusive of acquired intangible assets amortization shown separately below)
   1,287,894   1,496,225   1,335,728 
   
 
 
  
 
 
  
 
 
 
Gross profit
   1,867,151   2,206,656   1,785,741 
Operating expenses:
             
Selling and administrative
   558,103   547,559   464,769 
Engineering and development
   440,591   427,609   374,964 
Acquired intangible assets amortization
   19,333   21,456   30,803 
Restructuring and other
   17,185   9,312   (13,202
   
 
 
  
 
 
  
 
 
 
Total operating expenses
   1,035,212   1,005,936   857,334 
   
 
 
  
 
 
  
 
 
 
Income from operations
   831,939   1,200,720   928,407 
Non-operating (income) expenses:
             
Interest income
   (6,379  (2,627  (5,982
Interest expense
   3,719   17,820   24,182 
Other (income) expense, net
   (5,786  24,572   9,192 
   
 
 
  
 
 
  
 
 
 
Income before income taxes
   840,385   1,160,955   901,015 
Income tax provision
   124,884   146,366   116,868 
   
 
 
  
 
 
  
 
 
 
Net income
  $715,501  $1,014,589  $784,147 
   
 
 
  
 
 
  
 
 
 
Net income per common share:
             
Basic
  $4.52  $6.15  $4.72 
   
 
 
  
 
 
  
 
 
 
Diluted
  $4.22  $5.53  $4.28 
   
 
 
  
 
 
  
 
 
 
Weighted average common shares—basic
   158,434   164,960   166,120 
   
 
 
  
 
 
  
 
 
 
Weighted average common shares—diluted
   169,734   183,625   183,042 
   
 
 
  
 
 
  
 
 
 

 

 

Years Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

 

 

(in thousands, except per share amount)

 

Revenues:

 

 

 

 

 

 

 

 

 

Products

 

$

2,096,286

 

 

$

2,591,572

 

 

$

3,196,575

 

Services

 

 

580,012

 

 

 

563,473

 

 

 

506,306

 

Total revenues

 

 

2,676,298

 

 

 

3,155,045

 

 

 

3,702,881

 

Cost of revenues:

 

 

 

 

 

 

 

 

 

Cost of products

 

 

882,892

 

 

 

1,042,555

 

 

 

1,300,106

 

Cost of services

 

 

256,658

 

 

 

245,339

 

 

 

196,119

 

Total cost of revenues (exclusive of acquired intangible assets
    amortization shown separately below)

 

 

1,139,550

 

 

 

1,287,894

 

 

 

1,496,225

 

Gross profit

 

 

1,536,748

 

 

 

1,867,151

 

 

 

2,206,656

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Selling and administrative

 

 

577,315

 

 

 

558,103

 

 

 

547,559

 

Engineering and development

 

 

418,089

 

 

 

440,591

 

 

 

427,609

 

Acquired intangible assets amortization

 

 

18,999

 

 

 

19,333

 

 

 

21,456

 

Restructuring and other

 

 

21,277

 

 

 

17,185

 

 

 

9,312

 

Total operating expenses

 

 

1,035,680

 

 

 

1,035,212

 

 

 

1,005,936

 

Income from operations

 

 

501,068

 

 

 

831,939

 

 

 

1,200,720

 

Non-operating (income) expenses:

 

 

 

 

 

 

 

 

 

Interest income

 

 

(27,348

)

 

 

(6,379

)

 

 

(2,627

)

Interest expense

 

 

3,806

 

 

 

3,719

 

 

 

17,820

 

Other (income) expense, net

 

 

(962

)

 

 

(5,786

)

 

 

24,572

 

Income before income taxes

 

 

525,572

 

 

 

840,385

 

 

 

1,160,955

 

Income tax provision

 

 

76,820

 

 

 

124,884

 

 

 

146,366

 

Net income

 

$

448,752

 

 

$

715,501

 

 

$

1,014,589

 

Net income per common share:

 

 

 

 

 

 

 

 

 

Basic

 

$

2.91

 

 

$

4.52

 

 

$

6.15

 

Diluted

 

$

2.73

 

 

$

4.22

 

 

$

5.53

 

Weighted average common shares—basic

 

 

154,310

 

 

 

158,434

 

 

 

164,960

 

Weighted average common shares—diluted

 

 

164,304

 

 

 

169,734

 

 

 

183,625

 

The accompanying notes are an integral part of the consolidated financial statements.

4
9

41


TERADYNE, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

   
Years Ended December 31,
 
   
2022
  
2021
  
2020
 
   
(in thousands)
 
Net income
  $715,501  $1,014,589  $784,147 
Other comprehensive (loss) income, net of tax:
             
Foreign currency translation adjustment, net of tax of $0, $0, $0, respectively
   (29,031  (36,207  48,903 
Available-for-sale marketable securities:
             
Unrealized (losses) gains on marketable securities arising during
 
period, net of tax of $(
3,388
),
$(
578
), $
1,629
, respectively
   (12,666  (2,255  5,839 
Less: Reclassification adjustment for losses (gains) included in net income, net of tax of $25, $(277), $(665), respectively
   301   (995  (2,365
   
 
 
  
 
 
  
 
 
 
    (12,365  (3,250  3,474 
Cash flow hedges:
             
Unrealized losses arising during period, net of tax of $(708), $0, $0, respectively
   (2,517  —     —   
Defined benefit post-retirement plan:
             
Amortization of prior service credit, net of tax $(2), $(2), $(2), respectively
   (7  (7  (7
   
 
 
  
 
 
  
 
 
 
Other comprehensive (loss) income
   (43,920  (39,464  52,370 
   
 
 
  
 
 
  
 
 
 
Comprehensive income
  $671,581  $975,125  $836,517 
   
 
 
  
 
 
  
 
 
 

 

 

Years Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Net income

 

$

448,752

 

 

$

715,501

 

 

$

1,014,589

 

Other comprehensive income (loss), net of tax:

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustment, net of tax of $0, $0, $0,
    respectively

 

 

17,407

 

 

 

(29,031

)

 

 

(36,207

)

Available-for-sale marketable securities:

 

 

 

 

 

 

 

 

 

Unrealized gains (losses) on marketable securities arising during
    period, net of tax of $
568, $(3,388), ($578), respectively

 

 

2,423

 

 

 

(12,666

)

 

 

(2,255

)

Less: Reclassification adjustment for losses (gains) included in net
    income, net of tax of $
12, $25, $(277), respectively

 

 

44

 

 

 

301

 

 

 

(995

)

 

 

2,467

 

 

 

(12,365

)

 

 

(3,250

)

Cash flow hedges:

 

 

 

 

 

 

 

 

 

Unrealized gains (losses) arising during period, net of tax of $1,537,
    $(
708), $0, respectively

 

 

5,464

 

 

 

(2,517

)

 

 

 

Less: Reclassification adjustment for losses included in net
    income, net of tax of $(
686), $0, $0, respectively

 

 

(2,441

)

 

 

 

 

 

 

 

 

 

3,023

 

 

 

(2,517

)

 

 

 

Defined benefit post-retirement plan:

 

 

 

 

 

 

 

 

 

Amortization of prior service credit, net of tax $(2), $(2), $(2),
    respectively

 

 

(7

)

 

 

(7

)

 

 

(7

)

Other comprehensive income (loss)

 

 

22,890

 

 

 

(43,920

)

 

 

(39,464

)

Comprehensive income

 

$

471,642

 

 

$

671,581

 

 

$

975,125

 

The accompanying notes are an integral part of the consolidated financial statements.

5
0

42


TERADYNE, INC.

CONSOLIDATED STATEMENTS OF CONVERTIBLE COMMON SHARES

AND SHAREHOLDERS’ EQUITY

     
Shareholders’ Equity
 
  
Convertible
Common
Shares
Value
  
Common
Stock
Shares
  
Common
Stock
Par
Value
  
Additional
Paid-in
Capital
  
Accumulated
Other
Comprehensive
(Loss) Income
  
(Accumulated
Deficit)
Retained
Earnings
  
Total
Shareholders’
Equity
 
  
(in thousands)
 
Year Ended December 31, 2019
 $—     166,410  $20,801  $1,720,129  $(18,854 $(241,918 $1,480,158 
Net issuance of common stock under stock-based plans
      1,230   154   4,696           4,850 
Stock-based compensation expense
              44,285           44,285 
Repurchase of common stock
      (1,517  (190          (88,275  (88,465
Cash dividends ($0.40 per share)
                      (66,540  (66,540
Convertible common shares
  3,787           (3,787          (3,787
Net income
                      784,147   784,147 
Other comprehensive income
                  52,370       52,370 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Year Ended December 31, 2020
  3,787   166,123   20,765   1,765,323   33,516   387,414   2,207,018 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Net issuance of common stock under stock-based plans
      899   113  ��(225          (112
Stock-based compensation expense
              45,632           45,632 
Repurchase of common stock
      (4,771  (597          (599,403  (600,000
Cash dividends ($0.40 per share)
                      (66,034  (66,034
Settlements of convertible notes
      8,148   1,018   984,622           985,640 
Exercise of convertible notes hedge call options
      (8,148)  (1,018  (986,082          (987,100
Convertible common shares
  (2,275          2,275           2,275 
Net income
                      1,014,589   1,014,589 
Other comprehensive loss
                  (39,464      (39,464
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Year Ended December 31, 2021
  1,512   162,251   20,281   1,811,545   (5,948  736,566   2,562,444 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Net issuance of common stock under stock-based plans
      761   96   (4,471          (4,375
Stock-based compensation expense
              48,466           48,466 
Repurchase of common stock
      (7,253  (907          (751,175  (752,082
Cash dividends ($0.44 per share)
                      (69,763  (69,763
Settlements of convertible notes
      1,495   187   (442          (255
Exercise of convertible notes hedge call options
      (1,495  (187  187           —   
Convertible common shares
  (1,512          1,512           1,512 
Cumulative effect of change in accounting principle related to convertible debt
              (100,834      94,600   (6,234
Net income
                      715,501   715,501 
Other comprehensive loss
                  (43,920      (43,920
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Year Ended December 31, 2022
 $—     155,759  $19,470  $1,755,963  $(49,868 $725,729  $2,451,294 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 

 

 

 

 

 

Shareholders’ Equity

 

 

 

Convertible
Common
Shares Value

 

 

Common
Stock Shares

 

 

Common
Stock
Par Value

 

 

Additional
Paid-in
Capital

 

 

Accumulated
Other
Comprehensive
Income (loss)

 

 

Retained
Earnings

 

 

Total
Shareholders’
Equity

 

 

 

(in thousands)

 

Year Ended December 31, 2020

 

$

3,787

 

 

 

166,123

 

 

$

20,765

 

 

$

1,765,323

 

 

$

33,516

 

 

$

387,414

 

 

 

2,207,018

 

Net issuance of common stock under stock-based plans

 

 

 

 

 

899

 

 

 

113

 

 

 

(225

)

 

 

 

 

 

 

 

 

(112

)

Stock-based compensation expense

 

 

 

 

 

 

 

 

 

 

 

45,632

 

 

 

 

 

 

 

 

 

45,632

 

Repurchase of common stock

 

 

 

 

 

(4,771

)

 

 

(597

)

 

 

 

 

 

 

 

 

(599,403

)

 

 

(600,000

)

Cash dividends ($0.40 per share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(66,034

)

 

 

(66,034

)

Settlements of convertible notes

 

 

 

 

 

8,148

 

 

 

1,018

 

 

 

984,622

 

 

 

 

 

 

 

 

 

985,640

 

Exercise of convertible notes hedge call options

 

 

 

 

 

(8,148

)

 

 

(1,018

)

 

 

(986,082

)

 

 

 

 

 

 

 

 

(987,100

)

Convertible common shares

 

 

(2,275

)

 

 

 

 

 

 

 

 

2,275

 

 

 

 

 

 

 

 

 

2,275

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,014,589

 

 

 

1,014,589

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(39,464

)

 

 

 

 

 

(39,464

)

Year Ended December 31, 2021

 

$

1,512

 

 

 

162,251

 

 

$

20,281

 

 

$

1,811,545

 

 

$

(5,948

)

 

$

736,566

 

 

$

2,562,444

 

Net issuance of common stock under stock-based plans

 

 

 

 

 

761

 

 

 

96

 

 

 

(4,471

)

 

 

 

 

 

 

 

 

(4,375

)

Stock-based compensation expense

 

 

 

 

 

 

 

 

 

 

 

48,466

 

 

 

 

 

 

 

 

 

48,466

 

Repurchase of common stock

 

 

 

 

 

(7,253

)

 

 

(907

)

 

 

 

 

 

 

 

 

(751,175

)

 

 

(752,082

)

Cash dividends ($0.44 per share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(69,763

)

 

 

(69,763

)

Settlements of convertible notes

 

 

 

 

 

1,495

 

 

 

187

 

 

 

(442

)

 

 

 

 

 

 

 

 

(255

)

Exercise of convertible notes hedge call options

 

 

 

 

 

(1,495

)

 

 

(187

)

 

 

187

 

 

 

 

 

 

 

 

 

 

Convertible common shares

 

 

(1,512

)

 

 

 

 

 

 

 

 

1,512

 

 

 

 

 

 

 

 

 

1,512

 

Cumulative-effect of change in accounting principle
     related to convertible debt

 

 

 

 

 

 

 

 

 

 

 

(100,834

)

 

 

 

 

 

94,600

 

 

 

(6,234

)

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

715,501

 

 

 

715,501

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(43,920

)

 

 

 

 

 

(43,920

)

Year Ended December 31, 2022

 

$

 

 

 

155,759

 

 

$

19,470

 

 

$

1,755,963

 

 

$

(49,868

)

 

$

725,729

 

 

$

2,451,294

 

Net issuance of common stock under stock-based plans

 

 

 

 

 

848

 

 

 

106

 

 

 

13,371

 

 

 

 

 

 

 

 

 

13,477

 

Stock-based compensation expense

 

 

 

 

 

 

 

 

 

 

 

57,940

 

 

 

 

 

 

 

 

 

57,940

 

Repurchase of common stock

 

 

 

 

 

(3,909

)

 

 

(489

)

 

 

 

 

 

 

 

 

(400,040

)

 

 

(400,529

)

Cash dividends ($0.44 per share)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(67,927

)

 

 

(67,927

)

Settlements of convertible notes

 

 

 

 

 

1,072

 

 

 

133

 

 

 

(133

)

 

 

 

 

 

 

 

 

 

Exercise of convertible notes hedge call options

 

 

 

 

 

(1,072

)

 

 

(133

)

 

 

133

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

448,752

 

 

 

448,752

 

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

22,890

 

 

 

 

 

 

22,890

 

Year Ended December 31, 2023

 

$

 

 

 

152,698

 

 

$

19,087

 

 

$

1,827,274

 

 

$

(26,978

)

 

$

706,514

 

 

$

2,525,897

 

The accompanying notes are an integral part of the consolidated financial statements.

5
1

43


TERADYNE, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

   
Years Ended December 31,
 
   
2022
  
2021
  
2020
 
   
(in thousands)
 
Cash flows from operating activities:
             
Net income
  $715,501  $1,014,589  $784,147 
Adjustments to reconcile net income from operations to net cash provided by operating activities:
             
Depreciation
   90,763   91,073   80,119 
Stock-based compensation
   48,228   45,643   44,906 
Provision for excess and obsolete inventory
   31,452   15,475   17,534 
Amortization
   19,912   34,412   46,624 
Deferred taxes
   (38,693  (17,305  (15,688
Retirement plans actuarial (gains) losses
   (25,584  (2,217  10,284 
Losses (gains) on investments
   9,985   (6,410  (7,898
Gains on sale of asset
   (3,410  —     —   
Loss on convertible debt conversion
   —     28,828   —   
Contingent consideration fair value adjustment
   —     (7,227  (23,271
Other
   2,353   271   1,557 
Changes in operating assets and liabilities, net of businesses acquired:
             
Accounts receivable
   50,628   (57,778  (129,451
Inventories
   (80,809  6,495   (8,438
Prepayments and other assets
   (140,713  (175,846  (64,418
Accounts payable and other accrued expenses
   (60,507  129,499   73,167 
Deferred revenue and customer advances
   (6,233  9,873   39,974 
Retirement plan contributions
   (5,116  (5,405  (5,382
Income taxes
   (29,834  (5,604  25,169 
   
 
 
  
 
 
  
 
 
 
Net cash provided by operating activities
   577,923   1,098,366   868,935 
   
 
 
  
 
 
  
 
 
 
Cash flows from investing activities:
             
Purchases of property, plant and equipment
   (163,249  (132,472  (184,977
Purchases of marketable securities
   (287,409  (661,781  (900,196
Proceeds from maturities of marketable securities
   222,941   660,148   479,678 
Proceeds from sales of marketable securities
   268,058   266,466   35,006 
Proceeds from sale of asset
   3,410   —     —   
Purchase of investment and acquisition of business
   —     (12,000  149 
Proceeds from insurance
   —     —     546 
   
 
 
  
 
 
  
 
 
 
Net cash provided by (used for) investing activities
   43,751   120,361   (569,794
   
 
 
  
 
 
  
 
 
 
Cash flows from financing activities:
             
Repurchase of common stock
   (752,082  (600,000  (88,465
Payments of convertible debt principal
   (66,759  (342,990  —   
Dividend payments
   (69,711  (65,977  (66,482
Payments related to net settlement of employee stock compensation awards
   (33,170  (32,303  (23,014
Issuance of common stock under stock purchase and stock option plans
   28,733   32,686   28,527 
Payments of contingent consideration
   —     —     (8,852
   
 
 
  
 
 
  
 
 
 
Net cash used for financing activities
   (892,989  (1,008,584  (158,286
   
 
 
  
 
 
  
 
 
 
Effects of exchange rate changes on cash and cash equivalents
   3,889   (2,065  (658
(Decrease) increase in cash and cash equivalents
   (267,426  208,078   140,197 
Cash and cash equivalents at beginning of year
   1,122,199   914,121   773,924 
   
 
 
  
 
 
  
 
 
 
Cash and cash equivalents at end of year
  $854,773  $1,122,199  $914,121 
   
 
 
  
 
 
  
 
 
 
Supplementary disclosure of cash flow information:
             
Cash paid for:
             
Interest
  $1,498  $4,236  $6,435 
Income taxes
  $193,246  $172,134  $106,577 
Non-cash investing activities:
             
Capital expenditures incurred but not yet paid:
  $1,826  $1,973  $3,666 

 

 

Years Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

Net income

 

$

448,752

 

 

$

715,501

 

 

$

1,014,589

 

Adjustments to reconcile net income from operations to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

Depreciation

 

 

92,118

 

 

 

90,763

 

 

 

91,073

 

Stock-based compensation

 

 

57,682

 

 

 

48,228

 

 

 

45,643

 

Provision for excess and obsolete inventory

 

 

28,358

 

 

 

31,452

 

 

 

15,475

 

Amortization

 

 

18,768

 

 

 

19,912

 

 

 

34,412

 

Retirement plans actuarial losses (gains)

 

 

2,703

 

 

 

(25,584

)

 

 

(2,217

)

Deferred taxes

 

 

(37,642

)

 

 

(38,693

)

 

 

(17,305

)

(Gains) losses on investments

 

 

(14,915

)

 

 

9,985

 

 

 

(6,410

)

Gains on sale of asset

 

 

 

 

 

(3,410

)

 

 

 

Loss on convertible debt conversion

 

 

 

 

 

 

 

 

28,828

 

Contingent consideration fair value adjustment

 

 

 

 

 

 

 

 

(7,227

)

Other

 

 

(955

)

 

 

2,353

 

 

 

271

 

Changes in operating assets and liabilities, net of businesses acquired:

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

70,977

 

 

 

50,628

 

 

 

(57,778

)

Inventories

 

 

5,327

 

 

 

(80,809

)

 

 

6,495

 

Prepayments and other assets

 

 

(43,101

)

 

 

(140,713

)

 

 

(175,846

)

Accounts payable and other accrued expenses

 

 

46,782

 

 

 

(60,507

)

 

 

129,499

 

Deferred revenue and customer advances

 

 

(57,210

)

 

 

(6,233

)

 

 

9,873

 

Retirement plan contributions

 

 

(5,492

)

 

 

(5,116

)

 

 

(5,405

)

Income taxes

 

 

(26,921

)

 

 

(29,834

)

 

 

(5,604

)

Net cash provided by operating activities

 

 

585,231

 

 

 

577,923

 

 

 

1,098,366

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

Purchases of property, plant and equipment

 

 

(159,642

)

 

 

(163,249

)

 

 

(132,472

)

Purchases of marketable securities

 

 

(161,906

)

 

 

(287,409

)

 

 

(661,781

)

Proceeds from maturities of marketable securities

 

 

85,042

 

 

 

222,941

 

 

 

660,148

 

Proceeds from sales of marketable securities

 

 

61,401

 

 

 

268,058

 

 

 

266,466

 

Proceeds from insurance

 

 

460

 

 

 

 

 

 

 

Issuance of convertible loan

 

 

(5,000

)

 

 

 

 

 

 

Proceeds from sale of asset

 

 

 

 

 

3,410

 

 

 

 

Purchase of investment and acquisition of business

 

 

 

 

 

 

 

 

(12,000

)

Net cash (used for) provided by investing activities

 

 

(179,645

)

 

 

43,751

 

 

 

120,361

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

Repurchase of common stock

 

 

(397,241

)

 

 

(752,082

)

 

 

(600,000

)

Dividend payments

 

 

(67,878

)

 

 

(69,711

)

 

 

(65,977

)

Payments of convertible debt principal

 

 

(50,264

)

 

 

(66,759

)

 

 

(342,990

)

Payments related to net settlement of employee stock compensation awards

 

 

(20,788

)

 

 

(33,170

)

 

 

(32,303

)

Issuance of common stock under stock purchase and stock option plans

 

 

34,259

 

 

 

28,733

 

 

 

32,686

 

Net cash used for financing activities

 

 

(501,912

)

 

 

(892,989

)

 

 

(1,008,584

)

Effects of exchange rate changes on cash and cash equivalents

 

 

(876

)

 

 

3,889

 

 

 

(2,065

)

(Decrease) increase in cash and cash equivalents

 

 

(97,202

)

 

 

(267,426

)

 

 

208,078

 

Cash and cash equivalents at beginning of year

 

 

854,773

 

 

 

1,122,199

 

 

 

914,121

 

Cash and cash equivalents at end of year

 

$

757,571

 

 

$

854,773

 

 

$

1,122,199

 

Supplementary disclosure of cash flow information:

 

 

 

 

 

 

 

 

 

Cash paid for:

 

 

 

 

 

 

 

 

 

Interest

 

$

296

 

 

$

1,498

 

 

$

4,236

 

Income taxes

 

$

140,239

 

 

$

193,246

 

 

$

172,134

 

Non-cash investing activities:

 

 

 

 

 

 

 

 

 

Capital expenditures incurred but not yet paid:

 

$

2,735

 

 

$

1,826

 

 

$

1,973

 

The accompanying notes are an integral part of the consolidated financial statements.

5
2

44


TERADYNE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

A.
THE COMPANY
A.
THE COMPANY

Teradyne, Inc. (“Teradyne”) is a leading global supplier of automated test equipment and robotics solutions. Teradyne designs, develops, manufactures and sells automaticautomated test systems and robotics products. Teradyne’s automaticautomated test systems are used to test semiconductors, wireless products, data storage and complex electronics systems in many industries including consumer electronics, wireless, automotive, industrial, computing, communications, and aerospace and defense industries. Teradyne’s robotics products include collaborative robotic arms, autonomous mobile robots, and advanced robotic control software used by global manufacturing, logistics and industrial customers to improve quality, increase manufacturing and material handling efficiency and decrease manufacturing and logistics costs. Teradyne’s automaticautomated test equipment and robotics products and services include:

semiconductor test (“Semiconductor Test”) systems;
storage and system level test (“Storage Test”) systems, defense/aerospace (“Defense/Aerospace”) test instrumentation and systems, and circuit-board test and inspection (“Production Board Test”) systems (collectively these products represent “System Test”);
wireless test (“Wireless Test”) systems; and
robotics (“Robotics”) products.

B.
ACCOUNTING POLICIES
B.
ACCOUNTING POLICIES

The consolidated financial statements include the accounts of Teradyne and its wholly owned subsidiaries. All significant intercompany balances and transactions are eliminated. Certain prior years’ amounts were reclassified to conform to the current year presentation.

Preparation of Financial Statements and Use of Estimates

The preparation of consolidated financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent liabilities. On an on-going basis, management evaluates its estimates, including those related to inventories, investments, goodwill, intangible and other long-lived assets, accounts receivable, income taxes, deferred tax assets and liabilities, pensions, warranties, contingent consideration liabilities, and loss contingencies. Management bases its estimates on historical experience and on appropriate and customary assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Due to the COVID-19 pandemic, there has been uncertainty and disruption in the global economy and our markets. Management is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of this Annual Report on Form 10-K. These estimates may change, as new events occur and additional information is obtained. Actual results may differ significantly from these estimates under different assumptions or conditions.

5
3

Revenue Recognition

Revenue from Contracts with Customers

In accordance with ASC 606, Teradyne recognizes revenues, when or as control is transferred to a customer. Teradyne’s determination of revenue is dependent upon a five-step process outlined below.

Teradyne accounts for a contract with a customer when there is written approval, the contract is committed, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of collection.
Teradyne periodically enters into contracts with customers in which a customer may purchase a combination of goods and services, such as products with extended warranty obligations. Teradyne determines performance obligations by assessing whether the products or services are distinct from the other elements of the contract. In order to be distinct, the product or service must perform either on its own or with readily available resources and must be separate within the context of the contract.

45


Teradyne determines the transaction price to be the amount of consideration to which Teradyne expects to be entitled to.
to, which is generally at contractually stated prices.
Transaction price is allocated to each individual performance obligation based on the standalone selling price of that performance obligation. Teradyne uses standalone transactions when available to value each performance obligation. If standalone transactions are not available, Teradyne will estimate the standalone selling price through market assessments or cost plus a reasonable margin analysis. Any discounts from standalone selling price are spread proportionally to each performance obligation.
In order to determine the appropriate timing for revenue recognition, Teradyne first determines if the transaction meets any of three criteria for over time recognition. If the transaction meets the criteria for over time recognition, Teradyne recognizes revenue as the good or service is delivered. Teradyne uses input variables such as hours or months utilized or costs incurred to determine the amount of revenue to recognize in a given period. Input variables are used as they best align consumption with benefit to the customer. For transactions that do not meet the criteria for over time recognition, Teradyne will recognize revenue at a point in time based on an assessment of the five criteria for transfer of control. Teradyne has concluded that revenue should be recognized when shipped or delivered based on contractual terms. Typically, acceptance of Teradyne’s products and services is a formality as Teradyne delivers similar systems, instruments and robots to standard specifications. In cases where acceptance is not deemed a formality, Teradyne will defer revenue recognition until customer acceptance.

Performance Obligations

Products

Teradyne products consist primarily of semiconductor test systems and instruments, defense/aerospace test instrumentation and systems, storage test systems and instruments, circuit-board test and inspection systems and instruments, wireless test systems and robotics products. Teradyne’s hardware is typically recognized at a point in time upon transfer of control to the customer.

Services

Teradyne services consist of extended warranties, training and application support, service agreements, post contract customer support (“PCS”) and replacement parts. Each service is recognized based on relative standalone selling price. Extended warranty, training and support, service agreements and PCS are recognized over time based on the period of service. Replacement parts are recognized at a point in time upon transfer of control to the customer.

Teradyne does not allow customer returns or provide refunds to customers for any products or services. Teradyne products include a standa

rd
standard 12
-month warranty. This warranty is not considered a distinct performance
5
4

obligation because it does not obligate Teradyne to provide a separate service to the customer and it cannot be purchased separately. Cost related to warranties are included in cost of revenues when product revenues are recognized.

As of December 31, 20222023 and 2021,2022, deferred revenue and customer advances consisted of the following and are included in the short and long-term deferred revenue and customer advances:

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Maintenance, service and training

 

$

66,458

 

 

$

78,089

 

Customer advances, undelivered elements and other

 

 

35,731

 

 

 

59,147

 

Extended warranty

 

 

34,897

 

 

 

56,180

 

Total deferred revenue and customer advances

 

$

137,086

 

 

$

193,416

 

46


   
2022
   
2021
 
   
(in thousands)
 
Maintenance, service and training
  $78,089   $81,826 
Customer advances, undelivered elements and other
   59,147    55,112 
Extended warranty
   56,180    64,168 
   
 
 
   
 
 
 
Total deferred revenue and customer advances
  $193,416   $201,106 
   
 
 
   
 
 
 

Product Warranty

Teradyne generally provides a one-year warranty on its products, commencing upon installation, acceptance or shipment. A provision is recorded upon revenue recognition to cost of revenues for estimated warranty expense based on historical experience. Related costs are charged to the warranty accrual as incurred. The balance below is included in other accrued liabilities:

 

 

Amount

 

 

 

(in thousands)

 

Balance at December 31, 2020

 

$

16,633

 

Accruals for warranties issued during the period

 

 

35,727

 

Accruals related to pre-existing warranties

 

 

(6,846

)

Settlements made during the period

 

 

(20,937

)

Balance at December 31, 2021

 

 

24,577

 

Accruals for warranties issued during the period

 

 

21,851

 

Accruals related to pre-existing warranties

 

 

(5,618

)

Settlements made during the period

 

 

(26,629

)

Balance at December 31, 2022

 

 

14,181

 

Accruals for warranties issued during the period

 

 

21,644

 

Accruals related to pre-existing warranties

 

 

(1,576

)

Settlements made during the period

 

 

(18,551

)

Balance at December 31, 2023

 

$

15,698

 

   
Amount
 
   
(in thousands)
 
Balance at December 31, 2019
  $8,996 
Accruals for warranties issued during the period
   28,490 
Accruals related to pre-existing warranties
   821 
Settlements made during the period
   (21,674
   
 
 
 
Balance at December 31, 2020
   16,633 
Accruals for warranties issued during the period
   35,727 
Accruals related to pre-existing warranties
   (6,846
Settlements made during the period
   (20,937
   
 
 
 
Balance at December 31, 2021
   24,577 
Accruals for warranties issued during the period
   21,851 
Accruals related to pre-existing warranties
   (5,618
Settlements made during the period
   (26,629
   
 
 
 
Balance at December 31, 2022
  $14,181 
   
 
 
 
5
5

When Teradyne receives revenue for extended warranties, beyond one year, it is deferred and recognized on a straight-line basis over the contract period. Related costs are expensed as incurred. The balance below is included in short and long-term deferred revenue and customer advances:

 

 

Amount

 

 

 

(in thousands)

 

Balance at December 31, 2020

 

$

51,929

 

Deferral of new extended warranty revenue

 

 

43,597

 

Recognition of extended warranty deferred revenue

 

 

(31,358

)

Balance at December 31, 2021

 

 

64,168

 

Deferral of new extended warranty revenue

 

 

33,686

 

Recognition of extended warranty deferred revenue

 

 

(41,674

)

Balance at December 31, 2022

 

 

56,180

 

Deferral of new extended warranty revenue

 

 

14,330

 

Recognition of extended warranty deferred revenue

 

 

(35,613

)

Balance at December 31, 2023

 

$

34,897

 

   
Amount
 
   
(in thousands)
 
Balance at December 31, 2019
  $30,677 
Deferral of new extended warranty revenue
   41,694 
Recognition of extended warranty deferred revenue
   (20,442
   
 
 
 
Balance at December 31, 2020
   51,929 
Deferral of new extended warranty revenue
   43,597 
Recognition of extended warranty deferred revenue
   (31,358
   
 
 
 
Balance at December 31, 2021
   64,168 
Deferral of new extended warranty revenue
   33,686 
Recognition of extended warranty deferred revenue
   (41,674
   
 
 
 
Balance at December 31, 2022
  $56,180 
   
 
 
 

Accounts Receivable and Allowance for Doubtful Accounts

Credit Losses

Trade accounts receivable are recorded at the invoiced amount and do not bear interest. Teradyne maintains allowances for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. Estimated allowances for doubtful accountscredit losses are reviewed periodically taking into account the customer’s recent payment history, the customer’s current financial statements and other information regarding the customer’s credit worthiness.creditworthiness. Account balances are written off against the allowance when it is determined the receivable will not be recovered.

Teradyne sells certain trade accounts receivables on a non-recourse basis to third-party financial institutions pursuant to factoring agreements. Teradyne accounts for these transactions as sales of receivables and presents cash proceeds as a cash provided by operating activities in the consolidated statements of cash flows. Total trade accounts receivable sold under the factoring agreements were $93.9$243.5 million and $111.3$93.9 million during 20222023 and 2021,2022, respectively. Factoring fees for the sales of receivables are recorded in interest expense and are not material.

47


Inventories
Table of Contents

Inventories

Inventories are stated at the lower of cost (first-in, first-out basis) or net realizable value. On a quarterly basis, Teradyne uses consistent methodologies to evaluate all inventories for net realizable value. Teradyne records a provision for both excess and obsolete inventory when such write-downs or write-offs are identified through the quarterly review process. The inventory valuation is based upon assumptions about future demand, product mix and possible alternative uses.

Investments

Teradyne accounts for its investments in debt and equity securities in accordance with the provisions of ASC 320-10, “

Investments—Debt and Equity Securities
.” ASC 320-10 requires that certain debt and equity securities be classified into one of three categories; trading, available-for-sale or held-to-maturity securities. On a quarterly basis, Teradyne reviews its investments to identify and evaluate those that have an indication of a potential other-than-temporary impairment. Factors considered in determining whether a loss is other-than-temporary include:

The length of time and the extent to which the market value has been less than cost;
5
6

The financial condition and near-term prospects of the issuer; and
The intent and ability to retain the investment in the issuer for a period of time sufficient to allow for any anticipated recovery in market value.

Teradyne uses the market and income approach techniques to value its financial instruments and there were no changes in valuation techniques during the twelve months ended December 31, 20222023 and 2021.

2022.

Teradyne measures its debt and equity investments at fair value, in accordance with ASC 820-10, ,

Fair Value Measurements and Disclosures.
” ASC 820-10 defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants and requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories:

Level 1: Quoted prices in active markets for identical assets as of the reporting date;

Level 2: Inputs other than Level 1, that are observable either directly or indirectly as of the reporting date. For example, a common approach for valuing fixed income securities is the use of matrix pricing. Matrix pricing is a mathematical technique used to value securities by relying on the securities’ relationship to other benchmark quoted prices, and is considered a Level 2 input; or

Level 3: Unobservable inputs that are not supported by market data. Unobservable inputs are developed based on the best information available, which might include Teradyne’s own data.

Teradyne’s debt investments are classified as Level 2, and equity investments are classified as Level 1. Acquisition-related contingent consideration is classified as Level 3. Teradyne determines the fair value of acquisition-related contingent consideration using a Monte Carlo simulation model. Assumptions utilized in the model include forecasted revenues, revenue volatility, earnings before interest and taxes, and discount rate.

Financial Assets and Financial Liabilities

Teradyne records changes in fair value of equity securities directly in earnings and realizedunrealized gains and losses in other (income) expense, net, in accordance with ASU 2016-01, “

Financial Instruments—Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities
.”

48


Prepayments
Table of Contents

Prepayments

Prepayments consist of the following:

 

 

2023 (1)

 

 

2022

 

 

 

(in thousands)

 

Contract manufacturer and supplier prepayments

 

$

502,257

 

 

$

491,105

 

Prepaid maintenance and other services

 

 

17,592

 

 

 

14,545

 

Prepaid taxes

 

 

16,083

 

 

 

18,625

 

Other prepayments

 

 

13,038

 

 

 

8,687

 

Total prepayments

 

$

548,970

 

 

$

532,962

 

(1)
Excludes $5.3 million of contract manufacturer and supplier prepayments, classified as assets held for sale. See Note E: “Assets held for sale” for additional information.
   
2022
   
2021
 
   
(in thousands)
 
Contract manufacturer and supplier prepayments
  $491,105   $364,478 
Prepaid taxes
   18,625    15,090 
Prepaid maintenance and other services
   14,545    13,660 
Other prepayments
   8,687    13,038 
  
 
 
   
 
 
 
Total prepayments
  $532,962   $406,266 
  
 
 
   
 
 
 

Retirement and Postretirement Plans

Teradyne recognizes net actuarial gains and losses and the change in the fair value of the plan assets in its operating results in the year in which they occur or upon any interim remeasurement of the plans. Teradyne calculates the expected return on plan assets using the fair value of the plan assets. Actuarial gains and losses are generally measured annually as of December 31 and, accordingly, recorded during the fourth quarter of each year or upon any interim remeasurement of the plans.

5
7

Teradyne reports net periodic pension cost and net periodic postretirement benefit costs in accordance with ASU 2017-07, “

Compensation—Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost
.” The service cost component of net benefit costs is reported in the same line item in the consolidated statement of operations as other employee compensation costs. The non-service components of net benefit costs such as interest cost, expected return on assets, amortization of prior service cost, and
actuarial
gains or losses, are reported within other (income) expense, net.

Goodwill, Intangible and Long-Lived Assets

Teradyne accounts for goodwill and intangible assets in accordance with ASC 350-10, “

Intangibles-Goodwill and Other.
” Intangible assets are amortized over their estimated useful economic life and are carried at cost less accumulated amortization. Goodwill is assessed for impairment at least annually in the fourth quarter, as of December 31, on a reporting unit basis, or more frequently when events and circumstances occur indicating that the recorded goodwill may be impaired.

In accordance with ASC 350-10, Teradyne has the option to perform a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If Teradyne determines this is the case, Teradyne is required to perform a quantitative goodwill impairment test to identify potential goodwill impairment and measure the amount of goodwill impairment loss to be recognized. If Teradyne determines that it is more likely than not that the fair value of the reporting unit is greater than its carrying amounts, a quantitative goodwill impairment test is not required.

In accordance with ASC 360-10, “

Impairment or Disposal of Long-Lived Assets,
” Teradyne reviews long-lived assets for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate. Each impairment test is based on a comparison of the estimated undiscounted cash flows to the recorded value of the asset. If impairment is indicated, the asset is written down to its estimated fair value based on a discounted cash flows analysis. The cash flows estimates used to determine the impairment, if any, contain management’s best estimates using appropriate assumptions and projections at that time.

Business Combination

Teradyne recognizes the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values at the date of acquisition. The fair value of identifiable intangible assets is based on detailed cash flows valuations that use information and assumptions provided by management. Teradyne estimates the fair value of contingent consideration at the time of the acquisition using all pertinent information known to us at the time to assess the probability of payment of contingent amounts or through the use of a Monte Carlo simulation model. Teradyne allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired and liabilities assumed to goodwill. The assumptions used in the valuations for our acquisitions may differ materially from actual results depending on performance of the acquired businesses and other factors. While Teradyne believes the assumptions used were appropriate, different assumptions in the valuation of assets acquired and liabilities assumed could have a material impact on the timing and extent of impact on our statements of operations. Goodwill is assigned to reporting units as of the date of the related acquisition.

49


Property, Plant and Equipment

Property, plant and equipment are stated at cost and depreciated over the estimated useful lives of the assets. Leasehold improvements and major renewals are capitalized and included in property, plant and equipment accounts, while expenditures for maintenance and repairs and minor renewals are charged to expense. When assets are retired, the assets and related accumulated depreciation are removed from the accounts and any resulting gain or loss is reflected in the consolidated statements of operations.

58


Teradyne provides for depreciation of its assets principally on the straight-line method with the cost of the assets being charged to expense over their useful lives as follows:

Buildings

40 years

Buildings

Building improvements

40

5 to 10 years

Building improvements
5 to 10 years

Leasehold improvements

Lesser of lease term or

10
years

Furniture and fixtures

10 years

Test systems manufactured internally

6 years

Machinery, equipment and software

3 to 5 years

Test systems manufactured internally are used by Teradyne for customer evaluations and manufacturing and support of its customers. Teradyne depreciates the test systems manufactured internally over a six-year life to cost of revenues, engineering and development, and selling and administrative expenses. Teradyne often sells internally manufactured test equipment to customers. Upon the sale of an internally manufactured test system, the net book value of the system is transferred to inventory and expensed as cost of revenues. The net book value of internally manufactured test systems sold in the years ended December 31, 2023, 2022, and 2021 and 2020 was $6.6$2.8 million, $16.6$6.6 million, and $7.3$16.6 million, respectively.

Convertible Debt

Teradyne adopted Accounting Standards Update (“ASU”) ASU 2020-06 – “Debt—Debt with Conversion and Other Options and Derivatives and Hedging—Contracts in Entity’s Own Equity,” on January 1, 2022 using the modified retrospective method of adoption. As a result of adoption, Teradyne recorded an increase of $1.4$1.4 million to current debt for unsettled shares, an increase of $1.8$1.8 million to deferred tax assets, an increase of $6.6$6.6 million to long-term debt for unamortized debt discount, and an increase to retained earnings of $94.6$94.6 million for the reclassification of the equity component. Mezzanine equity representing unsettled shares value was reduced to zero and additional paid-in capital was reduced by $100.8$100.8 million. In accordance with ASU 2020-06, Teradyne accounts for a convertible debt instrument as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. Unsettled shares are recorded in current debt, and there is no recognition of a debt discount, which was previously amortized to interest expense. Settled shares reduce the outstanding debt balance in an amount equal to the cash paid, but do not result in any gain or loss on extinguishment. We use the if-converted method in the diluted EPS calculation for convertible instruments.

Leases

Under ASC 842, a contract is or contains a lease when Teradyne has the right to control the use of an identified asset. Teradyne determines if an arrangement is a lease at inception of the contract, which is the date on which the terms of the contract are agreed to and the agreement creates enforceable rights and obligations. The commencement date of the lease is the date that the lessor makes an underlying asset available for use by Teradyne. As of December 31, 2022,2023, Teradyne does not have material leases that have not yet commenced.

Teradyne determines if the lease is an operating or finance lease at the lease commencement date based upon the terms of the lease and the nature of the asset. The lease term used to calculate the lease liability includes options to extend or terminate the lease when it is reasonably certain that the option will be exercised.

The lease liability is measured at the present value of future lease payments, discounted using the discount rate for the lease at the commencement date. As Teradyne is typically unable to determine the implicit rate, Teradyne uses an incremental borrowing rate based on the lease term and economic environment at commencement date. Teradyne initially measures payments based on an index by using the applicable rate at lease commencement. Variable payments that do not depend on an index are not included in the lease liability and are recognized as they are incurred. The right-of-use (“ROU”) asset is initially measured as the amount of lease liability, adjusted for any initial lease costs, prepaid lease payments, and reduced by any lease incentives.

59

50


Teradyne’s contracts often include non-lease components such as common area maintenance. Teradyne elected the practical expedient to account for the lease and non-lease components as a single lease component. For leases with a term of one year or less, Teradyne has elected not to record the lease asset or liability. The lease payments are recognized in the consolidated statement of earnings on a straight-line basis over the lease term. Teradyne includes lease costs within cost of revenues and operating expenses. See Note I: “Leases.”

Engineering and Development Costs

Teradyne’s products are highly technical in nature and require a large and continuing engineering and development effort. Software development costs incurred prior to the establishment of technological feasibility are charged to expense. Software development costs incurred subsequent to the establishment of technological feasibility are capitalized until the product is available for release to customers. To date, the period between achieving technological feasibility and general availability of the product has been short and software development costs eligible for capitalization have not been material. Engineering and development costs are expensed as incurred and consist primarily of salaries, contractor fees including non-recurring engineering charges related to product design, allocated facility costs, depreciation, and tooling costs.

Stock Compensation Plans and Employee Stock Purchase Plan

Stock-based compensation expense is based on the grant-date fair value estimated in accordance with the provisions of ASC 718-10, “

Compensation-Stock Compensation
.” Teradyne elects to account for forfeitures by applying an estimated forfeiture rate and recognizes compensation costs only for those stock-based compensation awards expected to vest. Under its stock compensation plans, Teradyne has granted stock options, restricted stock units and performance-based restricted stock units, and employees are eligible to purchase Teradyne’s common stock through its Employee Stock Purchase Plan (“ESPP”).

Excess tax benefits or tax deficiencies are recognized as a discrete tax benefit or discrete tax expense to the current income tax provision in Teradyne’s consolidated statements of operations, all excess tax benefits related to share-based payments are reported as cash flows from operating activities, and all cash payments made to taxing authorities on the employees’ behalf for withheld shares are presented as financing activities on the statement of cash flows.

Income Taxes

Deferred tax assets and liabilities are determined based on differences between financial reporting and tax basis of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The measurement of deferred tax assets is reduced by a valuation allowance if it is more likely than not that some or all of the deferred tax assets will not be realized. Teradyne performed the required assessment of positive and negative evidence regarding the realization of the net deferred tax assets in accordance with ASC 740,

“Accounting for Income Taxes.”
This assessment included the evaluation of scheduled reversals of deferred tax liabilities, estimates of projected future taxable income and tax-planning strategies. Although realization is not assured, based on its assessment, Teradyne concluded that it is more likely than not that such assets, net of the existing valuation allowance, will be realized.

Advertising Costs

Teradyne expenses all advertising costs as incurred. Advertising costs were $17.3$15.5 million, $13.4$17.3 million and $12.8$13.4 million in 2023, 2022 and 2021, and 2020, respectively.

Translation of Non-U.S. Currencies

The functional currency for all non-U.S. subsidiaries is the U.S. dollar, except for Universal Robots, MiR and Lemsys for which the local currency is its functional currency. All foreign currency denominated monetary

6
0

assets and liabilities are remeasured on a monthly basis into the functional currency using exchange rates in effect at the end of the period. All foreign currency denominated non-monetary assets and liabilities are remeasured into the functional currency using historical exchange rates. Net foreign exchange gains and losses resulting from remeasurement are included in other (income) expense, net. For Universal Robots, MiR and Lemsys, assets and liabilities are translated into U.S. dollars using exchange rates in effect at the end of the period. Revenues and expense amounts are translated using an average of exchange rates in effect during the period. Translation adjustments are recorded within accumulated other comprehensive income (loss) on the balance sheet.

Net foreign exchange gains and losses resulting from remeasurement are included in other (income) expense, net. For the years ended December 31, 2023, 2022 2021 and 2020,2021, losses (gains) from the remeasurement of the monetary assets and liabilities denominated in foreign currencies were $10.8$10.9 million, $(2.1)$10.8 million, and $2.6$(2.1) million, respectively.

51


These amounts do not reflect the corresponding (gains) losses from foreign exchange contracts. See Note H: “Financial Instruments” regarding foreign exchange contracts.

Net Income per Common Share

Basic net income per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the period. Except where the result would be anti-dilutive, diluted net income per common share is calculated by dividing net income by the sum of the weighted average number of common shares plus common stock equivalents, if applicable.

With respect to its convertible debt issued in 2016, Teradyne is required to settle the principal of the convertible debt in cash; accordingly, the principal amount is excluded from the determination of diluted earnings per share. As a result, Teradyne is accounting for the conversion spread using the treasury stock method.

Comprehensive Income

Comprehensive income includes net income, unrealized pension and postretirement prior service costs and benefits, unrealized gains and losses on investments in debt marketable securities, unrealized gains and losses on cash flow hedge and foreign currency translation adjustment.

C.
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS
C.
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS
For

In November 2023, the year endedFinancial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures", which will require us to disclose significant segment expenses and other segment items used by the Chief Operating Decision Maker ("CODM") on an annual and interim basis as well as provide in interim periods all disclosures about a reportable segment’s profit or loss and assets that are currently required annually. Additionally, we will be required to disclose the title and position of the CODM. The new standard is effective for fiscal years beginning after December 31, 2022, there were15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. This ASU will have no recently issued accounting pronouncements that had,impact on Teradyne’s results of operations, cash flows or are expectedfinancial condition. Upon adoption, Teradyne will apply the amendments in this ASU retrospectively to have, a material impact to our consolidatedall prior period disclosures presented in the financial statements.

D.
INVESTMENT IN OTHER COMPANY
On June 1, 2021, Teradyne invested $12.0 million

In December 2023, FASB issued ASU 2023-09 –“Income Taxes (Topic 740): Improvements to Income Tax Disclosures”, which requires expanded disclosures relating to the tax rate reconciliation, income taxes paid, income (loss) before income tax expense (benefit) and income tax expense (benefit), requiring a greater disaggregation of information for each. The provisions of ASU 2023-09 are effective for fiscal years beginning after December 15, 2024. The amendments in MachineMetrics, Inc. (“MachineMetrics”), a private company that develops and sells products to improve manufacturing performance through automated machine data collection, alerting, and analytics. Teradyne’s investment in MachineMetrics aligns with its strategy of providing and investing in leading edge products for automating industrial production processes in growing markets. The investment was recorded at cost and is evaluated for impairment or an indication of changes in fair value resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuerthis update should be applied on a quarterly basis. At December 31, 2022,prospective basis, but retrospective application is permitted. Teradyne is currently evaluating the valueimpact of the investment was $12.0 million, and there was no change during the year ended December 31, 2022.

this new standard.

6
1

52


E.
REVENUE

D. REVENUE

Disaggregation of Revenue

The following table provides information about disaggregated revenue by timing of revenue recognition, primary geographical market, and major product lines.

 

 

Semiconductor
Test

 

 

 

 

 

Robotics

 

 

 

 

 

 

 

 

 

 

System-on-a-chip

 

 

Memory

 

 

System
Test

 

 

Universal Robots

 

 

Mobile Industrial Robots

 

 

Wireless
Test

 

 

Corporate
and
Eliminations

 

 

Total

 

 

(in thousands)

 

For the Year Ended December 31, 2023 (1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Timing of Revenue Recognition

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Point in Time

 

$

1,141,882

 

 

$

356,417

 

 

$

268,379

 

 

$

296,252

 

 

$

66,986

 

 

$

129,399

 

 

$

 

 

$

2,259,315

 

Over Time

 

 

290,739

 

 

 

29,598

 

 

 

69,818

 

 

 

7,540

 

 

 

4,405

 

 

 

14,883

 

 

 

 

 

 

416,983

 

Total

 

$

1,432,621

 

 

$

386,015

 

 

$

338,197

 

 

$

303,792

 

 

$

71,391

 

 

$

144,282

 

 

$

 

 

$

2,676,298

 

Geographical Market

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asia Pacific

 

$

1,214,322

 

 

$

366,151

 

 

$

153,387

 

 

$

63,312

 

 

$

10,424

 

 

$

85,415

 

 

$

 

 

$

1,893,011

 

Americas

 

 

117,728

 

 

 

11,367

 

 

 

151,579

 

 

 

111,761

 

 

 

36,191

 

 

 

50,770

 

 

 

 

 

 

479,396

 

Europe, Middle East and Africa

 

 

100,571

 

 

 

8,497

 

 

 

33,231

 

 

 

128,719

 

 

 

24,776

 

 

 

8,097

 

 

 

 

 

 

303,891

 

Total

 

$

1,432,621

 

 

$

386,015

 

 

$

338,197

 

 

$

303,792

 

 

$

71,391

 

 

$

144,282

 

 

$

 

 

$

2,676,298

 

For the Year Ended December 31, 2022 (1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Timing of Revenue Recognition

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Point in Time

 

$

1,445,238

 

 

$

344,693

 

 

$

402,074

 

 

$

317,514

 

 

$

73,812

 

 

$

189,040

 

 

$

251

 

 

$

2,772,622

 

Over Time

 

 

261,646

 

 

 

29,013

 

 

 

67,272

 

 

 

8,218

 

 

 

3,594

 

 

 

12,680

 

 

 

 

 

 

382,423

 

Total

 

$

1,706,884

 

 

$

373,706

 

 

$

469,346

 

 

$

325,732

 

 

$

77,406

 

 

$

201,720

 

 

$

251

 

 

$

3,155,045

 

Geographical Market

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asia Pacific

 

$

1,514,964

 

 

$

360,176

 

 

$

294,350

 

 

$

73,930

 

 

$

15,724

 

 

$

140,767

 

 

$

 

 

$

2,399,911

 

Americas

 

 

122,575

 

 

 

11,987

 

 

 

146,040

 

 

 

112,203

 

 

 

35,213

 

 

 

47,350

 

 

 

251

 

 

 

475,619

 

Europe, Middle East and Africa

 

 

69,345

 

 

 

1,543

 

 

 

28,956

 

 

 

139,599

 

 

 

26,469

 

 

 

13,603

 

 

 

 

 

 

279,515

 

Total

 

$

1,706,884

 

 

$

373,706

 

 

$

469,346

 

 

$

325,732

 

 

$

77,406

 

 

$

201,720

 

 

$

251

 

 

$

3,155,045

 

For the Year Ended December 31, 2021 (1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Timing of Revenue Recognition

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Point in Time

 

$

1,989,979

 

 

$

365,441

 

 

$

409,383

 

 

$

305,512

 

 

$

60,884

 

 

$

204,247

 

 

$

 

 

$

3,335,446

 

Over Time

 

 

256,751

 

 

 

30,171

 

 

 

58,356

 

 

 

5,670

 

 

 

3,839

 

 

 

12,648

 

 

 

 

 

 

367,435

 

Total

 

$

2,246,730

 

 

$

395,612

 

 

$

467,739

 

 

$

311,182

 

 

$

64,723

 

 

$

216,895

 

 

$

 

 

$

3,702,881

 

Geographical Market

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asia Pacific

 

$

2,076,647

 

 

$

381,444

 

 

$

306,812

 

 

$

81,456

 

 

$

12,919

 

 

$

172,103

 

 

$

 

 

$

3,031,381

 

Americas

 

 

102,702

 

 

 

10,665

 

 

 

135,230

 

 

 

94,897

 

 

 

26,069

 

 

 

36,173

 

 

 

 

 

 

405,736

 

Europe, Middle East and Africa

 

 

67,381

 

 

 

3,503

 

 

 

25,697

 

 

 

134,829

 

 

 

25,735

 

 

 

8,619

 

 

 

 

 

 

265,764

 

Total

 

$

2,246,730

 

 

$

395,612

 

 

$

467,739

 

 

$

311,182

 

 

$

64,723

 

 

$

216,895

 

 

$

 

 

$

3,702,881

 

(1)
  
Semiconductor Test
     
Robotics
          
  
System-on-
a-chip
  
Memory
  
System

Test
  
Universal
Robots
  
Mobile
Industrial
Robots
  
Wireless

Test
  
Corporate

and

Eliminations
  
Total
 
           
(in thousands)
          
For the Year Ended December 31, 2022 (1)
                                
Timing of Revenue Recognition
                                
Point in Time
 $1,445,238  $344,693  $402,074  $317,514  $73,812  $189,040  $251  $2,772,622 
Over Time
  261,646   29,013   67,272   8,218   3,594   12,680   —     382,423 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Total
 $1,706,884  $373,706  $469,346  $325,732  $77,406  $201,720  $251  $3,155,045 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Geographical Market
                                
Asia Pacific
 $1,514,964  $360,176  $294,350  $73,930  $15,724  $140,767  $—    $2,399,911 
Americas
  122,575   11,987   146,040   112,203   35,213   47,350   251   475,619 
Europe, Middle East and Africa
  69,345   1,543   28,956   139,599   26,469   13,603   —     279,515 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Total
 $1,706,884  $373,706  $469,346  $325,732  $77,406  $201,720  $251  $3,155,045 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
For the Year Ended December 31, 2021 (1)
                                
Timing of Revenue Recognition
                                
Point in Time
 $1,989,979  $365,441  $409,383  $305,512  $60,884  $204,247  $—    $3,335,446 
Over Time
  256,751   30,171   58,356   5,670   3,839   12,648   —     367,435 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Total
 $2,246,730  $395,612  $467,739  $311,182  $64,723  $216,895  $—    $3,702,881 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Geographical Market
                                
Asia Pacific
 $2,076,647  $381,444  $306,812  $81,456  $12,919  $172,103  $—    $3,031,381 
Americas
  102,702   10,665   135,230   94,897   26,069   36,173   —     405,736 
Europe, Middle East and Africa
  67,381   3,503   25,697   134,829   25,735   8,619   —     265,764 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Total
 $2,246,730  $395,612  $467,739  $311,182  $64,723  $216,895  $—    $3,702,881 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
For the Year Ended December 31, 2020 (1)
                                
Timing of Revenue Recognition
                                
Point in Time
 $1,659,414  $363,324  $348,454  $214,212  $55,533  $163,834  $(604 $2,804,167 
Over Time
  217,975   18,884   61,275   7,269   2,717   9,182   —     317,302 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Total
 $1,877,389  $382,208  $409,729  $221,481  $58,250  $173,016  $(604 $3,121,469 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Geographical Market
                                
Asia Pacific
 $1,744,593  $364,000  $258,521  $60,277  $6,471  $143,969  $—    $2,577,831 
Americas
  77,671   12,999   128,482   64,164   30,186   22,544   (604  335,442 
Europe, Middle East and Africa
  55,125   5,209   22,726   97,040   21,593   6,503   —     208,196 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Total
 $1,877,389  $382,208  $409,729  $221,481  $58,250  $173,016  $(604 $3,121,469 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
(1)
Includes $8.2 million, $13.2 million and $10.0 million in 2022, 2021 and 2020, respectively, for leases of Teradyne’s systems recognized outside of ASC 606:
“Revenue from Contracts with Customers.”
6
2Includes $5.2 million, $8.2 million and $13.2 million in 2023, 2022 and 2021, respectively, for leases of Teradyne’s systems recognized outside of ASC 606: “Revenue from Contracts with Customers.”

Contract Balances

For the years ended December 31, 2023, 2022 2021 and 2020,2021, Teradyne recognized $112.4$108.1 million, $102.5$112.4 million and $91.0$102.5 million, respectively, that was included within the deferred revenue and customer advances balances at the beginning of the period. This revenue primarily relates to undelivered hardware, extended warranties, training, application support, and post contract support. Each of these represents a distinct performance obligation. As of December 31, 2022,2023, Teradyne ha

d
 $1,235.2had $1,124.6 million of unsatisfied performance obligations. Teradyne expects to recognize 89%90% of the remaining performance obligation in the next 12 months, 9% in 1-3 years, and 11%1% thereafter.

E.
ASSETS HELD FOR SALE

On November 7, 2023, Teradyne entered into a definitive agreement to sell Teradyne’s Device Interface Solutions ("DIS") business, a component of the Semiconductor Test segment, to Technoprobe S.p.A. for $85.0 million in 1-3 years.cash. As a result, the related assets and liabilities met the criteria and were classified as held-for-sale in Teradyne’s consolidated balance sheet as of December 31, 2023. The transaction, which does not qualify as a strategic shift required for discontinued operations treatment, is expected to close in the first half of 2024.

53


Assets held-for-sale comprise of the following as of December 31, 2023:

 

 

December 31,

 

 

 

2023

 

 

 

(in thousands)

 

Current assets:

 

 

 

Inventories, net

 

$

17,952

 

Prepayments

 

 

5,298

 

Total current assets held for sale

 

 

23,250

 

Property, plant and equipment, net

 

 

8,986

 

Operating lease right-of-use assets, net

 

 

2,545

 

Total assets held for sale

 

$

34,781

 

 

 

 

 

Current liabilities:

 

 

 

Accounts payable

 

$

6,356

 

Other accrued liabilities

 

 

552

 

Operating lease liabilities

 

 

471

 

Total current liabilities held for sale

 

 

7,379

 

Long-term operating lease liabilities

 

 

2,000

 

Total liabilities held for sale

 

$

9,379

 

Net assets held for sale

 

$

25,402

 

F.
INVENTORIES
F.
INVENTORIES

Inventories, net consisted of the following at December 31, 20222023 and 2021:2022:

 

 

2023 (1)

 

 

2022

 

 

 

(in thousands)

 

Raw material

 

$

258,422

 

 

$

256,065

 

Work-in-process

 

 

26,851

 

 

 

37,982

 

Finished goods

 

 

24,701

 

 

 

30,972

 

 

 

$

309,974

 

 

$

325,019

 

(1)
Excludes $18.0 million of primarily work-in-process inventories, net classified as assets held for sale. See Note E: “Assets held for sale” for additional information.
   
2022
   
2021
 
   
(in thousands)
 
Raw material
  $256,065   $155,641 
Work-in-process
   37,982    37,740 
Finished goods
   30,972    49,949 
   
 
 
   
 
 
 
   $325,019   $243,330 
   
 
 
   
 
 
 
G.
Inventory reserves for the years ended December 31, 2022 and 2021 were $136.8 million and $114.1 million, respectively.PROPERTY, PLANT AND EQUIPMENT
G.
PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment, net consisted of the following at December 31, 20222023 and 2021:2022:

 

 

2023 (1)

 

 

2022

 

 

 

(in thousands)

 

Land

 

$

19,487

 

 

$

18,481

 

Buildings

 

 

127,705

 

 

 

128,991

 

Machinery, equipment and software

 

 

1,047,235

 

 

 

1,059,880

 

Furniture and fixtures

 

 

28,093

 

 

 

29,929

 

Leasehold improvements

 

 

66,777

 

 

 

64,631

 

Construction in progress

 

 

54,799

 

 

 

22,470

 

 

 

1,344,096

 

 

 

1,324,382

 

Less: accumulated depreciation

 

 

898,604

 

 

 

905,699

 

 

$

445,492

 

 

$

418,683

 

(1)
Excludes $9.0 million of property, plant and equipment, net classified as assets held for sale. See Note E: “Assets held for sale” for additional information.
   
2022
   
2021
 
   
(in thousands)
 
Land
  $18,481   $17,207 
Buildings
   128,991    126,468 
Machinery, equipment and software
   1,059,880    994,828 
Furniture and fixtures
   29,929    28,743 
Leasehold improvements
   64,631    64,110 
Construction in progress
   22,470    8,105 
   
 
 
   
 
 
 
    1,324,382    1,239,461 
Less: accumulated depreciation
   905,699    852,221 
   
 
 
   
 
 
 
   $418,683   $387,240 
   
 
 
   
 
 
 

Depreciation of property, plant and equipment for the years ended December 31, 2023, 2022, and 2021 and 2020 was $90.8$92.1 million, $91.1$90.8 million, and $80.1$91.1 million, respectively. As of December 31, 20222023 and 2021,2022, the gross book value included in machinery and equipment for internally manufactured test systems being leased by customers was $5.8$5.1 million and $13.4$5.8 million, respectively. As of December 31, 20222023 and 2021,2022, the accumulated depreciation on these test systems was $5.6$4.9 million and $8.7$5.6 million, respectively.

54


H.
FINANCIAL INSTRUMENTS
H.
FINANCIAL INSTRUMENTS

Cash Equivalents

Teradyne considers all highly liquid investments with maturities of three months or less at the date of acquisition to be cash equivalents.

6
3

Marketable Securities

Teradyne’s equity and debt mutual funds are classified as Level 1 and available-for-sale debt securities are classified as Level 2. Contingent consideration is classified as Level 3. The vast majority of Level 2 securities are fixed income securities priced by third party pricing vendors. These pricing vendors utilize the most recent observable market information in pricing these securities or, if specific prices are not available, use other observable inputs like market transactions involving identical or comparable securities.

During the years ended December 31, 20222023 and 2021,2022, there were no transfers in or out of Level 1, Level 2, or Level 3 financial instruments.

Realized gains recorded in 2023, 2022, and 2021 and 2020 were $0.8$0.6 million, $3.1$0.8 million, and $4.6$3.1 million, respectively. Realized losses recorded in 2023 and 2022 and 2020 were $1.0$0.3 million and $0.3$1.0 million, respectively. No realized losses were recorded in 2021. Realized gains and losses are included in other (income) expense, net.

Unrealized gains on equity securities recorded during the years ended December 31, 2023, 2022 and 2021 and 2020 we

re $1.9were $8.9 million,
,
 $5.1 
$1.9million and $9.6$5.1 million, respectively. Unrealized losses on equity securities recorded during the years ended December 31, 2023, 2022, and 2021 and 2020 were
$1.7 million, $11.6 million
,
 $1.8 
million and $6.0$1.8 million, respectively. Unrealized gains and losses on equity securities are included in other (income) expense, net. Unrealized gains and losses on available-for-sale debt securities are included in accumulated other comprehensive income (loss) on the balance sheet.
6
4

The cost of securities sold is based on average cost.

55


The following table sets forth by fair value hierarchy Teradyne’s financial assets and liabilities that were measured at fair value on a recurring basis as of December 31, 20222023 and 2021:2022:

  
December 31, 2022
 

 

December 31, 2023

 

  
Quoted Prices

in Active

Markets for

Identical

Instruments

(Level 1)
   
Significant

Other

Observable

Inputs

(Level 2)
   
Significant

Unobservable

Inputs

(Level 3)
   
Total
 

 

Quoted Prices
in Active
Markets for
Identical
Instruments
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

 

Total

 

  
(in thousands)
 

 

(in thousands)

 

Assets
            

 

 

 

 

 

 

 

 

 

 

 

 

Cash
  $632,417   $—     $—     $632,417 

 

$

298,156

 

 

$

 

 

$

 

 

$

298,156

 

Cash equivalents
   161,767    60,589    —      222,356 

 

 

453,298

 

 

 

6,117

 

 

 

 

 

 

459,415

 

Available for sale securities:
            

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities
   —      50,856    —      50,856 

 

 

 

 

 

52,734

 

 

 

 

 

 

52,734

 

U.S. Treasury securities
   —      39,649    —      39,649 

 

 

 

 

 

41,808

 

 

 

 

 

 

41,808

 

Commercial paper
   —      7,159    —      7,159 

 

 

 

 

 

1,667

 

 

 

 

 

 

1,667

 

Debt mutual funds
   6,580    —      —      6,580 

 

 

8,773

 

 

 

 

 

 

 

 

 

8,773

 

U.S. government agency securities
   —      6,352    —      6,352 

 

 

 

 

 

4,892

 

 

 

 

 

 

4,892

 

Certificates of deposit and time deposits
   —      1,740    —      1,740 

 

 

 

 

 

21,772

 

 

 

 

 

 

21,772

 

Non-U.S. government securities
   —      535    —      535 

 

 

 

 

 

810

 

 

 

 

 

 

810

 

Equity securities:
            

 

 

 

 

 

 

 

 

 

 

 

 

Mutual funds
   37,518    —      —      37,518 

 

 

47,132

 

 

 

 

 

 

 

 

 

47,132

 

  
 
   
 
   
 
   
 
 
Total
  $838,282   $166,880   $—     $1,005,162 

 

$

807,359

 

 

$

129,800

 

 

$

 

 

$

937,159

 

Derivative assets
   —      86    —      86 

 

 

 

 

 

18,746

 

 

 

 

 

 

18,746

 

  
 
   
 
   
 
   
 
 
Total
  $838,282   $166,966   $—     $1,005,248 

 

$

807,359

 

 

$

148,546

 

 

$

 

 

$

955,905

 

  
 
   
 
   
 
   
 
 
Liabilities
            

 

 

 

 

 

 

 

 

 

 

 

 

Derivative liabilities
   —      4,215    —      4,215 

 

 

 

 

 

2,545

 

 

 

 

 

 

2,545

 

  
 
   
 
   
 
   
 
 
Total
  $—     $4,215   $—     $4,215 

 

$

 

 

$

2,545

 

 

$

 

 

$

2,545

 

  
 
   
 
   
 
   
 
 

 

 

 

 

 

 

 

 

 

 

 

 

Reported as follows:
            

 

 

 

 

 

 

 

 

 

 

 

 

 
  
(Level 1)
   
(Level 2)
   
(Level 3)
   
Total
 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

 

Total

 

  
(in thousands)
 

 

(in thousands)

 

Assets
            

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents
  $794,184   $60,589   $—     $854,773 

 

$

751,454

 

 

$

6,117

 

 

$

 

 

$

757,571

 

Marketable securities
   —      39,612    —      39,612 

 

 

 

 

 

62,154

 

 

 

 

 

 

62,154

 

Long-term marketable securities
   44,098    66,679    —      110,777 

 

 

55,905

 

 

 

61,529

 

 

 

 

 

 

117,434

 

Prepayments
   —      86    —      86 
  
 
   
 
   
 
   
 
 

Other current assets

 

 

 

 

 

18,746

 

 

 

 

 

 

18,746

 

Total
  $838,282   $166,966   $—     $1,005,248 

 

$

807,359

 

 

$

148,546

 

 

$

 

 

$

955,905

 

  
 
   
 
   
 
   
 
 
Liabilities
            

 

 

 

 

 

 

 

 

 

 

 

 

Other current liabilities
  $—     $4,215   $—     $4,215 

 

$

 

 

$

2,545

 

 

$

 

 

$

2,545

 

  
 
   
 
   
 
   
 
 
Total
  $—     $4,215   $—     $4,215 

 

$

 

 

$

2,545

 

 

$

 

 

$

2,545

 

  
 
   
 
   
 
   
 
 

6
5

56


   
December 31, 2021
 
   
Quoted

Prices

in Active

Markets for

Identical

Instruments

(Level 1)
   
Significant

Other

Observable

Inputs

(Level 2)
   
Significant

Unobservable

Inputs

(Level 3)
   
Total
 
   
(in thousands)
 
Assets
                    
Cash
  $628,740   $—     $—     $628,740 
Cash equivalents
   412,212    81,247    —      493,459 
Available for sale securities:
                    
Commercial paper
   —      189,620    —      189,620 
U.S. Treasury securities
   —      77,789    —      77,789 
Corporate debt securities
   —      56,901    —      56,901 
Debt mutual funds
   7,971    —      —      7,971 
U.S. government agency securities
   —      4,610    —      4,610 
Certificates of deposit and time deposits
   —      1,356    —      1,356 
Non-U.S. government securities
   —      589    —      589 
Equity securities:
                    
Mutual funds
   39,253    —      —      39,253 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $1,088,176   $412,112   $—     $1,500,288 
Derivative assets
   —      92    —      92 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $1,088,176   $412,204   $—     $1,500,380 
   
 
 
   
 
 
   
 
 
   
 
 
 
Liabilities
                    
Derivative liabilities
   —      118    —      118 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $—     $118   $—     $118 
   
 
 
   
 
 
   
 
 
   
 
 
 
Reported as follows:
                    
     
   
(Level 1)
   
(Level 2)
   
(Level 3)
   
Total
 
   
(in thousands)
 
Assets
                    
Cash and cash equivalents
  $1,040,952   $81,247   $—     $1,122,199 
Marketable securities
   —      244,231    —      244,231 
Long-term marketable securities
   47,224    86,634    —      133,858 
Prepayments
   —      92    —      92 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $1,088,176   $412,204   $—     $1,500,380 
   
 
 
   
 
 
   
 
 
   
 
 
 
Liabilities
                    
Other current liabilities
  $—     $118   $—     $118 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $—     $118   $—     $118 
   
 
 
   
 
 
   
 
 
   
 
 
 

 

 

December 31, 2022

 

 

 

Quoted Prices
in Active
Markets for
Identical
Instruments
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

 

Total

 

 

 

(in thousands)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

$

632,417

 

 

$

 

 

$

 

 

$

632,417

 

Cash equivalents

 

 

161,767

 

 

 

60,589

 

 

 

 

 

 

222,356

 

Available for sale securities:

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

 

 

 

 

50,856

 

 

 

 

 

 

50,856

 

U.S. Treasury securities

 

 

 

 

 

39,649

 

 

 

 

 

 

39,649

 

Commercial paper

 

 

 

 

 

7,159

 

 

 

 

 

 

7,159

 

Debt mutual funds

 

 

6,580

 

 

 

 

 

 

 

 

 

6,580

 

U.S. government agency securities

 

 

 

 

 

6,352

 

 

 

 

 

 

6,352

 

Certificates of deposit and time deposits

 

 

 

 

 

1,740

 

 

 

 

 

 

1,740

 

Non-U.S. government securities

 

 

 

 

 

535

 

 

 

 

 

 

535

 

Equity securities:

 

 

 

 

 

 

 

 

 

 

 

 

Mutual funds

 

 

37,518

 

 

 

 

 

 

 

 

 

37,518

 

Total

 

$

838,282

 

 

$

166,880

 

 

$

 

 

$

1,005,162

 

Derivative assets

 

 

 

 

 

86

 

 

 

 

 

 

86

 

Total

 

$

838,282

 

 

$

166,966

 

 

$

 

 

$

1,005,248

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Derivative liabilities

 

 

 

 

 

4,215

 

 

 

 

 

 

4,215

 

Total

 

$

 

 

$

4,215

 

 

$

 

 

$

4,215

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reported as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

 

Total

 

 

 

(in thousands)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

794,184

 

 

$

60,589

 

 

$

 

 

$

854,773

 

Marketable securities

 

 

 

 

 

39,612

 

 

 

 

 

 

39,612

 

Long-term marketable securities

 

 

44,098

 

 

 

66,679

 

 

 

 

 

 

110,777

 

Other current assets

 

 

 

 

 

86

 

 

 

 

 

 

86

 

Total

 

$

838,282

 

 

$

166,966

 

 

$

 

 

$

1,005,248

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Other current liabilities

 

$

 

 

$

4,215

 

 

$

 

 

$

4,215

 

Total

 

$

 

 

$

4,215

 

 

$

 

 

$

4,215

 

6
6

Changes in the fair value of Level 3 contingent consideration for the years ended December 31, 2022 and 2021 were as follows:
   
Contingent Consideration
 
   
(in thousands)
 
Balance at December 31, 2020
  $7,227 
Fair value adjustment (1)
   (7,227
   
 
 
 
Balance at December 31, 2021
   —   
   
 
 
 
Fair value adjustment
   —   
   
 
 
 
Balance at December 31, 2022
  $—   
   
 
 
 
(1)
During the year ended December 31, 2021, the fair value of contingent consideration for the earn-outs in connection with the acquisition of AutoGuide was reduced to zero, which resulted in a benefit of $7.2 million, primarily due to a decrease in forecasted revenues and earnings before interest and taxes.
On March 25, 2022, the arbitration claim filed by Industrial Automation LLC, sellers of AutoGuide, against Teradyne alleging non-compliance with the earn-out provisions of the Membership Interests Purchase Agreement, dated as of October 18, 2019, among Industrial Automation LLC, Teradyne and AutoGuide was settled for $26.7 million. As a result, Teradyne has no remaining earn-out obligations.

The carrying amounts and fair values of Teradyne’s financial instruments at December 31, 20222023 and 20212022 were as follows:

 

 

December 31, 2023

 

 

December 31, 2022

 

 

 

Carrying Value

 

 

Fair Value

 

 

Carrying Value

 

 

Fair Value

 

 

 

(in thousands)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

757,571

 

 

$

757,571

 

 

$

854,773

 

 

$

854,773

 

Marketable securities

 

 

179,588

 

 

 

179,588

 

 

 

150,389

 

 

 

150,389

 

Derivative assets

 

 

18,746

 

 

 

18,746

 

 

 

86

 

 

 

86

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Derivative liabilities

 

 

2,545

 

 

 

2,545

 

 

 

4,215

 

 

 

4,215

 

Convertible debt (1)

 

 

 

 

 

 

 

 

50,115

 

 

 

139,007

 

(1)
The carrying value represents the bifurcated debt component only, while the fair value is based on quoted market prices for the convertible note which includes the equity conversion features.
   
December 31, 2022
   
December 31, 2021
 
   
Carrying Value
   
Fair Value
   
Carrying Value
   
Fair Value
 
   
(in thousands)
 
Assets
                    
Cash and cash equivalents
  $854,773   $854,773   $1,122,199   $1,122,199 
Marketable securities
   150,389    150,389    378,089    378,089 
Derivative assets
   86    86    92    92 
Liabilities
                    
Derivative liabilities
  4,215   4,215   118   118 
Convertible debt (1)
   50,115    139,007    108,426    604,648 
(1)
The carrying value represents the bifurcated debt component only, while the fair value is based on quoted market prices for the convertible note which includes the equity conversion features.

The fair values of accounts receivable, net and accounts payable approximate the carrying amount due to the short-term nature of these instruments.

6
7

57


The following tables summarize the composition of available-for-sale marketable securities at December 31, 20222023 and 2021:

   
December 31, 2022
 
   
Available-for-Sale
        
   
Cost
   
Unrealized

Gain
   
Unrealized

(Loss)
  
Fair
Market

Value
   
Fair Market

Value of Investments

with Unrealized Losses
 
   
(in thousands)
 
Corporate debt securities
  $57,006   $3   $(6,153 $50,856   $50,667 
U.S. Treasury securities
   44,030    —      (4,381  39,649    39,649 
Commercial paper
   7,089    70    —     7,159    —   
Debt mutual funds
   6,997    —      (417  6,580    3,095 
U.S. government agency securities
   6,442    —      (90  6,352    6,352 
Certificates of deposit and time deposits
   1,740    —      —     1,740    —   
Non-U.S. government securities
   535    —      —     535    —   
   
 
 
   
 
 
   
 
 
  
 
 
   
 
 
 
   $123,839   $73   $(11,041 $112,871   $99,763 
   
 
 
   
 
 
   
 
 
  
 
 
   
 
 
 
2022:

 

 

December 31, 2023

 

 

 

Available-for-Sale

 

 

 

 

 

 

 

 

 

Cost

 

 

Unrealized
Gain

 

 

Unrealized
(Loss)

 

 

Fair Market
Value

 

 

Fair Market
Value of Investments
with Unrealized Losses

 

 

 

(in thousands)

 

Corporate debt securities

 

$

56,458

 

 

$

201

 

 

$

(3,925

)

 

$

52,734

 

 

$

44,263

 

U.S. Treasury securities

 

 

45,725

 

 

 

14

 

 

 

(3,931

)

 

 

41,808

 

 

 

35,080

 

Certificates of deposit and time deposits

 

 

21,772

 

 

 

 

 

 

 

 

 

21,772

 

 

 

 

Debt mutual funds

 

 

9,081

 

 

 

 

 

 

(308

)

 

 

8,773

 

 

 

3,303

 

U.S. government agency securities

 

 

4,898

 

 

 

 

 

 

(6

)

 

 

4,892

 

 

 

4,892

 

Commercial paper

 

 

1,633

 

 

 

34

 

 

 

 

 

 

1,667

 

 

 

 

Non-U.S. government securities

 

 

810

 

 

 

 

 

 

 

 

 

810

 

 

 

 

 

 

$

140,377

 

 

$

249

 

 

$

(8,170

)

 

$

132,456

 

 

$

87,538

 

Reported as follows:

   
Cost
   
Unrealized

Gain
   
Unrealized

(Loss)
  
Fair
Market

Value
   
Fair Market

Value of Investments

with Unrealized Losses
 
   
(in thousands)
 
Marketable securities
  $39,950   $70   $(408 $39,612   $30,713 
Long-term marketable securities
   83,889    3    (10,633  73,259    69,050 
   
 
 
   
 
 
   
 
 
  
 
 
   
 
 
 
   $123,839   $73   $(11,041 $112,871   $99,763 
   
 
 
   
 
 
   
 
 
  
 
 
   
 
 
 
   
December 31, 2021
 
       
Available-for-Sale
        
   
Cost
   
Unrealized

Gain
   
Unrealized

(Loss)
  
Fair
Market

Value
   
Fair Market

Value of Investments

with Unrealized Losses
 
   
(in thousands)
 
Commercial paper
  $189,614   $15   $(9 $189,620   $22,784 
U.S. Treasury securities
   77,707    551    (470  77,789    46,435 
Corporate debt securities
   52,266    4,863    (227  56,901    19,422 
Debt mutual funds
   7,928    43    —     7,971    —   
U.S. government agency securities
   4,617    5    (12  4,610    3,296 
Certificates of deposit and time deposits
   1,356    —      —     1,356    —   
Non-U.S. government securities
   589    —      —     589    —   
   
 
 
   
 
 
   
 
 
  
 
 
   
 
 
 
   $334,077   $5,477   $(718 $338,836   $91,937 
   
 
 
   
 
 
   
 
 
  
 
 
   
 
 
 

 

 

Cost

 

 

Unrealized
Gain

 

 

Unrealized
(Loss)

 

 

Fair Market
Value

 

 

Fair Market
Value of Investments
with Unrealized Losses

 

 

 

(in thousands)

 

Marketable securities

 

$

62,385

 

 

$

36

 

 

$

(267

)

 

$

62,154

 

 

$

34,844

 

Long-term marketable securities

 

 

77,992

 

 

 

213

 

 

 

(7,903

)

 

$

70,302

 

 

 

52,694

 

 

$

140,377

 

 

$

249

 

 

$

(8,170

)

 

$

132,456

 

 

$

87,538

 

 

 

December 31, 2022

 

 

 

 

 

 

Available-for-Sale

 

 

 

 

 

 

 

 

 

Cost

 

 

Unrealized
Gain

 

 

Unrealized
(Loss)

 

 

Fair Market
Value

 

 

Fair Market
Value of Investments
with Unrealized Losses

 

 

 

(in thousands)

 

Corporate debt securities

 

$

57,006

 

 

$

3

 

 

$

(6,153

)

 

$

50,856

 

 

$

50,667

 

U.S. Treasury securities

 

 

44,030

 

 

 

 

 

 

(4,381

)

 

 

39,649

 

 

 

39,649

 

Commercial paper

 

 

7,089

 

 

 

70

 

 

 

 

 

 

7,159

 

 

 

 

Debt mutual funds

 

 

6,997

 

 

 

 

 

 

(417

)

 

 

6,580

 

 

 

3,095

 

U.S. government agency securities

 

 

6,442

 

 

 

 

 

 

(90

)

 

 

6,352

 

 

 

6,352

 

Certificates of deposit and time deposits

 

 

1,740

 

 

 

 

 

 

 

 

 

1,740

 

 

 

 

Non-U.S. government securities

 

 

535

 

 

 

 

 

 

 

 

 

535

 

 

 

 

 

 

$

123,839

 

 

$

73

 

 

$

(11,041

)

 

$

112,871

 

 

$

99,763

 

Reported as follows:

 

 

Cost

 

 

Unrealized
Gain

 

 

Unrealized
(Loss)

 

 

Fair Market
Value

 

 

Fair Market
Value of Investments
with Unrealized Losses

 

 

 

(in thousands)

 

Marketable securities

 

$

39,950

 

 

$

70

 

 

$

(408

)

 

$

39,612

 

 

$

30,713

 

Long-term marketable securities

 

 

83,889

 

 

 

3

 

 

 

(10,633

)

 

$

73,259

 

 

 

69,050

 

 

$

123,839

 

 

$

73

 

 

$

(11,041

)

 

$

112,871

 

 

$

99,763

 

   
Cost
   
Unrealized

Gain
   
Unrealized

(Loss)
   
Fair
Market

Value
   
Fair Market

Value of Investments

with Unrealized Losses
 
   
(in thousands)
 
Marketable securities
  $244,213   $64   $(46  $244,231   $54,798 
Long-term marketable securities
   89,864    5,413    (672   94,605    37,139 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
   $334,077   $5,477   $(718  $338,836   $91,937 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 

As of December 31, 2023, the fair market value of investments with unrealized losses less than one year and greater than one year totaled $22.3 million and $65.2 million, respectively.

As of December 31, 2022, the fair market value of investments with unrealized losses less than one year and greater than one year totaled $66.3$66.3 million and $33.4$33.4 million, respectively.

68

58


As of December 31, 2021, the fair market value of investments with unrealized losses less than one year and greater than one year totaled $85.4 million and $6.5 million, respectively.

Teradyne reviews its investments to identify and evaluate investments that have an indication of possible impairment. Based on this review, Teradyne determined that the unrealized losses related to these investments at December 31, 20222023 and 2021,2022 were not other than temporary.

The contractual maturities of investments in available-for-sale marketable securities held at December 31, 20222023 were as follows:

 

 

Cost

 

 

Fair Value

 

 

 

(in thousands)

 

Due within one year

 

$

62,385

 

 

$

62,154

 

Due after 1 year through 5 years

 

 

23,703

 

 

 

23,319

 

Due after 5 years through 10 years

 

 

6,049

 

 

 

5,735

 

Due after 10 years

 

 

39,159

 

 

 

32,475

 

Total

 

$

131,296

 

 

$

123,683

 

   
Cost
   
Fair Value
 
   
(in thousands)
 
Due within one year
  $39,950   $39,612 
Due after 1 year through 5 years
   33,045    31,466 
Due after 5 years through 10 years
   4,782    4,232 
Due after 10 years
   39,065    30,981 
   
 
 
   
 
 
 
Total
  $116,842   $106,291 
   
 
 
   
 
 
 

Contractual maturities of investments in available-for-sale marketable securities held at December 31, 20222023 exclude debt mutual funds with the fair market value of $6.6$8.8 million as they do not have a contractual maturity date.

Derivatives

Teradyne conducts business in various foreign countries, with certain transactions denominated in local currencies. As a result, Teradyne is exposed to risks relating to changes in foreign currency exchange rates. Teradyne’s foreign currency risk management objective is to minimize the effect of exchange rate fluctuations associated with the remeasurement of monetary assets and liabilities denominated in foreign currencies, and changes in its cash inflows attributable to the forecasted cash flows from certain foreign currency denominated revenues.

To minimize the effect of exchange rate fluctuations associated with the remeasurement of monetary assets and liabilities denominated in foreign currencies, Teradyne enters into foreign currency forward contracts. The change in fair value of these derivatives is recorded directly in earnings and is used to offset the change in value of monetary assets and liabilities denominated in foreign currencies.

Teradyne also enters into foreign currency forward and option contracts designated as cash flow hedges to hedge the risk of changes in its cash inflows attributable to changes in foreign currency exchange rates. The cash flow hedges have maturities of less than six months and mature in the period of revenue recognition for certain products and services in backlog and forecasted to be recognized in a future period. Teradyne evaluates cash flow hedges for effectiveness at inception based on the critical terms match method. The hedges are not expected to incur any ineffectiveness however a quarterly qualitative assessment of effectiveness is done to determine if the critical terms match method remains appropriate to use. The change in fair value of the contracts is recorded in accumulated other comprehensive income (loss) and reclassified to earnings at maturity date.

Teradyne does not use derivative financial instruments for speculative purposes.

69

59


At December 31, 2023 and 2022, to hedge certain of its local currency balance sheet assets and 2021,liabilities, Teradyne had the following contracts to buy and sell non-U.S. currencies for U.S. dollars and other non-U.S. currencies with the following notional amounts:

 

 

Net Notional Value

 

 

 

December 31,
2023

 

 

December 31, 2022

 

 

 

(in millions)

 

Currency Hedged (Buy/Sell)

 

 

 

 

 

 

U.S. dollar/Taiwan dollar

 

$

42.7

 

 

$

29.2

 

U.S. dollar/Danish krone

 

 

36.0

 

 

 

 

U.S. dollar/Japanese yen

 

 

11.0

 

 

 

37.1

 

U.S. dollar/Korean won

 

 

7.2

 

 

 

6.4

 

U.S. dollar/British pound sterling

 

 

1.5

 

 

 

1.2

 

Euro/U.S. dollar

 

 

25.3

 

 

 

38.4

 

Singapore dollar/U.S. dollar

 

 

16.6

 

 

 

33.5

 

Philippine peso/U.S. dollar

 

 

10.1

 

 

 

2.7

 

Chinese yuan/U.S. dollar

 

 

1.0

 

 

 

2.2

 

Danish krone/U.S. dollar

 

 

0.7

 

 

 

 

Total

 

 

152.1

 

 

 

150.7

 

   
December 31, 2022
  
December 31, 2021
 
   
Buy

Position
  
Sell

Position
   
Net

Total
  
Buy

Position
  
Sell

Position
   
Net

Total
 
   
(in millions)
 
Japanese Yen
  $(37.1 $—     $(37.1 $(31.4 $—     $(31.4
Taiwan Dollar
   (29.2  —      (29.2  (35.1  —      (35.1
Korean Won
   (6.4  —      (6.4  (4.2  —      (4.2
British Pound Sterling
   (1.2  —      (1.2  (1.8  —      (1.8
Euro
   —     38.4    38.4   —     44.9    44.9 
Singapore Dollar
   —     33.5    33.5   —     61.9    61.9 
Philippine Peso
   —     2.7    2.7   —     3.9    3.9 
Chinese Yuan
   —     2.2    2.2   —     2.8    2.8 
   
 
 
  
 
 
   
 
 
  
 
 
  
 
 
   
 
 
 
Total
  $(73.9 $76.8   $2.9  $(72.5 $113.5   $41.0 
   
 
 
  
 
 
   
 
 
  
 
 
  
 
 
   
 
 
 

The change in the fair value of the outstanding contracts was a loss of $0.9$1.8 million and $0.1$0.9 million, respectively, at December 31, 20222023 and 2021.

2022.

Unrealized gains and losses on foreign currency forward contracts and foreign currency remeasurement gains and losses on monetary assets and liabilities are included in other (income) expense, net.

At December 31, 20222023 and 2021,2022, Teradyne had the following cash flow hedge contracts to buy and sell non-U.S. currencies for U.S. dollars with the following notional amounts:

 

 

Net Notional Value

 

 

 

December 31,
2023

 

 

December 31, 2022

 

 

 

(in millions)

 

Currency Hedged (Buy/Sell)

 

 

 

 

 

 

U.S. dollar/Japanese yen

 

$

35.5

 

 

$

61.2

 

U.S. dollar/Taiwan dollar

 

 

 

 

 

10.9

 

Japanese yen/U.S. dollar

 

 

 

 

 

23.4

 

Taiwan dollar/U.S. dollar

 

 

 

 

 

5.5

 

Total

 

$

35.5

 

 

$

101.0

 

   
December 31, 2022
   
December 31, 2021
 
   
Buy

Position
  
Sell

Position
   
Net

Total
   
Buy

Position
   
Sell

Position
   
Net

Total
 
   
(in millions)
 
Japanese Yen
  $(23.4 $61.2   $37.8   $—     $—     $—   
Taiwan Dollar
   (5.5  10.9    5.4    —      —      —   
   
 
 
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $(28.9 $72.1   $43.2   $—     $—     $—   
   
 
 
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 

The change in the fair value of the outstanding cash flow hedge contracts was a lossgain of $3.2$0.6 million at December 31, 2023 and a loss of $3.2 million at December 31, 2022.

Unrealized gains and losses on foreign currency cash flow hedge contracts are included in accumulated other comprehensive income (loss). At maturity, the gains or losses associated with cash flow hedge contracts are recorded to revenue.

On November 7, 2023, in connection with our agreement to acquire 10% investment in Technoprobe S.p.A we purchased a call option to buy 481.0 million Euros. The expiration date of the option is April 26, 2024. At December 31, 2023, the fair value of the outstanding contract was $17.4 million and an unrealized gain of $7.5 million was recorded in other (income) expense, net.

7
0

60


The

The following table summarizes the fair value of derivative instruments as of December 31, 20222023 and 2021:2022:

 

 

Balance Sheet Location

 

December 31,
2023

 

 

December 31,
2022

 

 

 

 

 

(in thousands)

 

Derivatives not designated as hedging instruments:

 

 

 

 

 

 

 

 

Foreign exchange forward contracts

 

Other current assets

 

$

733

 

 

$

86

 

Foreign exchange option contracts

 

Other current assets

 

 

17,364

 

 

 

 

Foreign exchange forward contracts

 

Other current liabilities

 

 

(2,545

)

 

 

(990

)

Derivatives designated as hedging instruments:

 

 

 

 

 

 

 

 

Foreign exchange forward contracts

 

Other current assets

 

 

648

 

 

 

 

Foreign exchange option contracts

 

Other current liabilities

 

 

 

 

 

(3,225

)

Total derivatives

 

 

 

$

16,200

 

 

$

(4,129

)

   
Balance Sheet Location
   
December 31,

2022
  
December 31,

2021
 
       
(in thousands)
 
Derivatives not designated as hedging instruments:
              
Foreign exchange forward contracts
   Prepayments   $86  $92 
Foreign exchange forward contracts
   Other current liabilities    (990  (118
Derivatives designated as hedging instruments:
              
Foreign exchange option contracts
   Other current liabilities    (3,225  —   
        
 
 
  
 
 
 
Total derivatives
       $(4,129 $(26
        
 
 
  
 
 
 

The following table summarizes the effect of derivative instruments in the statements of operations recognized for the years ended December 31, 2023, 2022, 2021, and 2020:

2021:

 

 

Location of (Gains) Losses
Recognized in Statement
of Operations

 

December 31,
2023

 

 

December 31,
2022

 

 

December 31,
2021

 

 

 

 

 

(in thousands)

 

Derivatives not designated as hedging instruments:

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange forward contracts (1)

 

Other (income) expense, net

 

$

(1,843

)

 

$

(2,482

)

 

$

6,488

 

Foreign exchange option contracts

 

Other (income) expense, net

 

 

(7,464

)

 

 

 

 

 

 

Derivatives designated as hedging instruments:

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange forward and option contracts

 

Revenue

 

 

(3,127

)

 

 

(251

)

 

 

 

Total derivatives

 

 

 

$

(12,434

)

 

$

(2,733

)

 

$

6,488

 

(1)
   
Location of (Gains) Losses
Recognized in Statement
of Operations
  
December 31,

2022
  
December 31,

2021
   
December 31,

2020
 
      
(in thousands)
 
Derivatives not designated as hedging instruments:
                 
Foreign exchange forward contracts
  Other (income) expense, net  $(2,482 $6,488   $3,515 
Derivatives designated as hedging instruments:
                 
Foreign exchange option contracts
  Revenue   (251)  —      —   
      
 
 
  
 
 
   
 
 
 
Total derivatives
     $(2,733 $6,488   $3,515 
      
 
 
  
 
 
   
 
 
 
The table does not reflect the corresponding gains and losses from the remeasurement of the monetary assets and liabilities denominated in foreign currencies. For the years ended December 31, 2023, 2022 2021 and 2020,2021, net losses (gains) from remeasurement of monetary assets and liabilities denominated in foreign currencies were $10.8$10.9 million, $(2.1)$10.8 million, and $2.6$(2.1) million, respectively.

See Note J: “Debt” regarding derivatives related to the convertible senior notes.

Concentration of Credit Risk

Financial instruments which potentially subject Teradyne to concentrations of credit risk consist principally of cash equivalents, marketable securities, forward currency contracts and accounts receivable. Teradyne’s cash equivalents consist primarily of money market funds invested in U.S. Treasuries and government agencies. Teradyne’s fixed income available-for-sale marketable securities have a minimum rating of AA by one or more of the major credit rating agencies. Teradyne places foreign currency forward contracts with high credit-quality financial institutions in order to minimize credit risk exposure. Concentrations of credit risk with respect to accounts receivable are limited due to the large number of geographically dispersed customers. Teradyne performs ongoing credit evaluations of its customers’ financial condition and from time to time may require customers to provide a letter of credit from a bank to secure accounts receivable. As of December 31, 2023, one customer of our Semiconductor Test segment, Texas Instruments Inc., accounted for 18% of our accounts receivable balance. There were no customers who accounted for more than 10%10% of our accounts receivable balance as of December 31,

2022 and 2021
.
2022.

I.
LEASES
I.
LEASES

Teradyne has facility and auto leases, which are accounted for as operating leases. Teradyne’s facility leases are primarily used for administrative functions, research and development, manufacturing, and storage and distribution. Remaining lease terms range from less than one year to twelve years.

7
1

For the yearyears ended December 31, 2023, 2022 2021 and 2020,2021, total lease expense was $40.1$42.7 million, $39.2$40.1 million, and $38.5$39.2 million respectively, and included $14.1$15.5 million, $12.6$14.1 million, and $12.1$12.6 million, respectively, of variable lease costs and $2.0$1.3 million, $1.8$2.0 million, and $3.4$1.8 million, respectively, of costs related to short-term leases, which are not recorded on the consolidated balance sheets.

61


At December 31, 2023, the weighted average remaining lease term and weighted average discount rate for operating leases was 6.3 years and 5.2%, respectively. At December 31, 2022, the weighted average remaining lease term and weighted average discount rate for operating leases was 5.9 years and 4.7%4.7%, respectively. At December 31, 2021, the weighted average remaining lease term and weighted average discount rate for operating leases was 5.3 years and 4.1%, respectively.

Supplemental cash flows information related to leases was as follows:

 

 

For the Years Ended

 

 

 

December 31,
2023

 

 

December 31,
2022

 

 

December 31,
2021

 

 

 

(in thousands)

 

Cash paid for amounts included in the measurement of lease
    liabilities included in operating cash flows:

 

$

26,059

 

 

$

20,775

 

 

$

24,593

 

Right-of-use assets obtained in exchange for new lease obligations

 

 

17,987

 

 

 

26,149

 

 

 

34,246

 

   
For the Years Ended
 
   
December 31,
2022
   
December 31,
2021
   
December 31,
2020
 
   
(in thousands)
 
Cash paid for amounts included in the measurement of lease liabilities included in operating cash flows:
  $20,775   $24,593   $24,136 
Right-of-use assets obtained in exchange for new lease obligations
   26,149    34,246    14,801 

Maturities of lease liabilities as of December 31, 20222023 were as follows:

 

 

Operating Lease (1)

 

 

 

(in thousands)

 

2024

 

$

21,045

 

2025

 

 

18,755

 

2026

 

 

15,074

 

2027

 

 

11,733

 

2028

 

 

7,622

 

Thereafter

 

 

23,906

 

     Total lease payments

 

 

98,135

 

Less imputed interest

 

 

(15,521

)

     Total lease liabilities

 

$

82,614

 

(1)
Excludes $2.5 million of lease liabilities classified as liabilities held for sale. See Note E: “Assets held for sale” for additional information.

J.
DEBT
   
Operating Lease
 
   
(in thousands)
 
2023
  $20,120 
2024
   18,239 
2025
   15,308 
2026
   10,635 
2027
   8,117 
Thereafter
   17,963 
   
 
 
 
Total lease payments
   90,382 
Less imputed interest
   (7,612
   
 
 
 
Total lease liabilities
  $82,770 
   
 
 
 
J.
DEBT

Convertible Senior Notes

On December 12, 2016, Teradyne completed a private offering of $460.0$460.0 million aggregate principal amount of 1.25%1.25% convertible senior unsecured notes (the “Notes”) due December 15, 2023 and received net proceeds, after issuance costs, of approximately $450.8$450.8 million, $33.0$33.0 million of which was used to pay the net cost of the convertible note hedge transactions and $50.1$50.1 million of which was used to repurchase 2.0 million shares of Teradyne’s common stock under its existing stock repurchase program from purchasers of the Notes in privately negotiated transactions effected through one of the initial purchasers or its affiliates conducted concurrently with the pricing of the Note offering. The Notes will mature on December 15, 2023, unless earlier repurchased or converted. The Notes bearbore interest at a rate of 1.25%1.25% per year payable semiannually in arrears on June 15 and December 15 of each year.year. The Notes will be convertible at the option of the noteholders at any time prior to the close of businessnotes matured on the business day immediately preceding SeptemberDecember 15, 2023 only under the following circumstances: (1) during any calendar quarter beginning after March 31, 2017 (and only during such calendar quarter), if the closing sale price of Teradyne’s common stock, for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately

7
2

preceding calendar quarter is greater than 130% of the conversion price on each applicable trading day;
(2)
 during the
five
business day period after any
five
consecutive trading day period (the “measurement period”) in which the trading price (as defined in the Indenture) per $
1,000
principal amount of Notes for each trading day of the measurement period was less than
98
% of the product of the closing sale price of Teradyne’s common stock and the conversion rate on each such trading day; and
(3)
 upon the occurrence of specified corporate events. On or after
September 15, 2023
until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their Notes at any time, regardless of the foregoing circumstances. Teradyne may satisfy its future conversion obligation by paying cash for the principal amount. Substantially all of the Notes and paying or delivering cash, shares of its common stock or a combination of cash and shares of its common stock, at Teradyne’s election for the amount in excess of principal. On November 
4
,
2021
, Teradyne made an irrevocable election under the Indenture to require the principal portion of the remaining Notes to be settled in cash. Aswere converted as of December
31
,
2022
, the conversion price was approximately $
31.46
per share of Teradyne’s common stock. The conversion rate is subject to adjustment under certain circumstances.
15, 2023.

During 2022, forty

-
two2023, twenty three debt holders elected to convert $66.8$50.2 million of debt principal. The conversion of the debt was settled in cash for principal amount and in shares for the excess of conversion value over principal amount. The 1.51.1 million shares issued to the debt holders were received from exercising the convertible notes hedge call options.
During 2021, sixty
-
four holders converted $343.0 million resulting in a loss of $28.8 million recorded to other (income) expense on the consolidated statement of operations. The amount of the loss was determined using the conversion value of the conversion transactions based on the fair value of debt immediately prior to conversion using an updated remaining expected life of the debt instrument and an updated borrowing rate for a similar debt instrument that does not have an associated convertible feature.
As of February 22, 2023, one hundred and twenty
-
four holders had exercised the option to convert $424.9 million worth of notes.

Concurrent with the offering of the Notes, Teradyne entered into convertible note hedge transactions (the “Note Hedge Transactions”) with the initial purchasers or their affiliates (the “Option Counterparties”). The Note Hedge Transactions cover, subject to customary anti-dilution adjustments, the number of shares of the common stock that underlie the Notes, with a strike price equal to the conversion priceNotes.

62


Separately and concurrent with the pricing of the Notes, Teradyne entered into warrant transactions with the Option Counterparties (the “Warrant Transactions”) in which it sold net-share-settled (or, at its election subject to certain conditions, cash-settled) warrants to the Option Counterparties. These transactions have been accounted for as an adjustment to our shareholders equity. The Warrant Transactions, which expire between March 18, 2024 and July 10, 2024, currently cover, subject to customary anti-dilution adjustments, approximately 14.614.7 million shares of common stock. As of December 31, 2022,2023, the strike price of the warrants was approximately $39.48$39.40 per share. The strike price is subject to adjustment under certain circumstances. The Warrant Transactions could have a dilutive effect toresult in additional shares of Teradyne’s common stock being issued to the extent that the market price per share of Teradyne’s common stock, as measured under the terms of the Warrant Transactions, exceeds the applicable strike price of the warrants.

The Note Hedge Transactions are expected to reduce the potential dilution to Teradyne’s common stock upon any conversion of the Notes. However, the Warrant Transactions could separately have a dilutive effect to the extent that the market value per share of Teradyne’s common stock exceeds the applicable strike price of the warrant.

The net cost of the Note Hedge Transactions, after being partially offset by the proceeds from the sale of the warrants, was approximately $33.0$33.0 million.

In connection with establishing their initial hedge of these convertible note hedge and warrant transactions, the Option Counterparties have entered into various derivative transactions with respect to Teradyne’s common stock and/or purchased shares of Teradyne’s common stock or other securities, including the Notes, concurrent

7
3

with, or shortly after, the pricing of the Notes. In addition, the Option Counterparties may modify their hedge positions by entering into or unwinding various derivative transactions with respect to Teradyne’s common stock or by selling Teradyne’s common stock or other securities, including the Notes, in secondary market transactions (and may do so during any observation period related to the conversion of the Notes). These activities could adversely affect the value of Teradyne’s common stock and the Notes.

Originally, Teradyne allocated $100.8$100.8 million of the $460.0$460.0 million principal amount of the Notes to the equity component, which represented a discount to the debt and was amortized to interest expense using the effective interest method through December 2023. Effective January 1, 2022, Teradyne adopted ASC 2020-06 using the modified retrospective method of transition and accounts for the debt as a single liability measured at its amortized cost. As a result of the adoption, Teradyne recorded an increase of $1.4$1.4 million to current debt for unsettled shares, an increase of $1.8$1.8 million to deferred tax assets, an increase of $6.6$6.6 million to long-term debt for unamortized debt discount, and an increase to retained earnings of $94.6$94.6 million for the reclassification of the equity component. Mezzanine equity representing unsettled shares value was reduced to zero and additional paid-in capital was reduced by $100.8$100.8 million.

Debt issuance fees of approximately $0.1 million at December 31, 2022, are being amortized to interest expense using the effective interest method over the seven-year term of the Notes.

The below tables represent the key components of Teradyne’s convertible senior notes:

 

 

For the Years Ended

 

 

 

December 31,
2023

 

 

December 31,
2022

 

 

 

(in thousands)

 

Debt principal

 

$

 

 

$

50,228

 

Unamortized debt issuance fees

 

 

 

 

 

113

 

Net carrying amount of convertible debt

 

$

 

 

$

50,115

 

 

 

For the Years Ended

 

 

 

December 31,
2023

 

 

December 31,
2022

 

 

 

(in thousands)

 

Contractual interest expense on the coupon

 

$

312

 

 

$

732

 

Amortization of the issuance fees recognized as interest expense

 

 

113

 

 

 

209

 

Total interest expense on the convertible debt

 

$

425

 

 

$

941

 

   
December 31,
2022
   
December 31,
2021
 
   
(in thousands)
 
Debt principal
  $50,228   $116,980 
Unamortized debt issuance fees (1)
   113    8,554 
   
 
 
   
 
 
 
Net carrying amount of convertible debt
  $50,115   $108,426 
   
 
 
   
 
 
 
Reported as follows:
   
December 31,
2022
   
December 31,
2021
 
   
(in thousands)
 
Current debt
  $50,115   $19,182 
Long-term debt
   —      89,244 
   
 
 
   
 
 
 
Net carrying amount of convertible debt
  $50,115   $108,426 
   
 
 
   
 
 
 
   
For the Years Ended
 
   
December 31,
2022
   
December 31,
2021
 
   
(in thousands)
 
Contractual interest expense on the coupon
  $732   $3,009 
Amortization of the issuance fees recognized as interest expense (2)
   209    11,019 
   
 
 
   
 
 
 
Total interest expense on the convertible debt
  $941   $14,028 
   
 
 
   
 
 
 
(1)
Unamortized debt issuance fees as of December 31, 2021 include unamortized debt discount of $8.0 million, which was eliminated with the adoption of ASU 2020-06 on January 1, 2022.
(2)
For the year ended December 31, 2021 includes the amortization of debt discount component, which was eliminated with the adoption of ASU 2020-06 on January 1, 2022.
7
4

As of December 31, 2022, the conversion price was approximately $31.46 per share and if converted the value of the notes was $139.5 million.
Additional conversions of approximately $15.1 million of debt principal will occur in the first quarter of 2023 and the liability is included in current debt.
Teradyne expects to make principal interest payments of $0.4 million in the next 12 months.

Revolving Credit Facility

On May 1, 2020, Teradyne entered into a credit agreement (the “Credit Agreement”) with Truist Bank, as administrative agent and collateral agent, and the lenders party thereto. The Credit Agreement provides for a three-year, senior secured revolving credit facility of $400.0$400.0 million (the “Credit Facility”).

On December 10, 2021, the Credit Agreement was amended to extend maturity date of the Credit Facility to December 10, 2026. On October 5, 2022, the Credit Agreement was amended to increase the amount of the Credit Facility to $750.0$750.0 million from $400.0$400.0 million.

63


The Credit Agreement provides that, subject to customary conditions, Teradyne may seek to obtain from existing or new lenders the available incremental amount under the Credit Facility, not to exceed the greater of $200.0$200.0 million or 15%15% of consolidated EBIDTA. The interest rate applicable to loans under the Credit Facility are, at Teradyne’s option, equal to either a base rate plus a margin ranging from 0.00%0.00% to 0.75%0.75% per annum or SOFR plus a margin ranging from 1.10%1.10% to 1.85%1.85% per annum, based on the consolidated leverage ratio of Teradyne. In addition, Teradyne will pay a commitment fee on the unused portion of the commitments under the Credit Facility ranging from 0.15%0.15% to 0.25%0.25% per annum, based on the then applicable consolidated leverage ratio.

Teradyne is not required to repay any loans under the Credit Facility prior to maturity, subject to certain customary exceptions. Teradyne is permitted to prepay all or any portion of the loans under the Credit Facility prior to maturity without premium or penalty, other than customary SOFR breakage costs.

The Credit Agreement contains customary events of default, representations, warranties and affirmative and negative covenants that, among other things, limit Teradyne’s ability to sell assets, grant liens on assets, incur other secured indebtedness and make certain investments and restricted payments, all subject to exceptions set forth in the Credit Agreement. The Credit Agreement also requires Teradyne to satisfy two financial ratios measured as of the end of each fiscal quarter; a consolidated leverage ratio and an interest coverage ratio.

The Credit Facility is guaranteed by certain of Teradyne’s domestic subsidiaries and collateralized by assets of Teradyne and such subsidiaries, including a pledge of 65%65% of the capital stock of certain foreign subsidiaries.

As of February 22, 2023,2024, the Credit Agreement was undrawn and Teradyne was in compliance with all covenants under the Credit Agreement.

K.
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
7
5

K.
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

Changes in accumulated other comprehensive income (loss), which is presented net of tax, consist of the following:

 

 

Foreign
Currency
Translation
Adjustment

 

 

Unrealized
Gains (Losses) on
Marketable
Securities

 

 

Unrealized (Losses) Gains on
Cash Flow Hedges

 

 

Retirement
Plans Prior
Service
Credit

 

 

Total

 

 

 

(in thousands)

 

Balance at December 31, 2021, net of tax of $0, $1,055, $0,
    $(
1,128), respectively

 

$

(10,818

)

 

$

3,704

 

 

$

 

 

$

1,166

 

 

$

(5,948

)

Other comprehensive loss before reclassifications, net of tax of
    $
0, $(3,388), $(708), $0, respectively

 

 

(29,031

)

 

 

(12,666

)

 

 

(2,517

)

 

 

 

 

 

(44,214

)

Amounts reclassified from accumulated other comprehensive
    income (loss), net of tax of $
0, $25, $0, $(2), respectively

 

 

 

 

 

301

 

 

 

 

 

 

(7

)

 

 

294

 

Net current period other comprehensive loss, net of tax of $0,
    $(
3,363), $(708), $(2), respectively

 

 

(29,031

)

 

 

(12,365

)

 

 

(2,517

)

 

 

(7

)

 

 

(43,920

)

Balance at December 31, 2022, net of tax of $0, $(2,308), $(708),
    $(
1,130), respectively

 

$

(39,849

)

 

$

(8,661

)

 

$

(2,517

)

 

$

1,159

 

 

$

(49,868

)

Other comprehensive gain before reclassifications, net of tax of
    $
0, $568, $1,537, $0, respectively

 

 

17,407

 

 

 

2,423

 

 

 

5,464

 

 

 

 

 

 

25,294

 

Amounts reclassified from accumulated other comprehensive
    income (loss), net of tax of $
0, $12, $(686), $(2),
    respectively

 

 

 

 

 

44

 

 

 

(2,441

)

 

 

(7

)

 

 

(2,404

)

Net current period other comprehensive gain (loss), net of tax
    of $
0 $580, $851, $(2), respectively

 

 

17,407

 

 

 

2,467

 

 

 

3,023

 

 

 

(7

)

 

 

22,890

 

Balance at December 31, 2023, net of tax of $0, $(1,728), $143,
    $(
1,132), respectively

 

$

(22,442

)

 

$

(6,194

)

 

$

506

 

 

$

1,152

 

 

$

(26,978

)

   
Foreign

Currency

Translation

Adjustment
  
Unrealized

Gains
(Losses) on

Marketable

Securities
  
Unrealized

Losses on

Cash Flow
Hedges
  
Retirement

Plans Prior

Service

Credit
  
Total
 
         
(in thousands)
       
Balance at December 31, 2020, net of tax of $0, $1,910, $0, $(1,126), respectively
  $25,389  $6,954  $—    $1,173  $33,516 
Other comprehensive loss before reclassifications, net of tax of $0, $(578), $0, $0, respectively
   (36,207  (2,255  —     —     (38,462
Amounts reclassified from accumulated other comprehensive income, net of tax of $0, $(277), $0, $(2), respectively
   —     (995  —     (7  (1,002
   
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Net current period other comprehensive loss, net of tax of $0, $(855), $0, $(2), respectively
   (36,207  (3,250  —     (7  (39,464
   
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Balance at December 31, 2021, net of tax of $0, $1,055, $0, $(1,128), respectively
  $(10,818 $3,704  $—    $1,166  $(5,948
   
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Other comprehensive loss before reclassifications, net of tax of $0, $(3,388), $(708), $0, respectively
   (29,031  (12,666  (2,517  —     (44,214
Amounts reclassified from accumulated other comprehensive income
 
(loss),
 net of tax of $0, $25, $0, $(2), respectively
   —     301   —     (7  294 
   
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Net current period other comprehensive loss, net of tax of $0, $(3,363), $(708), $(2), respectively
   (29,031  (12,365  (2,517  (7  (43,920
   
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Balance at December 31, 2022, net of tax of $0, $(2,308), $(708), $(1,130), respectively
  $(39,849 $(8,661 $(2,517 $1,159  $(49,868
   
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
7
6

64


Reclassifications out of accumulated other comprehensive income (loss) to the statements of operations for the years ended December 31, 2023, 2022, 2021, and 2020,2021, were as follows:

Details about Accumulate Other Comprehensive Income (Loss) Components

 

For the years ended

 

 

Affected Line Item
in the Statements
of Operations

 

 

December 31,
2023

 

 

December 31,
2022

 

 

December 31,
2021

 

 

 

 

 

(in thousands)

 

 

 

Available-for-sale marketable securities

 

 

 

 

 

 

 

 

 

 

 

Unrealized (losses) gains, net of tax of $(12), $(25), $277,
    respectively

 

$

(44

)

 

$

(301

)

 

$

995

 

 

Other (income) expense, net

Cash flow hedges:

 

 

 

 

 

 

 

 

 

 

 

Unrealized gains, net of tax of $686, $0, $0, respectively

 

 

2,441

 

 

 

 

 

 

 

 

Revenue

Defined benefit pension and postretirement plans:

 

 

 

 

 

 

 

 

 

 

 

Amortization of prior service benefit, net of tax of $2, $2, $2,
    respectively

 

 

7

 

 

 

7

 

 

 

7

 

 

(a)

Total reclassifications, net of tax of $676, $(23), $279, respectively

 

$

2,404

 

 

$

(294

)

 

$

1,002

 

 

Net income

(a)
The amortization of prior service credit is included in the computation of net periodic pension cost and postretirement benefit; see Note P: “Retirement Plans.”
L.
GOODWILL AND INTANGIBLE ASSETS
Details about Accumulated
Other Comprehensive Income
 (Loss)
Components
  
For the year
s
ended
   
Affected Line Item

in the Statements

of Operations
 
   
December 31,

2022
  
December 31,

2021
   
December 31,

2020
     
      
(in thousands)
         
Available-for-sale marketable securities
                   
Unrealized (losses) gains, net of tax of $(25), $277, $665, respectively
  $(301 $995   $2,365    Other (income)
expense, net
 
 
Defined benefit pension and postretirement plans:
                   
Amortization of prior service benefit, net of tax of $2, $2, $2, respectively
   7   7    7    (a
   
 
 
  
 
 
   
 
 
      
Total reclassifications, net of tax of $(23), $279, $667, respectively
  $(294 $1,002   $2,372    Net income 
   
 
 
  
 
 
   
 
 
      
(a)
The amortization of prior service credit is included in the computation of net periodic pension cost and postretirement benefit; see Note P: “Retirement Plans.”
L.
GOODWILL AND INTANGIBLE ASSETS

Goodwill

Teradyne performs its annual goodwill impairment test as required under the provisions of ASC 350-10, “

Intangibles—Goodwill and Other,
” on December 31 of each fiscal year unless interim indicators of impairment exist. Goodwill is considered to be impaired when the net book value of a reporting unit exceeds its estimated fair value.

Teradyne has the option to perform a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If Teradyne determines this is the case, Teradyne is required to perform a quantitative goodwill impairment test to identify potential goodwill impairment and measure the amount of goodwill impairment loss to be recognized. If Teradyne determines that it is more likely than not that the fair value of the reporting unit is greater than its carrying amounts, the quantitative goodwill impairment test is not required. In performing the quantitative goodwill impairment test, Teradyne determines the fair value of a reporting unit using the results derived from an income approach and a market approach, weighting the fair value determined under each approach to determine an estimated fair value for a reporting unit. The income approach is estimated through the discounted cash flows (“DCF”) analysis. Determining fair value requires the exercise of significant judgment, including judgments about appropriate discount rates, perpetual growth rates, and the amount and timing of expected future cash flows. Discount rates are based on a weighted average cost of capital (“WACC”), which represents the average rate a business must pay its providers of debt and equity, plus a risk premium. The WACC used to test goodwill is derived from a group of comparable companies. The cash flows employed in the DCF analysis are derived from internal forecasts and external market forecasts. The market approach estimates the fair value of the reporting unit by utilizing the market comparable method which is based on revenue and earnings multiples from comparable companies. If the estimated fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is not impaired. If the carrying amount of a reporting unit exceeds its estimated fair value, then the goodwill is written down by the amount that carrying value exceeds the fair value of the reporting unit, but not below zero.

On September 15, 2020, Teradyne announced the appointment of Gregory Smith as President of Teradyne’s Robotics reportable segment effective October 1, 2020. With the appointment of Gregory Smith, the Robotics
7
7

reportable segment, which includes UR and MiR
,
is considered one operating segment and one reporting unit. Teradyne performed a goodwill impairment test at the time of the change in operating segments, which indicated the fair value of Teradyne’s reporting units exceeded their carrying values.

In the fourth quarter of 2022,2023, Teradyne performed the annual goodwill impairment test, completing a quantitative assessment for the Robotics reporting unit and a qualitative assessment for the Wireless Test and System Test reporting units

.units. There was
no
impairment as a result of the annual test performed in the fourth quarter of 2022.2023. Key assumptions in the goodwill valuation model are forecasted revenues, discount rate, earnings before interest and taxes, and revenue multiples from comparable companies. A change in any of these key assumptions could result in the reporting unit being impaired in a future period.

In the fourth quarter of 2021,2022, Teradyne performed the annual goodwill impairment test, completing a quantitative assessment for the Robotics reporting unit and a qualitative assessment for the Wireless Test and System Test reporting units and qualitative assessment for the

Robotics
reporting unit.units. There was no impairment as a result of the annual test performed in the fourth quarter of 2021.2022. Key assumptions in the goodwill valuation model are forecasted revenues, discount rate, earnings before interest and taxes, and revenue multiples from comparable companies. A change in any

65


Contents

The changes in the carrying amount of goodwill by reportable segments for the years ended December 31, 20222023 and 20212022 are as follows:

 

 

Robotics

 

 

Wireless
Test

 

 

Semiconductor
Test

 

 

System
Test

 

 

Total

 

 

 

(in thousands)

 

Balance at December 31, 2021:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Goodwill

 

$

405,971

 

 

$

361,819

 

 

$

262,101

 

 

$

158,699

 

 

$

1,188,590

 

Accumulated impairment losses

 

 

 

 

 

(353,843

)

 

 

(260,540

)

 

 

(148,183

)

 

 

(762,566

)

 

 

405,971

 

 

 

7,976

 

 

 

1,561

 

 

 

10,516

 

 

 

426,024

 

Foreign currency translation adjustment

 

 

(22,805

)

 

 

 

 

 

(24

)

 

 

 

 

 

(22,829

)

Balance at December 31, 2022:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Goodwill

 

 

383,166

 

 

 

361,819

 

 

 

262,077

 

 

 

158,699

 

 

 

1,165,761

 

Accumulated impairment losses

 

 

 

 

 

(353,843

)

 

 

(260,540

)

 

 

(148,183

)

 

 

(762,566

)

 

 

383,166

 

 

 

7,976

 

 

 

1,537

 

 

 

10,516

 

 

 

403,195

 

Foreign currency translation adjustment

 

 

12,297

 

 

 

 

 

 

160

 

 

 

 

 

 

12,457

 

Balance at December 31, 2023:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Goodwill

 

 

395,463

 

 

 

361,819

 

 

 

262,237

 

 

 

158,699

 

 

 

1,178,218

 

Accumulated impairment losses

 

 

 

 

 

(353,843

)

 

 

(260,540

)

 

 

(148,183

)

 

 

(762,566

)

 

 

$

395,463

 

 

$

7,976

 

 

$

1,697

 

 

$

10,516

 

 

$

415,652

 

   
Robotics
  
Wireless

Test
  
Semiconductor

Test
  
System

Test
  
Total
 
         
(in thousands)
       
Balance at December 31, 2020:
                     
Goodwill
  $433,752  $361,819  $262,155  $158,699  $1,216,425 
Accumulated impairment losses
   —     (353,843  (260,540  (148,183  (762,566
   
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
    433,752   7,976   1,615   10,516   453,859 
Foreign currency translation adjustment
   (27,781  —     (54  —     (27,835
   
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Balance at December 31, 2021:
                     
Goodwill
   405,971   361,819   262,101   158,699   1,188,590 
Accumulated impairment losses
   —     (353,843  (260,540  (148,183  (762,566
   
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
    405,971   7,976   1,561   10,516   426,024 
Foreign currency translation adjustment
   (22,805  —     (24  —     (22,829
   
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Balance at December 31, 2022:
                     
Goodwill
   383,166   361,819   262,077   158,699   1,165,761 
Accumulated impairment losses
   —     (353,843  (260,540  (148,183  (762,566
   
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
   $383,166  $7,976  $1,537  $10,516  $403,195 
   
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 

Intangible Assets

Teradyne reviews long-lived assets for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate.

There were no events or circumstances indicating that the carrying value of intangible and long-lived assets may not be recoverable in 2023, 2022 2021 and 2020.

2021.

7
8

Amortizable intangible assets consist of the following and are included in intangible assets, net on the balance sheets:

 

 

December 31, 2023

 

 

 

Gross
Carrying
Amount (1)

 

 

Accumulated
Amortization (1)

 

 

Foreign Currency Translation Adjustment

 

 

Net
Carrying
Amount

 

 

 

(in thousands)

 

Developed technology

 

$

267,706

 

 

$

(243,191

)

 

$

(5,343

)

 

$

19,172

 

Customer relationships

 

 

52,109

 

 

 

(47,850

)

 

 

232

 

 

 

4,491

 

Tradenames and trademarks

 

 

59,007

 

 

 

(46,021

)

 

 

(1,245

)

 

 

11,741

 

Total intangible assets

 

$

378,822

 

 

$

(337,062

)

 

$

(6,356

)

 

$

35,404

 

 

 

December 31, 2022

 

 

 

Gross
Carrying
Amount (1)

 

 

Accumulated
Amortization (1)

 

 

Foreign Currency Translation Adjustment

 

 

Net
Carrying
Amount

 

 

 

(in thousands)

 

Developed technology

 

$

270,967

 

 

$

(234,208

)

 

$

(5,935

)

 

$

30,824

 

Customer relationships

 

 

57,739

 

 

 

(51,186

)

 

 

172

 

 

 

6,725

 

Tradenames and trademarks

 

 

59,387

 

 

 

(41,930

)

 

 

(1,528

)

 

 

15,929

 

Total intangible assets

 

$

388,093

 

 

$

(327,324

)

 

$

(7,291

)

 

$

53,478

 

(1)
In 2023 and 2022, $9.3 million and $1.6 million, respectively, of amortizable intangible assets became fully amortized and have been eliminated from the gross carrying amount and accumulated amortization.

66


   
December 31, 2022
 
   
Gross

Carrying

Amount (1)
   
Accumulated

Amortization (1)
   
Foreign
Currency
Translation
Adjustment
   
Net

Carrying

Amount
 
   
(in thousands)
 
Developed technology
  $270,967   $(234,208  $(5,935  $30,824 
Customer relationships
   57,739    (51,186   172    6,725 
Tradenames and trademarks
   59,387    (41,930   (1,528   15,929 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total intangible assets
  $388,093   $(327,324  $(7,291  $53,478 
   
 
 
   
 
 
   
 
 
   
 
 
 
   
December 31, 2021
 
   
Gross

Carrying

Amount
   
Accumulated

Amortization
   
Foreign Currency
Translation
Adjustment
   
Net

Carrying

Amount
 
   
(in thousands)
 
Developed technology
  $272,547   $(223,413  $(4,093  $45,041 
Customer relationships
   57,739    (48,921   209    9,027 
Tradenames and trademarks
   59,387    (37,237   (583   21,567 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total intangible assets
  $389,673   $(309,571  $(4,467  $75,635 
   
 
 
   
 
 
   
 
 
   
 
 
 
(1)
In 2022, $1.6 million of amortizable intangible assets became fully amortized and have been eliminated from the gross carrying amount and accumulated amortization.

Aggregate intangible assets amortization expense for the years ended December 31, 2023, 2022, and 2021, and 2020, was $19.3$19.0 million, $21.5$19.3 million, and $30.8$21.5 million, respectively. Estimated intangible assets amortization expense for each of the five succeeding fiscal years is as follows:

Year

 

Amortization Expense

 

 

 

(in thousands)

 

2024

 

$

18,983

 

2025

 

 

11,402

 

2026

 

 

2,390

 

2027

 

 

1,173

 

2028

 

 

1,092

 

Thereafter

 

 

364

 

M.
COMMITMENTS AND CONTINGENCIES
Year
  
Amortization Expense
 
   
(in thousands)
 
2023
  $18,835 
2024
   18,527 
2025
   11,230 
2026
   2,350 
2027
   1,134 
Thereafter
   1,402 
M.
COMMITMENTS AND CONTINGENCIES

Purchase Commitments

As of December 31, 2022,2023, Teradyne had entered into non-cancelable purchase commitments for certain components and materials. The purchase commitments covered by the agreements aggregate to approximately $654.8$414.4 million, of which $570.3$379.1 million is for less than one year.

Legal Claims

Teradyne is subject to various legal proceedings and claims which have arisen in the ordinary course of business such as, but not limited to, patent, employment, commercial and environmental matters. Teradyne believes that it has meritorious defenses against all pending claims and intends to vigorously contest them. While

79


it is not possible to predict or determine the outcomes of any pending claims or to provide possible ranges of losses that may arise, Teradyne believes the potential losses associated with all of these actions are unlikely to have a material adverse effect on its business, financial position or results of operations.

On March 8, 2021, Industrial Automation LLC, sellers of AutoGuide, submitted a demand for arbitration against Teradyne and AutoGuide in Wilmington, Delaware alleging that Teradyne and AutoGuide breached certain provisions of the Membership Interests Purchase Agreement (the “Purchase Agreement”), dated as of October 18, 2019, among Industrial Automation LLC, Teradyne and AutoGuide. The arbitration demand sought full acceleration of the maximum earn-out amount payable under the Purchase Agreement, or $106.9$106.9 million, for the alleged breach of the earn-out provisions of the Purchase Agreement. On March 25, 2022, the arbitration claim was settled for $26.7$26.7 million. As a result, Teradyne has no remaining earn-out obligations.

Guarantees and Indemnification Obligations

Teradyne provides indemnification, to the extent permitted by law, to its officers, directors, employees and agents for liabilities arising from certain events or occurrences, while the officer, director, employee, or agent, is or was serving, at Teradyne’s request in such capacity. Teradyne may enter into indemnification agreements with certain of its officers and directors. With respect to acquisitions, Teradyne provides indemnifications to or assumes indemnification obligations for the current and former directors, officers and employees of the acquired companies in accordance with the acquired companies’ by-laws and charter. As a matter of practice, Teradyne has maintained directors’ and officers’ liability insurance coverage including coverage for directors and officers of acquired companies.

Teradyne enters into agreements in the ordinary course of business with customers, resellers, distributors, integrators and suppliers. Most of these agreements require Teradyne to defend and/or indemnify the other party against intellectual property infringement claims brought by a third party with respect to Teradyne’s products. From time to time, Teradyne also indemnifies customers and business partners for damages, losses and liabilities they may suffer or incur relating to personal injury, personal property damage, product liability, breach of confidentiality obligations and environmental claims relating to the use of Teradyne’s products and services or resulting from the acts or omissions of Teradyne, its employees, authorized agents or subcontractors. On occasion, Teradyne has also provided guarantees to customers regarding the delivery and performance of its products in addition to the warranty described below.

As a matter of ordinary course of business, Teradyne warrants that its products will substantially perform in accordance with its standard published specifications in effect at the time of delivery. Most warranties have a one-year duration commencing from installation. A provision is recorded upon revenue recognition to cost of revenues for estimated warranty expense based upon historical experience. When Teradyne receives revenue for extended warranties beyond the standard duration, the revenue is deferred

67


and recognized on a straight-line basis over the contract period. Related costs are expensed as incurred. As of December 31, 2022,2023 and 2021,2022, Teradyne had a product warranty accrual of $14.2$15.7 million and $24.6$14.2 million, respectively, included in other accrued liabilities, and revenue deferrals related to extended warranties of $56.2$34.9 million and $64.2$56.2 million, respectively, included in short and long-term deferred revenue and customer advances.

In addition, in the ordinary course of business, Teradyne provides minimum purchase guarantees to certain vendors to ensure continuity of supply against the market demand. Although some of these guarantees provide penalties for cancellations and/or modifications to the purchase commitments as the market demand decreases, most of the guarantees do not. Therefore, as the market demand decreases, Teradyne re-evaluates these guarantees and determines what charges, if any, should be recorded.

With respect to its agreements covering product, business or entity divestitures and acquisitions, Teradyne provides certain representations, warranties and covenants to purchasers and agrees to indemnify and hold such purchasers harmless against breaches of such representations, warranties and covenants. Many of the

8
0

indemnification claims have a definite expiration date while some remain in force indefinitely. With respect to its acquisitions, Teradyne may, from time to time, assume the liability for certain events or occurrences that took place prior to the date of acquisition.

As a matter of ordinary course of business, Teradyne occasionally guarantees certain indebtedness obligations of its subsidiary companies, limited to the borrowings from financial institutions, purchase commitments to certain vendors, and lease commitments to landlords.

Based on historical experience and information known as of December 31, 2022,2023, and 2021,2022, except for product warranty, Teradyne has not recorded any liabilities for these guarantees and obligations because the amount would be immaterial.

N.
NET INCOME PER COMMON SHARE
N.
NET INCOME PER COMMON SHARE

The following table sets forth the computation of basic and diluted net income per common share:

 

 

2023

 

 

2022

 

 

2021

 

 

 

(in thousands, except per share amounts)

 

Net income for basic and diluted net income per share

 

$

448,752

 

 

$

715,501

 

 

$

1,014,589

 

Weighted average common shares-basic

 

 

154,310

 

 

 

158,434

 

 

 

164,960

 

Effect of dilutive potential common shares:

 

 

 

 

 

 

 

 

 

Convertible note hedge warrant shares (1)

 

 

8,897

 

 

 

8,806

 

 

 

9,956

 

Incremental shares from assumed conversion of convertible notes (2)

 

 

633

 

 

 

1,763

 

 

 

7,435

 

Restricted stock units

 

 

423

 

 

 

657

 

 

 

1,180

 

Stock options

 

 

34

 

 

 

52

 

 

 

86

 

Employee stock purchase rights

 

 

7

 

 

 

22

 

 

 

8

 

Dilutive potential common shares

 

 

9,994

 

 

 

11,300

 

 

 

18,665

 

Weighted average common shares-diluted

 

 

164,304

 

 

 

169,734

 

 

 

183,625

 

Net income per common share-basic

 

$

2.91

 

 

$

4.52

 

 

$

6.15

 

Net income per common share-diluted

 

$

2.73

 

 

$

4.22

 

 

$

5.53

 

(1)
Convertible notes hedge warrant shares were calculated using the difference between the average Teradyne stock price for the period and the warrant price, multiplied by the number of warrant shares. The result of this calculation, representing the total intrinsic value of the warrant, was divided by the average Teradyne stock price for the period.
(2)
Incremental shares from the assumed conversion of the convertible notes was calculated using the difference between the average Teradyne stock price for the period and the conversion price, multiplied by the number of convertible notes shares. The result of this calculation, representing the total intrinsic value of the convertible debt, was divided by the average Teradyne stock price for the period.
   
2022
   
2021
   
2020
 
   
(in thousands, except per share amounts)
 
Net income for basic and diluted net income per share
  $715,501   $1,014,589   $784,147 
   
 
 
   
 
 
   
 
 
 
Weighted average common shares-basic
   158,434    164,960    166,120 
Effect of dilutive potential common shares:
               
Convertible note hedge warrant shares (1)
   8,806    9,956    6,989 
Incremental shares from assumed conversion of convertible notes (2)
   1,763    7,435    8,528 
Restricted stock units
   657    1,180    1,264 
Stock options
   52    86    131 
Employee stock purchase rights
   22    8    10 
   
 
 
   
 
 
   
 
 
 
Dilutive potential common shares
   11,300    18,665    16,922 
   
 
 
   
 
 
   
 
 
 
Weighted average common shares-diluted
   169,734    183,625    183,042 
   
 
 
   
 
 
   
 
 
 
Net income per common share-basic
  $4.52   $6.15   $4.72 
   
 
 
   
 
 
   
 
 
 
Net income per common share-diluted
  $4.22   $5.53   $4.28 
   
 
 
   
 
 
   
 
 
 
(1)
Convertible notes hedge warrant shares were calculated using the difference between the average Teradyne stock price for the period and the warrant price, multiplied by the number of warrant shares. The result of this calculation, representing the total intrinsic value of the warrant, was divided by the average Teradyne stock price for the period.
(2)
Incremental shares from the assumed conversion of the convertible notes was calculated using the difference between the average Teradyne stock price for the period and the conversion price, multiplied by the number of convertible notes shares. The result of this calculation, representing the total intrinsic value of the convertible debt, was divided by the average Teradyne stock price for the period.

The computation of diluted net income per common share for 2023 excludes the effect of the potential exercise of stock options to purchase approximately 0.1 million shares and restricted stock units to purchase approximately 0.1 million shares because the effect would have been anti-dilutive. The computation of diluted net income per common share for 2022 excludes the effect of the potential exercise of stock options to purchase approximately 0.1 million shares and restricted stock units to purchase approximately 0.4 million shares because the effect would have been anti-dilutive.

68


The computationO.
RESTRUCTURING AND OTHER

During the year ended December 31, 2023, Teradyne recorded $14.7 million of diluted net income per common shareseverance charges related to headcount reductions of 215 people primarily in Semiconductor Test and Robotics, which included charges related to a voluntary early retirement program for 2021 excludes the effectemployees meeting certain conditions, a $3.1 million of the potential exerciseacquisition and divestiture expenses related to Technoprobe transaction, a $1.5 million contract termination charge, and a charge of stock options to purchase approximately 0.1$1.1 million shares and restricted stock units to purchase approximately 0.1 million shares because the effect would have been anti-dilutive.

O.
RESTRUCTURING AND OTHER
for an increase in environmental liability.

During the year ended December 31, 2022, Teradyne recorded a charge of $14.7$14.7 million related to the arbitration claim filed against Teradyne and AutoGuide related to an earn-out dispute, which was settled on March 25, 2022 for $26.7$26.7 million, $2.9$2.9 million of severance charges primarily in Robotics, and a charge of $2.7$2.7 million for an increase in environmental and legal liabilities, partially offset by a $3.4$3.4 million gain on sale of asset.

8
1

During the year ended December 31, 2021, Teradyne recorded a charge of $12.0$12.0 million related to the arbitration claim filed against Teradyne and AutoGuide related to an earn-out dispute, $1.5$1.5 million of severance charges primarily in Robotics, $0.5$0.5 million of acquisition related compensation and expenses, and $2.5$2.5 million for other expenses, offset by a $7.2$7.2 million gain for the decrease in the fair value of the AutoGuide contingent consideration liability.

During the year ended December 31, 2020, Teradyne recorded a $19.7 million gain for the decrease in the fair value of the AutoGuide contingent consideration liability, and a $3.5 million gain for the decrease in the fair value of the MiR contingent consideration liability, partially offset by a charge of $4.0 million for contract termination settlement, $2.5 million of acquisition related compensation and expenses, $2.3 million of severance charges primarily in Robotics, and $1.2 million of other expenses.P.
RETIREMENT PLANS
P.
RETIREMENT PLANS

ASC 715

,
Compensation—Retirement Benefits,
” requires an employer with defined benefit plans or other postretirement benefit plans to recognize an asset or a liability on its balance sheet for the overfunded or underfunded status of the plans as defined by ASC 715. The pension asset or liability represents a difference between the fair value of the pension plan’s assets and the projected benefit obligation at December 31. Teradyne uses a December 31 measurement date for all of its plans.

Defined Benefit Pension Plans

Teradyne has defined benefit pension plans covering a portion of domestic employees and employees of certain non-U.S. subsidiaries. Benefits under these plans are based on employees’ years of service and compensation. Teradyne’s funding policy is to make contributions to the plans in accordance with local laws and to the extent that such contributions are tax deductible. The assets of these plans consist primarily of fixed income and equity securities. In addition, Teradyne has an unfunded supplemental executive defined benefit plan in the United States to provide retirement benefits in excess of levels allowed by the Employment Retirement Income Security Act (“ERISA”) and the Internal Revenue Code (the “IRC”), as well as unfunded qualified foreign plans.

In 2023, Teradyne’s projected benefit obligations increased primarily due to actuarial losses of approximately $6.0 million across all pension plans from increases in discount rates, and approximately $1.0 million of losses from foreign exchange effects for foreign plans. In 2022, Teradyne’s projected benefit obligations decreased primarily due to actuarial gains of approximately $59.1$59.1 million across all pension plans from increases in discount rates, and approximately $3.1$3.1 million gain from foreign exchange effects for foreign plans. In 2021, Teradyne’s projected benefit obligations decreased primarily due to actuarial gains of approximately $8.7 million across all pension plans from increases in discount rates, and approximately $3.3 million gain from foreign exchange effects for foreign plans.

82

69


The December 31 balances of these defined benefit pension plans assets and obligations are shown below:

 

 

2023

 

 

2022

 

 

 

United States

 

 

Foreign

 

 

United States

 

 

Foreign

 

 

 

(in thousands)

 

Assets and Obligations

 

 

 

 

 

 

 

 

 

 

 

 

Change in benefit obligation:

 

 

 

 

 

 

 

 

 

 

 

 

Projected benefit obligation:

 

 

 

 

 

 

 

 

 

 

 

 

Beginning of year

 

$

143,814

 

 

$

29,935

 

 

$

192,472

 

 

$

45,774

 

Service cost

 

 

1,063

 

 

 

446

 

 

 

1,588

 

 

 

784

 

Interest cost

 

 

6,888

 

 

 

1,057

 

 

 

4,886

 

 

 

482

 

Actuarial loss (gain)

 

 

3,229

 

 

 

2,738

 

 

 

(45,932

)

 

 

(13,181

)

Benefits paid

 

 

(10,807

)

 

 

(947

)

 

 

(9,200

)

 

 

(863

)

Liability (gain) loss due to settlement

 

 

 

 

 

(254

)

 

 

 

 

 

 

Non-U.S. currency movement

 

 

 

 

 

1,009

 

 

 

 

 

 

(3,061

)

End of year

 

 

144,187

 

 

 

33,984

 

 

 

143,814

 

 

 

29,935

 

Change in plan assets:

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of plan assets:

 

 

 

 

 

 

 

 

 

 

 

 

Beginning of year

 

 

111,760

 

 

 

2,087

 

 

 

149,578

 

 

 

2,017

 

Actual return on plan assets

 

 

8,613

 

 

 

43

 

 

 

(31,835

)

 

 

153

 

Company contributions

 

 

3,051

 

 

 

1,028

 

 

 

3,217

 

 

 

949

 

Benefits paid

 

 

(10,807

)

 

 

(947

)

 

 

(9,200

)

 

 

(863

)

Settlements gain

 

 

 

 

 

(254

)

 

 

 

 

 

 

Non-U.S. currency movement

 

 

 

 

 

(28

)

 

 

 

 

 

(169

)

End of year

 

 

112,617

 

 

 

1,929

 

 

 

111,760

 

 

 

2,087

 

Funded status

 

$

(31,570

)

 

$

(32,055

)

 

$

(32,054

)

 

$

(27,848

)

  
2022
  
2021
 
  
United States
  
Foreign
  
United States
  
Foreign
 
  
(in thousands)
 
Assets and Obligations
                
Change in benefit obligation:
                
Projected benefit obligation:
                
Beginning of year
 $192,472  $45,774  $202,233  $50,988 
Service cost
  1,588   784   1,784   941 
Interest cost
  4,886   482   4,427   337 
Actuarial (gain) loss
  (45,932  (13,181  (6,432  (2,257
Benefits paid
  (9,200  (863  (9,337  (925
Liability (gain) loss due to settlement
  —     —     (204  —   
Non-U.S. currency movement
  —     (3,061  —     (3,310
  
 
 
  
 
 
  
 
 
  
 
 
 
End of year
  143,814   29,935   192,472   45,774 
  
 
 
  
 
 
  
 
 
  
 
 
 
Change in plan assets:
                
Fair value of plan assets:
                
Beginning of year
  149,578   2,017   158,855   1,856 
Actual return on plan assets
  (31,835  153   (3,217  33 
Company contributions
  3,217   949   3,276   1,022 
Benefits paid
  (9,200  (863  (9,337  (925
Non-U.S. currency movement
  —     (169  —     31 
  
 
 
  
 
 
  
 
 
  
 
 
 
End of year
  111,760   2,087   149,578   2,017 
  
 
 
  
 
 
  
 
 
  
 
 
 
Funded status
 $(32,054 $(27,848 $(42,894 $(43,757
  
 
 
  
 
 
  
 
 
  
 
 
 

The following table provides amounts recorded within the account line items of the statements of financial position as of December 31:

 

 

2023

 

 

2022

 

 

 

United States

 

 

Foreign

 

 

United States

 

 

Foreign

 

 

 

(in thousands)

 

Retirement plans assets

 

$

11,504

 

 

$

 

 

$

11,761

 

 

$

 

Accrued employees’ compensation and withholdings

 

 

(3,110

)

 

 

(1,255

)

 

 

(3,055

)

 

 

(1,191

)

Retirement plans liabilities

 

 

(39,964

)

 

 

(30,800

)

 

 

(40,760

)

 

 

(26,657

)

Funded status

 

$

(31,570

)

 

$

(32,055

)

 

$

(32,054

)

 

$

(27,848

)

   
2022
   
2021
 
   
United

States
   
Foreign
   
United

States
   
Foreign
 
   
(in thousands)
 
Retirement plans assets
  $11,761   $—     $15,110   $—   
Accrued employees’ compensation and withholdings
   (3,055   (1,191   (3,288   (936
Retirement plans liabilities
   (40,760   (26,657   (54,716   (42,821
   
 
 
   
 
 
   
 
 
   
 
 
 
Funded status
  $(32,054  $(27,848  $(42,894  $(43,757
   
 
 
   
 
 
   
 
 
   
 
 
 

The accumulated benefit obligation for the United States defined benefit pension plans was $140.6$142.2 million and $187.5$140.6 million at December 31, 20222023 and 2021,2022, respectively. The accumulated benefit obligation for foreign defined benefit pension plans was $28.6$32.6 million and $42.5$28.6 million at December 31, 2023 and 2022, and 2021, respectively.

Information for pension plans with an accumulated benefit obligation in excess of plan assets as of December 31:

 

 

2023

 

 

2022

 

 

 

United States

 

 

Foreign

 

 

United States

 

 

Foreign

 

 

 

(in millions)

 

Projected benefit obligation

 

$

43.1

 

 

$

34.0

 

 

$

43.8

 

 

$

29.9

 

Accumulated benefit obligation

 

 

42.6

 

 

 

32.5

 

 

 

42.3

 

 

 

28.6

 

Fair value of plan assets

 

 

 

 

 

1.9

 

 

 

 

 

 

2.1

 

   
2022
   
2021
 
   
United
States
   
Foreign
   
United
States
   
Foreign
 
   
(in millions)
 
Projected benefit obligation
  $43.8   $29.9   $58.0   $45.8 
Accumulated benefit obligation
   42.3    28.6    55.7    42.5 
Fair value of plan assets
   —      2.1    —      2.0 
8
3

70


Expense

Expense

For the years ended December 31, 2023, 2022, 2021, and 2020,2021, Teradyne’s net periodic pension cost (income) cost was comprised of the following:

 

 

2023

 

 

2022

 

 

2021

 

 

 

United
States

 

 

Foreign

 

 

United
States

 

 

Foreign

 

 

United
States

 

 

Foreign

 

 

 

(in thousands)

 

Components of Net Periodic Pension Cost (Income):

 

 

 

 

 

 

 

 

 

 

 

 

 

Service cost

 

$

1,063

 

 

$

446

 

 

$

1,588

 

 

$

784

 

 

$

1,784

 

 

$

941

 

Interest cost

 

 

6,888

 

 

 

1,057

 

 

 

4,886

 

 

 

482

 

 

 

4,427

 

 

 

337

 

Expected return on plan assets

 

 

(5,194

)

 

 

(45

)

 

 

(2,927

)

 

 

(75

)

 

 

(3,858

)

 

 

(67

)

Net actuarial loss (gain)

 

 

18

 

 

 

2,735

 

 

 

(11,170

)

 

 

(13,259

)

 

 

643

 

 

 

(2,223

)

Settlement (gain) loss

 

 

(209

)

 

 

5

 

 

 

 

 

 

 

 

 

(204

)

 

 

 

Total net periodic pension cost (income)

 

$

2,566

 

 

$

4,198

 

 

$

(7,623

)

 

$

(12,068

)

 

$

2,792

 

 

$

(1,012

)

   
2022
  
2021
  
2020
 
   
United

States
  
Foreign
  
United

States
  
Foreign
  
United

States
  
Foreign
 
   
(in thousands)
 
Components of Net Periodic Pension (Income) Cost:
                         
Service cost
  $1,588  $784  $1,784  $941  $1,773  $907 
Interest cost
   4,886   482   4,427   337   5,770   516 
Expected return on plan assets
   (2,927  (75  (3,858  (67  (4,840  (65
Net actuarial(gain) loss
   (11,170  (13,259  643   (2,223  6,463   2,949 
Settlement (gain) loss
   —     —     (204  —     451   —   
   
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Total net periodic pension (income) cost
  $(7,623 $(12,068 $2,792  $(1,012 $9,617  $4,307 
   
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 

Weighted Average Assumptions to Determine Net Periodic Pension Cost at January 1:

   
2022
  
2021
  
2020
 
   
United States
  
Foreign
  
United States
  
Foreign
  
United States
  
Foreign
 
Discount rate
   2.5  1.1  2.2  0.7  2.8  1.1
Expected return on plan assets
   2.0   4.0   2.4   3.5   3.0   3.8 
Salary progression rate
   2.4   2.2   2.4   2.3   2.6   2.5 

 

 

2023

 

 

2022

 

 

2021

 

 

 

United
States

 

 

Foreign

 

 

United
States

 

 

Foreign

 

 

United
States

 

 

Foreign

 

Discount rate

 

 

3.5

%

 

 

3.5

%

 

 

2.5

%

 

 

1.1

%

 

 

2.2

%

 

 

0.7

%

Expected return on plan assets

 

 

4.8

 

 

 

1.8

 

 

 

2.0

 

 

 

4.0

 

 

 

2.4

 

 

 

3.5

 

Salary progression rate

 

 

2.4

 

 

 

2.1

 

 

 

2.4

 

 

 

2.2

 

 

 

2.4

 

 

 

2.3

 

Weighted Average Assumptions to Determine Pension Obligations at December 31:

 

 

2023

 

 

2022

 

 

 

United States

 

 

Foreign

 

 

United States

 

 

Foreign

 

Discount rate

 

 

4.7

%

 

 

3.0

%

 

 

4.9

%

 

 

3.5

%

Salary progression rate

 

 

2.5

 

 

 

2.4

 

 

 

2.5

 

 

 

2.1

 

   
2022
  
2021
 
   
United
States
  
Foreign
  
United
States
  
Foreign
 
Discount rate
   4.9  3.5  2.6  1.1
Salary progression rate
   2.5   2.1   2.4   2.2 

In developing the expected return on plan assets assumption, Teradyne evaluates input from its investment manager and pension consultants, including their forecast of asset class return expectations. Teradyne believes that 2.0%4.75% was an appropriate rate to use for fiscal year 20222023 for the U.S. Qualified Pension Plan (“U.S. Plan”).

Teradyne recognizes net actuarial gains and losses and the change in the fair value of the plan assets in its operating results in the year in which they occur or upon any interim remeasurement of the plans. Teradyne calculates the expected return on plan assets using the fair value of the plan assets. Actuarial gains and losses are generally measured annually as of December 31 and, accordingly, recorded during the fourth quarter of each year or upon any interim remeasurement of the plans.

The discount rate utilized to determine future pension obligations for the U.S. Plan is based on FTSE Pension Index adjusted for the plan’s expected cash flows and was 4.9%4.7% at December 31, 2022, up2023, down from 2.6%4.9% at December 31, 2021.

2022.

Plan Assets

As of December 31, 2022,2023, the fair value of Teradyne’s pension plans’ assets totaled $113.8$114.5 million, of which $111.8$112.6 million was related to the U.S. Plan and $2.1$1.9 million was related to the Taiwan defined benefit pension plan. Substantially all of Teradyne’s pension plans’ assets are held in individual trusts, which were established for the investment of assets of Teradyne’s sponsored retirement plans.

8
4

71


The following table provides weighted average pension asset allocation by asset category at December 31, 20222023 and 2021:2022:

 

 

2023

 

 

2022

 

 

 

United States

 

 

Foreign

 

 

United States

 

 

Foreign

 

Fixed income securities

 

 

94.0

%

 

 

%

 

 

94.0

%

 

 

%

Equity securities

 

 

5.0

 

 

 

 

 

 

5.0

 

 

 

 

Other

 

 

1.0

 

 

 

100.0

 

 

 

1.0

 

 

 

100.0

 

 

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

   
2022
  
2021
 
   
United
States
  
Foreign
  
United
States
  
Foreign
 
Fixed income securities
   94.0  —    94.0  —  
Equity securities
   5.0   —     5.0   —   
Other
   1.0   100.0   1.0   100.0 
   
 
 
  
 
 
  
 
 
  
 
 
 
    100.0  100.0  100.0  100.0
   
 
 
  
 
 
  
 
 
  
 
 
 

The assets of the U.S. Plan are overseen by the Teradyne Fiduciary Committee which is comprised of members of senior management drawn from appropriate diversified levels of the management team. The Fiduciary Committee is responsible for setting the policy that provides the framework for management of the U.S. Plan assets. In accordance with its responsibilities, the Fiduciary Committee meets on a regular basis to review the performance of the U.S. Plan assets and compliance with the investment policy. The policy sets forth an investment structure for managing U.S. Plan assets, including setting the asset allocation ranges, which are expected to provide an appropriate level of overall diversification required to maximize the long-term return on plan assets for a prudent and reasonable level of risk given prevailing market conditions, total investment return over the long term, and preservation of capital, while maintaining sufficient liquidity to pay the benefits of the U.S. Plan. The investment portfolio will not, at any time, have a direct investment in Teradyne stock. It may have indirect investment in Teradyne stock, if one of the funds selected by the investment manager invests in Teradyne stock. In developing the asset allocation ranges, third party asset allocation studies are periodically performed that consider the current and expected positions of the plan assets and funded status. Based on this study and other appropriate information, the Fiduciary Committee establishes asset allocation ranges taking into account acceptable risk targets and associated returns. The investment return objectives are to avoid excessive volatility and produce a rate of return that at least matches the Policy Index identified below. The manager’s investment performance is reviewed at least annually. Results for the total portfolio and for each major category of assets are evaluated in comparison with appropriate market indices and the Policy Index.

The target asset allocation and the index for each asset category for the U.S. Plan, per the investment policy, are as follows:

Asset Category:

Policy Index:

Target
Allocation

Asset Category:
Policy Index:
Target

Allocation

U.S. corporate fixed income

Bloomberg Barclays U.S. Corporate A or Better Index,20+ Year Index

75

43

%

U.S. corporate fixed income

Bloomberg U.S. Corporate A or Better Index, 5- 20 Year Index

32

U.S. government fixed income

Bloomberg Barclays U.S. Long Government3 - 10 year Treasury Bond Index

14

Global equity

MSCI World Minimum Volatility Index

5

High yield fixed income

Bloomberg Barclays

ICE BofA BB-B U.S. Corporate High Yield Constrained Index

5

Cash

Citigroup Three Month U.S.

ICE BofA 3-Month Treasury Bill

Index

1

Teradyne’s U.S. Plan invests primarily in common trust funds. Units held in the common trust funds are valued at the unit price as reported by the investment manager based on the asset value of the underlying investments; underlying investments in equity securities are valued at the last reported sales price, and underlying investments in fixed-income securities are generally valued using methods based upon market transactions for comparable securities.

During the years ended December 31, 20222023 and December 31, 2021,2022, there were no transfers of pension assets in or out of Level 1, Level 2, and Level 3.

8
5

72


The fair value of pension plan assets by asset category and by level at December 31, 20

2
22023 and December 31, 202
1
2022 were as follows:

 

 

December 31, 2023

 

 

 

United States

 

 

Foreign

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

 

(in thousands)

 

Fixed income securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

$

 

 

$

89,971

 

 

$

 

 

$

89,971

 

 

$

 

 

$

 

 

$

 

 

$

 

U.S. government securities

 

 

 

 

 

15,817

 

 

 

 

 

 

15,817

 

 

 

 

 

 

 

 

 

 

 

 

 

Global equity

 

 

 

 

 

5,691

 

 

 

 

 

 

5,691

 

 

 

 

 

 

 

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,929

 

 

 

 

 

 

1,929

 

Cash and cash equivalents

 

 

1,138

 

 

 

 

 

 

 

 

 

1,138

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

$

1,138

 

 

$

111,479

 

 

$

 

 

$

112,617

 

 

$

 

 

$

1,929

 

 

$

 

 

$

1,929

 

 

 

December 31, 2022

 

 

 

United States

 

 

Foreign

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

 

(in thousands)

 

Fixed income securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

$

 

 

$

89,403

 

 

$

 

 

$

89,403

 

 

$

 

 

$

 

 

$

 

 

$

 

U.S. government securities

 

 

 

 

 

15,631

 

 

 

 

 

 

15,631

 

 

 

 

 

 

 

 

 

 

 

 

 

Global equity

 

 

 

 

 

5,579

 

 

 

 

 

 

5,579

 

 

 

 

 

 

 

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,087

 

 

 

 

 

 

2,087

 

Cash and cash equivalents

 

 

1,147

 

 

 

 

 

 

 

 

 

1,147

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

$

1,147

 

 

$

110,613

 

 

$

 

 

$

111,760

 

 

$

 

 

$

2,087

 

 

$

 

 

$

2,087

 

   
December 31, 2022
 
   
United States
   
Foreign
 
   
Level 1
   
Level 2
   
Level 3
   
Total
   
Level 1
   
Level 2
   
Level 3
   
Total
 
   
(in thousands)
 
Fixed income securities:
                                        
Corporate debt securities
  $—     $89,403   $—     $89,403   $—     $—     $—     $—   
U.S. government securities
   —      15,631    —      15,631    —      —      —      —   
Global equity
   —      5,579    —      5,579    —      —      —      —   
Other
   —      —      —      —      —      2,087    —      2,087 
Cash and cash equivalents
   1,147    —      —      1,147    —      —      —      —   
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $1,147   $110,613   $—     $111,760   $—     $2,087   $—     $2,087 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
   
December 31, 2021
 
   
United States
   
Foreign
 
   
Level 1
   
Level 2
   
Level 3
   
Total
   
Level 1
   
Level 2
   
Level 3
   
Total
 
   
 
(in thousands)
 
Fixed income securities:
                                        
Corporate debt securities
  $—     $119,805   $—     $119,805   $—     $—     $—     $—   
U.S. government securities
   —      20,847    —      20,847    —      —      —      —   
Global equity
   —      7,426    —      7,426    —      —      —      —   
Other
   —      —      —      —      —      2,017    —      2,017 
Cash and cash equivalents
   1,500    —      —      1,500    —      —      —      —   
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $1,500   $148,078   $—     $149,578   $—     $2,017   $—     $2,017 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 

Contributions

Teradyne’s funding policy is to make contributions to the plans in accordance with local laws and to the extent that such contributions are tax deductible. During 2022,2023, Teradyne contributed $3.2$3.1 million to the U.S. supplemental executive defined benefit pension plan and $0.9$1.0 million to certain qualified plans for non-U.S. subsidiaries. During 2021,2022, Teradyne contributed $3.3$3.2 million to the U.S. supplemental executive defined benefit pension plan and $1.0$0.9 million to certain qualified plans for non-U.S. subsidiaries. In 2023,2024, contributions to the U.S. supplemental executive defined benefit pension plan and certain qualified plans from non-U.S. subsidiaries will be approximately $3.1$3.1 million and $1.3$1.4 million, respectively.

Contributions to the U.S. supplemental executive defined benefit pension plan and certain non-U.S. subsidiaries qualified plans will be approximately $6.4$6.6 million and $2.1$2.3 million, respectively, in 1 to 3 years, $7.1$7.1 million and $2.3$2.5 million, respectively, in 3 to 5 years and $17.4$16.9 million and $7.0$7.9 million, respectively, thereafter.

8
6

Expected Future Pension Benefit Payments

Future benefit payments are expected to be paid as follows:

 

 

United States

 

 

Foreign

 

 

 

(in thousands)

 

2024

 

$

10,210

 

 

$

1,312

 

2025

 

 

9,720

 

 

 

1,068

 

2026

 

 

9,863

 

 

 

1,191

 

2027

 

 

10,792

 

 

 

1,301

 

2028

 

 

10,795

 

 

 

1,238

 

2029-2032

 

 

51,857

 

 

 

8,832

 

73


   
United States
   
Foreign
 
   
(in thousands)
 
2023
  $10,323   $1,239 
2024
   9,274    1,055 
2025
   9,912    1,014 
2026
   9,971    1,130 
2027
   10,742    1,239 
2028-2031
   52,877    8,216 

Postretirement Benefit Plans

In addition to receiving pension benefits, U.S. Teradyne employees who meet early retirement eligibility requirements as of their termination dates may participate in Teradyne’s Welfare Plan, which includes medical and dental benefits up to age 65. Death benefits provide a fixed sum to retirees’ survivors and are available to all retirees. Substantially all of Teradyne’s current U.S. employees could become eligible for these benefits, and the existing benefit obligation relates primarily to those employees.

During the twelve months ended December 31, 2023, Teradyne recorded special termination benefit charges associated with a voluntary early retirement program.

The December 31 balances of the postretirement assets and obligations are shown below:

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Assets and Obligations

 

 

 

 

 

 

Change in benefit obligation:

 

 

 

 

 

 

Projected benefit obligation:

 

 

 

 

 

 

Beginning of year

 

$

5,345

 

 

$

7,210

 

Service cost

 

 

34

 

 

 

64

 

Interest cost

 

 

299

 

 

 

177

 

Actuarial loss (gain)

 

 

155

 

 

 

(1,155

)

Benefits paid

 

 

(1,413

)

 

 

(950

)

Special termination benefits

 

 

2,513

 

 

 

 

End of year

 

 

6,933

 

 

 

5,345

 

Change in plan assets:

 

 

 

 

 

 

Fair value of plan assets:

 

 

 

 

 

 

Beginning of year

 

 

 

 

 

 

Company contributions

 

 

1,413

 

 

 

950

 

Benefits paid

 

 

(1,413

)

 

 

(950

)

End of year

 

 

 

 

 

 

Funded status

 

$

(6,933

)

 

$

(5,345

)

   
2022
   
2021
 
   
(in thousands)
 
Assets and Obligations
          
Change in benefit obligation:
          
Projected benefit obligation:
          
Beginning of year
  $7,210   $8,515 
Service cost
   64    64 
Interest cost
   177    170 
Actuarial gain
   (1,155   (433
Benefits paid
   (950   (1,107
   
 
 
   
 
 
 
End of year
   5,345    7,210 
   
 
 
   
 
 
 
Change in plan assets:
          
Fair value of plan assets:
          
Beginning of year
   —      —   
Company contributions
   950    1,107 
Benefits paid
   (950   (1,107
   
 
 
   
 
 
 
End of year
   —      —   
   
 
 
   
 
 
 
Funded status
  $(5,345  $(7,210
   
 
 
   
 
 
 

The following table provides amounts recorded within the account line items of financial position as of December 31:

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Accrued employees’ compensation and withholdings

 

$

(1,508

)

 

$

(853

)

Retirement plans liabilities

 

 

(5,425

)

 

 

(4,492

)

Funded status

 

$

(6,933

)

 

$

(5,345

)

   
2022
   
2021
 
   
(in thousands)
 
Accrued employees’ compensation and withholdings
  $(853  $(930
Retirement plans liability
   (4,492   (6,280
   
 
 
   
 
 
 
Funded status
  $(5,345  $(7,210
   
 
 
   
 
 
 
8
7

The following table provides amounts recognized in accumulated other comprehensive income (loss) as of December 31:

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Prior service credit, before tax

 

$

(23

)

 

$

(31

)

Deferred taxes

 

 

(1,691

)

 

 

(1,689

)

Total recognized in other comprehensive income (loss), net of tax

 

$

(1,714

)

 

$

(1,720

)

74


Expense

   
2022
   
2021
 
   
(in thousands)
 
Prior service credit, before tax
  $(31  $(40
Deferred taxes
   (1,689   (1,688
   
 
 
   
 
 
 
Total recognized in other comprehensive income (loss), net of tax
  $(1,720  $(1,728
   
 
 
   
 
 
 
Expense

For the years ended December 31, 2023, 2022, 2021, and 2020,2021, Teradyne’s net periodic postretirement benefit cost (income) cost was comprised of the following:

 

 

2023

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Components of Net Periodic Postretirement Benefit Cost (income):

 

Service cost

 

$

34

 

 

$

64

 

 

$

64

 

Interest cost

 

 

299

 

 

 

177

 

 

 

170

 

Amortization of prior service credit

 

 

(9

)

 

 

(9

)

 

 

(9

)

Net actuarial loss (gain)

 

 

155

 

 

 

(1,155

)

 

 

(433

)

Special termination benefits

 

 

2,513

 

 

 

 

 

 

 

Total net periodic postretirement benefit cost (income)

 

 

2,992

 

 

 

(923

)

 

 

(208

)

Changes in Plan Assets and Benefit Obligations Recognized in Other
    Comprehensive Income:

 

 

 

 

 

 

 

 

 

Reversal of amortization items:

 

 

 

 

 

 

 

 

 

Prior service credit

 

 

9

 

 

 

9

 

 

 

9

 

Total recognized in other comprehensive income

 

 

9

 

 

 

9

 

 

 

9

 

Total recognized in net periodic postretirement cost (income) and other
    comprehensive income

 

$

3,001

 

 

$

(914

)

 

$

(199

)

   
2022
   
2021
   
2020
 
   
(in thousands)
 
Components of Net Periodic Postretirement Benefit Income (cost ):
               
Service cost
  $64   $64   $57 
Interest cost
   177    170    240 
Amortization of prior service credit
   (9   (9   (9
Net actuarial (gain) loss
   (1,155   (433   421 
   
 
 
   
 
 
   
 
 
 
Total net periodic postretirement benefit (income) cost
   (923   (208   709 
   
 
 
   
 
 
   
 
 
 
Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income:
               
Reversal of amortization items:
               
Prior service credit
   9    9    9 
   
 
 
   
 
 
   
 
 
 
Total recognized in other comprehensive income
   9    9    9 
   
 
 
   
 
 
   
 
 
 
Total recognized in net periodic postretirement (income) cost and other comprehensive income
  $(914  $(199  $718 
   
 
 
   
 
 
   
 
 
 

Weighted Average Assumptions to Determine Net Periodic Postretirement Benefit Income as of January 1:

   
2022
  
2021
  
2020
 
Discount rate
   2.6  2.2  3.0
Initial health care cost trend rate
   7.3   7.3   7.1 
Ultimate health care cost trend rate
   4.5   4.5   4.5 
Year in which ultimate health care cost trend rate is reached
   2029   2029   2026 

 

 

2023

 

 

2022

 

 

2021

 

Discount rate

 

 

5.0

%

 

 

2.6

%

 

 

2.2

%

Initial health care cost trend rate

 

 

7.2

 

 

 

7.3

 

 

 

7.3

 

Ultimate health care cost trend rate

 

 

4.5

 

 

 

4.5

 

 

 

4.5

 

Year in which ultimate health care cost trend rate is reached

 

2032

 

 

2029

 

 

2029

 

Weighted Average Assumptions to Determine Postretirement Benefit Obligation as of December 31:

 

 

2023

 

 

2022

 

 

2021

 

Discount rate

 

 

4.7

%

 

 

5.0

%

 

 

2.6

%

Initial health care trend

 

 

7.7

 

 

 

7.2

 

 

 

7.3

 

Ultimate health care trend

 

 

4.5

 

 

 

4.5

 

 

 

4.5

 

Medical cost trend rate decrease to ultimate rate in year

 

 

2033

 

 

 

2032

 

 

 

2029

 

   
2022
  
2021
  
2020
 
Discount rate
   5.0  2.6  2.2
Initial medical trend
   7.2   7.3   7.3 
Ultimate health care trend
   4.5   4.5   4.5 
Medical cost trend rate decrease to ultimate rate in year
   2032   2029   2029 
88


Contributions

Contributions to the U.S. postretirement benefit plan will be approximately $0.9$1.5 million in 2023, $1.32024, $1.6 million in 1 to 3 years, $0.8$1.2 million in 3 to 5 years and $1.3$2.0 million, thereafter.

Expected Future Benefit Payments

Future benefit payments are expected to be paid as follows:

 

 

Benefit Payments

 

 

 

(in thousands)

 

2024

 

$

1,508

 

2025

 

 

924

 

2026

 

 

701

 

2027

 

 

637

 

2028

 

 

568

 

2029-2032

 

 

2,004

 

75


Q.
STOCK-BASED COMPENSATION
   
Benefit Payments
 
   
(in thousands)
 
2023
  $853 
2023
   688 
2024
   573 
2025
   436 
2027
   386 
2028-2031
   1,291 
Q.
STOCK-BASED COMPENSATION

Stock Compensation Plans

On February 1, 2023 (the “Retirement Date”), Mark E. Jagiela retired as Chief Executive Officer of Teradyne and a member of Teradyne's Board of Directors, and Teradyne entered into an agreement (the “Retirement Agreement”) with Mr. Jagiela. Under the Retirement Agreement, Mr. Jagiela's unvested time-based restricted stock units and stock options granted prior to his Retirement Date were modified to allow continued vesting; and any vested options or options that vest during that period may be exercised for the remainder of the applicable option term. During 2023, Teradyne recorded a stock-based compensation expense of $5.9 million related to the Retirement Agreement.

Under Teradyne’s stock compensation plans, Teradyne grants time-based restricted stock units, performance-based restricted stock units, and stock options, and employees are eligible to purchase Teradyne’s common stock through its Employee Stock Purchase Plan (“ESPP”).

Service-based restricted stock unit awards granted to employees vest in equal annual installments over four years.years. Restricted stock unit awards granted to non-employee directors vest after a one-year period, with 100%100% of the award vesting on the earlier of (a) the first anniversary of the grant date or (b) the date of the following year’s Annual Meeting of Shareholders. Teradyne expenses the cost of the restricted stock unit awards subject to time-based vesting, which is determined to be the fair market value of the shares at the date of grant, ratably over the period during which the restrictions lapse.

Performance-based restricted stock units (“PRSUs”) granted to Teradyne’s executive officers may have a performance metric based on relative total shareholder return (“TSR”). Teradyne’s three-year TSR performance is measured against the New York Stock Exchange (“NYSE”) Composite Index. The final number of TSR PRSUs that vest will vary based upon the level of performance achieved from 0%0% to 200%200% of the target shares. The TSR PRSUs will vest upon the three-year anniversary of the grant date. The TSR PRSUs are valued using a Monte Carlo simulation model. The number of units expected to be earned, based upon the achievement of the TSR market condition, is factored into the grant date Monte Carlo valuation. Compensation expense is recognized on a straight-line basis over the shorter of the three-year service period or the period from the grant to the date described in the retirement provisions below. Compensation expense for executive officers meeting the retirement provisions prior to the grant date is recognized during the year following the grant. Compensation expense is recognized regardless of the eventual number of units that are earned based upon the market condition, provided the executive officer remains an employee at the end of the three-year period. Compensation expense is reversed if at any time during the three-year service period the executive officer is no longer an employee, subject to the retirement and termination eligibility provisions noted below.

PRSUs granted to Teradyne’s executive officers may also have a performance metric based on three-year cumulative non-GAAP profit before interest and tax (“PBIT”) as a percent of Teradyne’s revenue. Non-GAAP PBIT is a financial measure equal to GAAP income from operations less restructuring and other, net; amortization of acquired intangible assets; acquisition and divestiture related charges or credits; pension actuarial gains and losses; non-cash convertible debt interest expense; and other non-recurring gains and charges. The final

8
9

number of PBIT PRSUs that vest will vary based upon the level of performance achieved from 0%0% to 200%200% of the target shares. The PBIT PRSUs will vest upon the three-year anniversary of the grant date. Compensation expense is recognized on a straight-line basis over the shorter of the three-year service period or the period from the grant date to the date described in the retirement provisions below. Compensation expense for executive officers meeting the retirement provisions prior to the grant date is recognized during the year following the grant. Compensation expense is recognized based on the number of units that are earned based upon the three-year Teradyne PBIT as a percent of Teradyne’s revenue, provided the executive officer remains an employee at the end of the three-year period subject to the retirement and termination eligibility provisions noted below.

If a PRSU recipient’s employment ends prior to the determination of the performance percentage due to (1) permanent disability or death or (2) retirement or termination other than for cause, after attaining both at least age sixty and at least ten years of service, then all or a portion of the recipient’s PRSUs (based on the actual performance percentage achieved on the determination date) will vest on the date the performance percentage is determined. Except as set forth in the preceding sentence, no PRSUs will vest if the executive officer is no longer an employee at the end of the three-year period. Stock options to purchase Teradyne’s common stock at 100%100% of the fair market

value
on the grant date vest in equal annual installments over four years from the grant date and have a maximum term of seven years.
years.

During 2023, 2022 2021 and 2020,2021, Teradyne granted 0.40.5 million, 0.30.4 million and 0.40.3 million of service-based restricted stock unit awards to employees at a weighted average grant date fair value of $109.42, $114.16,$102.45, $109.42, and $71.31,$114.16, respectively.

76


During 2023, 2022 2021, and 2020,2021, Teradyne granted 0.1 million of service-based restricted stock unit awards to non-employee directors at a weighted average grant date fair value of $105.93, $128.70,$90.50, $105.93, and $66.56,$128.70, respectively.

During 2023, 2022 2021, and 2020,2021, Teradyne granted 0.1 million of PBIT PRSUs with a grant date fair value of $110.84, $113.65$102.91, $110.84 and $70.94,$113.65, respectively.

During 2023, 2022 2021 and 2020,2021, Teradyne granted 0.1 million TSR PRSUs, with a grant date fair value of $101.06, $125.02,$139.04, $101.06, and $89.93,$125.02, respectively. The fair value was estimated using the Monte Carlo simulation model with the following assumptions:

 

 

2023

 

 

2022

 

 

2021

 

Risk-free interest rate

 

 

4.0

%

 

 

1.4

%

 

 

0.2

%

Teradyne volatility-historical

 

 

49.7

%

 

 

47.1

%

 

 

43.9

%

NYSE Composite Index volatility-historical

 

 

24.1

%

 

 

22.7

%

 

 

22.9

%

Dividend yield

 

 

0.4

%

 

 

0.4

%

 

 

0.4

%

   
2022
  
2021
  
2020
 
Risk-free interest rate
   1.4  0.2  1.5
Teradyne volatility-historical
   47.1  43.9  34.9
NYSE Composite Index volatility-historical
   22.7  22.9  11.4
Dividend yield
   0.4  0.4  0.6

Expected volatility was based on the historical volatility of Teradyne’s stock and the NYSE Composite Index for each of the 2023, 2022 2021 and 20202021 grants over the most recent three-year period. The risk-free interest rate was determined using the U.S. Treasury yield curve in effect at the time of each of the grants. Dividend yield was based upon an estimated annual dividend amount of $0.44$0.44 per share for 2023, $0.44 per share for 2022, $0.40and $0.40 per share for 2021, and $0.40 per share for 2020, divided by Teradyne’s stock price on the grant date of $112.12$104.12 for the 2023 grants, $112.12 for the 2022 grants, $113.48and $113.48 for the 2021 grants,grants.

During 2023, 2022 and $72.10 for the 2020 grants.

During 2022, 2021, and 2020, Teradyne granted 0.1 million of service-based stock options to executive officers at a weighted average grant date fair value of $39.01, $36.60,$41.23, $39.01, and $20.93,$36.60, respectively.

9
0

The fair value of stock options was estimated using the Black-Scholes option-pricing model with the following assumptions:

 

 

2023

 

 

2022

 

 

2021

 

Expected life (years)

 

 

4.0

 

 

 

4.0

 

 

 

5.0

 

Risk-free interest rate

 

 

3.8

%

 

 

1.6

%

 

 

0.4

%

Volatility-historical

 

 

46.6

%

 

 

43.7

%

 

 

37.8

%

Dividend yield

 

 

0.4

%

 

 

0.4

%

 

 

0.4

%

   
2022
  
2021
  
2020
 
Expected life (years)
   4.0   5.0   5.0 
Risk-free interest rate
   1.6  0.4  1.5
Volatility-historical
   43.7  37.8  32.0
Dividend yield
   0.4  0.4  0.5

Teradyne determined the stock options’ expected life based upon historical exercise data for executive officers, the age of the executive officers and the terms of the stock option grant. Volatility was determined using historical volatility for a period equal to the expected life. The risk-free interest rate was determined using the U.S. Treasury yield curve in effect at the time of grant. Dividend yield was based upon an estimated annual dividend amount of $0.44$0.44 per share divided by Teradyne’s stock on the grant date of $112.12$104.15 for the 2023 grant, and $112.12 for the 2022 grant, $0.40and $0.40 per share divided by Teradyne’s stock price on the grant date of $113.48$113.48 for the 2021 grants, and $72.61 for the 2020 grants.

Stock compensation plan activity for the years 2023, 2022 2021, and 2020,2021, is as follows:

 

 

2023

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Restricted Stock Units:

 

 

 

 

 

 

 

 

 

Non-vested at January 1

 

 

1,317

 

 

 

1,417

 

 

 

1,789

 

Awarded

 

 

728

 

 

 

660

 

 

 

447

 

Vested

 

 

(609

)

 

 

(709

)

 

 

(749

)

Forfeited

 

 

(58

)

 

 

(51

)

 

 

(70

)

Non-vested at December 31

 

 

1,378

 

 

 

1,317

 

 

 

1,417

 

Stock Options:

 

 

 

 

 

 

 

 

 

Outstanding at January 1

 

 

188

 

 

 

171

 

 

 

216

 

Granted

 

 

41

 

 

 

42

 

 

 

34

 

Exercised

 

 

(56

)

 

 

(25

)

 

 

(78

)

Forfeited

 

 

(2

)

 

 

 

 

 

(1

)

Expired

 

 

 

 

 

 

 

 

 

Outstanding at December 31

 

 

171

 

 

 

188

 

 

 

171

 

Vested and expected to vest at December 31

 

 

171

 

 

 

188

 

 

 

171

 

Exercisable at December 31

 

 

68

 

 

 

69

 

 

 

30

 

77


   
2022
   
2021
   
2020
 
   
(in thousands)
 
Restricted Stock Units:
               
Non-vested at January 1
   1,417    1,789    2,269 
Awarded
   660    447    616 
Vested
   (709   (749   (1,028
Forfeited
   (51   (70   (68
   
 
 
   
 
 
   
 
 
 
Non-vested at December 31
   1,317    1,417    1,789 
   
 
 
   
 
 
   
 
 
 
Stock Options:
               
Outstanding at January 1
   171    216    319 
Granted
   42    34    56 
Exercised
   (25   (78   (159
Forfeited
   —      (1   —   
Expired
   —      —      —   
   
 
 
   
 
 
   
 
 
 
Outstanding at December 31
   188    171    216 
   
 
 
   
 
 
   
 
 
 
Vested and expected to vest at December 31
   188    171    216 
   
 
 
   
 
 
   
 
 
 
Exercisable at December 31
   69    30    27 
   
 
 
   
 
 
   
 
 
 

Total shares available for the years 2023, 2022 2021, and 2020:2021:

 

 

2023

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Shares available:

 

 

 

 

 

 

 

 

 

Available for grant at January 1

 

 

5,062

 

 

 

5,713

 

 

 

6,123

 

Options granted

 

 

(41

)

 

 

(42

)

 

 

(34

)

Options forfeited

 

 

2

 

 

 

 

 

 

1

 

Restricted stock units awarded

 

 

(728

)

 

 

(660

)

 

 

(447

)

Restricted stock units forfeited

 

 

58

 

 

 

51

 

 

 

70

 

Available for grant at December 31

 

 

4,353

 

 

 

5,062

 

 

 

5,713

 

   
2022
   
2021
   
2020
 
   
(in thousands)
 
Shares available:
               
Available for grant at January 1
   5,713    6,123    6,727 
Options granted
   (42   (34   (56
Options forfeited
   —      1    —   
Restricted stock units awarded
   (660   (447   (616
Restricted stock units forfeited
   51    70    68 
   
 
 
   
 
 
   
 
 
 
Available for grant at December 31
   5,062    5,713    6,123 
   
 
 
   
 
 
   
 
 
 
9
1

Weighted average restricted stock unit award date fair value information for the years 2023, 2022 2021, and 2020,2021, is as follows:

 

 

2023

 

 

2022

 

 

2021

 

Non-vested at January 1

 

$

88.71

 

 

$

67.97

 

 

$

47.84

 

Awarded

 

 

105.05

 

 

 

108.74

 

 

 

115.51

 

Vested

 

 

75.55

 

 

 

54.27

 

 

 

43.99

 

Forfeited

 

 

102.12

 

 

 

85.71

 

 

 

65.52

 

Non-vested at December 31

 

$

101.00

 

 

$

88.71

 

 

$

67.97

 

   
2022
   
2021
   
2020
 
Non-vested at January 1
  $67.97   $47.84   $35.58 
Awarded
   108.74    115.51    72.76 
Vested
   54.27    43.99    31.53 
Forfeited
   85.71    65.52    45.36 
Non-vested at December 31
  $88.71   $67.97   $47.84 

Restricted stock unit awards aggregate intrinsic value information at December 31 for the years 2023, 2022 2021, and 20202021 is as follows:

 

 

2023

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Vested

 

$

62,001

 

 

$

95,408

 

 

$

101,679

 

Outstanding

 

 

149,504

 

 

 

115,087

 

 

 

231,763

 

Expected to vest

 

 

135,238

 

 

 

108,666

 

 

 

231,246

 

   
2022
   
2021
   
2020
 
   
(in thousands)
 
Vested
  $95,408   $101,679   $71,582 
Outstanding
   115,087    231,763    214,509 
Expected to vest
   108,666    231,246    210,301 

Restricted stock units weighted average remaining contractual terms (in years) information at December 31 for the years 2023, 2022 2021, and 20202021 is as follows:

 

 

2023

 

 

2022

 

 

2021

 

Outstanding

 

 

1.13

 

 

 

0.99

 

 

 

0.89

 

Expected to vest

 

 

1.13

 

 

 

0.99

 

 

 

0.89

 

   
2022
   
2021
   
2020
 
Outstanding
   0.99    0.89    0.96 
Expected to vest
   0.99    0.89    0.96 

Weighted average stock options exercise price information for the year ended December 31, 20222023 is as follows:

 

 

2023

 

Outstanding at January 1

 

$

76.52

 

Options granted

 

 

104.15

 

Options exercised

 

 

39.71

 

Options forfeited

 

 

112.57

 

Options cancelled

 

 

113.03

 

Outstanding at December 31

 

 

94.85

 

Exercisable at December 31

 

 

81.53

 

   
2022
 
Outstanding at January 1
  $62.13 
Options granted
   112.12 
Options exercised
   37.13 
Options forfeited
   —   
Options cancelled
   —   
Outstanding at December 31
   76.52 
Exercisable at December 31
   55.90 

The total cash received from employees as a result of employee stock options exercised during the years ended December 31, 2023, 2022 and 2021, and 2020, was $0.9$2.2 million, $3.1$0.9 million, and $3.8$3.1 million, respectively. In connection with these exercises, the tax benefit realized by Teradyne for the years ended December 31, 2023, 2022 and 2021, and 2020, was $0.1$0.2 million, $0.4$0.1 million, and $1.5$0.4 million, respectively.

78


Stock option aggregate intrinsic value information for the years ended December 31, 2023, 2022 2021, and 20202021 is as follows:

 

 

2023

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Exercised

 

$

3,901

 

 

$

2,030

 

 

$

6,345

 

Outstanding

 

 

2,647

 

 

 

3,963

 

 

 

17,356

 

Expected to vest

 

 

696

 

 

 

1,583

 

 

 

13,500

 

Vested and exercisable

 

 

1,950

 

 

 

2,380

 

 

 

3,856

 

   
2022
   
2021
   
2020
 
   
(in thousands)
 
Exercised
  $2,030   $6,345   $9,682 
Outstanding
   3,963    17,356    16,083 
E
xpected to vest
   1,583    13,500    13,499 
Vested and exercisable
   2,380    3,856    2,584 
9
2

Stock options weighted average remaining contractual terms (in years) information at December 31, for the years 2023, 2022 2021, and 20202021 is as follows:

 

 

2023

 

 

2022

 

 

2021

 

Outstanding

 

 

4.4

 

 

 

4.2

 

 

 

4.4

 

Expected to vest

 

 

5.1

 

 

 

4.8

 

 

 

4.8

 

Vested and exercisable

 

 

3.4

 

 

 

3.1

 

 

 

2.5

 

   
2022
   
2021
   
2020
 
Outstanding
   4.2    4.4    4.6 
E
xpected to vest
   4.8    4.8    4.9 
Vested and exercisable 
   3.1    2.5    2.5 

As of December 31, 2022,2023, total unrecognized expense related to non-vested restricted stock unit awards and stock options was $61.1$73.7 million and is expected to be recognized over a weighted average period of 2.5 years.

In 2022, 2021 and 2020, Teradyne recognized a discrete tax benefit of $12.3 million, $14.7 million and $9.6 million, respectively, related to net excess tax benefit.

Employee Stock Purchase Plan

Under the ESPP, eligible employees may purchase shares of common stock through regular payroll deductions of up to 10%10% of their compensation, to a maximum of shares with a fair market value of $25,000$25,000 per calendar year, not to exceed 6,000 shares. Under the plan, the price paid for the common stock is equal to 85%85% of the stock price on the last business day of the six-month purchase period.

In July 2023, 0.2 million shares of common stock were issued to employees who participated in the plan during the first half of 2023 at the price of $94.64 per share. In January 2024, Teradyne issued 0.2 million shares of common stock to employees who participated in the plan during the second half of 2023 at the price of $92.25 per share.

In July 2022, 0.2 million shares of common stock were issued to employees who participated in the plan during the first half of 2022 at the price of $76.12$76.12 per share. In January 2023, Teradyne issued 0.2 million shares of common stock to employees who participated in the plan during the second half of 2022 at the price of $74.25$74.25 per share.

In July 2021, 0.1 million shares of common stock were issued to employees who participated in the plan during the first half of 2021 at the price of $113.87$113.87 per share. In January 2022, Teradyne issued 0.1 million shares of common stock to employees who participated in the plan during the second half of 2021 at the price of $139.00$139.00 per share.

In July 2020, 0.2 million shares of common stock were issued to employees who participated in the plan during the first half of 2020 at the price of $71.83 per share. In January 2021, Teradyne issued 0.1 million shares of common stock to employees who participated in the plan during the second half of 2020 at the price of $101.91 per share.

As of December 31, 2022,2023, there were 3.93.5 million shares available for grant under the ESPP.

The following table provides the effect to income from operations for recording stock-based compensation for the years ended December 31, 2023, 2022, 2021, and 2020:2021:

 

 

2023

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Cost of revenues

 

$

4,208

 

 

$

4,050

 

 

$

4,196

 

Engineering and development

 

 

10,659

 

 

 

9,992

 

 

 

9,783

 

Selling and administrative

 

 

42,815

 

 

 

34,186

 

 

 

31,664

 

Stock-based compensation

 

 

57,682

 

 

 

48,228

 

 

 

45,643

 

Income tax benefit

 

 

(10,397

)

 

 

(11,493

)

 

 

(14,389

)

Total stock-based compensation expense after income taxes

 

$

47,285

 

 

$

36,735

 

 

$

31,254

 

R.
SAVINGS PLAN
   
2022
   
2021
   
2020
 
   
(in thousands)
 
Cost of revenues
  $4,050   $4,196   $4,227 
Engineering and development
   9,992    9,783    12,039 
Selling and administrative
   34,186    31,664    28,640 
   
 
 
   
 
 
   
 
 
 
Stock-based compensation
   48,228    45,643    44,906 
Income tax benefit
   (11,493   (14,389   (13,060
   
 
 
   
 
 
   
 
 
 
Total stock-based compensation expense after income taxes
  $36,735   $31,254   $31,846 
   
 
 
   
 
 
   
 
 
 
9
3

R.
SAVINGS PLAN

Teradyne sponsors a defined contribution employee retirement savings plan (“Savings Plan”) covering substantially all U.S. employees. Under the Savings Plan, employees may contribute up to 20%20% of their compensation (subject to Internal Revenue Service limitations). The Savings Plan provides for a discretionary employer match that is determined each year. In 2023, 2022 2021 and 2020, 2021,

79


Teradyne matched 100%100% of eligible employee contributions up to 4%4% of their compensation for employees not accruing benefits in the U.S. Qualified Pension Plan. There was no match for employees still actively accruing benefits in the U.S. Qualified Pension Plan. Teradyne’s contributions vest 25%25% per year for the first four years of employment, and contributions for those employees with four years of service vest immediately.

In addition, Teradyne sponsors an unfunded U.S. Supplemental Savings Plan to provide savings benefits in excess of those allowed by the Employee Retirement Income Security Act of 1974 and the Internal Revenue Code. The provisions of this plan are the same as the Savings Plan. The liability for the U.S. Supplemental Savings Plan at December 31, 2023 and 2022, and 2021, was $44.1$55.9 million and $47.2$44.1 million, respectively, and is included in retirement plan liabilities. Teradyne contributes to defined contributions savings plans for its foreign employees. Under Teradyne’s savings plans, amounts charged to the statements of operations for the years ended December 31, 2023, 2022, and 2021 and 2020 were $30.1$30.5 million, $26.9$30.1 million, and $21.7$26.9 million, respectively.

S.
INCOME TAXES
S.
INCOME TAXES

The components of income before income taxes and the provision (benefit) for income taxes as shown in the consolidated statements of operations were as follows:

 

 

2023

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Income before income taxes:

 

 

 

 

 

 

 

 

 

U.S.

 

$

307,997

 

 

$

385,968

 

 

$

403,451

 

Non-U.S.

 

 

217,575

 

 

 

454,417

 

 

 

757,504

 

 

$

525,572

 

 

$

840,385

 

 

$

1,160,955

 

Provision (benefit) for income taxes:

 

 

 

 

 

 

 

 

 

Current:

 

 

 

 

 

 

 

 

 

U.S. Federal

 

$

58,063

 

 

$

86,692

 

 

$

58,218

 

Non-U.S.

 

 

54,037

 

 

 

74,204

 

 

 

105,153

 

State

 

 

2,362

 

 

 

2,681

 

 

 

300

 

 

 

114,462

 

 

 

163,577

 

 

 

163,671

 

Deferred:

 

 

 

 

 

 

 

 

 

U.S. Federal

 

 

(27,459

)

 

 

(36,739

)

 

 

(15,106

)

Non-U.S.

 

 

(8,584

)

 

 

1,232

 

 

 

(4,300

)

State

 

 

(1,599

)

 

 

(3,186

)

 

 

2,101

 

 

 

(37,642

)

 

 

(38,693

)

 

 

(17,305

)

Total provision for income taxes:

 

$

76,820

 

 

$

124,884

 

 

$

146,366

 

   
2022
   
2021
   
2020
 
   
(in thousands)
 
Income before income taxes:
               
U.S.
  $385,968   $403,451   $312,153 
Non-U.S.
   454,417    757,504    588,862 
   
 
 
   
 
 
   
 
 
 
   $840,385   $1,160,955   $901,015 
   
 
 
   
 
 
   
 
 
 
Provision (benefit) for income taxes:
               
Current:
               
U.S. Federal
  $86,692   $58,218   $58,678 
Non-U.S.
   74,204    105,153    75,193 
State
   2,681    300    (1,315
   
 
 
   
 
 
   
 
 
 
    163,577    163,671    132,556 
   
 
 
   
 
 
   
 
 
 
Deferred:
               
U.S. Federal
   (36,739   (15,106   (12,604
Non-U.S.
   1,232    (4,300   (5,127
State
   (3,186   2,101    2,043 
   
 
 
   
 
 
   
 
 
 
    (38,693   (17,305   (15,688
   
 
 
   
 
 
   
 
 
 
Total provision for income taxes:
  $124,884   $146,366   $116,868 
   
 
 
   
 
 
   
 
 
 

Income tax expense for 2023, 2022 and 2021 and 2020 totaled $124.9$76.8 million, $146.4$124.9 million, and $116.9$146.4 million, respectively. The effective tax rate for 2023, 2022 and 2021 was 14.6%, 14.9% and 2020 was 14.9%, 12.6% and 13.0%12.6%, respectively.

At December 31, 2022,2023, Teradyne’s remaining tax liability resulting from the U.S. one-time transition tax on the mandatory deemed repatriation of foreign earnings amounts to $67.0$59.1 million. Teradyne will pay approximately $7.9$14.8 million related to the transition tax in 2023, $34.52024, and $44.3 million in 1 to 3 years, and $24.6 million in 3 to 5 years.

94

Teradyne has made an accounting policy election to account for global intangible low-taxed income (“GILTI”) as a component of tax expense in the period in which Teradyne is subject to the rules and therefore did not provide any deferred tax impacts of GILTI in its consolidated financial statements.

On July 27, 2015, in Altera Corp. (“Altera”) v. Commissioner, the U.S. Tax Court issued an opinion invalidating the regulations relating to the treatment of stock-based compensation expense in an intercompany cost-sharing arrangement. A final decision was issued by the Tax Court in December 2015. The IRS appealed the decision in June 2016. On July 24, 2018, the U.S. Court of Appeals for the Ninth Circuit (“Ninth Circuit”) issued a decision that was subsequently withdrawn and a reconstituted panel conferred on the appeal. On June 7, 2019, the Ninth Circuit upheld the cost-sharing regulations. On November 12, 2019,

,
the Ninth Circuit denied Altera’s petition for rehearing of its case. Altera’s application for certiorari to the Supreme Court was declined on June 22, 2020. In the fourth quarter of 2020 and 2021, Teradyne recognized approximately $2.3$2.5 million of tax expense and $2.5 million of tax benefit in 2020 and 2021, respectively, related to the inclusion of stock-based compensation in its intercompany cost-sharing arrangement.

80


The decrease in the effective tax rate from 2022 to 2023 is primarily attributable to increases in benefit from tax credits and the U.S. foreign derived intangible income deduction. These decreases in expense were partially offset by a shift in the geographic distribution of income, which increased the income subject to taxation in higher tax rate jurisdictions relative to lower tax rate jurisdictions and a reduction in benefit from equity compensation.

The increase in the effective tax rate from 2021 to 2022 is primarily attributable to a shift in the geographic distribution of income, which increased the income subject to taxation in higher tax rate jurisdictions relative to lower tax rate jurisdictions, increases in expense from U.S. global low-taxed income and increases in expense from non-deductible officer compensation. These increases in expense were partially offset by increases in benefits from the U.S. foreign derived intangible income deduction and tax credits.

The decrease in the effective tax rate from 2020 to 2021 is primarily attributable to a decrease in the expense from U.S. global low-taxed income partially offset by a decrease in the benefit from foreign tax credits and a shift in the geographic distribution of income, which increased the income subject to taxation in higher tax rate jurisdictions relative to lower tax rate jurisdictions.

A reconciliation of the effective tax rate for the years 2023, 2022 2021 and 20202021 is as follows:

 

 

2023

 

 

2022

 

 

2021

 

U.S. statutory federal tax rate

 

 

21.0

%

 

 

21.0

%

 

 

21.0

%

Foreign taxes

 

 

2.5

 

 

 

(1.9

)

 

 

(4.5

)

Non-deductible officers’ compensation

 

 

1.1

 

 

 

1.3

 

 

 

0.8

 

U.S. global intangible low-taxed income

 

 

0.8

 

 

 

1.2

 

 

 

0.6

 

State income taxes, net of federal tax benefit

 

 

0.1

 

 

 

(0.1

)

 

 

0.2

 

U.S. research and development credit

 

 

(4.2

)

 

 

(1.8

)

 

 

(1.4

)

U.S. foreign derived intangible income

 

 

(3.9

)

 

 

(3.1

)

 

 

(2.3

)

Foreign tax credits

 

 

(3.3

)

 

 

(1.0

)

 

 

(0.5

)

Equity compensation

 

 

(0.4

)

 

 

(1.1

)

 

 

(1.0

)

Other, net

 

 

0.9

 

 

 

0.4

 

 

 

(0.3

)

 

 

14.6

%

 

 

14.9

%

 

 

12.6

%

   
2022
  
2021
  
2020
 
U.S. statutory federal tax rate
   21.0  21.0  21.0
Non-deductible officers’ compensation
   1.3   0.8   0.5 
U.S. global intangible low-taxed income
   1.2   0.6   2.1 
U.S. foreign derived intangible income
   (3.1  (2.3  (2.2
Foreign taxes
   (1.9  (4.5  (5.6
U.S. research and development credit
   (1.8  (1.4  (1.3
Equity compensation
   (1.1  (1.0  (0.8
Foreign tax credits
   (1.0  (0.5  (1.2
State income taxes, net of federal tax benefit
   (0.1  0.2   0.3 
Other, net
   0.4   (0.3  0.2 
   
 
 
  
 
 
  
 
 
 
    14.9  12.6  13.0
   
 
 
  
 
 
  
 
 
 

Teradyne qualifies for a tax holiday in Singapore by fulfilling the requirements of an agreement with the Singapore Economic Development Board under which certain headcount and spending requirements must be met. The tax savings attributable to the Singapore tax holiday for the years ended December 31, 2023, 2022 and 2021 and 2020 were $16.0$1.4 million or $0.09$0.01 per diluted share, $33.3$16.0 million or $0.18$0.09 per diluted share, and $29.9$33.3 million or $0.16$0.18 per diluted share, respectively. In November 2020, Teradyne entered into an agreement with the Singapore Economic Development Board which extended our Singapore tax holiday under substantially similar terms to the agreement which expired on December 31, 2020. The new tax holiday is scheduled to expire on December 31, 2025.

2025. Teradyne does not anticipate entering into a similar tax holiday agreement with the Singapore Economic Development Board when the current agreement expires.

95

81


Significant components of Teradyne’s deferred tax assets (liabilities) as of December 31, 20222023 and 20212022 were as follows:

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Deferred tax assets:

 

 

 

 

 

 

Tax credits

 

$

112,571

 

 

$

105,503

 

Research and development

 

 

82,571

 

 

 

47,760

 

Accruals

 

 

25,644

 

 

 

30,747

 

Pension liabilities

 

 

24,997

 

 

 

21,335

 

Lease liabilities

 

 

21,167

 

 

 

18,679

 

Inventory valuations

 

 

19,289

 

 

 

22,554

 

Deferred revenue

 

 

13,807

 

 

 

14,909

 

Equity compensation

 

 

7,179

 

 

 

6,578

 

Vacation accrual

 

 

6,096

 

 

 

5,856

 

Net operating loss carryforwards

 

 

5,737

 

 

 

1,857

 

Investment impairment

 

 

3,292

 

 

 

3,292

 

Intangible assets

 

 

2,323

 

 

 

350

 

Marketable securities

 

 

128

 

 

 

2,283

 

Other

 

 

953

 

 

 

2,520

 

Gross deferred tax assets

 

 

325,754

 

 

 

284,223

 

Less: valuation allowance

 

 

(109,251

)

 

 

(103,807

)

Total deferred tax assets

 

$

216,503

 

 

$

180,416

 

Deferred tax liabilities:

 

 

 

 

 

 

Right of use assets

 

$

(19,016

)

 

$

(16,607

)

Depreciation

 

 

(16,681

)

 

 

(19,078

)

Contingent consideration

 

 

(5,214

)

 

 

(5,214

)

Total deferred tax liabilities

 

$

(40,911

)

 

$

(40,899

)

Net deferred assets

 

$

175,592

 

 

$

139,517

 

   
2022
   
2021
 
   
(in thousands)
 
Deferred tax assets:
          
Tax credits
  $105,503   $98,378 
Research and development
   47,760    —   
Accruals
   30,747    41,459 
Inventory valuations
   22,554    20,991 
Pension liabilities
   21,335    28,722 
Lease liability
   18,679    16,484 
Deferred revenue
   14,909    11,164 
Equity compensation
   6,578    6,630 
Vacation accrual
   5,856    6,050 
Investment impairment
   3,292    3,292 
Marketable securities
   2,283    —   
Net operating loss carryforwards
   1,857    1,721 
Intangible assets
   350    —   
Other
   2,520    774 
   
 
 
   
 
 
 
Gross deferred tax assets
   284,223    235,665 
Less: valuation allowance
   (103,807   (97,170
   
 
 
   
 
 
 
Total deferred tax assets
  $180,416   $138,495 
   
 
 
   
 
 
 
Deferred tax liabilities:
          
Depreciation
  $(19,078  $(10,691
Right-of-use assets
   (16,607   (14,738
Contingent consideration
   (5,214   (5,214
Intangible assets
       (8,531
Marketable securities
       (3,220
   
 
 
   
 
 
 
Total deferred tax liabilities
  $(40,899  $(42,394
   
 
 
   
 
 
 
Net deferred assets
  $139,517   $96,101 
   
 
 
   
 
 
 

As of December 31, 20222023 and 2021,2022, Teradyne evaluated the likelihood that it would realize deferred income taxes to offset future taxable income and concluded that it is more likely than not that a substantialthe majority of its deferred tax assets will be realized through consideration of both the positive and negative evidence. At December 31, 20222023 and 2021,2022, Teradyne maintained a valuation allowance for certain deferred tax assets of $103.8$109.3 million and $97.2$103.8 million, respectively, primarily related to state net operating losses and state tax credit carryforwards, due to the uncertainty regarding their realization. Adjustments could be required in the future if Teradyne estimates that the amount of deferred tax assets to be realized is more or less than the net amount recorded.

96

At December 31, 2022,2023, Teradyne had tax effected operating loss carryforwards that expire in the following years:

 

 

State
Operating Loss
Carryforwards

 

 

Foreign
Operating Loss
Carryforwards

 

 

 

(in thousands)

 

2024

 

$

6

 

 

$

 

2025

 

 

4

 

 

 

 

2026

 

 

 

 

 

 

2027

 

 

 

 

 

 

2028

 

 

23

 

 

 

83

 

2029-2033

 

 

121

 

 

 

500

 

2034-2038

 

 

31

 

 

 

 

Beyond 2038

 

 

 

 

 

 

Non-expiring

 

 

30

 

 

 

4,939

 

Total

 

$

215

 

 

$

5,522

 

   
State

Operating Loss

Carryforwards
   
Foreign

Operating Loss

Carryforwards
 
   
(in thousands)
 
2023
  $222   $—   
2024
   6    —   
2025
   4    —   
2026
   —      —   
2027
   —      —   
2028-2032
   299    676 
2033-2037
   44    3 
Beyond 2037
   24    —   
Non-expiring
   29    550 
   
 
 
   
 
 
 
Total
  $628   $1,229 
   
 
 
   
 
 
 

Teradyne has approximately $138.4$147.1 million of tax credit carryforwards including federal business tax credits of approximately $2.4$3.4 million which expire in 2028 through 2032,2033, and state tax credits of $136.1$143.8 million, of which $72.0$76.5 million do not expire and the remainder expires in the years 2023 through 2042.2043.

82


Teradyne’s gross unrecognized tax benefits for the years ended December 31, 2023, 2022 2021 and 20202021 were as follows:

 

 

2023

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Beginning balance as of January 1

 

$

15,608

 

 

$

14,465

 

 

$

17,903

 

Additions:

 

 

 

 

 

 

 

 

 

Tax positions for current year

 

 

 

 

 

1,398

 

 

 

1,417

 

Tax positions for prior years

 

 

3,024

 

 

 

13

 

 

 

30

 

Reductions:

 

 

 

 

 

 

 

 

 

Tax positions for prior years

 

 

(26

)

 

 

(56

)

 

 

(1,639

)

Expiration of statutes

 

 

 

 

 

(212

)

 

 

(3,246

)

Ending balance as of December 31

 

$

18,606

 

 

$

15,608

 

 

$

14,465

 

   
2022
   
2021
   
2020
 
   
(in thousands)
 
Beginning balance as of January 1
  $14,465   $17,903   $21,180 
Additions:
               
Tax positions for current year
   1,398    1,417    1,082 
Tax positions for prior years
   13    30    66 
Reductions:
               
Tax positions for prior years
   (56   (1,639   (2,989
Expiration of statutes
   (212   (3,246   (1,436
   
 
 
   
 
 
   
 
 
 
Ending balance as of December 31
  $15,608   $14,465   $17,903 
   
 
 
   
 
 
   
 
 
 

Current year additions primarily relate to foreign transfer pricing and prior year reductions relate to federal and state research credits. Prior year reductions and expirations of statute relate to foreign net operating loss carryforwards.

Of the $15.6$18.6 million of unrecognized tax benefits as of December 31, 2022, $10.12023, $12.9 million would impact the consolidated income tax rate if ultimately recognized. The remaining $5.5$5.7 million would impact deferred taxes if recognized.

As of December 31, 2022,2023, Teradyne does not anticipate a material change inestimates that it is reasonably possible that the balance of unrecognized tax benefits duringmay decrease approximately $2.8 million in the next twelve months.

months as a result of the resolution of an audit and a lapse of statutes of limitation. The estimated decrease relates to transfer pricing and state research credits.

Teradyne records all interest and penalties related to income taxes as a component of income tax expense. Accrued interest and penalties related to income tax items at December 31, 20222023 and 20212022 amounted to $0.4$1.3 million and $0.3$0.4 million, respectively. For the years ended December 31, 2023, 2022 2021 and 2020,2021, expense of $0.1$0.9 million, expense of $0.1 million, and benefit of $0.9 million, and expense of $0.2$0.9 million, respectively, was recorded for interest and penalties related to income tax items.

97

Teradyne is subject to U.S. federal income tax, as well as income tax in multiple state, local and foreign jurisdictions. As of December 31, 2022,2023, all material state and local income tax matters have been concluded through 2017,2018, all material federal income tax matters have been concluded through 2017 and all material foreign income tax matters have been concluded through 2016.2015. However, in some jurisdictions, including the United States, operating losses and tax credits may be subject to adjustment until such time as they are utilized and the year of utilization is closed to adjustment.

As of December 31, 2022,2023, Teradyne is not permanently reinvested with respect to the unremitted earnings of non-U.S. subsidiaries to the extent that those earnings exceed local statutory and operational requirements. Remittance of those earnings is not expected to result in material income tax.

T.
OPERATING SEGMENT, GEOGRAPHIC AND SIGNIFICANT CUSTOMER INFORMATION

On August 16, 2022, the Inflation Reduction Act of 2022 (“IRA”) was signed into law. The IRA introduced a 15% alternative minimum tax based on the financial statement income of certain large corporations (“CAMT”), effective January 1, 2023. Teradyne currently does not expect the CAMT to have a material impact on its financial results.

On December 15, 2022, the European Union ("EU") Member States formally adopted the EU’s Pillar Two Directive, which generally provides for a minimum effective tax rate of 15%, as established by the Organization for Economic Co-operation and Development ("OECD") Pillar Two Framework. The EU’s Pillar Two Directive effective dates are January 1, 2024, and January 1, 2025, for different aspects of the directive. On July 17, 2023, the OECD published Administrative Guidance proposing certain safe harbor rules that effectively extend certain effective dates to January 1, 2027. Certain EU Member States where Teradyne has foura legal presence have recently enacted the directive and administrative guidance into their local tax legislation. Additionally, countries outside the EU where Teradyne has a legal presence have enacted similar language as the EU Members States in their local tax legislation. Teradyne is closely monitoring these developments and evaluating the potential financial impact on future periods. Based upon preliminary calculations for calendar year 2024, Teradyne anticipates it will meet the safe harbors in most jurisdictions, and any remaining tax under the rules should be immaterial.

83


T.
OPERATING SEGMENT, GEOGRAPHIC AND SIGNIFICANT CUSTOMER INFORMATION

Teradyne has fourreportable segments (Semiconductor Test, System Test, Wireless Test and Robotics). Each of the reportable segments represents an individual operating segment. On September 15, 2020, Teradyne announced the appointment of Gregory Smith as President of Robotics reportable segment effective October 1, 2020. With the appointment of the President of Robotics, the Robotics reportable segment is considered one operating segment and one reporting unit.

The Semiconductor Test segment includes operations related to the design, manufacturing and marketing of semiconductor test products and services. The System Test segment includes operations related to the design, manufacturing and marketing of products and services for storage and system level test, defense/aerospace instrumentation test, and circuit-board test. The Wireless Test segment includes operations related to the design, manufacturing and marketing of wireless test products and services. The Robotics segment includes operations related to the design, manufacturing and marketing of collaborative robotic arms, autonomous mobile robots and advanced robotic control software. Each operating segment has a segment manager who is accountable to and maintains regular contract with Teradyne’s chief operating decision maker (Teradyne’s chief executive officer) to discuss operating activities, financial results, forecasts, and plans for the segment.

Teradyne evaluates performance based on several factors, of which the primary financial measure is business segment income (loss) before income taxes. The accounting policies of the business segments are the same as those described in Note B: “Accounting Policies.”

98

Segment information for the years ended December 31, 2023, 2022 2021, and 20202021 is as follows:

 

Semiconductor
Test

 

 

System
Test

 

 

Robotics

 

 

Wireless
Test

 

 

Segment
Total

 

 

Corporate
and Eliminations

 

 

Consolidated

 

 

(in thousands)

 

2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

$

1,818,636

 

 

$

338,197

 

 

$

375,183

 

 

$

144,282

 

 

$

2,676,298

 

 

$

 

 

$

2,676,298

 

Income (loss) before taxes (1)(2)

 

453,320

 

 

 

94,073

 

 

 

(54,251

)

 

 

30,568

 

 

 

523,710

 

 

 

1,862

 

 

 

525,572

 

Total assets (3)

 

1,329,522

 

 

 

182,084

 

 

 

737,323

 

 

 

68,291

 

 

 

2,317,220

 

 

 

1,169,604

 

 

 

3,486,824

 

Property additions

 

113,415

 

 

 

3,643

 

 

 

40,739

 

 

 

1,845

 

 

 

159,642

 

 

 

 

 

 

159,642

 

Depreciation and amortization expense

 

77,745

 

 

 

3,801

 

 

 

25,527

 

 

 

4,043

 

 

 

111,116

 

 

 

(230

)

 

 

110,886

 

2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

$

2,080,590

 

 

$

469,346

 

 

$

403,138

 

 

$

201,720

 

 

$

3,154,794

 

 

$

251

 

 

$

3,155,045

 

Income (loss) before taxes (1)(2)

 

634,488

 

 

 

166,879

 

 

 

(16,244

)

 

 

66,820

 

 

 

851,943

 

 

 

(11,558

)

 

 

840,385

 

Total assets (3)

 

1,382,623

 

 

 

165,925

 

 

 

665,638

 

 

 

94,298

 

 

 

2,308,484

 

 

 

1,192,768

 

 

 

3,501,252

 

Property additions

 

126,898

 

 

 

7,275

 

 

 

25,712

 

 

 

3,364

 

 

 

163,249

 

 

 

 

 

 

163,249

 

Depreciation and amortization expense

 

76,532

 

 

 

3,235

 

 

 

25,339

 

 

 

4,991

 

 

 

110,097

 

 

 

578

 

 

 

110,675

 

2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

$

2,642,342

 

 

$

467,739

 

 

$

375,905

 

 

$

216,895

 

 

$

3,702,881

 

 

$

 

 

$

3,702,881

 

Income (loss) before taxes (1)(2)

 

976,988

 

 

 

163,064

 

 

 

(8,167

)

 

 

83,543

 

 

 

1,215,428

 

 

 

(54,473

)

 

 

1,160,955

 

Total assets (3)

 

1,245,596

 

 

 

170,954

 

 

 

701,196

 

 

 

107,513

 

 

 

2,225,259

 

 

 

1,584,166

 

 

 

3,809,425

 

Property additions

 

115,618

 

 

 

3,905

 

 

 

9,821

 

 

 

3,128

 

 

 

132,472

 

 

 

 

 

 

132,472

 

Depreciation and amortization expense

 

75,982

 

 

 

3,156

 

 

 

27,336

 

 

 

6,055

 

 

 

112,529

 

 

 

12,956

 

 

 

125,485

 

(1)
Included in Corporate and Eliminations are interest income, interest expense, net foreign exchange gains (losses), intercompany eliminations, pension and postretirement plan actuarial gains (losses), legal and environmental fees, contingent consideration adjustments, acquisition and divestiture related expenses, contract termination settlement charge, an expense for the modification of Teradyne's former chief executive officer's outstanding equity awards, and loss on convertible debt conversions in 2021.
(2)
  
Semiconductor

Test
  
System

Test
  
Robotics
  
Wireless

Test
  
Corporate

and
Eliminations
  
Consolidated
 
  
(in thousands)
 
2022
                        
Revenues
 $2,080,590  $469,346  $403,138  $201,720  $251  $3,155,045 
Income (loss) before taxes (1)(2)
  634,488   166,879   (16,244  66,820   (11,558  840,385 
Total assets (3)
  1,382,623   165,925   665,638   94,298   1,192,768   3,501,252 
Property additions
  126,898   7,275   25,712   3,364   —     163,249 
Depreciation and amortization expense
  76,532   3,235   25,339   4,991   578   110,675 
2021
                        
Revenues
 $2,642,342  $467,739  $375,905  $216,895  $—    $3,702,881 
Income (loss) before taxes (1)(2)
  976,988   163,064   (8,167  83,543   (54,473  1,160,955 
Total assets (3)
  1,245,596   170,954   701,196   107,513   1,584,166   3,809,425 
Property additions
  115,618   3,905   9,821   3,128   —     132,472 
Depreciation and amortization expense
  75,982   3,156   27,336   6,055   12,956   125,485 
2020
                        
Revenues
 $2,259,597  $409,729  $279,731  $173,016  $(604 $3,121,469 
Income (loss) before
taxes (1)(2)
  739,695   152,092   (24,019  41,950   (8,703  901,015 
Total assets (3)
  1,070,378   138,295   712,936   106,273   1,624,464   3,652,346 
Property additions
  168,055   3,092   8,899   4,931   —     184,977 
Depreciation and amortization expense
  64,998   3,426   36,242   6,258   15,819   126,743 
(1)
Included in Corporate and Eliminations are interest income, interest expense, net foreign exchange gains (losses), intercompany eliminations, pension and postretirement plan actuarial gains (losses), legal and environmental fees, contingent consideration adjustments, acquisition related charges and compensation and loss on convertible debt conversions in 2021. 
(2)
Included in income (loss) before taxes are charges and credits related to restructuring and other, inventory charges and loss on convertible debt conversions in 2021.
(3)
Total assets are attributable to each segment. Corporate assets consist of cash and cash equivalents, marketable securities and certain other assets.
Included in income (loss) before taxes are charges and credits related to restructuring and other, inventory charges and loss on convertible debt conversions in 2021.
(3)
99
Total assets are attributable to each segment. Semiconductor Test includes $34.8 million of total assets classified as assets held for sale. See Note E: “Assets held for sale” for additional information. Corporate assets consist of cash and cash equivalents, marketable securities and certain other assets.

84


Included in each segment are charges and credits in the following line items in the statements of operations:

 

 

For the Years Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Semiconductor Test:

 

 

 

 

 

 

 

 

 

Cost of revenues—inventory charge

 

$

22,482

 

 

$

21,456

 

 

$

6,661

 

Restructuring and other—employee severance

 

 

5,666

 

 

 

 

 

 

 

System Test:

 

 

 

 

 

 

 

 

 

Cost of revenues—inventory charge

 

$

1,855

 

 

$

1,730

 

 

$

641

 

Restructuring and other—employee severance

 

 

1,541

 

 

$

 

 

$

 

Robotics:

 

 

 

 

 

 

 

 

 

Cost of revenues—inventory charge

 

$

2,275

 

 

$

3,668

 

 

$

6,403

 

Restructuring and other—employee severance

 

 

3,707

 

 

 

2,115

 

 

 

1,210

 

Restructuring and other—acquisition & divestiture related expenses

 

 

 

 

 

 

 

 

1,000

 

Wireless:

 

 

 

 

 

 

 

 

 

Cost of revenues—inventory charge

 

$

1,746

 

 

$

4,598

 

 

$

1,770

 

Corporate and Eliminations:

 

 

 

 

 

 

 

 

 

Selling and administrative—equity modification charge

 

$

5,889

 

 

$

 

 

$

 

Restructuring and other—employee severance

 

 

3,599

 

 

 

 

 

 

 

Restructuring and other—acquisition & divestiture related expenses

 

 

3,562

 

 

 

 

 

 

(513

)

Restructuring and other—contract termination

 

 

1,511

 

 

 

 

 

 

 

Restructuring and other—environmental and legal liabilities

 

 

1,100

 

 

 

2,700

 

 

 

1,971

 

Other (income) expense, net—gain on foreign exchange option

 

 

(7,464

)

 

 

 

 

 

 

Restructuring and other—legal settlement charge

 

 

 

 

 

14,700

 

 

 

12,000

 

Restructuring and other—gain on sale of asset

 

 

 

 

 

(3,410

)

 

 

 

Other (income) expense, net—loss on convertible debt conversion

 

 

 

 

 

 

 

 

28,828

 

Restructuring and other—AutoGuide contingent consideration adjustment

 

 

 

 

 

 

 

 

(7,227

)

   
For the Years Ended December 31,
 
   
2022
  
2021
  
2020
 
   
(in thousands)
 
Semiconductor Test:
             
Cost of revenues—inventory charge
  $21,456  $6,661  $11,013 
Contract termination settlement fee
   —     —     4,000 
System Test:
             
Cost of revenues—inventory charge
  $1,730  $641  $887 
Robotics:
             
Cost of revenues—inventory charge
  $3,668  $6,403  $834 
Restructuring and other—employee severance
   2,115   1,210   1,584 
Restructuring and other—acquisition related expenses and compensation
   —     1,000   985 
Wireless Test:
             
Cost of revenues—inventory charge
  $4,598  $1,770  $4,800 
Corporate and Eliminations:
             
Restructuring and other—legal settlement charge
  $14,700  $12,000  $—   
Restructuring and other—
environmental and legal liabilities
   2,700   1,971   —   
Restructuring and other—gain on sale of asset
   (3,410  —     —   
Other (income) expense, net—loss on convertible debt conversion
   —     28,828   —   
Restructuring and other—AutoGuide contingent consideration adjustment
   —     (7,227  (19,724
Restructuring and other—MiR contingent consideration adjustment
   —     —     (3,546
Restructuring and other—acquisition related expenses and compensation
   —     (513  1,728 
Selling and administrative—equity modification charge
   —     —     766 

Information as to Teradyne’s revenues by country is as follows:

 

 

2023

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Revenues from customers (1):

 

 

 

 

 

 

 

 

 

United States

 

$

433,661

 

 

$

469,948

 

 

$

392,626

 

Korea

 

 

394,690

 

 

 

544,816

 

 

 

502,167

 

Taiwan

 

 

384,842

 

 

 

626,424

 

 

 

1,117,874

 

China

 

 

314,899

 

 

 

491,798

 

 

 

631,963

 

Japan

 

 

281,742

 

 

 

162,920

 

 

 

166,231

 

Europe

 

 

273,784

 

 

 

268,384

 

 

 

259,954

 

Philippines

 

 

189,419

 

 

 

124,107

 

 

 

166,838

 

Singapore

 

 

116,969

 

 

 

99,503

 

 

 

121,582

 

Thailand

 

 

91,818

 

 

 

137,356

 

 

 

138,812

 

Malaysia

 

 

89,197

 

 

 

142,203

 

 

 

136,774

 

Rest of the World

 

 

105,277

 

 

 

87,586

 

 

 

68,060

 

 

 

$

2,676,298

 

 

$

3,155,045

 

 

$

3,702,881

 

(1)
Revenues attributable to a country are based on location of customer site.
   
2022
   
2021
   
2020
 
   
(in thousands)
 
Revenues from customers (1):
               
Taiwan
  $626,424   $1,117,874   $1,178,068 
Korea
   544,816    502,167    391,571 
China
   491,798    631,963    465,722 
United States
   469,948    392,626    321,674 
Europe
   268,384    259,954    205,587 
Japan
   162,920    166,231    143,983 
Malaysia
   142,203    136,774    56,096 
Thailand
   137,356    138,812    138,787 
Philippines
   124,107    166,838    68,887 
Singapore
   99,503    121,582    76,460 
Rest of the World
   87,586    68,060    74,634 
   
 
 
   
 
 
   
 
 
 
   $3,155,045   $3,702,881   $3,121,469 
   
 
 
   
 
 
   
 
 
 
(1)
Revenues attributable to a country are based on location of customer site.

In 2023, revenues from Texas Instruments Inc., a customer of our Semiconductor Test segment, accounted for 10% of our consolidated revenues. In 2021, and 2020, revenues from Taiwan Semiconductor Manufacturing Company Ltd., a customer of Teradyne’s Semiconductor Test segment, accounted for

12% and 15%12%,
respectively, of Teradyne’s consolidated revenues. Teradyne estimates consolidated revenues driven by Qualcomm, a customer of our Semiconductor Test, System Test, and Wireless Test segments, combining direct and indirect sales, accounted for approximately 11%11% of its consolidated revenues in 2022 and less than 10% in 2021 and 2020.2022. Teradyne estimates consolidated revenues driven by one OEM customer, of our Semiconductor Test and Wireless Test segments, combining
10
0

direct sales to that customer with sales to the customer’s OSATs (which include Taiwan Semiconductor Manufacturing Company Ltd.), accounted for less than 10%19% in 2021.

85


Contents

Long-lived assets by geographic area:

 

 

United
States

 

 

Foreign (1)

 

 

Total

 

 

 

(in thousands)

 

December 31, 2023 (2)

 

$

322,445

 

 

$

207,995

 

 

$

530,440

 

December 31, 2022

 

$

328,341

 

 

$

164,076

 

 

$

492,417

 

(1)
   
United

States
   
Foreign
   
Total
 
   
(in thousands)
 
December 31, 2022
  $328,341   $164,076   $492,417 
December 31, 2021
  $308,438   $147,609   $456,047 

U.
STOCK REPURCHASE PROGRAM 
In January 2021, Teradyne’s Board of Directors cancelled the January 2020 repurchase program and approved a repurchase program for up to $2.0 billion of common stock. In 2022, Teradyne repurchased 7.3 million shares of common stock for $752.1 million at an average price of $103.69 per share. In 2021, Teradyne repurchased 4.8 million shares of common stock for $600.0 million at an average price of $125.74 per share. The cumulative repurchases under this repurchase program asAs of December 31, 2023 and December 31, 2022, long-lived assets attributable to Denmark were 12.0$78.1 million sharesand $42.5 million, respectively.
(2)
Includes $11.5 million of common stocklong-lived assets classified as assets held for $1,352.1 million at an average price per share of $112.44.sale. See Note E: “Assets held for sale” for additional information.
U.
STOCK REPURCHASE PROGRAM

In January 2023, Teradyne’s Board of Directors cancelled the January 2021 repurchase program and approved a new repurchase program for up to $2.0$2.0 billion of common stock. In 2023, Teradyne intends to repurchase up to $500.0 

repurchased 3.9million shares of its common stock for a total cost of $400.5 million at an average price of $102.47 per share. In 2022, Teradyne repurchased 7.3 million shares of common stock for $752.1 million at an average price of $103.69 per share. The cumulative repurchases under the January 2021 repurchase program as of December 31, 2022 were 12.0 million shares of common stock for $1,352.1 million at an average price per share of $112.44.

The total cost of shares acquired includes commissions and, starting in 2023, based on market conditions.

The total price includes commissionsrelated excise tax, and is recorded as a reduction to retained earnings.

V.
SUBSEQUENT EVENTS
V.
SUBSEQUENT EVENTS

In January 2023,2024, Teradyne’s Board of Directors declared

a
9% increase in the quarterly cash dividend o
f
to $0.11
0.12 per share to be paid on March 17, 202315, 2024 to shareholders of record as of February 17, 2023. 16, 2024.

While Teradyne declared a quarterly cash dividend and authorized a share repurchase program, it may reduce or eliminate the cash dividend or share repurchase program in the future. Future cash dividends and stock repurchases are subject to the discretion of Teradyne’s Board of Directors which will consider, among other things, Teradyne’s earnings, capital requirements and financial condition.

Mark E. Jagiela retired as Chief Executive Officer of Teradyne and as a member of Teradyne’s Board of Directors effective February 1, 2023. In connection with his retirement, Teradyne entered into an agreement on January 31, 2023 with Mr. Jagiela (the “Retirement Agreement”). Under the Retirement Agreement, Mr. Jagiela’s unvested service based restricted stock units and stock options granted prior to his Retirement Date will continue to vest in accordance with their terms through February 1, 2026; and any vested options or options that vest during that period may be exercised for the remainder of the applicable option term. In the Retirement Agreement, Mr. Jagiela agreed to be bound by non-competition and non-solicitation restrictions through February 1, 2026. The Retirement Agreement also includes additional, standard terms and conditions relating to Mr. Jagiela’s separation from Teradyne. Teradyne will record a stock-based compensation expense of approximately $5.8 million in the first quarter of 2023 related to the Retirement Agreement.
101

86


SUPPLEMENTARY INFORMATION

(Unaudited)

Item 9:
Changes in and disagreements with accountants on accounting and financial disclosure

Item 9: Changes in and disagreements with accountants on accounting and financial disclosure

None.

Item 9A:
Controls and procedures

Item 9A: Controls and procedures

Disclosure Controls and Procedures

As of the end of the period covered by this report, our management, with the participation of our CEO and CFO, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15(b) promulgated under the Exchange Act. Based upon that evaluation, our CEO and CFO concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective in ensuring that material information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, including ensuring that such material information is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting during the fourth fiscal quarter ended December 31, 20222023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Management’s Annual Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). Under the supervision and with the participation of our management, including our CEO and CFO, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in

Internal Control—Integrated Framework
(2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our evaluation under the framework in
Internal Control—Integrated Framework (2013)
, our management concluded that our internal control over financial reporting was effective as of December 31, 2022.
2023.

The effectiveness of our internal control over financial reporting as of December 31, 20222023 has been audited by PricewaterhouseCoopers LLP, our independent registered public accounting firm, as stated in their report which is included under Item 8 of this Annual Report.

Inherent Limitations on Effectiveness of Controls

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Item 9B:
Other Information
None.
Item 9C:
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Item 9B: Other Information

Our officers (as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) (“Section 16 Officers”) and directors from time to time enter into contracts, instructions or written plans for the purchase or sale of our securities that are intended to satisfy the conditions specified in Rule 10b5-1(c) under the Exchange Act for an affirmative defense against liability for trading in securities on the basis of material nonpublic information. We refer to these contracts, instructions, and written plans as “Rule 10b5-1 trading plans” and each one as a “Rule 10b5-1 trading plan.” During our fiscal quarter ended December 31, 2023, no Section 16 Officer or director adopted, modified or terminated a Rule 10b5-1 trading plan.

Item 9C: Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Not applicable.

102

87


PART III

Item 10:
Directors, Executive Officers and Corporate Governance
Certain

Item 10: Directors, Executive Officers and Corporate Governance

The information relating to our directors and executive officers, committee information, reports and charters, executive compensation, security ownership of certain beneficial owners and management and related stockholder matters, and certain relationships and related transactions is incorporatedrequired by reference herein fromthis Item 10 will be included in our definitive proxy statementProxy Statement in connection with our 2024 Annual Meeting of Shareholders to be held on May 12, 2023.9, 2024. The proxy statementProxy Statement will be filed with the SEC not later than 120 days after the close of the fiscal year.year covered by this Annual Report and is incorporated herein by reference.

We have adopted a written code of business conduct that applies to all of our employees, officers and directors, including our principal executive officer, principal financial officer and principal accounting officer. Our Code of Conduct is available on our investor relations website at investors.teradyne.com under the section entitled "Governance Policies" in the "Governance" menu. If we make any substantive amendments to our Code of Conduct or grant any of our directors or executive officers any waiver, including any implicit waiver, from a provision of our Code of Conduct, we will disclose the nature of the amendment or waiver on our website or in a Current Report on Form 8-K.

Item 11: Executive Compensation

The information required by this Item 11 will be included in our definitive Proxy Statement in connection with our 2024 Annual Meeting of Shareholders to be held on May 9, 2024. The Proxy Statement will be filed with the SEC not later than 120 days after the close of the fiscal year covered by this Annual Report and is incorporated herein by reference. For this purpose, the Compensation Committee Report included in such proxy statement is specifically not incorporated herein. Also see “Item 1: Business—Our Executive Officers.”

Item 11:
Executive Compensation

Item 12: Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The information relating to our directors and executive officers, executive compensation, security ownership of certain beneficial owners and management and related stockholder matters, and certain relationships and related transactions is incorporatedrequired by reference herein fromthis Item 12 will be included in our definitive proxy statementProxy Statement in connection with our 2024 Annual Meeting of Shareholders to be held on May 12, 2023.9, 2024. The proxy statementProxy Statement will be filed with the SEC not later than 120 days after the close of the fiscal year. Foryear covered by this purpose, the Compensation CommitteeAnnual Report included in such proxy statement is specifically not incorporated herein.

Item 12:
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Certain information relating to our directors and executive officers, executive compensation, security ownership of certain beneficial owners and management and related stockholder matters, and certain relationships and related transactions is incorporated herein by reference herein from our definitive proxy statement in connection with our Annual Meeting of Shareholders to be held May 12, 2023. The proxy statement will be filed with the SEC not later than 120 days after the close of the fiscal year. For this purpose, the Compensation Committee Report included in such proxy statement is specifically not incorporated herein.reference. Also see “Item 7: Management’s Discussion and Analysis of Financial Condition and Results of Operations—Equity Compensation Plans.”
Item 13:
Certain Relationships and Related Transactions, and Director Independence

Item 13: Certain Relationships and Related Transactions, and Director Independence

The information relating to our directors and executive officers, executive compensation, security ownership of certain beneficial owners and management and related stockholder matters, and certain relationships and related transactions is incorporatedrequired by reference herein fromthis Item 13 will be included in our definitive proxy statementProxy Statement in connection with our 2024 Annual Meeting of Shareholders to be held on May 12, 2023.9, 2024. The proxy statementProxy Statement will be filed with the SEC not later than 120 days after the close of the fiscal year. Foryear covered by this purpose, the Compensation CommitteeAnnual Report and is incorporated herein by reference.

Item 14: Principal Accountant Fees and Services

The information required by this Item 14 will be included in such proxy statement is specifically not incorporated herein.

Item 14:
Principal Accountant Fees and Services
Certain information relating to audit fees and other of Teradyne’s independent registered public accounting firm is incorporated by reference herein from our definitive proxy statementProxy Statement in connection with our 2024 Annual Meeting of Shareholders to be held on May 12, 2023.9, 2024. The proxy statementProxy Statement will be filed with the SEC not later than 120 days after the close of the fiscal year. Foryear covered by this purpose, the Audit CommitteeAnnual Report included in such proxy statementand is specifically not incorporated herein.
herein by reference.

103

88


PART IV

Item 15:
Exhibits and Financial Statement Schedule
.

Item 15: Exhibits and Financial Statement Schedule.

15(a)(1) Financial Statements

The following consolidated financial statements are included in Item 8:

Page

Page

Report of Independent Registered Public Accounting Firm (PricewaterhouseCoopers LLP, PCAOB ID
No 238)

238)

45

38

48

40

49

41

50

42

51

43

52

44

15(a)(2) Financial Statement Schedule

The following consolidated financial statement schedule is included in Item 15(c):

Schedule II—Valuation and Qualifying Accounts

Schedules other than those listed above have been omitted since they are either not required or information is otherwise included.

15(a)(3) Listing of Exhibits

The Exhibits which are filed with this report or which are incorporated by reference herein are set forth in the Exhibit Index.

89


15(c) Financial Statement Schedules

104

TERADYNE, INC.

SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS

Column A

 

Column B

 

 

Column C

 

 

Column D

 

 

Column E

 

 

Column F

 

Description

 

Balance at
Beginning
of Period

 

 

Additions
Charged to
Cost and
Expenses

 

 

Other

 

 

Deductions

 

 

Balance at
End of Period

 

 

 

(in thousands)

 

Valuation reserve deducted in the balance sheet
   from the asset to which it applies:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2023 Allowance for credit losses

 

$

1,955

 

 

$

301

 

 

$

23

 

 

$

291

 

 

$

1,988

 

2022 Allowance for credit losses

 

$

2,012

 

 

$

500

 

 

$

(6

)

 

$

551

 

 

$

1,955

 

2021 Allowance for credit losses

 

$

2,034

 

 

$

500

 

 

$

(27

)

 

$

495

 

 

$

2,012

 

Column A

 

Column B

 

 

Column C

 

 

Column D

 

 

Column E

 

 

Column F

 

Description

 

Balance at
Beginning
of Period

 

 

Additions
Charged to
Cost and
Expenses

 

 

Other

 

 

Deductions

 

 

Balance at
End of Period

 

 

 

(in thousands)

 

Valuation reserve deducted in the balance sheet
   from the asset to which it applies:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred taxes:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2023 Valuation allowance

 

$

103,807

 

 

$

5,759

 

 

$

59

 

 

$

374

 

 

$

109,251

 

2022 Valuation allowance

 

$

97,170

 

 

$

7,652

 

 

$

21

 

 

$

1,036

 

 

$

103,807

 

2021 Valuation allowance

 

$

84,962

 

 

$

13,502

 

 

$

 

 

$

1,294

 

 

$

97,170

 

Column A
  
Column B
   
Column C
   
Column D
  
Column E
   
Column F
 
Description
  
Balance at

Beginning of Period
   
Additions

Charged to

Cost and Expenses
   
Other
  
Deductions
   
Balance at

End of Period
 
   
(in thousands)
 
Valuation reserve deducted in the balance sheet from the asset to which it applies:
         
Accounts receivable:
         
2022 Allowance for doubtful account
  $2,012   $500   $(6 $551   $1,955 
  
 
 
   
 
 
   
 
 
  
 
 
   
 
 
 
2021 Allowance for doubtful account
  $2,034   $500   $(27 $495   $2,012 
  
 
 
   
 
 
   
 
 
  
 
 
   
 
 
 
2020 Allowance for doubtful account
  $1,736   $356   $32  $90   $2,034 
  
 
 
   
 
 
   
 
 
  
 
 
   
 
 
 
Column A
  
Column B
   
Column C
   
Column D
  
Column E
   
Column F
 
Description
  
Balance at

Beginning of Period
   
Additions

Charged to

Cost and Expenses
   
Other
  
Deductions
   
Balance at

End of Period
 
   
(in thousands)
 
Valuation reserve deducted in the balance sheet from the asset to which it applies:
         
Inventory:
         
2022 Inventory reserve
  $114,055   $31,452   $1,926  $10,595   $136,838 
  
 
 
   
 
 
   
 
 
  
 
 
   
 
 
 
2021 Inventory reserve
  $110,587   $15,475   $1,335  $13,342   $114,055 
  
 
 
   
 
 
   
 
 
  
 
 
   
 
 
 
2020 Inventory reserve
  $103,556   $17,534   $(521 $9,982   $110,587 
  
 
 
   
 
 
   
 
 
  
 
 
   
 
 
 
Column A
  
Column B
   
Column C
   
Column D
   
Column E
   
Column F
 
Description
  
Balance at

Beginning of Period
   
Additions

Charged to

Cost and Expenses
   
Other
   
Deductions
   
Balance at

End of Period
 
   
(in thousands)
 
Valuation reserve deducted in the balance sheet from the asset to which it applies:
          
Deferred taxes:
          
2022 Valuation allowance
  $97,170   $7,652   $21   $1,036   $103,807 
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
2021 Valuation allowance
  $84,962   $13,502   $—     $1,294   $97,170 
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
2020 Valuation allowance
  $77,177   $7,785   $—     $   $84,962 
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Item 16:
Form 10-K Summary

Item 16: Form 10-K Summary

Not applicable.

90


105
Table of Contents


EXHIBIT INDEX

The following designated exhibits are, as indicated below, either filed herewith or have heretofore been filed with the Securities and Exchange Commission and are referred to and incorporated by reference to such filings.

Exhibit

No.

Description

Description

SEC Document Reference

  3.1

Restated Articles of Organization.

Exhibit 3.1 to Teradyne’s Current Report on Form 8-K filed on May 13, 2021.

  3.2

Amended and Restated By-laws, as amended.

Exhibit 3.1 to Teradyne’s Current Report on Form 8-K filed on September 6, 2022.January 29, 2024.

  4.1

Indenture dated as of December 12, 2016, between Teradyne, Inc. and Wilmington Trust, National Association, as trustee.

Exhibit 4.1 to Teradyne’s Current Report on Form 8-K filed on December 12, 2016.

  4.2

First Supplemental Indenture dated as of November 4, 2021 between Teradyne, Inc. and Wilmington Trust, National Association, as trustee.

Exhibit 4.1 to Teradyne’s Quarterly Report on Form 10-Q for the quarter ended October 3, 2021.

  4.3

Description of Teradyne, Inc. Securities Registered under Section 12 of the Exchange Act.

Filed herewith.

10.1†

Standard Manufacturing Agreement entered into as of November 24, 2003 by and between Teradyne and Solectron.

Exhibit 10.1 to Teradyne’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2007.

10.2†

Second Amendment to Standard Manufacturing Agreement, dated as of August 27, 2007, by and between Teradyne and Solectron.

Exhibit 10.3 to Teradyne’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2007.

10.3†

Sixth Amendment to Standard Manufacturing Agreement, dated as of July 27, 2009, by and between Teradyne and Flextronics Corporation.

Exhibit 10.5 to Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009.

10.4

Addendum to Standard Manufacturing Agreement (Authorized Purchase Agreement)—Revised July 1, 2010.

Exhibit 10.6 to Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2010.

10.5

Eighth Amendment to Standard Manufacturing Agreement, dated as of April 13, 2012, by and between Teradyne and Flextronics Sales & Marketing North Asia (L) LTD.

Exhibit 10.7 to Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012.

10.6†

Ninth Amendment to Standard Manufacturing Agreement, dated as of September 17, 2012, by and between Teradyne and Flextronics Sales & Marketing North Asia (L) LTD.

Exhibit 10.8 to Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012.

10.7

2006 Equity and Cash Compensation Incentive Plan, as amended. *

Exhibit 10.2 to Teradyne’s Current Report on Form 8-K filed on May 13, 2021.

10.8

Danish Sub-Plan to the 2006 Equity and Cash Compensation Incentive Plan.

Exhibit 10.10 to Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018.

106


Exhibit
No.

Description

SEC Document Reference

10.9

Form of Performance-Based Restricted Stock Unit Agreement for Executive Officers under 2006 Equity and Cash Compensation Incentive Plan.*

Exhibit 10.9 to Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

10.10

Form of Time-Based Restricted Stock Unit Agreement for Executive Officers under 2006 Equity and Cash Compensation Incentive Plan.*

Exhibit 10.10 to Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

10.11

Form of Executive Officer Stock Option Agreement under 2006 Equity and Cash Compensation Incentive Plan, as amended. *

Exhibit 10.11 to Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

10.12

Form of Restricted Stock Unit Agreement for Directors under 2006 Equity and Cash Compensation Incentive Plan.*

Exhibit 10.12 to Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2016.

91


10.13

1996 Employee Stock Purchase Plan, as amended.*

Filed herewith.Exhibit 10.13 to Teradyne's Annual Report on Form 10-K for the fiscal year ended December 31, 2022.

10.14

Danish Sub-Plan to the 1996 Employee Stock Purchase Plan.

Exhibit 10.15 to Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019

10.15

Deferral Plan for Non-Employee Directors, as amended.*

Exhibit 10.1 to Teradyne’s Quarterly Report on form 10-Q for the quarter ended October 3, 2021.

10.16

Supplemental Savings Plan, as amended and restated.*

Exhibit 10.18 to Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2008.

10.17

Supplemental Executive Retirement Plan, as restated.*

Exhibit 10.19 to Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2008.

10.18

Agreement Regarding Termination Benefits dated January 31, 2023 between Teradyne and Gregory S. Smith.*

Filed herewith.Exhibit 10.18 to Teradyne's Annual Report on Form 10-K for the fiscal year ended December 31, 2022.

10.19

Employment Agreement dated May 7, 2004 between Teradyne and Mark Jagiela.*

Exhibit 10.37 to Teradyne’s Quarterly Report on Form 10-Q for the quarter ended July 4, 2004.

10.20

Executive Officer Retirement Agreement dated July 17, 2019 between Teradyne and Gregory R. Beecher.*

Exhibit 10.1 to Teradyne’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2019.

10.21

Executive Officer Agreement dated January 31, 2023 between Teradyne and Mark Jagiela.*

Filed herewith.Exhibit 10.21 to Teradyne's Annual Report on Form 10-K for the fiscal year ended December 31, 2022.

10.22

Amended and Restated Executive Officer Change in Control Agreement dated May 26, 2009 between Teradyne and Charles J. Gray, as amended.*

Exhibit 10.30 to Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012.

10.23

Employment Agreement dated July 24, 2009 between Teradyne and Charles J. Gray.*

Exhibit 10.1 to Teradyne’s Quarterly Report on Form 10-Q for the quarter ended April 4, 2010.

107


Exhibit
No.

Description

SEC Document Reference

10.24

Executive Officer Agreement dated January 25, 2024 between Teradyne and Charles J. Gray.*

Exhibit 10.1 to Teradyne's Current Reprot on Form 8-K/A filed January 29, 2024

10.25

Amended and Restated Executive Officer Change in Control Agreement dated June 30, 2012 between Teradyne and Walter G. Vahey, as amended.*

Exhibit 10.32 to Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012.

10.25

10.26

Employment Agreement dated February 6, 2013 between Teradyne and Walter G. Vahey.*

Exhibit 10.33 to Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012.

10.26

10.27

Executive Officer Change in Control Agreement dated September 1, 2014 between Teradyne, Inc. and Bradford Robbins.*

Exhibit 10.1 to Teradyne’s Quarterly Report on Form 10-Q for the quarter ended September 28, 2014.

10.27

10.28

Employment Agreement dated September 1, 2014 between Teradyne, Inc. and Bradford Robbins.*

Exhibit 10.2 to Teradyne’s Quarterly Report on Form 10-Q for the quarter ended September 28, 2014.

10.28

10.29

Executive Change in Control Agreement dated February 8, 2016 between Teradyne, Inc. and Gregory S. Smith.*

Exhibit 10.1 to Teradyne’s Quarterly Report on Form 10-Q for the quarter ended April 3, 2016.

10.29

10.30

Employment Agreement dated February 8, 2016 between Teradyne, Inc. and Gregory S. Smith.*

Exhibit 10.2 to Teradyne’s Quarterly Report on Form 10-Q for the quarter ended April 3, 2016.

10.30

10.31

Teradyne Offer of Employment dated February 8, 2019 for Sanjay Mehta.*

Exhibit 10.1 to Teradyne’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019.

10.31

10.32

Executive Officer Change in Control Agreement dated April 25, 2019 between Teradyne, Inc. and Sanjay Mehta.*

Exhibit 10.2 to Teradyne’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019.

10.32

10.33

Employment Agreement dated April 25, 2019 between Teradyne, Inc. and Sanjay Mehta.*

Exhibit 10.3 to Teradyne’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019.

10.33

10.34

Agreement Regarding Termination Benefits dated April 25, 2019 between Teradyne, Inc. and Sanjay Mehta.*

Exhibit 10.4 to Teradyne’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019.

92


10.35

10.34

Executive Officer Change in Control Agreement dated October 1, 2020 between Teradyne, Inc. and Richard Burns.*

Exhibit 10.1 to Teradyne’s Quarterly Report on Form 10-Q for the quarter ended September 27, 2020.

10.35

10.36

Executive Officer Change in Control Agreement dated August 21, 2023 between Teradyne, Inc. and Ujjwal Kumar.*

Exhibit 10.1 to Teradyne's Quarterly Report on Form 10-Q for the quarter ended October 1, 2023.

10.37

Employment Agreement dated June 27, 2023 between Teradyne, Inc. and Ujjwal Kumar.*

Exhibit 10.2 to Teradyne's Quarterly Report on Form 10-Q for the quarter ended October 1, 2023

10.38

Executive Officer Change in Control Agreement dated February 2, 2024 between Teradyne, Inc. and Ryan Driscoll.*

Filed herewith.

10.39

Employment Agreement dated October 1, 2020 between Teradyne, Inc. and Richard Burns.*

Exhibit 10.2 to Teradyne’s Quarterly Report on Form 10-Q for the quarter ended September 27, 2020.

10.36

10.40

Time-Based Restricted Stock Unit Agreement dated May 1, 2019 for Sanjay Mehta under 2006 Equity and Cash Compensation Plan.*

Exhibit 10.5 to Teradyne’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019.

10.37

10.41

Form of Indemnification Agreement.*

Exhibit 10.24 to Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006.

10.38

10.42

LitePoint Corporation 2002 Stock Plan.

Exhibit 10.43 to Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2011.

108


Exhibit
No.

Description

SEC Document Reference

10.39

10.43

Letter Agreement, dated December 6, 2016, between Barclays Bank PLC and Teradyne, Inc., regarding the Base Warrants.

Exhibit 10.1 to Teradyne’s Current Report on Form 8-K filed December 12, 2016.

10.40

10.44

Letter Agreement, dated December 6, 2016, between Bank of America, N.A., and Teradyne, Inc. regarding the Base Warrants.

Exhibit 10.2 to Teradyne’s Current Report on Form 8-K filed December 12, 2016.

10.41

10.45

Letter Agreement, dated December 6, 2016, between Wells Fargo Bank, National Association and Teradyne, Inc. regarding the Base Warrants.

Exhibit 10.3 to Teradyne’s Current Report on Form 8-K filed December 12, 2016.

10.42

10.46

Letter Agreement, dated December 6, 2016, between Barclays Bank PLC and Teradyne, Inc. regarding the Base Call Option Transaction.

Exhibit 10.4 to Teradyne’s Current Report on Form 8-K filed December 12, 2016.

10.43

10.47

Letter Agreement, dated December 6, 2016, between Bank of America, N.A. and Teradyne, Inc. regarding the Base Call Option Transaction.

Exhibit 10.5 to Teradyne’s Current Report on Form 8-K filed December 12, 2016.

10.44

10.48

Letter Agreement, dated December 6, 2016, between Wells Fargo Bank, National Association and Teradyne, Inc. regarding the Base Call Option Transaction.

Exhibit 10.6 to Teradyne’s Current Report on Form 8-K filed December 12, 2016.

10.45

10.49

Letter Agreement, dated December 9, 2016, between Barclays Bank PLC and Teradyne, Inc., regarding the Additional Warrants

Exhibit 10.7 to Teradyne’s Current Report on Form 8-K filed December 12, 2016.

10.46

10.50

Letter Agreement, dated December 9, 2016, between Bank of America, N.A., and Teradyne, Inc. regarding the Additional Warrants.

Exhibit 10.8 to Teradyne’s Current Report on Form 8-K filed December 12, 2016.

10.47

10.51

Letter Agreement, dated December 9, 2016, between Wells Fargo Bank, National Association and Teradyne, Inc. regarding the Additional Warrants.

Exhibit 10.9 to Teradyne’s Current Report on Form 8-K filed December 12, 2016.

10.48

10.52

Letter Agreement, dated December 9, 2016, between Barclays Bank PLC and Teradyne, Inc. regarding the Additional Call Option Transaction.

Exhibit 10.10 to Teradyne’s Current Report on Form 8-K filed December 12, 2016.

10.49

10.53

Letter Agreement, dated December 9, 2016, between Bank of America, N.A. and Teradyne, Inc. regarding the Additional Call Option Transaction

Exhibit 10.11 to Teradyne’s Current Report on Form 8-K filed December 12, 2016.

93


10.50

10.54

Letter Agreement, dated December 9, 2016, between Wells Fargo Bank, National Association and Teradyne, Inc. regarding the Additional Call Option Transaction.

Exhibit 10.12 to Teradyne’s Current Report on Form 8-K filed December 12, 2016.

10.51

10.55

Credit Agreement dated May 1, 2020 among Teradyne, Inc., Truist Bank, as the administrative agent, issuing bank and swingline lender, and other lenders party thereto.

Exhibit 10.1 to Teradyne’s Current Report on Form 8-K filed May 5, 2020.

109


Exhibit
No.

Description

SEC Document Reference

10.52

10.56

First Amendment to Credit Agreement dated December 10, 2021 among Teradyne, Inc., Truist Bank, as the administrative agent, issuing bank and swingline lender, and other lenders party thereto.

Exhibit 10.52 to Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

10.53

10.57

Second Amendment to Credit Agreement dated October 5, 2022 among Teradyne, Inc., Truist Bank, as the administrative agent, issuing bank and swingline lender, and other lenders party thereto.

Exhibit 10.1 to Teradyne’s Quarterly Report on Form 10-Q for the quarter ended October 2, 2022.

21.1

Subsidiaries of Teradyne.

Filed herewith.

23.1

Consent of PricewaterhouseCoopers LLP.

Filed herewith.

31.1

Rule 13a-14(a) Certification of Principal Executive Officer.

Filed herewith.

31.2

Rule 13a-14(a) Certification of Principal Financial Officer.

Filed herewith.

32.1

Section 1350 Certification of Principal Executive Officer.

Furnished herewith.

32.2

Section 1350 Certification of Principal Financial Officer.

Furnished herewith.

101

97.1

Policy for Recoupment of Incentive Compensation.

Filed herewith.

101

The following financial information from Teradyne, Inc.’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022,2023, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) Consolidated Balance Sheets as of December 31, 20222023 and December 31, 2021,2022, (ii) Consolidated Statements of Operations for the years ended December 31, 2023, 2022 2021 and 2020,2021, (iii) Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2023, 2022 2021 and 20202021 (iv) Consolidated Statements of Shareholders’ Equity for the years ended December 31, 2023, 2022 2021 and 2020,2021, (v) Consolidated Statements of Cash Flows for the years ended December 31, 2023, 2022 2021 and 2020,2021, and (vi) the Notes to Consolidated Financial Statements.

104

The cover page of the Annual Report on Form 10-K formatted in Inline XBRL (included in Exhibit 101).

-Confidential treatment granted.

*

-Management contract or compensatory plan.

110† -Confidential treatment granted.

* -Management contract or compensatory plan.

94



SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized this 22nd day of February 2023.2024.

TERADYNE, INC.

TERADYNE, INC.

By:

/S/ SANJAY MEHTA

By:

/S/ SANJAY MEHTA

Sanjay Mehta,

Vice President, Chief Financial Officer and

Treasurer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature

Title

Date

Signature

Title

Date

/S/ PAULPAUL J. TUFANOTUFANO

Paul J. Tufano

Chair of the Board

February 22, 2023

2024

/S/ GREGORY SMITH

Gregory Smith

Chief Executive Officer (Principal Executive Officer) and Director

February 22, 2023

2024

/S/ SANJAY MEHTASANJAY MEHTA

Sanjay Mehta

Vice President, Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer)

February 22, 2023

2024

/S/ EDWIN J. GILLIS

Edwin J. Gillis

DirectorFebruary 22, 2023

/S/ TIMOTHYTIMOTHY E. GUERTINGUERTIN

Timothy E. Guertin

Director

Director

February 22, 2023

2024

/S/ PETER HERWECK

Peter Herweck

DirectorFebruary 22, 2023

/S/ MERCEDES JOHNSONPETER HERWECK

Mercedes Johnson

Peter Herweck

Director

Director

February 22, 2023

2024

/S/ MERCEDES JOHNSON

Mercedes Johnson

Director

February 22, 2024

/S/ ERNEST E. MADDOCK

Ernest E. Maddock

Director

Director

February 22, 2023

2024

/S/ MARILYN MATZ

Marilyn Matz

DirectorFebruary 22, 2023

/S/ Fouad TamerMARILYN MATZ

Fouad Tamer

Marilyn Matz

Director

Director

February 22, 20232024

/S/ FOUAD TAMER

Fouad Tamer

Director

February 22, 2024

/S/ BRIDGET VAN KRALINGEN

Bridget van Kralingen

Director

February 22, 2024

111

95